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1. Introduction 
 
Since the first proposal of “spiro-concept” for organic material science by Salbeck et 
al. in the 1990s,1 the following systematic studies have shown that compounds possessing 
spiro functionality are key substances for application in organic functional devices, such as 
organic semi-conductors, in monolayers, in light-emitting diodes (OLEDs) and in dye-
sensitized solar cells.2 The spiro concept is based on the connection of two or more more 
aromatic π-systems via an sp3-hybridized atom (a typical example is 9,9’-spirobifluorene, 
Figure 1). 
 
 
Figure 1. 9,9’-Spirobifluorene SBF  
 
The spiro compounds have improved morphological and thermal stability in 
comparison with the individual parent π-systems. The perpendicular arrangement efficiently 
suppresses unwanted excimer (excited dimer) formation reactions, extended π-systems 
increase the solubility in organic non-polar solvents and stability of the molecule in excited 
state, leading to high-emission color stability.1b,2a In particular, the latter property is one of the 
key characteristics for continuous light-emitting devices. In the last decade, many studies on 
photophysical stability, electronic properties and applications of electroluminescent layers 
based on spiro compounds have been reported.2b,3 Furthermore, several reports predict that 
such organic light-emitting diodes (OLEDs), phosphorescent organic light-emitting diodes 
(PhOLEDs),3a white organic light-emitting diodes (WOLEDs)4 and other devices will become 
the future of illumination systems.5 
Substituted 9,9’-spirobifluorenes and dispiroindenofluorenes constitute a class of 
polycyclic aromatic hydrocarbon spiro compounds (Figure 2) that significantly contribute to 
the aforementioned areas because of their unique physical and chemical properties.1-6 The 
thesis will deal with development of new synthetic pathways for preparation of various 
1,2,3,4-tetrasubstituted spirobifluorenes (SBFs), dispiroindeno[2,1-c]fluorenes (DS-IFs) and 
their derivatives as well as with possibilities for tuning of their photophysical properties. 
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Figure 2. 1,2,3,4-Tetrasubstituted SBF and DS-IF compounds in comparison 
  
8 
 
2.  Literature Review 
2.1.  Synthesis of fluorene compounds 
 
Polycyclic aromatic hydrocarbons (PAHs) are one of the most extensively studied 
organic substances for their unique properties and broad applications in many areas of 
chemistry, e.g. materials science. For the synthesis of fluorenes, mainly two disconnection 
approaches A and B have been used, leading to suitably substituted diphenyl methane 
compounds (Scheme 1, Disconnection A) or biphenyls as starting materials (Disconnection 
B). Ring-closing reactions can be performed under either transition metal-, Lewis acid-, or 
base-mediated or -catalyzed conditions. 
 
 
Scheme 1. General disconnection approaches A and B of fluorenes  
 
2.1.1.  Acid- and base-catalyzed synthesis 
 
One of the most used synthetic strategies, based on intramolecular Friedel-Crafts 
reaction starting from biphenyl or benzophenone precursors, was developed in the 1970s.7 At 
present, a number of synthetic strategies utilizing substituted (1,1’-biphenyl)-2-carboxylic 
acids I and their derivatives (e.g. amides) are available (Scheme 2). As typical examples may 
serve reactions carried out in the presence of thionyl chloride (SOCl2),8a,b polyphosphoric acid 
(PPA),8c methanesulfonic acid (MsOH)8d and trifluoroacetic anhydride ((CF3CO)2O)8e 
producing substituted fluorenones II. In addition, mixtures of bis(pyridine)iodonium(I) 
tetrafluoro-borate/HBF4 (IPy2BF4/HBF4)8f or tetraethylammonium bromide/potassium 
persulfate (TEAB/K2S2O8)8g were also successfully used to perform ring closing Friedel-
Crafts reaction of (1,1’-biphenyl)-2-carbaldehydes to fluorenones II. 
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Scheme 2. Friedel-Crafts reactions of I to fluorenes II 
 
Recently, AlCl3-catalyzed reaction of differently substituted (1,1’-biphenyl)-2-
carbaldehydes III in the presence of sulfonamide has been reported. It demonstrated that 9-
aminofluorenes IV can be easily accessed in up to 88% (Scheme 3).9 
 
 
Scheme 3. AlCl3-catalyzed condensation cyclization cascade from III to fluorenones II 
 
In 2006, Rueping et al. introduced Friedel-Crafts benzylation of substituted 2-
phenylbenzyl alcohols V with Bi(OTf)3 as Lewis acid to promote cyclization to fluorenes VI 
in up to 95% yield (Scheme 4).10 
 
 
Scheme 4. Bi(OTf)3-promoted intramolecular benzylation reaction of V to fluorenes VI 
 
In addition to Lewis acids, base-mediated reactions have also been used to synthesize 
compounds with the fluorene scaffold. This method is based on the use of a sterically 
hindered base (LDA) in a combination with a tertiary amide VII, which undergoes cyclization 
to provide benzofluorenone VIII. However, this method suffers from a setback such as a 
limited functional group tolerance (Scheme 5).11 
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Scheme 5. LDA-mediated synthesis of benzofluorenes VIII 
 
Another base-promoted synthetic approach was developed by Studer et al. They 
explored radical cross-dehydrogenative coupling via base-mediated homolytic aromatic 
substitution. They prepared fluorenones II in up to 84% from (1,1’-biphenyl)-2-carbaldehydes 
III using t-BuOOH as oxidant. FeCp2 was the most effective radical chain initiator (Scheme 
6).12 
 
 
Scheme 6. Base-promoted radical cross-dehydrogenative coupling in (1,1’-biphenyl)-2- 
carbaldehydes III to fluorenones II 
 
The syntheses of symmetrically octa- and nonamethylated fluorenes were studied as 
well, particularly by O’Hare13a and Tilley13b. Both synthetic procedures were based on the use 
of 1,2,3,4-tetramethylbenzene IX as the starting material. In the first case, O’Hare used highly 
alkaline conditions for cyclization of the monobrominated benzophenone X to fluorenone XII 
in 53% isolated yield. In the second approach, Tilley used electrophilic aromatic substitution 
and cyclization of XI with paraformaldehyde, producing the target fluorene XIII in 80% yield 
(Scheme 7). 
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Scheme 7. Synthesis of octamethylfluorenone XII and octamethylfluorene XIII 
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2.1.2.  Transition metal-catalyzed synthetic approaches 
 
In addition to acid- and base-catalyzed synthetic approaches, many examples of 
transition metal-catalyzed reactions have emerged during the past several decades; however, 
many of them suffer from similar drawbacks and limitations as the aforementioned 
strategies.14 As a typical starting material used in syntheses of functionalized fluorenes serve 
substituted benzophenones, diarylmethanes, or biaryl compounds. In addition to these 
precursors, also new methods based on utilization of various alkenes, alkynes and their 
derivatives for annulation have appeared. 
 
 
2.1.2.1. Benzophenones/diarylmethanes as precursors 
 
In the early 1980s, Ames and Opalko described the first pioneering studies on 
intramolecular dehydrogenative coupling of halogenated diaryl derivatives using catalytic 
Pd(II)-acetate under basic conditions, albeit with many side products.15 As a representative of 
Rh-complex catalyzed formation of fluorenones, Blum et al. developed conversion of benzoic 
anhydride into fluorenones catalyzed by RhCl(PPh3)3 in the late 1960s.16 More recently, 
numerous procedures based on intramolecular cyclization of substituted benzophenones XIV 
into target fluorenones II catalyzed by Pd-, Ag- or Cu-compounds have been reported 
(Scheme 8).  
 
 
Scheme 8. Synthetic pathways to fluorenones II from substituted benzophenones XIV 
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Shi17a and Cheng17b independently and concurrently developed Pd-catalyzed oxidative 
dehydrogenative dual C-H-functionalization of benzophenones in 2012 (Scheme 8, approach 
A1 and A2). Recently, a heterogeneous catalytic dual C-H activation system (Pd on MgLa) 
have been also developed (Approach A3).17c Direct intramolecular arylation of substituted 
halogenated benzophenones was carried out under Pd-17d or Cu-catalysis17e (Approach B1 and 
B2). In addition to these approaches, radical decarboxylative C-H arylation under Ag-catalysis 
was reported as well (Approach C).17f 
Several other diarylmethane derivatives were applied in syntheses of fluorene 
compounds. Miura et al. presented Rh- and Ir-catalyzed dehydrogenative cyclization via 
double C-H bond cleavage of XV to form fluorene XVI in the presence of Cu salts (Scheme 
9).18 
 
 
Scheme 9. Rh- and Ir-catalyzed synthesis of fluorene XVI from diarylmethanes XV 
 
Another example of syntheses of compounds with the fluorene scaffold from diaryl 
ether, benzophenone, or diarylmethane derivatives consists of a Ag-catalyzed Pschorr-type 
radical cyclization. It furnished the target benzofurane, fluorenone, and fluorene compounds 
in up to 77% isolated yields (Scheme 10).19 
 
 
Scheme 10. Ag-catalyzed synthesis fluorenes XVIII from diarylethers, benzophenones, or 
diarylmethanes 
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In addition to these approaches, a two-step Pd-complex catalyzed procedure starting 
from substituted bromobenzaldehydes and arylboronic acids was developed. In a one-pot 
reaction various arylboronic acids XIX were added to the carbonyl group of 2-
bromobenzaldehydes XX initially forming intermediate benzylic alcohols and, upon heating, 
the intermediate underwent cyclization via a C-H activation and oxidation sequence, 
producing the target fluorenone compounds II in up to 90% (Scheme 11).20 
 
 
Scheme 11. One-step synthesis of 2-bromobenzaldehydes XIX with arylboronic acids XX 
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2.1.2.2. Syntheses starting from 1,1’-biphenyls and tandem reactions 
2.1.2.2.1. 1,1’-Biphenyls as precursors 
 
The second approach, using transition metal-catalyzed reactions to provide fluorene 
and fluorenone compounds, is based on the use of appropriately substituted biphenyls. One of 
the first reports on the synthesis of fluorenes based on the use of transition metal compounds, 
albeit a stoichiometric one, appeared in the late 1980s. It was based on reactions of 2,2´-
dilithiobiphenyls XXI with PPh3(CO4)ReBr that served as the CO source. The corresponding 
substituted fluorenones II were obtained in up to 68% isolated yields (Scheme 12, A).21a In 
2000, Larock reported a Pd-complex catalyzed cyclocarbonylation of 2-halo-1,1’-biphenyls 
XXII with CO (1 atm) to synthesize fluorenones II in up to quantitative yields (Scheme 12, 
B).21b,c 
 
 
Scheme 12 Synthetic procedure for fluorenones II from (A) dilithiobiphenyl XXI or (B) 2-
halo-1,1’-biphenyls XXII  
 
Currently, many approaches to fluorenes are based on Pd-complex catalyzed C-H 
bond activation and functionalization. As typical examples may serve transformations of 2-
(halomethyl)-1,1’-biphenyls XXIII or 2-alkynyl-1,1’-biphenyls XXV to fluorenes XXIV 
(Scheme 13, A)22a and XXVI (Scheme 13, B).22b The reactions proceed via an intramolecular 
dehydrogenative cyclization with good-to-excellent yields in all reactions. In addition, a Pd-
catalyzed decarboxylative cyclization of (1,1’-biphenyl)-2-carboxylic acids XXVII using      
t-butyl isocyanide as the carbonyl source was also explored and it gave rise to substituted 
fluorenones II (Scheme 13, C).22c 
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Scheme 13. Pd-catalyzed synthesis of fluorenones II 
 
Although Pd-complex catalyzed methods have been the most commonly used for the 
synthesis of fluorene derivatives, also Rh-complex catalyzed procedures have been developed 
as well. These methods have found its application either in intramolecular insertion of 
carbenes in biaryldiazoacetates XXVIII to form fluorenyl carboxylates XXIX (Scheme 14, A, 
the patent did not show any specific catalytic system)23a or in intramolecular acylation of 
biarylcarboxylic acids XXVII to form fluorenones II (Scheme 14, B).23b 
 
 
Scheme 14. Rh-catalyzed synthesis of fluorene-9-carboxylates XXIX and fluorenones II 
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In 2014, the groups of Echavarren and Ye independently published two different Au-
catalyzed synthetic procedures to form fluorenes. Echavarren showed that a Au-complex 
catalyzed retro-Buchner reaction of 2-(2,4,6-cycloheptatrien-1-yl)-1,1’-biphenyls XXX 
provided fluorenes XXIV (Scheme 15, A).24a Ye et al. exploited a Au-complex intermolecular 
oxidative cyclization 2-alkynyl-1,1’-biphenyls XXXI in the presence of N-oxides to fluorene-
9-carboxylic acid amides XXXII (Scheme 15, B).24b 
 
 
Scheme 15. Au-catalyzed formation of XXIV and fluorenylcaboxylic acid amides XXXII 
The last examples of transition metal-catalyzed or -promoted strategies for the 
synthesis of fluorenes from the parent biaryl precursors are Mo- and Nb-catalyzed reactions.  
Double activation of C-F and C-H bonds in substituted 2-trifluoromethylbiphenyls 
XXXIII with low valent Nb-compounds (prepared by reduction with LiAlH4) was used for 
the synthesis of fluorenes XXIV in up to 92% yield (Scheme 16, A).25a In the area of Mo-
catalyzed reactions, nanostructured MoO3 was used to initiate intramolecular benzylation 
(Friedel-Crafts reaction) of [(1,1’-biphenyl)-2-yl]methanol XXXIV forming fluorene XXIV 
in 88% yield (Scheme 16, B).25b 
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Scheme 16. Nb- and Mo-catalyzed formation of fluorenes XXIV 
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2.1.2.2.2. Tandem syntheses via biaryl intermediates 
 
Development of tandem procedures for preparation of fluorenes via biphenyl 
intermediates is highly desirable, because they shorten the reaction sequence and avoid the 
need for the synthesis of the intermediate. The tandem procedures comprise two synthetic 
steps based on two reaction. In most cases the first step is a cross-coupling reaction that 
provides the intermediate biphenyls. These then, without isolation, undergo the second step: a 
ring-closing reaction.  
In 2006, Hu et al. published a series of Pd-complex catalyzed reactions of variously 
substituted 1,2-dihaloarenes or tosylated haloarenes XXXV with sterically hindered Grignard 
reagents XXXVI forming the biphenyl intermediates. The subsequent cyclization proceeded 
via the C-H bond activation of the methyl group followed by cross coupling producing the 
desired fluorenes XXIV (Scheme 17).26 
 
 
Scheme 17. Tandem Pd-catalyzed synthesis of fluorenes XXIV 
 
In addition to Grignard reagents, various arylboronic acids were used in Suzuki cross-
coupling with substituted haloarenes. Tandem Pd-catalyzed Suzuki cross-coupling of 
substituted 2-methylphenylboronic acids XX with 1,2-dihaloarenes XXXVII followed by 
cyclization through the C-H bond activation was used for synthesis of fluorenes XXIV 
(Scheme 18, A).27a A similar approach was also used in the reaction of 1,2-dihaloarenes 
XXXVII and arylboronic acids XX under CO atmosphere in Pd-catalyzed synthesis to 
provide fluorenones II (Scheme 18, B).27b Alternatively, Suzuki cross-coupling of 2-
bromobenzaldehydes XIX and 2-bromophenylboronic acids XX giving rise to intermediate 
2’-bromo-(1,1’-biphenyl)-2-carbaldehydes was also used as the first step. It was then followed 
by intramolecular addition of arylpalladium species to the carbonyl group forming 
fluorenones II (Scheme 18, C).27c 
20 
 
 
Scheme 18. Tandem Pd-catalyzed procedures for synthesis of various fluorenes XXIV and 
fluorenones II 
 
In addition to this approach, 2-halobenzaldehydes have been often used for the Pd-
catalyzed cross-coupling step with other substrates, e.g. silanes and boronates. In 2005, 
Larock et al. reported a Pd-catalyzed tandem annulation of 2-halobenzaldehydes XIX and 2-
trimethylsilylaryl triflates XXXVIII to furnish fluorenones II in up to 75% yields. In this 
approach, the intermediate aryne was formed in situ and it was subsequently added to 
arylpalladium species, forming a new arylpalladium species. This intermediate was then 
intramolecularly added to the carbonyl group giving rise to fluorenones II (Scheme 19, 
A).28a,b Another tandem cyclization based on Pd-catalyzed cross-coupling of 2-
bromobenzaldehyde XIX and potassium 3-hydroxyphenyl trifluoroborate XXXIX followed 
by cyclization to fluorenones II was reported (Scheme 19, B).28c 
21 
 
 
Scheme 19. Pd-catalyzed method for synthesis of fluorenones II  
 
In 2016, You et al. successfully conducted, for the first time, chelation-assisted C-H 
activation of aromatic carboxylic acids. They used Pd-catalyzed ortho-selective oxidative C-H 
cross-coupling of benzoic acids XL with arenes XLI, followed by intramolecular Friedel-
Crafts acylation to furnish target fluorenones II (Scheme 20).29 
 
 
Scheme 20. Pd-catalyzed C-H cross-coupling of carboxylic acids XL followed by Friedel-
Crafts reaction to fluorenes II 
 
Finally, other examples of tandem Pd-catalyzed cross-coupling and cyclization 
procedures involved the use of oximes, nitriles or benzyl amines. Cheng30a,b and Shi30c 
reported a Pd-catalyzed functionalization of ortho-methyl oximes XLII with arylboronic 
acids XX to biphenyl aldoximes, followed by cyclization (Scheme 21, A). The subsequent 
acidic hydrolysis yielded fluorenones II. This approach was similar to the previous 
mechanistic studies by Larock et al.30d The second approach used Pd-catalyzed remote nitrile-
22 
 
directed dual C-H activation of substituted benzonitriles XLIII and subsequent reaction with 
aryl iodides XXIV (Scheme 21, B).30e,f Interestingly, even reactions of simple benzylamines 
XXXV with aryl iodides XXXIV were suitable for tandem Pd-catalyzed synthesis of 
fluorenones II (Scheme 21, C).30g 
 
 
Scheme 21. Syntheses of fluorenones II by using Pd-catalyzed tandem reaction  
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2.1.2.3. Alkene and alkyne derivatives as precursors 
 
Following two previously described transition metal-catalyzed approaches that were 
based on the use of benzophenone/diarylmethane derivatives (Section 2.1.2.1) or various 
substituted biphenyl precursors (Section 2.1.2.2), other synthetic approaches using various 
substituted alkenes and alkynes as starting materials have also emerged in the last decades. 
The first synthetic strategy is based on the annulation of enynes and alkynes. In the 
first method fluorenes XLVIII were synthesized under Au-catalysis from 1,3-enynes XLVI 
and propargyl esters XLVII. The reaction was initiated by intermolecular cyclopropanation of 
enynes via gold carbenoids, which were formed by rearrangement of propargyl esters. The 
rearrangement started with coordination of the cationic gold catalyst followed by 5-endo-dig 
cyclization that lead to formation of tertiary carbocation. Then, after several other skeletal 
rearrangements, cyclopropyl ring opening and nucleophilic substitution followed forming the 
target fluorene XLVIII (Scheme 22, A).31a The second approach, using appropriately 
substituted enynes and alkynes as starting material, was reported by Liang et al. They 
successfully applied BiCl3-catalyzed reaction of (Z)-pent-2-en-yl acetates XLIX with 
ethynylarenes L via tandem isomerization/Friedel-Crafts intermolecular electrophilic 
reaction/cycloisomerization/aromatization sequence to form substituted fluorenes LI (Scheme 
22, B).31b,c 
 
 
Scheme 22. Au- and Bi-catalyzed enyne and alkyne-based annulation reactions to fluorenes 
XLVIII and LI 
24 
 
In 2013, two new similar approaches were reported for the synthesis of fluorenes using 
reactions of dienes with alkynes. They involved either inter- or intramolecular reaction 
pathways. The intermolecular approach to fluorenones II was based on the following reaction 
sequence: Co-catalyzed Diels-Alder reaction of aryl-substituted propiolates LII and 
appropriately substituted dienes LIII, followed by DDQ oxidation providing in situ a 
biphenyl intermediate, followed by acidic Friedel-Crafts cyclization to form target fluorenone 
II (Scheme 23, A).32a The intramolecular pathway utilized TiCl4-mediated cyclization of 
substituted hept-4,6-diene-1-yn-3-ols LIV. The propargylic alcohol was converted in the 
presence of TiCl4 into the diene-allenylic cation intermediate through Meyer-Schuster 
rearrangement, which underwent electrocyclization and isomerization, thereby forming the 
target fluorenes LV (Scheme 23, B).32b 
 
 
Scheme 23. Conversion of alkynes and dienes to fluorenes II and LV 
 
Lastly, a class of not fully conjugated fluorenes, i.e. compounds with incomplete 
aromatic systems, can also be assembled using unsaturated molecular systems. Radical 
cyclization of 1,6-enynes LVI to unsaturated compounds with the fluorene scaffold LVII was 
conducted using either AgSCF333a or Ag(OAc) in the presence of diphenylphosphine oxide 
(Scheme 24).33b It underwent a regioselective radical intramolecular addition to the alkyne 
moiety through the same mechanistic pathway. The addition yielded an alkenyl radical 
intermediate, which subsequently formed the secondary radical by 6-exo-trig ring closing. 
Intramolecular addition of this intermediate to the aromatic ring formed the target compounds 
LVII.  
25 
 
 
Scheme 24. Ag-promoted radical formation of non-fully aromatic fluorenes XLVII  
 
In addition to the Ag-mediated radical approach, also Au-catalysis and, very recently, 
Cu-mediated cyclization of 1,6-diynes were also reported. Au-catalysis of substituted, non-
activated diynes LVIII promoted intramolecular [3+2] cycloaddition via a Au-(I)-containing 
π-alkyne moiety to form a vinylgold intermediate. Subsequently, this intermediate underwent 
either 5-exo-dig or Nazarov cyclization, thus forming the fluorenes LIX (Scheme 25, A).34a In 
the second approach, treatment of substituted 1,6-diynes LVIII with Cu and sodium sulfonate 
led to the formation of two new C-C bonds and the assembly of fluorenes LX. The reaction 
involved tandem nucleophilic addition of sulfonate and the subsequent cascade cyclization via 
an ionic mechanism (Scheme 25, B).34b 
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Scheme 25. Au-catalyzed and Cu-mediated annulations to of LVIII to LIX and LX 
  
27 
 
2.1.3.  1,2,3,4-Tetrasubstituted fluorenes 
 
Synthesis of 1,2,3,4-tetrasubstituted fluorenes is quite challenging due to high level of 
substitution. In this respect only a handful of procedures have been developed so far. One of 
the first approaches to 1,2,3,4-tetrasubstituted fluorenes was developed in 2009 by Takahashi 
et al. and was based on Lewis-acid mediated rearrangement of homo-substituted 
bis(indenyl)zirconacyclopentadienes, prepared by reductive dimerization of the corresponding 
alkynes with reduced titanocene. The zirconacyclopentadienes were treated with an excess of 
TiCl4 that promoted the skeletal rearrangement, formally addition of the 
ziconacyclopentadiene moiety to the indenyl ligand, resulting in the formation of 1,2,3,4-
tetrasubstituted fluorenes XXIV in up to 90% yield (Scheme 26).35 
 
 
Scheme 26. Zr-catalyzed formation of 1,2,3,4-tetrasubstituted fluorenes 
 
The second approach, for the preparation of the same tetrasubstituted fluorene scaffold 
was based on the use of Dewar benzenes. The Dewar benzenes were prepared by a reaction of 
methyl phenylpropynoate LXI with tetraalkylcyclobutadiene-AlCl3 complexes LXII. Then 
the ester moiety was hydrolyzed to free carboxylic acid and photochemically rearranged to 
substituted (1,1’-biphenyl)-2-carboxylic acids. The treatment of the acids with thionyl 
chloride furnished the 1,2,3,4-tetrasubstituted fluorenones II (Scheme 27).8a 
 
 
Scheme 27. Formation of a 1,2,3,4-tetrasubstituted fluorenones II from substituted 
cyclobutadienes 
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Since the above mentioned methods to 1,2,3,4-tetrasubstituted fluorene and 
fluorenones have limitations with respect to substituents R, development of other methods 
was desirable.  
As a part of my previous project I studied a new reaction pathway for the synthesis of 
1,2,3,4-tetrasubstituted fluorenes based on a transition metal catalyzed [2+2+2] 
cyclotrimerization of symmetrically substituted diynes with alkynes to provide various alkyl 
and aryl substituted 9H-fluorenes in up to 93% isolated yield (see section 4.1.1).36 
Soon after publishing of my study, the group of Ratovelomanana-Vidal et al. reported 
in 2016 modified [2+2+2] cyclotrimerization reaction of diynones LXIII with alkynes to 
furnish fluorenones II by using Ru-catalysis under simple conditions (solvent-free, no 
additional ligands, no additives) in up to 84% yield (Scheme 28).37 
 
 
Scheme 28. Ru-catalyzed route to unsymmetrically substituted fluorenones II  
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2.2.  Synthesis of indeno[2,1-c]fluorene compounds 
 
In contrast to the vast research on syntheses of fluorenes conducted thus far, few 
synthetic strategies for indeno[2,1-c]fluorenes have been developed or are available. In fact, 
only a handful of studies have been published after the pioneering work of Ginsburg, 
Chardonnens and Stanfield, in the 1960s. They synthesized indeno[2,1-c]fluorenes via Lewis 
acid-assisted annulations of 3,3’-bi-(indenyl-cyclohepta-2,7-dienyls) or 
phenylcinnamalones.38 The family of indenofluorenes consist of five different constitutional 
isomers,39 chemistry and synthesis of which have been studied to different extents. These 
studies have mostly focused on the synthesis of indeno[1,2-a]fluorene, indeno[2,1-a]fluorene, 
indeno[1,2-b]fluorene and indeno[2,1-b]fluorene isomers, overlooking the indeno[2,1-
c]fluorene isomer (Figure 3).  
 
 
Figure 3. Isomers of the dihydroindenofluorene family 
 
Furthermore, almost all known examples of the reported synthesis of indeno[2,1-
c]fluorenes are based on either intramolecular Friedel-Crafts reaction (Scheme 29, 
Disconnection approach A), on intermolecular Diels-Alder reaction (Disconnection approach 
B) or on a combination of both. 
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Scheme 29. General disconnection approaches A and B for indeno[2,1-c]fluorenes 
 
The most intramolecular Friedel-Crafts reactions (Disconnection A) use substituted 
terphenyls bearing diester groups LXIV and acids, e.g. polyphosphoric acid (PPA),6b FeCl36c 
or H2SO4,6d to catalyze the double Friedel-Crafts reaction to furnish indeno[2,1-
c]fluorendiones LXV (Scheme 30, A). Moreover, a similar Friedel-Crafts reaction for the 
assembly of LXVII was also reported by Poriel et al., in 2015. They started from substituted 
9,9’-spirobifluorene LXVI bearing 2-ethyl benzoate functionality at position 4 of the core 
structure and used MsOH to mediate the cyclization (Scheme 30, B).6a 
 
 
Scheme 30. Intramolecular Friedel-Crafts reaction for synthesis of indeno[2,1-c]fluorene 
LXVII 
 
In 2014, Chen et al. presented another synthetic approach for the preparation of 
substituted indeno[2,1-c]fluorenes based on intermolecular Diels-Alder reaction. The reaction 
included Diels-Alder reaction of diene LXVIII with an excess of maleic anhydride. The 
subsequent aromatization with Pb(OAc)4 led to the formation of indeno[2,1-c]fluorene LXIX 
in a high yield of 90% (Scheme 31).6e 
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Scheme 31. Intermolecular Diels-Alder reaction to indeno[2,1-c]fluorene LXIX 
 
Another strategy combining the two above mentioned synthetic approaches was also 
developed. The synthesis included intermolecular Diels-Alder reaction of indanocyclone 
LXX with 9-ethynyl-9-fluorenol LXXI, which led to the formation of a mixture of fluorenone 
LXXII and its structural isomer LXXII-a in a 1:1 ratio. Friedel-Crafts alkylation took place 
in the presence of HOAc/catalytic amount of HCl mixture under reflux and produced 
monospirobifluorene-indeno[2,1-c]fluorene LXXIII in a high yield of 96% (Scheme 32).6f 
 
 
Scheme 32. Diels-Alder/intramolecular Friedel-Crafts reaction to indeno[2,1-c]fluorene 
LXXIII 
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An unusual synthetic strategy, significantly differing from pathways A and B, was 
developed in the group of Tessier et al. in 1991. This approach consists of lithium-induced 
cyclization of tribenzocyclotriyne LXXIV. It was shown that combining 4 equivalents lithium 
with tribenzocyclotriyne LXXIV in THF under anaerobic conditions yielded dianion LXXV. 
Its methanolysis gave rise to the target indeno[2,1-c]fluorene LXXVI (Scheme 33).40 
 
 
Scheme 33. Synthesis of indeno[2,1-c]fluorene LXXVI from tribenzocyclotriyne LXXIV 
 
Using the parent indeno[2,1-c]fluorene-5,8-dione LXXVII, Haley et al. synthesized, 
for the first time, fully conjugated and antiaromatic indeno[2,1-c]fluorenes LXXVIII and 
LXXIX (Scheme 34).6g,41 In their pioneering study, they found that indeno[2,1-c]fluorenes 
LXXVIII have high electron affinities and small HOMO-LUMO energy gaps, thus 
suggesting that these modified indeno[2,1-c]fluorenes LXXVIII and LXXIX are attractive 
candidates for applications in organic electronic devices. 
 
 
Scheme 34. Synthesis antiaromatic indeno[2,1-c]fluorene LXXVIII and LXXIX 
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 All these synthetic approaches show that the preparation of indeno[2,1-c]fluorenes is 
still challenging task. With respect to the above said, it is possible to constitute that there has 
not been developed a general synthetic strategy for preparation of regioselectively substituted 
indeno[2,1-c]fluorenes yet. Moreover, the preparation of specifically substituted indeno[2,1-
c]fluorenes is still challenging and requires specific methods. Therefore the area of synthesis 
of variously substituted fluorenes or indenofluorenes remains highly attractive and interesting 
field of organic synthesis. 
 
  
34 
 
3. Aim of the Work 
 
As shown in the previous chapter, scientific literature describes numerous pathways 
for the synthesis of compounds containing the fluorene skeleton and the corresponding 9,9’-
spirobifluorenes (SBFs). Nevertheless, a possibility of developing of a general method for the 
regioselective synthesis of unsymmetrically substituted fluorenes and their properties has not 
been explored thus far. Therefore, the aims of this thesis were the following: 
 
a)  To develop a synthetic pathway for compounds with the fluorene scaffold using 
catalytic [2+2+2] cyclotrimerization of symmetrically or unsymmetrically substituted diynol 
precursors (R1 and R2) with alkynes to selectively form 1,2,3,4-tetrasubstituted fluorenols and 
their SBF derivatives (Scheme 35). 
 
 
Scheme 35. Proposed synthetic pathway for SBF using transition metal-catalyzed [2+2+2] 
cyclotrimerization 
 
b)  To assess the effect of different alkyl, aromatic and extended π-aromatic hydrocarbon 
substituents (R1 and R2) at positions 1 and 4 on the photophysical properties of the 
corresponding SBFs.  
 
c)  To extend the SBF synthetic method to the preparation of dispiroindeno[2,1-c] 
fluorenes (DS-IFs). They can be considered as extended SBF derivatives (Scheme 36). 
 
 
Scheme 36. Proposed pathway of synthesis of DS-IFs using the synthetic approach developed 
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d)  To assess substituent effects (R1 and R2 or substituents R3 and R4) on the 
photophysical properties of DS-IFs (Scheme 36), as performed for the SBFs. 
 
e)  To develop a synthesis route to a new class of [7]-helical DS-IFs by using the 
cyclotrimerization approach (Scheme 37).  
 
 
Scheme 37. Proposed synthetic strategy for (P)- and (M)-[7]-helical DS-IFs 
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4.  Results and Discussion 
4.1.  9,9’-Spirobifluorenes (SBFs) 
4.1.1.  Study for the synthesis of 9H-fluorene 
 
In my previous study, I was able to find suitable reaction conditions for a transition 
metal catalyzed [2+2+2] cyclotrimerization of substituted diynes with alkynes to provide 
1,2,3,4-tetrasubstituted 9H-fluorenes.36 
These fluorenes were synthesized using two sets of symmetrically substituted diynes. 
The diynes were prepared by one-step Negishi coupling of the corresponding alkynylzinc 
halides with 2-iodobenzyl bromide using a Pd catalyst.42 Then, different catalytic systems for 
[2+2+2] cyclotrimerization containing Co, Ru, Ni and Rh complexes were studied. Excluding 
the Ru-catalysts, all other catalysts gave rise to the desired 9H-fluorenes. The rhodium 
complex (Wilkinson’s catalyst, RhCl(PPh3)3, 10 mol%) proved to be the most powerful 
catalyst for [2+2+2] cyclotrimerization of the diynes with alkynes to provide various alkyl 
and aryl substituted 9H-fluorene derivatives in up to 93% isolated yield (Scheme 38). The 
substituent screening was then performed. Various symmetrically (R2 = R3 = Me, Et, n-Pr, 
CH2OH) and unsymmetrically (R2 = H, R3 = Ph, Fc) substituted alkynes were applied in the 
cyclotrimerization reaction. The results showed that 3-hexyne (R2 = R3 = Et) was the most 
suitable reaction partner for Rh-catalyzed cyclotrimerization.36 
 
 
Scheme 38. General synthetic approach for 9H-fluorenes 
 
These compounds were originally synthesized to serve as η5- or η6- ligands for several 
transition metals, because unsymmetrically substituted 9H-fluorenes are potential ligands for 
asymmetrical catalysis.43 However, all attempts to form complexes of 1,2,3,4-tetrasubstituted 
9H-fluorenes with transition metals, such as Mn and Fe, failed. 
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4.1.2. Study for the synthesis of 1,2,3,4-tetrasubstituted fluorenols 
 
As shown above, the transition metal catalyzed reaction of diynes and alkynes was 
successfully used to synthesize tetrasubstituted 9H-fluorenes, but no further applications of 
these compounds were found. Therefore, the focus of this project shifted towards preparing 
the structurally related 1,2,3,4-tetrasubstituted fluorenols. 
In contrast to 9H-fluorenes, fluorenols have the hydroxyl functional group at position 
9. The presence of the hydroxyl group enables fluorenols to undergo conversion into the 
corresponding 9,9´-spirobifluorenes (SBFs). Moreover, I hypothesized that selective 
substitution at positions 1-4 of the SBFs framework could be used to tune their properties 
based on a recent research study on 2- and 4-substituted SBFs,44 although a systematic study 
of substituent effects on SBFs has not been reported thus far. Therefore, I aimed to develop a 
general synthetic strategy for the regioselective synthesis of variously substituted SBFs using 
the cyclotrimerization method previously developed for the synthesis of tetrasubstituted 9H-
fluorenes according to the reaction sequence below (Scheme 39).36 
 
 
Scheme 39. General synthethic route for 1,2,3,4-tetrasubstituted fluorenols 
 
Thus, the goal of this study was to assess whether the previously developed reaction 
pathway is also applicable for the synthesis of 1,2,3,4-tetrasubstituted fluorenols. For this 
purpose, the following objectives were considered: 
a) to find suitable diynol compounds for [2+2+2] cyclotrimerization reaction, 
b) to study applicable catalytic systems for the [2+2+2] cyclotrimerization reaction, 
c) to test different alkynes in the [2+2+2] cyclotrimerization reaction, and 
d) to assess the effect of hydroxyl group protection. 
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a)  Either 2-bromobenzaldehyde or 2-iodobenzaldehyde could have been chosen as 
commercially available starting material; however, the former was used because of its lower 
price. In the first step, Sonogashira coupling of 2-bromobenzaldehyde with phenylacetylene 
using PdCl2(PPh3)2 (5 mol%) and CuI (10 mol%) with triethylamine as base in THF at 80 °C 
for 3h yielded 1a in 95% isolated yield. The subsequent alkynylation with lithium 
phenylacetylide in THF at -78 °C gave rise to the symmetrically substituted diynol 2a in 86% 
isolated yield (82% after two steps, Scheme 40). 
 
 
Scheme 40. Synthesis of diynol 2a 
 
b)  Initially, diynol 2a was applied as the model compound for the [2+2+2] 
cyclotrimerization study with different alkynes in the presence of various catalytic systems. 
The first task was to find suitable catalytic reaction conditions for the [2+2+2] 
cyclotrimerization of 2a with alkynes. For this purpose, reactions of diynol 2a and 3-hexyne 
3b, as a representative of internal alkynes, were performed using various transition metal-
based (Co, Ru, Ni, Rh) catalytic systems (Table 1). Similar to the study of 9H-fluorene 
synthesis, the highest yield (76%) of the desired fluorenol 4ab (Entry 1) was found when 
using the Wilkinson’s catalyst (RhCl(PPh3)3). The other catalytic systems, consisting of 
CpCo(CO)2 and Ni(cod)2/2PPh3, also furnished fluorenol 4ab, albeit in lower yields of 11% 
and 19%, respectively (Entries 2 and 3). No product was formed only in the case of 
Cp*RuCl(cod), and the starting material was fully recovered. Subsequent attempts to change 
the reaction conditions also failed (Entries 4 and 5). 
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Table 1. Transition metal complex-catalyzed cyclotrimerization reactions of 2a with 3b 
 
 
c) At this stage, the substituent effect of different symmetrically substituted internal 
alkynes 3 on cyclotrimerization with 2a was tested. Therefore, alkynes were classified 
according to Charton steric parameters (upsilon steric parameter υef) of the R substituents. 
Alkynes with small substituents such as 3a (R = Me, υef = 0.52), 3b (R = Et, υef = 0.56) and 
3d (R = CH2OH, υef = 0.53), alkyne 3c with a medium size substituent (R = n-Pr, υef = 0.68) 
and alkynes 3e-3g with sterically more demanding aryl substituents (R = Ph, υmin = 0.57, υmax 
= 2.15) were chosen.45 Interestingly, the product was formed only when using alkyl 
substituted alkynes (3a-3d). In detail, fluorenol 4aa was synthesized in cyclotrimerization 
reaction with 2-butyne 3a, albeit in a low yield (25%; Table 2, Entry 1). The low yield most 
likely resulted from the high volatility of the alkyne (27 °C boiling point). Thus, the 
concentration of the alkyne in the liquid phase was presumably low because the reaction was 
performed at 90 °C. Increasing the quantity of 3a to 5 or 10 equivalents in a closed system 
failed to give fluorenol 4aa in higher yields. The reactions of 3-hexyne and 4-octyne provided 
products 4ab and 4ac in 76% and 24% yield, respectively (Entries 2 and 3). Gratifyingly, the 
cyclotrimerization with 1,4-butynediol 3d gave fluorenol 4ad in 76% yield (Entry 4). 
However, the reactions of 2a with arylalkynes 3e-3g unexpectedly did not give aryl-
substituted fluorenols 4ae-4ag, most likely due to steric hindrance (Entries 5-7). The 
comparison of the reactions of 2a with 3-hexyne 3b or with 4-octyne 3c shows that steric 
effects (3b, υef = 0.56; 3c, υef = 0.68) decrease the product yield from 76 to 24% (Entries 2 
and 3). 
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Table 2. Rh-catalyzed cyclotrimerization reactions of 2a with alkynes 3 
 
 
d)  Lastly, the effect of the hydroxyl group protection at diynol 2a for the Rh-catalyzed 
cyclotrimerization with various alkynes was assessed. The protection of the free hydroxyl 
group at 2a was achieved using TBSCl and imidazole/DMAP at 0 °C. The product 2a-TBS 
was obtained in a surprisingly low yield of 53% after isolation (Scheme 41). All attempts to 
improve these yields by changing reaction conditions such as time (up to 24h), temperature 
(up to 50 °C) and additives (bases) failed. The TBS group was chosen as the protecting group 
because it can be selectively removed with fluoride based reagents under mild reaction 
conditions.  
 
 
Scheme 41. Synthesis of protected diynol 2a-TBS 
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The protected diynol 2a-TBS was then subjected to Rh-catalyzed cyclotrimerization 
using different alkyl and aryl substituted internal alkynes, such as 2-butyne (3a), 3-hexyne 
(3b), 4-octyne (3c), 1,4-but-2-ynediol (3d), diphenylethyne (3e), di(4-tolyl)ethyne (3f), and 
bis(4-trifluoromethylphenyl)ethyne (3g) (Table 3).  
The cyclotrimerization reaction of 2a-TBS with alkyl substituted alkynes 3a-d yielded 
1,2,3,4-tetrasubstituted fluorenols 4a-d-TBS (Entries 1-4). The reaction with 3a gave 4aa-
TBS (R = Me, Entry 1) in 19% yield, with 3b it furnished 4ab-TBS (R = Et, Entry 2) in 71% 
yield, with 3c it afforded 4ac-TBS (R = n-Pr, Entry 3) in 6% yield, and with 3d 4ad-TBS (R 
= CH2OH, Entry 4) was formed in 82% yield. In all cases, except 4ad-TBS, the yields of 
products were slightly lower than those of the reaction with the unprotected diynol 2a (see 
Table 2). No cyclotrimerization occurred and no products were detected in the reactions with 
aryl-substituted alkynes 3e-g (Entries 5-7). 
 
Table 3. Results from Rh-catalyzed cyclotrimerization reactions of 2a-TBS with alkynes 3 
 
 
These results showed no significant effect of the hydroxyl group protection on the 
outcome of the cyclotrimerization reaction. Therefore, unprotected diynols were used in 
subsequent experiments. The results showed that 3-hexyne 3b was the most suitable internal 
alkyne. Hence, this hexyne 3b was selected for all further reactions. But-2-yne-1,4-diol 3d 
yielded the corresponding fluorenols 4ad and 4ad-TBS in the same or in even higher yields 
than those of 3-hexyne 3b, but the presence of two additional hydroxyl group could affect the 
subsequent steps of the synthesis.   
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4.1.3. Synthesis of 1,2,3,4-tetrasubstituted SBFs and analysis of the effect of the 
substituents at positions 1 and 4 on its photophysical properties  
 
All synthesized fluorenols can be converted into the corresponding SBFs. The 
properties of the SBFs may be tuned by selective substitution at positions 1-4, yet no 
systematic study on the effect of the substituent on the photophysical properties of SBFs has 
been conducted thus far, as previously stated in section 4.1.2. This is particularly relevant 
when considering that SBFs have useful properties in organic optoelectronics, such as thermal 
and morphological stability, and their photophysical properties depend on their substituents. 
Initially, in addition to the previously obtained diynol 2a, three other diynols 2b-d 
with different combinations of substituents at the ends of the triple bond in symmetrical and 
unsymmetrical alignment were prepared. The synthesis started with Sonogashira coupling of 
2-bromobenzaldehyde with pent-1-yne or phenylacetylene (Pd(PPh3)2Cl2 (5 mol%), CuI (10 
mol%), NEt3, THF, 80 °C, 3h) producing 1a and 1b in 95 and 92% isolated yields, 
respectively. Their subsequent alkynylation with pent-1-yn-1-yllithium or lithium 
phenylacetylide in THF at -78 °C gave rise to the set of 2a-d, again in very high isolated 
yields ranging from 86 to 96%. 
Diynols 2a-d were then cyclotrimerized with 3-hexyne 3b in the presence of 
Wilkinson’s catalyst (10 mol%) under the previously used conditions (toluene, 90 °C, 16h). 
Fluorenols 4ab, 4bb, 4cb and 4db were obtained in 38-76% isolated yields (Scheme 42). In 
some cases the formation of homo-coupled product from diynols 2a-d was observed as minor 
side products (3-7%). Attempts to overcome the homocoupling reaction by slow addition of 
diynols 2a-d into the reaction mixture and to increase the amount of the alkyne 3b to 5 or 
even 10 equivalents failed. 
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Scheme 42. Synthesis of unsymmetrically 1,2,3,4-tetrasubstituted fluorenols 4 
 
Then, fluorenols 4ab, 4bb, 4cb and 4db were converted into the corresponding SBFs. 
Initially, fluorenols 4 were oxidized with pyridinium chlorochromate (PCC) in 
dichloromethane at 25 °C to the corresponding fluorenones 5a-d. Fluorenones 5a, 5b, 5c, and 
5d were isolated in 89, 94, 93 and 90% yields, respectively. Subsequently, fluorenones 5 were 
converted into the desired SBFs 6a-d using a two-step approach46 consisting of 2-
lithiobiphenyl addition to 5a-d that was followed by treatment with a mixture of acetic acid 
containing a catalytic amount of concentrated HCl at 110 °C. SBFs 6a, 6b, 6c, and 6d were 
obtained in 66, 74, 68, and 83% yields. In summary, regioselectively 1,2,3,4-tetrasubstituted 
SBFs 6a-d were obtained, through the five-step synthetic pathway using the Rh-catalyzed 
cyclotrimerization as the key step, in overall yields ranging from 24 to 37% (Scheme 43, 
overall yields are in parenthesis). The structures of 6a and 6c were unequivocally confirmed 
by a single-crystal X-ray structure analysis (Figures 4 and 5). 
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Scheme 43. Synthesis of 1,2,3,4-tetrasubstituted SBFs 6a-d 
 
 
Figure 4. Platon plot of 6a showing displacement ellipsoids at a 30% probability level 
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Figure 5. Platon plot of 6c showing displacement ellipsoids at a 30% probability level 
 
After preparing the set of SBFs 6a-d, their photophysical properties were studied. 
Initially, the UV/Vis absorption spectra were recorded. Samples were measured in 10-6 M 
solutions in cyclohexane and the relative quantum yields Φs were determined using 9,10-
diphenylanthracene (DPA) as the standard. To calculate the relative quantum yields Φs, DPA 
and the sample molecules must have the same absorption value at a certain wavelength. This 
specific wavelength, the isobestic point, is used as excitation wavelength λexc in the further 
measurement of fluorescence emission spectroscopy. In this case the comparison of 
absorption spectra show the isobestic points at 242 and 243 nm, respectively and were used as 
λexc for the emission spectroscopy. 
The analysis of the fluorescence emission spectral data (Figure 6 and Table 4) showed 
that: 
a) Compounds 6a and 6c with the phenyl substituents at position 4 show broad emission 
peaks at 330/333 nm after excitation at 242 nm and 243 nm, respectively.  
b) Compounds 6b and 6d with the n-propyl substituent at position 4 have narrower 
emission patterns with emission maxima at 315 nm and smaller emission peaks at 328 nm 
after excitation at 243 nm and 242 nm, repectively.  
c) The quantum yields of all four compounds, namely 6a (Φs = 0.62), 6b (Φs = 0.72), 6c 
(Φs = 0.48) and 6d (Φs = 0.87), have similar values. These results show that substituted SBFs 
have good to high quantum yields. 
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Figure 6. Absorption and emission spectral data of 6a-d in 10-6 M samples 
 
Table 4. Photophysical properties of 6a-d (10-6 M in cyclohexane) 
 
 
These observations and comparisons led to the following conclusions: 
a) Substituents at position 4 strongly affect the photophysical properties of SBFs. A 
significant difference was observed in the red shift of the fluorescence emission spectra 
caused by these substituents. The presence of the phenyl substituent at position 4 of 6a and 6c 
(λmax = 333 and 330 nm) red-shifted the emission maxima by more than 15 nm in comparison 
with the propyl substituted SBFs 6b and 6d (λmax = 315 nm for both).  
b) The well-resolved profile with distinct peaks in the emission spectra of 6b and 6d 
match the spectra of similar compounds in the same solvent, such as the parent SBF (λem = 
310, 323 nm),44a 2-phenyl-SBF (λem = 335, 351 nm) and 2-pyrimidyl-SBF (λem = 338, 355 
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nm).44b The broad emission band of 6a and 6c may be a characteristic property of aromatic 
substitution at position 4 of SBFs.  
c) The measured emission spectra of 6a/6c and 6b/6d show that the substituent at 
position 1 of the SBF has negligible, if at all any, effect on the fluorescence emission shift or 
on the quantum yield. The quantum yields for all measured SBFs 6 (Φs = 0.48-0.87) are also 
in accordance with previously reported results.44  
In summary, I was able to synthesize selectively 1,2,3,4-tetrasubstituted SBFs in a 
five-step approach from commercially available compounds. The Rh-catalyzed [2+2+2] 
cyclotrimerization approach developed in this study was used as the key step. Furthermore, a 
preliminary analysis of the effect of the substituent at positions 1 and 4 on the photophysical 
properties of SBFs was conducted. The results indicate a connection between the aromatic 
substituents at position 4 of the SBF and a red shift of the fluorescence emission peak towards 
the visible light region. Therefore, substitution at this particular position is an interesting 
option for further synthetic modification. 
  
48 
 
4.1.4. Synthesis of SBFs bearing different substituents at position 4 
 
In the previous chapter, I showed that 4-aryl substituents of SBFs red shift the 
fluorescence emission wavelength of these compounds. Thus, the next step of this study on 
the modulation of photophysical properties of SBF derivatives was to use different 
substituents at position 4. This approach was divided into three stages: 
a) to synthesize 4-substituted SBFs with 4-substituted phenyl groups bearing electron-
donating and -withdrawing groups, 
b) to synthesize the SBFs with extended aromatic moieties at position 4,  
c) to attach fused π-aromatic hydrocarbons (PAHs) at position 4 of SBFs. 
 
 
4.1.4.1. Synthesis of 4-substituted phenyl groups at position 4 of SBFs 
 
In the first stage, a set of 4-substituted SBFs bearing 4-substituted phenyl groups was 
prepared. The 4-substituted phenyl groups encompassed moieties bearing electron-donating 
and -withdrawing functional groups. Because of structural similarity with compounds in 
section 4.1.3, the same five-step synthetic approach was applied.47  
In the first step, 3-alkynylated benzaldehydes 7a-g were synthesized by using 
Sonogashira coupling (Pd(PPh3)2Cl2 (5 mol%), CuI (10 mol%), NEt3, THF, 80 °C, 3h) of 2-
bromobenzaldehyde with various 4-substituted phenylacetylenes having various electron-
donating (OMe, Me, H) and -withdrawing (Ph, Cl, CF3, CN) groups. The corresponding 
alkynylbenzaldehydes 7a-g were obtained in good isolated yields in the range of 80 to 96%. 
The subsequent alkynylation of 7a-g with lithium p-tolylacetylide at -78 °C in THF gave rise 
to diynols 8a-g in 84 to 96% yields (Scheme 44).  
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Scheme 44. Synthesis of substituted diynols 8a-g 
 
In the third step, I applied the previously developed Wilkinson’s complex catalyzed 
cyclotrimerization (RhCl(PPh3)3 (10 mol%), toluene, 90 °C, 16 h, for further details, see 
section 4.1.3) to mediate reactions of substituted diynols with small internal alkynes. As 
already mentioned, 3-hexyne 3b was chosen as the most suitable compound for the 
cyclotrimerization reactions with diynols. The catalytic [2+2+2] cyclotrimerization of diynols 
8a-g with 3b proceeded to provide the desired fluorenols 9a-g in the range of 30 to 64% 
isolated yields (Scheme 45). These isolated yields matched the previously reported values 
obtained for 4ab, 4bb, 4cb and 4db, which were ranging from 38 to 76% (section 4.1.3.). 
Similar to the previous results also in this case the homo-coupling product of diynols 8a-g 
was observed as minor side product (2-5%) and the same attempts (slow addition of diynol 
and increase of alkyne concentration, section 4.1.3) failed to suppress this unwanted side 
reaction.  
In the next step, fluorenols 9a-g were oxidized with PCC in dichloromethane at 25 °C 
uneventfully to fluorenones 10a-g in good to high isolated yields (61-86%). Finally, the 
fluorenones 10a-g were converted to SBFs 11a-f by reaction with 2-lithiobiphenyl that was 
followed by treatment with a mixture of acetic acid containing a catalytic amount of 
concentrated HCl at 110 °C. The final SBFs 11a-f were obtained in high isolated yields 
ranging from 63% to 90%. The overall yields from the commercially available starting 
material after five steps were in a reasonable range from 19 to 34% (Scheme 45, overall yields 
in parenthesis). Only in the case of 11g (R = CN), 2-lithiobiphenyl added preferentially to the 
more reactive cyano group, thereby leading to the imine product. Changes in reaction 
conditions to suppress imine formation and to favor addition to the carbonyl group were not 
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met with success. The structures of the SBFs 11a, 11c and 11e were unequivocally confirmed 
by a single-crystal X-ray analysis (Figures 7-9). 
 
 
Scheme 45. Synthesis of 4-aryl substituted SBFs 11a-f 
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Figure 7. Platon plot of 11a showing displacement ellipsoids at a 50% probability level 
 
 
Figure 8. Platon plot of 11c showing displacement ellipsoids at a 50% probability level 
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Figure 9. Platon plot of 11e showing displacement ellipsoids at a 50% probability level 
 
The X-ray diffraction data of all three SBFs showed large dihedral angles (almost 
perpendicular) between the SBF and the para-decorated aryl substituents at position 4. In 
detail, for 11a the angles between C4-C5-C6 and C37-C38-C42 were 86°, for 11c the angles 
between C8-C9-C44 and C10-C11-C47 were 94° and for 11e the angles between C20-C24-
C25 and C26-C27-C31 were 83°. This high rotation may be caused by the ethyl substituent at 
position 3 of the SBFs.  
The almost perpendicular arrangement between the SBFs and the substituents at 
position 4 may affect the electron distribution within the molecule. This can in particular 
influence and lower the ability for a strong performance in photophysical properties, 
especially after excitation. Nevertheless, based on results obtained for 4-aryl-substituted 
SBFs2,44,48 and our previous results regarding 1,2,3,4-tetrasubstituted SBFs,36 these 
compounds presumably undergo planarization by stabilization of the excited state, which then 
improves the alignment and interaction of extended π-systems at the central carbon 
atoms.44a,49  
Besides, also the aromatic substituent at position 1 of the SBF showed large dihedral 
angles. But in contrast to position 4, substituents at position 1 of the SBF are not influencing 
the photophysical properties at all, as found in the previous study (see section 4.1.3). 
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4.1.4.2. Synthesis of extended aromatic substituents at position 4 of SBFs 
 
In the second stage, besides the effect of electron-donating and -withdrawing groups at 
the 4-substituted phenyl group of the SBFs at position 4, the effect on aromatic systems, such 
as biphenyl or diphenylethynyl moieties at the same position of the SBFs, was studied. In 
order to attach these substituents at position 4, 4-bromophenyl-substituted SBF 11h was 
deemed the most suitable key intermediate to synthesize the desired 4-substituted SBF 
derivatives. 
For the synthesis of the key compound 11h, the above mentioned five-step synthetic 
approach was modified. Specifically, to avoid competing side reactions in the Pd-catalyzed 
Sonogashira cross-coupling of 2-bromobenzaldehyde and 1-bromo-4-ethynylbenzene, the 
approach to diynol 8h had to be changed. First, 2-ethynylbenzaldehyde was allowed to react 
with lithium p-tolylacetylide at -78 °C in THF to furnish diynol 12a. 12a was then reacted 
with 1-bromo-4-iodobenzene under Sonogashira coupling conditions (Pd(PPh3)2Cl2 (5 mol%), 
CuI (10 mol%), NEt3, THF, 80 °C, 3h) to give diynol 8h that was isolated in excellent yield of 
96%. Cyclotrimerization using RhCl(PPh3)3 (10 mol%) as the catalyst in toluene for 16h at 90 
°C gave rise to fluorenol 9h in an unsatisfactory isolated yield of 26% (Scheme 46, 
Conditions A). This rather low yield combined with a high catalytic loading led to 
optimization of the reaction conditions. An extensive screening of cyclotrimerization 
reactions with Wilkinson’s catalyst under various conditions was carried out. It included 
different solvents, catalytic loadings, reaction temperatures, time and additives (Tables 5-11). 
After a lot of experiments, suitable catalytic conditions were found, which consisted of using 
the Wilkinson`s catalyst (RhCl(PPh3)3, 3 mol%) and the additive Ag2CO3 (6 mol%) in THF 
under microwave irradiation (MW, 1.5 h, 180 °C) (Conditions B). In this case the isolated 
yield of 9h almost doubled to 57% (Table 11, Entry 4). 
 
54 
 
 
Scheme 46. Synthesis of 4-bromophenyl substituted fluorenol 9h 
 
Table 5. Reaction condition parameters screened for Rh-catalyzed cyclotrimerization of 9h 
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Table 6. Variation of the catalyst loading and solvents 
Entry Solvent Catalyst (mol%) T (°C) t (h) Additive (6 mol%) Recovered 8h (%)a 9h, Yield (%)a 
1 toluene 5 90 16   30 
2 toluene 5 90 16 Ag2CO3  32 
3 DMF 5 90 16   8 
4 DMF 5 90 16 Ag2CO3  15 
5 toluene 4 90 16   29 
6 toluene 4 90 16 Ag2CO3  36 
7 toluene 3 90 16  7 25 
8 toluene 3 90 16 Ag2CO3 11 28 
9 toluene 2 90 16  28 15 
10 toluene 2 90 16 Ag2CO3 41 14 
11 toluene 2 90 96  14 19 
12 toluene 2 90 96 Ag2CO3 8 21 
13 toluene 1 90 96  23 16 
14 toluene 1 90 96 Ag2CO3 20 18 
a
 Isolated yields 
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Table 7. Variation of additives 
Entry Solvent Catalyst (mol%) T (°C) t (h) Additive (6 mol%) Recovered 8h (%)a 9h, Yield (%)a 
1 toluene 4 90 16 AgSbF6  9 
2 toluene 4 90 16 AgNO3  37 
3 toluene 4 90 16 AgOOCCF3 13 21 
4 toluene 4 90 16 AgOTf  0 
5 toluene 4 90 16 Ag3PO4 16 21 
6 toluene 4 90 16 AgBF4  6 
7 toluene 4 90 16 AgOOCCH3  19 
8 toluene 4 90 16 AgClO4 31 7 
9 toluene 4 90 16 Ag2SO4  31 
a
 Isolated yields 
 
Table 8. Variation of solvent 
Entry Solvent Catalyst (mol%) T (°C) t (h) Additive(6mol%)  Recovered 8h (%)a 9h, Yield (%)a 
1 CH2Cl2 4 90 16 Ag2CO3 5 30 
2 Et2O 4 90 16 Ag2CO3 10 32 
3 THF 4 90 16 Ag2CO3  41 
a
 Isolated yields 
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Table 9. Cyclotrimerization in THF in the presence of different additives 
Entry Solvent Catalyst (mol%) T (°C) t (h) Additive (6 mol%) Recovered 8h (%)a 9h, Yield (%)a 
1 THF 4 90 16 -  48 
2 THF 4 90 16 AgNO3 38 29 
2 THF 4 90 16 AgOTf  21 
4 THF 4 90 16 AgOOCCF3 93 5 
a
 Isolated yields 
 
Table 10. Effect of temperature 
Entry Solvent Catalyst (mol%) T (°C) t (h) Additive(6 mol%) Recovered 8h (%)a 9h, Yield (%)a 
1 THF 4 50 16 Ag2CO3 67 15 
2 THF 4 50 16 - 81 11 
3 THF 4 70 16 Ag2CO3 29 26 
4 THF 4 70 16 - 31 29 
5 THF 4 80 16 Ag2CO3  42 
6 THF 4 80 16 -  41 
7 THF 4 110 16 Ag2CO3  35 
8 THF 4 110 16 -  33 
9 THF 4 150 1, MW Ag2CO3 10 37 
10 THF 4 150 1, MW -  34 
a
 Isolated yields   
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Table 10 (continued). Effect of temperature 
Entry Solvent Catalyst (mol%) T (°C) t (h) Additive(6 mol%) Recovered 8h (%)a 9h, Yield (%)a 
11 THF 4 150 1.5, MW Ag2CO3  41 
12 THF 4 150 1.5, MW -  29 
13 THF 4 180 1, MW Ag2CO3  51 
14 THF 4 180 1, MW - 6 40 
15 THF 4 180 2, MW Ag2CO3  32 
16 THF 4 180 1, MW AgOTf  3 
17 THF 4 180 1, MW AgSbF6  4 
18 THF 4 180 1, MW AgNO3  32 
19 THF 4 180 1, MW Ag2SO4  6 
a
 Isolated yields   
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Table 11. Variation of the catalyst loading and temperature 
Entry Solvent Catalyst (mol%) T (°C) t (h) Additive (6 mol%) Recovered 8h (%)a 9h, Yield (%)a 
1 THF 10 180 1, MW Ag2CO3  47 
2 THF 5 180 1, MW Ag2CO3  43 
3 THF 3 180 1, MW Ag2CO3  49 
4 THF 3 180 1.5, MW Ag2CO3  57 
5 THF 2 180 1, MW Ag2CO3  32 
6 THF 4 170 1, MW Ag2CO3  51 
7 THF 3 170 1, MW Ag2CO3  37 
8 THF 2 170 1, MW Ag2CO3  27 
9 THF 4 190 1, MW Ag2CO3  43 
10 THF 3 190 1, MW Ag2CO3  40 
a
 Isolated yields 
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Having found suitable conditions for preparation of fluorenol 9h in a good yield under 
catalytic conditions B, the next step was conducted. Fluorenol 9h was subjected to oxidation 
with PCC in dichloromethane at 25 °C to give fluorenone 10h in a nice 93% isolated yield. Its 
subsequent reaction 10h with 2-lithiobiphenyl followed by treatment with a mixture of acetic 
acid and a catalytic amount of concentrated HCl at 110 °C gave SBF 11h isolated in 74% 
yield. Thus SBF 11h was formed in 36% overall yield after five steps (Scheme 47, the overall 
yield is in parenthesis).  
 
 
Scheme 47. Synthesis of 4-bromophenyl substituted SBF 11h 
 
SBF 11h was then transformed by using a Pd-catalyzed Suzuki cross coupling reaction 
into 13a and 13b. The reactions with (4-methoxyphenyl)boronic acid or (4-(trifluoromethyl) 
phenyl)boronic acid were catalyzed by Pd(OAc)2 in the presence of K2CO3 in a mixture of 
EtOH/H2O at 80 °C. The desired SBF 13a with electron-donating (R = OMe) and SBF 13b 
with electron-withdrawing (R = CF3) substituents were obtained in 62 and 58% isolated 
yields, respectively (Scheme 48).  
 
 
Scheme 48. Synthetic procedure for Pd-catalyzed Suzuki reactions to 13a and 13b 
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A similar approach was used for the synthesis of SBFs 14a-c bearing 4-substituted 
diphenylethynyl substituents at position 4 of the SBF framework. In this instance Sonogashira 
cross coupling of 11h with 4-substituted phenylacetylenes was used. First, the reaction of 11h 
with 4-ethynylanisole (R = OMe) was carried out in the presence of PdCl2(PPh3)2 (5 mol%), 
CuI (10 mol%) and diisopropylamine as a base under microwave irradiation at 180 °C to give 
14a in 54% isolated yield. The reactions of 11h with phenylacetylene (R = H) or 1-ethynyl-4-
(trifluoromethyl)benzene (R = CF3) proceeded already at 80 °C, albeit under slightly different 
reaction conditions. Specifically, SBF 14b (R = H) was synthesized in 72% yield by using 
PEPPSITM-IPr (5 mol%), CuI (10 mol) and triethylamine in THF after 3h, whereas SBF 14c 
(R = CF3) was formed 57% isolated yield by using PdCl2(PPh3)2 (5 mol%), CuI (10 mol%) 
and triethylamine as base in DMF after 16h reaction time.(Scheme 49).  
 
 
Scheme 49. Synthetic procedure for Pd-catalyzed Sonogashira reactions to 14a-c 
 
The structures of 13a and 14b were unequivocally confirmed by a single-crystal X-ray 
analysis (Figures 10 and 11), and the diffraction data showed a similar behavior when 
analyzing the alignment of the aryl substituent at position 4, as previously observed in SBF 
11c. In the case of 13a the twisting angle between the parent fluorene plane C4-C5-C6 and the 
phenyl moiety C37-C38-C42, which is connected to the SBF, had the angle of 83° and in the 
case of 14b this angle was 75°. This may be explained by the same effect as previously 
described when discussing the anomaly in deformation of SBF 11a, 11c and 11e. 
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Figure 10. Platon plot of 13a show displacement ellipsoids at a 50% probability level 
 
 
Figure 11. Platon plot of 14b show displacement ellipsoids at a 50% probability level 
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SBFs 14 contain the internal triple bond. In general, alkynes are suitable reaction 
partners in the reaction with 6,9-(Me2S)-arachno-B10H12 to form the corresponding 1,2-
carboranes.50 Thus SBFs 14 can be suitable substrates to form the corresponding carborane 
and the carborane itself might be an interesting target to study its photophysical properties. 
The previous studies have shown that 1,2-diaryl substituted carboranes exhibit interesting 
absorption and fluorescence emission properties due to their unique “face-on” conformation 
of the aryl substituents.51 Accordingly, 14a was converted with 6,9-(Me2S)-arachno-B10H12 in 
toluene at 120 °C for 16h into carborane-14a containing the SBF moiety in 60% isolated 
yield (Scheme 50). Its structure was unequivocally confirmed by a single crystal X-ray 
analysis and showed indeed the “face-on” conformation of the 1,2-aryl substituents of the 
carborane structure (Figure 12). 
 
 
Scheme 50. Conversion of 14a into carborane containing SBF carborane-14a  
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Figure 12. Platon plot of carborane-14a show displacement ellipsoids at a 50% probability 
level 
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4.1.4.3. Synthesis of fused π-aromatic hydrocarbons at position 4 of SBFs 
 
Fused polyaromatic hydrocarbons (PAHs) represent another class of substituents that 
can be attached at position 4 of SBFs. PAHs, such as naphthalene, anthracene, phenanthrene 
or pyrene, have been studied since the 1970s and have shown interesting photophysical 
properties such as the fluorescence emission wavelength in the 350-420 nm range and 
reasonable quantum yields of Φ = 0.18-0.72 in H2O or ethanol.52 Thus, SBFs having the PAH 
based substituents at position 4 seemed to be promising moieties to tune light emission 
wavelength and quantum yields. 
In the first step, 2-ethynylbenzaldehyde was alkynylated with pent-1-yn-1-yllithium in 
THF at -78 °C to form diynol 12b possessing the terminal triple bond in 95% isolated yield. 
The choice for the n-propyl substituent at position 1 was based on the fact that it has a 
negligible effect, if any, on the photophysical properties of the SBF at all (Section 4.1.3). In 
the next step, 12b was converted to diynols 15a-d with halo-PAHs (the use of ethynyl-
substituted PAHs was also considered, but the above mentioned approach was chosen because 
of commercial availability of the halo-PAHs). The diynols 15a-d were formed by Sonogashira 
coupling (PdCl2(PPh3)2 (5 mol%), CuI (10 mol%), NEt3, THF, 80 °C, 3h) of 12b with 2-
iodonaphthalene, 9-iodoanthracene, 9-iodophenanthrene and 1-iodopyrene, respectively, in 
good isolated yields ranging from 41 to 71%. The yields were lower in comparison to the 
previous results of Sonogashira coupling with phenyl halides used for preparation of 7 (see 
section 4.1.4.1). This might be explained by a lower reactivity of diynol 12b compared to aryl 
acetylenes, where the yields were ranging from 80 to 96%. 
With diynols 15a-d in hand, cyclotrimerization reactions were performed. All were 
reacted with 3-hexyne 3b under the developed catalytic condition (RhCl(PPh3)3 (3 mol%), 
Ag2CO3 (6 mol%), THF, 180 °C, MW) into fluorenols 16a-d in good isolated yields ranging 
from 45 to 59%, which were similar or even higher than previously observed results for 9a-g 
(30-61%, section 4.1.4.1). The subsequent oxidation with PCC in dichloromethane at 25 °C 
gave rise to fluorenones 17a-d uneventfully in very high yields ranging from 83 to 91%. In 
the last step, reactions of 2-lithiobiphenyl with fluorenones 17a-d, followed by treatment with 
a mixture of acetic acid and a catalytic amount of concentrated HCl at 110 °C furnished SBFs 
18a-d with fused π-aromatic hydrocarbons at position 4 in high yields ranging from 51 to 
91%. The overall yields were again in an acceptable range from 9 to 26% (Scheme 51, the 
overall yields are in parenthesis).  
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Scheme 51. Synthetic route of 4-PAH substituted SBF 18a-d 
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Figure 13. Platon plot of 18b showing displacement ellipsoids at a 50% probability level 
 
The structure of 18b was confirmed by a single-crystal X-ray analysis (Figure 13) and 
showed an almost right angle of 91.8° between the plane of the attached phenanthryl moiety 
C34-C33-C46 and the fluorene part of the SBF with C4-C5-C6. Thus, also in this case, the 
molecular twist findings match the results previously observed for SBFs 11, 13 and 14. 
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4.1.5.  Photophysical properties of 4-substituted SBFs 
 
Until now, three different sets of 4-aryl substituted SBFs were prepared. They 
consisted of:  
a) 11a-f with electron-donating and -withdrawing groups at the 4-aryl substituent,  
b) 13a and 13b with 4-substituted biphenyl moieties and 14a-c, with 4-substituted 4-(2-
(phen-1’-yl)ethynylphenyl moieties, one example of carborane-14a and, 
c) SBFs 18a-d with the fused π-aromatic hydrocarbons at position 4. 
 
All photophysical properties were measured under the same conditions, including a 
sample concentration of 10-6 M in cyclohexane, and the relative quantum yields Φs were 
calculated with DPA as the reference at the isobestic point. 
 The first set, 4-aryl substituted SBFs 11a-f was subjected to photophysical properties. 
After the absorption spectra were measured, the isobestic points of SBFs 11a-f with the 
reference DPA (see section 4.1.3) were determined and were in the range of λ
 
= 240-243 nm. 
These specific isobestic points then were used as excitation wavelengths λexc for the 
fluorescence emission spectroscopy and the results from the emission data are shown in 
Figures 14 and 15 and in Table 12. 
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Figure 14. Absorption spectra (left) and normalized and corrected emission spectral data of 
11 in 10-6 M samples (right) 
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Figure 15. Plot of emission wavelength versus σpara Hammett constants 
 
Table 12. Photophysical properties (10-6 M in cyclohexane) of 11 and σpara Hammett 
constants  
 
 
The results showed that indeed electron-donating and -withdrawing groups had an 
effect on the emission wavelength maxima. Moreover there was a reasonable correlation of 
the emission wavelength maxima with the σpara Hammett constants (Figure 15).53 The 
obtained data indicate that the emission maxima were red-shifted in the presence of electron-
deficient para-groups. This was clearly demonstrated by the difference of more than 30 nm 
between 11a (λem = 330 nm, σpara = -0.268) and 11f (λem = 361 nm, σpara = 0.54). The quantum 
yields of SBFs 11 were in general high (Φs = 0.50-0.87) and match those of other 4-aryl 
substituted SBF derivatives.2,3a,8d,44,48 Notwithstanding, it should be noted that, in comparison 
with the parent 4-phenyl-substituted SBF (λem = 358 nm, Φs = 0.40)2a  and with 11d, which 
also have 4-phenyl substituent, the quantum yield, Φs = 0.66, was even better. Surprisingly, 
the difference of 25 nm in the emission maximum between 4-phenyl-substituted SBF and 11d 
(λem = 333 nm) was rather high. 
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Additionally, the only exception to the linear correlation between σpara and the 
emission wavelength maximum was observed in 11c (σpara = -0.01). The effect of one 
additional π-system on the SBF may explain the red-shifted emission wavelength (λem = 367 
nm) and the very high quantum yield, Φs = 0.87. 
After these results, samples 13a, 13b and 14a-c were also analyzed and compared with 
11c because the structure of 11c is similar to that of the extended biaryl substituents at 
position 4 of SBFs without electron-donating or -withdrawing groups. The photophysical 
properties of 13 and 14 were measured under the same conditions and using DPA as reference 
as well. However, in contrast to the parent biphenyl substituted SBF 11c, neither the biphenyl 
substituted derivatives SBF 13 nor the diphenylethynyl substituted derivatives SBF 14 
showed a significant red shift. Only the relative quantum yields Φs increased (Figure 16 and 
Table 13). A detailed analysis of the results shows that the emissiom wavelength maxima λem 
of all samples ranged from 366 to 370 nm, thus matching the λem measured for 11c (λem = 367 
nm). The measured quantum yields Φs ranged from 0.65, for 13a, to 1.00, for 14c with the 
electron-withdrawing CF3 substituent (Table 13), thereby showing that they are some of the 
most powerful 4-substituted SBFs prepared thus far regarding quantum yields.2a,3a,8d,44,48,49 
The analysis of carborane-14a showed no fluorescence emission after excitation in 
the range of λexc = 250-330 nm, although the “face-on” conformation was confirmed based on 
X-ray data.  
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Figure 16. Absorption spectra (left) and normalized and corrected emission spectral data of 
13 and 14 in 10-6 M samples (right) 
 
Table 13. Photophysical properties of 13a-b and 14a-c (10-6 M in cyclohexane) 
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The photophysical properties of the last set with PAH-substituted SBFs 18a-d, were 
also analyzed, and the results are shown in Figure 17. Although all four samples exhibit 
absorption spectra in the range of λabs = 250-330 nm, only 18b-d also showed red-shifted 
emission (λem = 353-429 nm). The emission quantum yields were low for 18b (Φs = 0.12, 
Table 14) and 18d (Φs = 0.11), but very high in the case of the anthranyl-substituted SBF 18c 
(Φs = 0.80). It is noteworthy that the fluorescence emission spectra of 18c and 18d show 
emission patterns similar to those of the parent π-aromatic hydrocarbons anthracene and 
pyrene, albeit red-shifted by almost 30 nm and 10 nm, respectively.54,55 
 
 
Figure 17. Absorption spectra (left) and normalized and corrected emission spectral data of 
18 in 10-6 M samples (right)  
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Table 14. Photophysical properties for 18b-d (10-6 M in cyclohexane) 
 
  
75 
 
4.1.6.  Summary and outlook of 4-substituted SBFs 
 
In the first part of the study, 19 different substituted SBFs at position 4 were 
synthesized. These substituents included various electron-donating and -withdrawing groups, 
aromatic substituents and even fused π-extended aromatic hydrocarbons (PAHs). The results 
showed the effect of different substituents on the photophysical properties of SBFs and 
indicate the existence of π-conjugation breaking between the 4-substituent and the fluorene, 
based on X-ray data. Indeed, the X-ray data of all analyzed substituted SBFs reveal a large 
and, in most cases, almost perpendicular arrangement between the aforementioned fragments. 
This unique property disrupts the electronic coupling between them,48 which is presumably 
restored, at least partly, by planarization of the molecular structure during the stabilization of 
the excited state.44a,49 This characteristic of steric hindrance may be used to tune the π-
conjugation intensity in materials science for applications in electronic devices. Because of 
the spiro-framework, these 4-substituted SBFs also exhibit superior thermal and 
morphological stability,1 which are key properties for a broad range of applications.2 
Although the effect on 4-substituted SBFs must be further studied, the results already show a 
high potential for key contributions to the fields of materials science and to organic 
electronics. 
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4.2.  Dispiroindeno[2,1-c]fluorenes (DS-IFs) 
4.2.1.  Retrosynthesis of indeno[2,1-c]fluorenes 
 
 In the previous chapters, a new synthetic approach to 1,2,3,4-tetrasubstituted SBFs 
was described and their photophysical properties were studied (Section 4.1). In this chapter, 
the synthesis of structurally related indenofluorenes (IF), dihydroindenoflurenes and 
dispiroindenofluorenes was examined (DS-IF). DS-IFs, due to their structural similarity with 
SBFs, belong to the same class of condensed polyaromatic hydrocarbons. Similarly to SBFs, 
the DS-IFs are potential candidates for several applications, specifically in organic 
electronics, dyes and photovoltaic cells.6a-g,41 
The indenofluorene framework is composed of the fluorene unit and the indene unit. 
The indene unit can be attached to different edges of the fluorene scaffold leading to 5-
membered family of the corresponding regioisomers: 7,12-dihydroindeno[1,2-a]fluorene, 
11,12-dihydroindeno[2,1-a]fluorene, 6,12-dihydroindeno[1,2-b]fluorene, 5,7-
dihydroindeno[2,1-b]fluorene and 5,8-dihydroindeno[2,1-c]fluorene (Figure 18).39 
 
 
Figure 18. Isomers of the dihydroindenofluorene family 
 
Synthetic approaches for the synthesis of the first four regioisomeric 
dihydroindenofluorenes have been extensively studied, yet only few reports on the synthesis 
of the last regioisomer - indeno[2,1-c]fluorene - are available. Furthermore, almost all known 
examples of the synthesis of indeno[2,1-c]fluorenes are based on intramolecular Friedel-
Crafts-type cyclizations (Scheme 52, Disconnection approach A), on intermolecular Diels-
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Alder cyclization (Disconnection approach B) or on a combination of both approaches (for 
further details, please see: 2.1. Synthesis of indeno[2,1-c]fluorene). 
 
 
Scheme 52. General disconnection approaches A and B for indeno[2,1-c]fluorenes 
 
The limited approaches for the synthesis of indeno[2,1-c]fluorenes narrow the choices 
of suitably substituted starting material. Moreover, no general approach for the selective 
synthesis of the substituted indenofluorenes and structure-property analysis has been 
developed thus far. However, the indeno[2,1,-c]fluorenes can be seen as more structurally 
complex congener of fluorenes. Thus, the previously developed synthetic approach to 1,2,3,4-
tetrasubstituted SBFs based on catalytic [2+2+2] cyclotrimerization could also be used for 
preparation indeno[2,1-c]fluorenes (IFs) and their dispiro derivatives (DS-IFs).  
The retrosynthetic approach indicates that the DS-IFs could be formed from diketones 
that can be obtained from substituted indeno[2,1-c]fluorenediols by oxidation. The diols can 
be formed in a transition metal-catalyzed intramolecular [2+2+2] cyclotrimerization as the 
key step from substituted triyndiols. The triyndiols can be formed using the alkynylation 
protocol with lithium acetylides from dialdehydes that in turn can be obtained by Sonogashira 
coupling, as shown in the previous chapters (Scheme 53).36,47 The desired DS-IFs can then 
also be studied upon their photophysical properties. 
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Scheme 53. Retrosynthetic approach for substituted indeno[2,1-c]fluorene-5,8-diols 
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4.2.2.   Synthesis of substituted DS-IFs 
4.2.2.1. Synthesis of symmetrically substituted DS-IFs 
 
 Preparation of triyndiols 19 consisted of 2 steps. The first step was the Sonogashira 
coupling of commercially available 2-bromobenzaldehyde and 2-ethynylbenzaldehyde using 
PdCl2(PPh3)2 (5 mol%) and CuI (10 mol%) with triethylamine as a base in THF at 80 °C for 
3h furnishing dialdehyde 19 in 96% isolated yield. In the second step, twofold alkynylation of 
the dialdehyde with various 4-substituted lithium phenylacetylides (R = MeO-, Me-, Ph-, Br-, 
CF3-) or other acetylides (R = thienyl-, n-Pr-, TMS-, 1-naphthyl-) at -78 °C gave rise to nine 
symmetrically substituted triyndiols 20 in very high isolated yields ranging from 77 to 95% 
(Scheme 54).  
 
 
Scheme 54. Synthesis of symmetrically substituted triyndiols 20a-i 
 
Since the cyclotrimerization is the key step of DS-IF formation, the rhodium-complex 
catalyzed [2+2+2] cyclotrimerization to form indeno[2,1-c]fluorene-5,8-diols 21 in the third 
step was studied. Prior to the experiments, DFT calculations (B3LYP/6-311+G(d,p) at T = 
453.15 K) were done to determine the free energy ∆G of the conversion of both cis and trans 
stereoisomers of triyndiols 20 into indeno[2,1-c]fluorene-5,8-diols 21. The ∆G values of         
-381.78 kJ/mol (cis-isomer) and -378.04 kJ/mol (trans-isomer) showed that the conversion is 
energetically favorable despite the high torsional strain caused by steric hindrance in all five 
ortho-fused rings. Encouraged by the favorable computational results, experiments ensued. 
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Regarding intramolecular [2+2+2] cyclotrimerization reaction conditions of 20, the 
ones previously used, based on Wilkinson’s catalysts (3 mol%) and Ag2CO3 (6 mol%) as an 
additive in THF under microwave irradiation (1.5 h, 180 °C), were applied. Gratifyingly, the 
desired indeno[2,1-c]fluorene-5,8-diols 21 were formed in very high isolated yields (73-96%) 
as inseparable mixtures of diastereoisomers. In contrast to intermolecular cyclotrimerizations, 
no side reactions, such as homo-coupling (Section 4.1), occured in this step. In the cases of 
triyndiols 20a-c, 20e and 20f a full conversion of the starting material into the target 
indeno[2,1-c]fluorene-5,8-diols was obtained. In the cases of compounds 21d with 4-
bromoaryl substituted and 21i with naphthyl substituted indeno[2,1-c]fluorene-5,8-diols the 
yields were slightly lower (84% and 83%, respectively). The lowest yield of 73% was 
observed in the case of n-propyl substituted indeno[2,1-c]fluorene-5,8-diol 21g. The only 
exception among the symmetrically substituted indeno[2,1-c]fluorene-5,8-diols was the 
monosilylated diol 21h. The monosilylated diol 21h was obtained after work-up of the 
reaction mixture as the result of protodesilylation. Similar mono-desilylation reactions have 
already been observed and explained by the effect of sterically driven protosilylation during 
the purification process on silica gel.56 
Then, 2-step conversion of indeno[2,1-c]fluorene-5,8-diols into DS-IFs consisting of 
oxidation and the final formation of the target product ensued. In the fourth step, diols 21a-i 
were subjected to oxidation with PCC in dichloromethane at 25 °C forming the corresponding 
indeno[2,1-c]fluorene-5,8-diones 22a-i in almost quantitative isolated yields ranging from 83 
to 96%. In the final step, the reaction of indeno[2,1-c]fluorene-5,8-diones 22a-i with two 
equivalents of 2-lithiobiphenyl, followed by acidic cyclization using acetic acid and HCl at 
110 °C furnished symmetrically substituted 5,8-dispiroindeno[2,1-c]fluorenes (DS-IFs) 23a-i 
in very good yields (52-83%, Scheme 55). The overall yields of the successfully applied five-
step synthesis of symmetrically substituted DS-IFs 23a-i ranged from 28 to 60% (the overall 
yields are specified in parenthesis). 
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Scheme 55. Synthetic pathway of symmetrically substituted DS-IFs 23 
 
The structure of DS-IF 23b was unequivocally determined by a single crystal X-ray 
structure analysis and showed a high degree of molecular twist in the altering ortho-fused 
five- and six-membered ring structure (Figure 19).  
 
 
Figure 19. Platon plot of 23b showing displacement ellipsoids at a 50% probability level 
 
 
82 
 
The derived dihedral angles add up to a high twisting angle of the backbone in which 
the dihedral angle of the fused ring system 1-2-3 was 15.5°, the angle of the fused ring system 
2-3-4 was 18.3° and the dihedral angle of the ring system 3-4-5 was 3.2° (Figure 20). The 
total value of 32.4° was almost three times higher than the 13° backbone twisting of the 
parent 5,8-dispiroindeno[2,1-c]fluorene, as reported by Poriel et.al.6a Furthermore, the 
aromatic substituents at positions 6 and 7 are almost perpendicular to ring 3, as shown for 
SBF derivatives. 
 
  
Figure 20.Visualization of DS-IF backbone twisting 
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4.2.2.2. Synthesis of unsymmetrically substituted DS-IFs 
 
In the previous chapter, the symmetrically substituted SD-IFs 23 were synthesized in 
good overall yields. In addition to symmetrically substituted 23, it is assumed that the same 
methodology can be applied for synthesis of unsymmetrically substituted DS-IF derivatives. 
As far as properties of the unsymmetrically substituted DS-IFs are concerned, it is expected 
that they should exhibit interesting photophysical properties. For example, the interplay of 
electron-donating and -withdrawing groups within one molecule could result in dramatical 
change of their fluorescence emission spectra. With this goal in mind, strategies were 
developed for: 
a) synthesis of DS-IF with different substituents at positions 6 and 7 and  
b) synthesis of DS-IF with different substituents at positions 3 and 10.  
 
a) Synthesis of DS-IF with different substituents at positions 6 and 7 
In the first step, unsymmetrically substituted indeno[2,1-c]fluorene-5,8-diols at 
positions 6 and 7 were prepared. For this purpose, alkyne 24 and diyne 25 were synthesized 
using alkynylation reaction of the commercially available starting materials. More 
specifically, alkyne 24 was formed by alkynylation reaction of 2-iodobenzaldehyde with 
lithium (4-trifluoromethylphenyl)acetylide at -78 °C in THF for 3h in 83% isolated yield. 
Diynol 25 was also synthesized by alkynylation reaction of 2-ethynylbenzaldehyde with 
lithium (4-methoxyphenyl)acetylide at -78 °C in THF for 3h in 94% isolated yield. 
Compounds 24 and 25 were then connected using the Sonogashira cross-coupling reaction 
(PdCl2(PPh3)2 (5 mol%), CuI (10 mol%), NEt3, THF, 80 °C, 3h) to form triyndiol 26 in 91% 
isolated yield (Scheme 56). Gratifyingly, triyndiol 26 was cyclotrimerized in the presence of 
Wilkinson’s catalyst under the previously studied conditions (RhCl(PPh3)3 (3 mol%), Ag2CO3 
(6 mol%), THF, 180 °C, MW, 1.5h) into indeno[2,1-c]fluorene-5,8-diol 27 in a very high 
yield of 84%. Subsequently, oxidation to the corresponding indeno[2,1-c]fluorene-5,8-dione 
28 with PCC in dichloromethane at 25 °C also furnished 28 in a high isolated yield of 80%. 
Lastly, the unsymmetrically substituted DS-IF 29 was synthesized by reaction of 28 with 2 
equivalents of 2-lithiobiphenyl, followed by treatment with a mixture of acetic acid and a 
catalytic amount of concentrated HCl at 110 °C in a 65% isolated yield. The five-step 
synthetic pathway allowed synthesizing 29 in the overall yield of 33% (shown in parenthesis).   
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Scheme 56. Synthesis of unsymmetrically substituted DS-IF 29 (Pathway A) 
 
b) Synthesis of DS-IF with different substituents at positions 3 and 10. 
The synthesis started with the preparation of substituted 3-ethynylbenzaldehyde S1 
and bromobenzaldehyde S2. 3-Ethynylbenzaldehyde S1 was formed by Sonogashira reaction 
of 2-bromo-5-methoxybenzaldehyde with trimethylsilylacetylene using PdCl2(PPh3)2 (5 
mol%) and CuI (10 mol%) with triethylamine as base in THF at 80 °C for 3h. After filtration 
and evaporation of the solvents, the crude was subjected to deprotection of the TMS group 
under basic conditions using K2CO3 in a mixture of MeOH/H2O at 0 °C. It furnished S1 with 
terminal triple bond in 96% isolated yield.57 Bromobenzaldehyde S2 was formed by 
metallation of 4-trifluoromethylbromobenzene with LDA at -78 °C for 30min, then addition 
of DMF followed and the reaction mixture was stirred additionally at 25 °C for 1h yielding S2 
in 89% yield after acidic work-up and isolation.58 Sonogashira reaction of S1 with S2 
(PdCl2(PPh3)2 (5 mol%), CuI (10 mol%), NEt3, THF, 80 °C, 3h) gave rise to dialdehyde 30 in 
72% isolated yield. The substituted dialdehyde 30 was alkynylated with lithium p-
tolylacetylide at -78 °C in THF into triyndiol 31 in 75% isolated yield (Scheme 57).  
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Scheme 57. Synthesis of unsymmetrically substituted triyndiol 31 
 
Next, the intramolecular Rh-catalyzed cyclotrimerization was attempted. The 
previously used reaction conditions (Wilkinson’s catalyst (3 mol%), Ag2CO3 (6 mol%), THF, 
180 °C, MW, 1.5h) were applied and triyndiol 31 was converted into the desired 
unsymmetrically substituted indeno[2,1-c]fluorene-5,8-diol 32, albeit in a slightly lower 
isolated yield of 60%. To understand why the yield of the reaction was somewhat lower than 
in the case of indeno[2,1-c]fluorene-5,8-diols 21a-i, which showed almost full conversion 
(Section 4.2.2.1, Scheme 55), additional experiments were carried out. The reaction 
conditions, such as reaction time (30min–1.5h) and temperature (100–180 °C) were changed. 
Although in all experiments triyndiol 31 was fully consumed, judged by the disappearance of 
the starting material (TLC analysis), no change in yields of 32 were observed. Partial 
decomposition of 31 during the course of the reaction to undefined products cannot be 
excluded. Oxidation of 32 with PCC in dichloromethane at 25 °C furnished the corresponding 
unsymmetrically substituted indeno[2,1-c]fluorene-5,8-dione 32 in a high isolated yield of 
87%. In the last step, reaction of 32 with 2 equivalents of 2-lithiobiphenyl, followed by 
treatment with a mixture of acetic acid and a catalytic amount of concentrated HCl at 110 °C 
provided the unsymmetrically substituted DS-IF 34 in 84% isolated yield. The overall yield of 
the six-step reaction procedure was 21% (Scheme 58). 
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Scheme 58. Synthesis of unsymmetrically substituted DS-IF 34 (Pathway B) 
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4.2.3. Preparation of [7]-helical DS-IFs 
 
Until now, a set of nine symmetrically substituted DS-IFs, 23, and two 
unsymmetrically substituted DS-IFs 29 bearing substituents at positions 6 and 7 and 34 at 
positions 3 and 10 were prepared. In this step the developed synthetic method for the 
preparation of DS-IFs was applied to DS-IFs with more than five ortho-fused rings. Although 
the synthetic strategy was the same, now 1-bromo-2-naphthaldehyde was used as the starting 
material to synthesize DS-IFs possessing the [7]- helical DS-IF scaffold. Such compounds are 
structurally related to [7]-helical fluorenes and their heterocyclic analogs.59 
The reaction sequence started with Sonogashira coupling of 1-bromo-2-
naphthaldehyde with ethynyltrimethylsilane and was performed using PdCl2(PPh3)2 (5 mol%) 
and CuI (10 mol%) with triethylamine as a base in THF at 80 °C for 3h. The product was not 
isolated, but was instead filtered, and the solvents were removed. The subsequent removal of 
the TMS protection group under basic conditions with MeOH/K2CO3 at 0 °C furnished 1-
ethynyl-2-naphthaldehyde 36 in almost quantitative yield of 96%. In the following step, the 
second Sonogashira reaction of 1-bromo-2-naphthaldehyde (PdCl2(PPh3)2 (5 mol%), CuI (10 
mol%), NEt3, THF, 80 °C, 3h) with 36 gave rise to dialdehyde 37, again, in an almost 
quantitative isolated yield (96%). In the third step, the subsequent alkynylation of 37 with 
different 4-substituted lithium phenylacetylides (R = MeO-, H-, CF3-) in THF at -78 °C 
provided three symmetrically substituted triyndiols 38a-c in very high isolated yields ranging 
from 76 to 94%.  
With triyndiols 38a-c in hand, catalytic cyclotrimerization reactions followed. As in 
the previous cases, the [2+2+2] cyclotrimerization, catalyzed by RhCl(PPh3)3 (3 mol%) with 
Ag2CO3 (6 mol%) as additive in THF under MW irradiation at 180 °C, gave the desired [7]-
helical indenofluorenediols 39a-c in almost quantitative isolated yields (94-96%) as racemic 
mixtures of (M)- and (P)-helical enantiomers. Gratifyingly, these examples show the potential 
and efficiency of the Rh-catalyzed [2+2+2] cyclotrimerization. In particular, the excellent 
yield of the synthesis of the highly twisted helical systems (39a-c), consisting of all ortho-
fused six- and five-membered rings, highlights the importance of the intramolecular [2+2+2] 
cyclotrimerization key step. In this study, no attempts were performed to synthesize 
enantiomerically enriched molecules 39 or to separate the racemic mixtures into individual 
enantiomers. 
Finally, the  [7]-helical indenofluorenediols 39a-c were converted into [7]-helical DS-
IFs by oxidation and formation of the dispiroderivatives (the final products). For this purpose, 
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39a-c were oxidized with PCC in dichloromethane at 25 °C forming [7]-helical 
indenofluorenediones 40a-c in high isolated yields ranging from 82 to 95%. Then, the two-
step conversion based on the reaction of 40a-c with 2-lithiobiphenyl and followed by 
treatment with a mixture of acetic acid and a catalytic amount of concentrated HCl at 110 °C 
furnished [7]-helical DS-IFs 41a-c in high yields ranging from 76 to 79%.  
In summary, three [7]-helical DS-IFs 41a-c were formed in six steps from the 
commercially available starting materials, the overall yields were in a very good range of 48-
56% (Scheme 59, overall yields are shown in parenthesis). 
 
 
Scheme 59. Synthesis of extended [7]-helical DS-IF 41 
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The helical structures of 40a and 41a were unequivocally confirmed by a single crystal 
X-ray analysis (41a, Figure 21). The data show dihedral angles of 7.4° for the ring system 1-
2-3, 14.8° for 2-3-4, 24.0° for 3-4-5, 23.3° for 4-5-6 and 2.0° for 5-6-7 (Figure 22). The total 
sum of 64.1° reflects the high degree of molecular twist. The molecular twisting angles of 
structurally related [7]-helical compounds range from 82.8 to 97.8°.59a,b Thus, the degree of 
molecular twist in [7]-helical DS-IF 41a is lower, most likely due to the presence of two 
cyclopentadiene rings. 
 
 
Figure 21. Platon plot of 41a showing displacement ellipsoids at a 50% probability level 
 
         
Figure 22. Colorized visualization of (P)-[7]-helical DS-IF 41a backbone twisting 
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4.2.4. Analysis of photophysical properties 
4.2.4.1. Photophysical properties of DS-IFs 23, 29 and 34 
 
In the previous sections, a set of nine symmetrically substituted DS-IFs 23a-i, two 
unsymmetrically substituted DS-IFs 29 and 34 and three [7]-helical DS-IFs 41a-c were 
synthesized. 
Firstly, the analysis of the absorption spectral data with DPA as the standard reference 
was conducted for the symmetrically substituted DS-IF 23a-i. The data of the absorption 
spectroscopy show that the isobestic point for the further calculation of relative quantum 
yields of DS-IFs 23a-i was best in the range from 264 to 271 nm. The subsequent 
fluorescence emission data after excitation at corresponding λexc = 264-271 nm showed a 
maximum in the very narrow range of 359-380 nm (Figure 23) and quantum yields ranging 
from Φs = 0.09-0.70 (Table 15) for all DS-IFs, except 23h with TMS-substituent, which 
showed no emission in this area.  
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Figure 23. Absorption and normalized emission spectral data of symmetrically substituted 
DS-IFs 23 in10-6 M 
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Table 15. Photophysical properties for 23a-i (10-6 M in cyclohexane) 
 
 
The unsymmetrically substituted DS-IFs 29 and 34 showed, after excitation at the 
isobestic point λexc = 272 nm (for 29) and λexc = 268 nm (for 34), fluorescence emission 
maxima at λem = 370 nm and 389 nm (Figure 24) and quantum yields Φs = 0.54 and 0.60, 
respectively (Table 16).  
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 Figure 24. Absorption and normalized emission spectral data of unsymmetrically substituted 
DS-IF 29 and 34 
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Table 16. Photophysical properties for 29 and 34 (10-6 M in cyclohexane) 
exc /nm em /nm sa
272
268
370
389
0.54
0.60
Sample
29
34
a Quantum yields were calculated
relative to DPA ( r = 0.97).
max
 
 
Comparative analysis with parent 5,8-dispiroindeno[2,1-c]fluorene showed that:6a  
1)  Instead of two distinct emission peaks, all substituted DS-IFs show only one 
maximum emission peak, which overlaps a second emission peak in some cases.  
2)  All symmetrically substituted compounds 23 show the emission maximum λem = 359-
380 nm red-shifted by 1-22 nm in relation to the unsubstituted DS-IF (λem = 358 nm).  
3)  Electron-rich substituents apparently enhanced the red shift of the emission maxima, 
particularly 4-methoxyphenyl and thienyl substituents (23a and 23f, both λem = 380 nm) at 
positions 6 and 7 of the DS-IF. They both show a 22 nm shift in relation to the parent DS-IF.  
4)  The effect of the electron-donating and -withdrawing substituents directly attached to 
the DS-IF (34, λem = 389 nm, substituents at positions 3 and 10) is stronger than that of 4-
phenyl-substituted moieties at positions 6 and 7 of the DS-IF 29 (λem = 370 nm). This may be 
explained by the virtually perpendicular arrangement of the DS-IF and its substituents at 
positions 6 and 7, as shown by a X-ray single-crystal analysis of 23b (for details, please see: 
4.2.2.1). More specifically, this molecular twist may lead to weaker interactions between π-
systems, thereby decreasing the effect of substituents on the photophysical properties of the 
DS-IFs. Nevertheless, partial restoration of the planar arrangement presumably occurs in the 
excited state. The actual effect of twisted π-systems and their interactions with parent DS-IFs 
is not yet fully clarified, thus requiring further studies.2a,3a,8d,44,48,49 
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4.2.4.2. Photophysical properties of [7]-helical DS-IFs 41 
 
Similarly to the analysis of DS-IFs 23, 29 and 34 above (Section 4.2.4.1), the 
photophysical properties of [7]-helical DS-IFs 41 were also analyzed. After excitation at the 
isobestic point λexc = 269 nm for all three compounds, the fluorescence emission data of 41a-c 
showed red-shifted emission in the range of λem = 398-428 nm (Figure 25) with excellent 
quantum yields ranging from Φs = 0.75-0.88 (Table 17). 
 
Figure 25. Absorption and emission spectral data of symmetrically substituted [7]-helical DS-
IF 41 in10-6 M in cyclohexane 
 
Table 17. Photophysical properties for 41a-c (10-6 M in cyclohexane) 
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In comparison with the 5-ring containing DS-IFs 23a (R = OMe, λem = 380 nm) 23c (R 
= H, λem = 366 nm) and 23e (R = CF3, λem = 364 nm), the [7]-helical DSF-IFs 41a (R = OMe, 
λem = 428 nm), 41b (R = H, λem = 428 nm) and 41c (R = CF3, λem = 423 nm) show a shift in 
emission maxima by approximately 60 nm. This red shift of emission wavelength is cleary 
affected by the modulated π-extended structure. It is noteworthy that the compounds 41 
showed the highest quantum yields (Φs = 0.75-0.88), whereas other [7]-helical molecules have 
quantum yields Φ = 0.30-0.40.59 
In summary, it was possible to apply the previously developed reaction sequence for 
the preparation of 1,2,3,4-tetrasubstituted SBFs to synthesize a set of substituted DS-IFs. 
Thus, for the first time, 12 molecules were prepared containing symmetrically and 
unsymmetrically substituted DS-IFs and three molecules of [7]-helical DS-IFs. Furthermore, 
these π-extended [7]-helical DS-IFs 41 show very high quantum yields and fluorescence 
emission maxima in the blue region of visible light. Therefore, these DS-IFs could be, 
similarly to the SBFs, good candidates for applications materials science, such as in organic 
electronics and light-emitting devices (OLEDs), in dyes or even photovoltaic cells.6a-g,41 
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5. Conclusion 
 
In this study a new synthetic method based on a Rh-complex catalyzed [2+2+2] 
cyclotrimerization of compounds with the triple bonds for preparation of fluorenes and its 
congeners was presented. The method was applied in syntheses of (a) selectively 1,2,3,4-
tetrasubstituted SBFs, (b) symmetrically and unsymmetrically substituted DS-IFs, and (c) [7]-
helical DS-IFs. This general reaction pathway consists of five or six steps and its length 
depended only on the availability of the starting materials.  
 
a) In total, 19 different 1,2,3,4-tetrasubstituted SBFs with various substituents at position 
4 were prepared. These substituents included electron-donating and -withdrawing groups, 
aromatic substituents and π-extended aromatic hydrocarbon moieties. The key step was the 
catalytic cyclotrimerization of diynols with internal alkynes (the best results were obtained 
with 3-hexyne). All cyclotrimerization products were isolated in yields ranging from 45 to 
76%. Additionally, an extensive screening of cyclotrimerization reactions with Wilkinson’s 
catalyst under various reaction conditions (temperature, time, solvent and additives) was 
carried out as well. 1,2,3,4-Tetrasubstituted SBFs were synthesized in good overall yields 
(ranging from 9 to 34%) from the commercially available starting material (Scheme 52). The 
photophysical properties of all SBFs were analyzed by absorption and emission spectroscopy. 
Fluorescence emission maxima λem were in the range of 315-389 nm with quantum yields Φs 
up to 1.00. 
 
 
Scheme 52. Synthetic pathway for SBFs using Rh-catalyzed [2+2+2] cyclotrimerization 
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b) 9 symmetrically and 2 unsymmetrically substituted DS-IFs at positions 6 and 7 were 
synthesized bearing various electron-donating and -withdrawing groups by using the same 
strategy. The Rh-complex catalyzed [2+2+2] cyclotrimerization of the prepared triyndiols 
gave rise to indeno[2,1-c]fluorene-5,8-diols that were isolated in yields ranging from 73 to 
96% for symmetrically (Scheme 53) and from 60 to 84% for unsymmetrically substituted 
derivatives (Scheme 54). Subsequently, the corresponding DS-IFs were prepared from 
indeno[2,1-c]fluorene-5,8-diols in overall yields ranging from 21 to 60%. The photophysical 
properties of all DS-IFs were analyzed by absorption and emission spectroscopy. 
Fluorescence emission maxima were in the range of λem = 351-389 nm and quantum yields Φs 
were up to 0.70.  
 
 
Scheme 53. Synthetic pathway for symmetrically substituted DS-IF using Rh-catalyzed 
[2+2+2] cyclotrimerization 
 
 
Scheme 54. Synthetic pathway for unsymmetrically substituted DS-IF using Rh-catalyzed 
[2+2+2] cyclotrimerization 
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c) Finally, a set of three [7]-helical DS-IFs was prepared by using the same synthetic 
pathway from various commercially available starting compounds. The Rh-complex catalyzed 
[2+2+2] cyclotrimerization with triyndiols possessing the naphthalene units provided [7]-
helical indenofluorenediols that were isolated in yields ranging from 94 to 96%. 
Subsequently, the corresponding [7]-helical DS-IFs were formed from [7]-helical 
indenofluorenediols with overall yields ranging from 48 to 56% (Scheme 55). The 
photophysical properties of [7]-helical DS-IFs were again analyzed by absorption and 
emission spectroscopy. Fluorescence emission maxima were in the range of λem = 423-428 nm 
with quantum yields Φs up to 0.80. These molecules have one of the highest measured 
quantum yields among the class of helicene like compounds recorded thus far. 
 
 
Scheme 55. Synthetic pathway for [7]-helical DS-IFs using Rh-catalyzed [2+2+2] 
cyclotrimerization 
 
In summary, this short and high-yielding five- or six-step synthetic pathway opens 
several possibilities for the preparation of new and selectively substituted SBFs and DS-IFs at 
different positions. The Rh-catalyzed [2+2+2] cyclotrimerization emerged as the key step of 
this synthesis using the Wilkinson’s catalyst (RhClPPh3)3) as the most powerful catalyst. The 
systematic study provide useful guidelines for the future tuning and design of substituted 9,9’-
spirobifluorenes and dispiroindeno[2,1-c]fluorenes with predefined properties and their 
application in materials science. 
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6.  Experimental part 
6.1.  General 
 
All reagents were commercially available and obtained from Sigma-Aldrich, Acros 
Organics, and Strem Chemicals companies. Solvents were purified and dried by distillation: 
tetrahydrofuran (THF) and toluene from sodium/benzophenone, dichloromethane from 
calcium hydride. Other solvents and all reagents were used without further purification. All 
reactions were performed under argon atmosphere unless otherwise noted. Chromatography 
was performed on Merck Silica gel 60. Thin layer chromatography was performed on Merck 
silica gel 60 F254 coated aluminium sheets. The 1H NMR and 13C NMR spectra were recorded 
on a  Bruker AVANCE III Spectrometer (1H at 600 MHz and 13C at 150 MHz) or on Bruker 
AVANCE III Spectrometer (1H at 400 MHz and 13C at 100 MHz) as solutions in CDCl3, 
chemical shifts are given in δ-scale (1H NMR spectra were referenced to residual peak of 
CDCl3 at δ 7.26, 13C NMR spectra to CDCl3 at δ 77.00), coupling constants J are given in Hz. 
The following abbreviations are used to describe spin multiplicity: s = singlet, d = doublet, t = 
triplet, q = quartet, m = multiplet, dd = doublet of doublet, dt = doublet of triplet, dq = doublet 
of quartet, tt = triplet of triplet. Assignments of proton resonances were confirmed, when 
possible, by known literature data. The IR spectra were recorded on a Bruker IFS 55 
spectrometer in KBr tablets and are reported in wave numbers (cm-1). In case of liquids or oils 
the compounds were dissolved in acetone, mixed with KBr and the acetone evaporated. The 
MS spectra were recorded on a VG-Analytical ZAB-SEQ device. All melting points are 
uncorrected and were determined on a Kofler apparatus. 
  
100 
 
6.2.  Synthesis of 9,9’-spirobifluorene scaffolds 
6.2.1.  Synthesis of starting material 2, 8 and 12 
 
A:  General procedure for Sonogashira reaction60 (preparation of 1 and 7). 2-
Bromobenzaldehyde (230 µL, 2.0 mmol), PdCl2(PPh3)2 (69 mg, 0.1 mmol, 5 mol%) and CuI 
(38 mg, 0.2 mmol, 10 mol%) were dissolved in a Schlenk flask with reflux condensor in 
triethylamine (7 mL) and THF (7 mL), afterwards alkyne compound (2.4 mmol) was added 
and the reaction was stirred 3h under reflux. The reaction mixture was cooled down, filtered 
off with celite/silica and washed with diethyl ether. The organic fraction was concentrated on 
vacuum evaporator. Column chromatography of the residue on silica gel (hexanes/EtOAc) 
provided products. 
 
2-(Phenylethynyl)benzaldehyde (1a). With phenylacetylene (260 µL, 2.4 mmol) following 
the general procedure A. Column chromatography (5/1 hexanes/EtOAc) 
yielded 399 mg (96%) of the title compound as a yellow oil: 1H NMR (600 
MHz, CDCl3) δ 10.66 (d, J = 0.8 Hz, 1H), 7.95 (ddd, J = 7.8, 1.4, 0.6 Hz, 1H), 
7.65 (ddd, J = 7.8, 1.3, 0.6 Hz, 1H), 7.59 (dt, J = 7.4, 1.4 Hz, 1H), 7.56-7.58 
(m, 2H), 7.44-7.47 (m, 1H), 7.38-7.40 (m, 3H); 13C NMR (150 MHz, CDCl3) δ 191.7, 135.8, 
133.8, 133.2, 131.7, 129.1, 128.6, 128.5, 127.2, 126.9, 122.3, 96.3, 84.9. The spectral data 
were in accordance with previously published results.45 
 
2-(Pent-1-yn-1-yl)benzaldehyde (1b). With 2-bromobenzaldehyde (500 µL, 4.0 mmol) and 
1-pentyne (600 µL, 6.0 mmol) following the general procedure A. Column 
chromatography (5/1 hexanes/EtOAc) yielded 631 mg (92%) of the title 
compound as a yellow oil: 1H NMR (600 MHz, CDCl3) δ 10.54 (d, J = 0.9 Hz, 
1H), 7.87 (m, 1H), 7.49 (m, 2H), 7.35-7.38 (m, 1H), 2.45 (t, J = 7.1 Hz, 2H), 1.65 (m, 2H), 
1.06 (t, J = 7.4 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 192.1, 135.9, 133.6, 133.3, 127.9, 
127.8, 126.9, 98.0, 76.4, 22.0, 21.5, 13.6. The spectral data were in accordance with 
previously published results. 45 
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2-((4-Methoxyphenyl)ethynyl)benzaldehyde (7a). With 4-ethynylanisole (311 µL, 2.4 
mmol) following the general procedure A. Column chromatography (10/1 
hexanes/EtOAc) yielded 450 mg (96%) of the title compound as yellow 
oil: 1H NMR (600 MHz, CDCl3) δ 10.65 (d, J = 0.8 Hz, 1H), 7.93 (ddd, J 
= 7.8, 1.3, 0.5 Hz, 1H), 7.61 (ddd, J = 7.8, 1.3, 0.5 Hz, 1H), 7.57 (dt, J = 
7.3, 1.4 Hz, 1H), 7.51 (m, 2H), 7.43 (m, 1H), 6.91 (m, 2H), 3.85 (s, 3H); 13C NMR (150 MHz, 
CDCl3) δ 191.9, 160.2, 135.7, 133.8, 133.2, 133.0, 128.2, 127.4, 127.2, 114.4, 114.2, 96.6, 
83.8, 55.4. The spectral data were in accordance with previously published results.61 
 
2-(p-Tolylethynyl)benzaldehyde (7b). With p-tolylacetylene (305 µL, 2.4 mmol) following 
the general procedure A. Column chromatography (10/1 hexanes/EtOAc) 
yielded 392 mg (89%) of the title compound as pale yellow solid: 1H NMR 
(600 MHz, CDCl3) δ 10.66 (d, J = 0.8 Hz, 1H), 7.95 (ddd, J = 7.8, 1.4, 0.5 
Hz, 1H), 7.63 (ddd, J = 7.8, 1.3, 0.5 Hz, 1H), 7.58 (dt, J = 7.4, 1.4 Hz, 1H), 
7.47 (m, 2H), 7.44 (m, 1H), 7.19 (m, 2H), 2.39 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 191.8, 
139.4, 135.7, 133.7, 133.1, 131.6, 129.3, 128.4, 127.17, 127.15, 119.2, 96.6, 84.3, 21.6. The 
spectral data were in accordance with previously published results.62 
 
2-([1,1'-Biphenyl]-4-ylethynyl)benzaldehyde (7c). With 4-ethynylbiphenyl (428 mg, 2.4 
mmol) following the general procedure A. Column chromatography (10/1 
hexanes/EtOAc) yielded 520 mg (92%) of the title compound as a light 
yellow solid: 1H NMR (600 MHz, CDCl3) δ 10.68 (d, J = 0.8 Hz, 1H), 7.96 
(dd, J = 7.8, 1.0 Hz, 1H), 7.59-7.86 (m, 8H), 7.47 (m, 3H), 7.38 (m, 1H); 
13C NMR (150 MHz, CDCl3) δ 191.7, 141.8, 140.1, 135.8, 133.8, 133.2, 132.1, 128.9, 128.6, 
127.8, 127.3, 127.2, 127.1, 126.9, 121.2, 96.3, 85.6. The spectral data were in accordance 
with previously published results.63 
 
2-(Phenylethynyl)benzaldehyde (7d). With phenylacetylene (260 µL, 2.4 mmol) following 
the general procedure A. Column chromatography (5/1 hexanes/EtOAc) 
yielded 399 mg (96%) of the title compound as a yellow oil: 1H NMR (600 
MHz, CDCl3) δ 10.66 (d, J = 0.8 Hz, 1H), 7.95 (ddd, J = 7.8, 1.4, 0.6 Hz, 1H), 
7.65 (ddd, J = 7.8, 1.3, 0.6 Hz, 1H), 7.59 (dt, J = 7.4, 1.4 Hz, 1H), 7.56-7.58 
O
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(m, 2H), 7.44-7.47 (m, 1H), 7.38-7.40 (m, 3H); 13C NMR (150 MHz, CDCl3) δ 191.7, 135.8, 
133.8, 133.2, 131.7, 129.1, 128.6, 128.5, 127.2, 126.9, 122.3, 96.3, 84.9. The spectral data 
were in accordance with previously published results.60 
 
2-((4-Chlorophenyl)ethynyl)benzaldehyde (7e). With 1-chloro-4-ethynylbenzene (238 mg, 
2.4 mmol) following the general procedure A. Column chromatography 
(10/1 hexanes/EtOAc) yielded 431 mg (90%) of the title compound as a 
colorless oil: 1H NMR (600 MHz, CDCl3) δ 10.62 (d, J = 0.8 Hz, 1H), 7.95 
(ddd, J = 7.8, 1.4, 0.6 Hz, 1H), 7.64 (ddd, J = 7.8, 1.3, 0.6 Hz, 1H), 7.60 (dt, 
J = 7.3, 1.4 Hz, 1H), 7.46-7.51 (m, 3H), 7.36-7.38 (m, 2H); 13C NMR (150 MHz, CDCl3) δ 
191.5, 133.8, 133.2, 132.9, 128.9, 128.8, 127.5, 126.4, 120.8, 95.1, 85.9. The spectral data 
were in accordance with previously published results.64 
 
2-((4-(Trifluoromethyl)phenyl)ethynyl)benzaldehyde (7f). With 1-ethynyltrifluortoluene 
(392 µL, 2.4 mmol) following the general procedure A. Column 
chromatography (5/1 hexanes/EtOAc) yielded 442 mg (80%) of the title 
compound as a light brown solid: 1H NMR (600 MHz, CDCl3) δ 10.62 (d, 
J = 0.8 Hz, 1H), 7.97 (ddd, J = 7.8, 1.4, 0.5 Hz, 1H), 7.64-7.68 (m, 5H), 
7.59 (dt, J = 7.4, 1.4 Hz, 1H), 7.50 (m, 1H); 13C NMR (150 MHz, CDCl3) δ 191.2, 136.0, 
133.8, 133.4, 131.9, 130.8 (q, 2JC-F = 32.8 Hz), 129.2, 127.6, 126.1, 125.8, 125.4 (q, 3JC-F = 
3.8 Hz), 121.1-126.5 (q, 1JC-F = 272.3 Hz), 94.5, 87.2. The spectral data were in accordance 
with previously published results.64 
 
4-((2-Formylphenyl)ethynyl)benzonitrile (7g). With 4-ethynylbenzonitrile (305 mg, 2.4 
mmol) following the general procedure A. Column chromatography (10/1 
hexanes/EtOAc) yielded 392 mg (84%) of the title compound as a light 
yellow solid: 1H NMR (600 MHz, CDCl3) δ 10.59 (d, J = 0.8 Hz, 1H), 7.97 
(ddd, J = 7.8, 1.3, 0.5 Hz, 1H), 7.65-7.69 (m, 5H), 7.63 (dt, J = 7.3, 1.4 Hz, 
1H), 7.53 (m, 1H); 13C NMR (150 MHz, CDCl3) δ 191.0, 136.0, 133.9, 133.5, 132.19, 132.16, 
129.5, 127.9, 127.2, 125.3, 118.3, 112.3, 94.1, 89.1. The spectral data were in accordance 
with previously published results.65 
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B:  General procedure for alkynylation reaction60 (preparation of 2, 8, 12). n-BuLi 
1.6M (1.8 mL, 2.7 mmol) was added dropwise to a solution of 1-ethynyl-4-p-toluene (340 µL, 
2.7 mmol) in anhydrous THF (15 mL), at -78 °C. After 30min of stirring, starting material S 
(1.78 mmol) in THF (5 mL) was added and the reaction mixture was stirred for 5 min at -78 
°C, afterwards it was allowed to warm up to ambient temperature and the reaction was stirred 
4h. Then NH4Cl aq was used to quench the reaction mixture, it was extracted with diethyl 
ether (3 x 15 mL), the combined organic fractions were washed with a saturated solution of 
NaHCO3 and brine, the organic layer was dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure. Column chromatography of the residue on silica gel 
(hexanes/EtOAc) provided products. 
 
3-Phenyl-1-(2-(phenylethynyl)phenyl)prop-2-yn-1-ol (2a). With 1a (0.64 g, 2.8 mmol) and 
phenylacetylene (3.3 mmol) following the general procedure B. Column 
chromatography (5/1 hexanes/EtOAc) yielded 0.73 g (86%) of the title 
compound as pale yellow oil: 1H NMR (600 MHz, CDCl3) δ 7.81 (d, J = 7.8 
Hz, 1H), 7.59-7.61 (m, 3H), 7.48 (d, J = 7.8 Hz, 2H), 7.42 (t, J = 7.7 Hz, 1H), 7.35-7.38 (m, 
4H), 7.30-7.33 (m, 3H), 6.19 (s, 1H), 2.89 (s, 1H); 13C NMR (150 MHz, CDCl3) δ 142.2, 
132.5, 131.7, 131.6, 128.9, 128.6, 128.5, 128.4, 128.3, 128.2, 126.8, 122.8, 122.5, 121.4, 95.0, 
88.3, 86.6, 86.5, 63.7. The spectral data were in accordance with previously published 
results.65 
 
(3-Phenyl-1-(2-(phenylethynyl)phenyl)prop-2-yn-1-yl)oxy-tert-butyldimethylsilane (2a-
TBS). 2a (0.87 g, 3.3 mmol) was dissolved in anhydrous DMF (30 mL) and 
cooled to 0 °C. Imidazole (0.34 g, 4.9 mmol), DMAP (60.5 mg, 0.50 mmol) 
and afterwards TBDMSCl (0.59 g, 3.9 mmol) were added and the reaction 
was stirred for 30 min at 0 °C. Afterwards the reaction mixture was allowed to reach 25 °C 
and stirred for 6 h. The reaction mixture was quenched with a saturated solution of 
ammonium chloride and extracted by diethyl ether (3 × 20 mL), combined organic fractions 
were washed with brine, dried over anhydrous MgSO4, filtered and concentrated on vacuum 
evaporator. The residue was purified by column chromatography on silica gel (10/1 
hexanes/EtOAc) to yield 0.61 g (53%) of the title compound as a light brown oil: 1H NMR 
(600 MHz, CDCl3) δ 7.82 (m, 1H), 7.55-7.58 (m, 2H), 7.54 (m, 1H), 7.39-7.43 (m, 3H), 7.35-
7.38 (m, 3H), 7.32 (dt, J = 7.6, 1.3 Hz, 1H), 7.25-7.28 (m, 3H), 6.21 (s, 1H), 0.97 (s, 9H), 
0.26 (s, 3H), 0.20 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 143.6, 132.0, 131.6, 131.5, 128.8, 
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128.42, 128.38, 128.13, 128.10, 127.6, 126.5, 123.3, 123.1, 120.8, 94.6, 90.1, 87.1, 85.0, 63.6, 
25.8, 18.4, -4.4, -4.8; IR (KBr) νmax 3058, 3028, 2956, 2926, 2854, 1598, 1488, 1473, 1443, 
1323, 1251, 1111, 1075, 866, 842, 752 cm-1; HRMS (m/z) for C29H30OSiNa (M + Na) calcd: 
445.19581, found: 445.19583; Rf (10/1 hexanes/EtOAc) = 0.67 (silica gel plate). 
 
1-(2-(Phenylethynyl)phenyl)hex-2-yn-1-ol (2b). With 1a (90 mg, 0.44 mmol) and 1-pentyne 
(65 µL, 0.65 mmol) following the general procedure B. Column 
chromatography (5/1 hexanes/EtOAc) yielded 115 mg (95%) of the title 
compound as a light yellow oil: 1H NMR (600 MHz, CDCl3) δ 7.74 (m, 1H), 
7.55-7.57 (m, 3H), 7.39 (dt, J = 7.5, 1.4 Hz, 1H), 7.35-7.37 (m, 3H), 7.31 (dt, J = 7.6, 1.4 Hz, 
1H), 5.96 (m, 1H), 2.62 (d, J = 5.1 Hz, 1H), 2.25 (dt, J = 7.1, 2.1 Hz, 2H), 1.56 (m, 2H), 0.98 
(t, J = 7.4 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 142.9, 132.4, 131.6, 128.8, 128.6, 128.4, 
128.1, 126.6, 122.9, 121.3, 94.7, 87.5, 86.7, 79.5, 63.4, 22.0, 20.8, 13.5; IR (KBr) νmax 3554, 
3327, 3052, 3031, 2962, 2929, 2866, 2836, 2280, 2223, 1598, 1494, 1446, 1278, 1183, 1132, 
1036, 994, 758 cm-1; HRMS (m/z) for C20H18O (M + Cl) calcd: 274.1358, found: 274.1360; Rf 
(1/1 hexanes/EtOAc) = 0.52 (silica gel plate). 
 
1-(2-(Pent-1-yn-1-yl)phenyl)-3-phenylprop-2-yn-1-ol (2c). With 1b (172 mg, 1.0 mmol) 
and phenylacetylene (134 µL, 1.2 mmol) following the general procedure B. 
Column chromatography (5/1 hexanes/EtOAc) yielded 265 mg (96%) of the 
title compound as a yellow oil: 1H NMR (600 MHz, CDCl3) δ 7.73 (dd, J = 
7.6, 1.4 Hz, 1H), 7.47 (m, 2H), 7.45 (dd, J = 7.5, 1.1 Hz, 1H), 7.34 (dt, J = 7.6, 1.4 Hz, 1H), 
7.30-7.32 (m, 3H), 7.28 (dt, J = 7.6, 1.4 Hz, 1H), 6.07 (d, J = 3.5 Hz, 1H), 2.84 (d, J = 4.7 Hz, 
1H), 2.47 (t, J = 7.0 Hz, 2H), 1. 86 (m, 2H), 1.08 (t, J = 7.4 Hz, 3H); 13C NMR (150 MHz, 
CDCl3) δ 142.1, 132.6, 131.7, 128.4, 128.22, 128.18, 128.1, 126.7, 122.6, 122.2, 96.3, 88.3, 
86.4, 78.7, 63.8, 22.1, 21.6, 13.6. The spectral data were in accordance with previously 
published results.67 
 
1-(2-(Pent-1-yn-1-yl)phenyl)hex-2-yn-1-ol (2d). With 1b (172 mg, 1.0 mmol) and 1-pentyne 
(150 µL, 1.5 mmol) following the general procedure B. Column 
chromatography (5/1 hexanes/EtOAc) yielded 223 mg (93%) of the title 
compound as a slight yellow oil: 1H NMR (600 MHz, CDCl3) δ 7.67 (d, J = 
7.3 Hz, 1H), 7.41 (d, J = 7.6 Hz, 1H), 7.31 (dt, J = 7.6, 1.2 Hz, 1H), 7.24 (dt, J = 7.6, 1.3 Hz, 
1H), 5.85 (m, 1H), 2.63 (d, J = 5.5 Hz, 1H), 2.44 (t, J = 7.0 Hz, 2H), 2.25 (dt, J = 7.0, 2.0 Hz, 
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2H), 1.67 (m, 2H), 1.58 (m, 2H), 1.07 (t, J = 7.4 Hz, 3H), 1.00 (t, J = 7.4 Hz, 3H); 13C NMR 
(150 MHz, CDCl3) δ 142.7, 132.5, 128.1, 128.0, 126.5, 122.1, 96.0, 87.4, 79.46, 78.1, 63.5, 
22.2, 22.0, 21.6, 20.97, 13.6, 13.5. The spectral data were in accordance with previously 
published results.60 
 
1-(2-((4-Methoxyphenyl)ethynyl)phenyl)-3-(p-tolyl)prop-2-yn-1-ol (8a). With 7a (450 mg, 
1.9 mmol) following the general procedure B. Column chromatography 
(5/1 hexanes/EtOAc) yielded 560 mg (84%) of the title compound as 
pale yellow oil: 1H NMR (600 MHz, CDCl3) δ 7.78 (dd, J = 7.7, 1.3 Hz, 
1H), 7.55 (dd, J = 7.6, 1.3 Hz, 1H), 7.51 (m, 2H), 7.39 (dt, J = 7.6, 1.3 
Hz, 1H), 7.35 (m, 2H), 7.33 (dt, J = 7.6, 1.4 Hz, 1H), 7.10 (d, J = 7.9 Hz, 2H), 6.88 (m, 2H), 
6.15 (d, J = 5.9 Hz, 1H), 3.83 (s, 3H), 2.84 (d, J = 5.9 Hz, 1H), 2.34 (s, 3H); 13C NMR (150 
MHz, CDCl3) δ 159.9, 142.1, 138.6, 133.1, 132.3, 131.6, 129.0, 128.5, 128.2, 126.8, 121.8, 
119.4, 114.9, 114.1, 95.1, 87.6, 86.6, 85.4, 63.9, 55.3, 21.5. The spectral data were in 
accordance with previously published results.67 
 
3-(p-Tolyl)-1-(2-(p-tolylethynyl)phenyl)prop-2-yn-1-ol (8b). With 7b (392 mg, 1.78 mmol) 
following the general procedure B. Column chromatography (5/1 
hexanes/EtOAc) yielded 545 mg (91%) of the title compound as pale 
yellow oil: 1H NMR (600 MHz, CDCl3) δ 7.78 (dd, J = 7.8, 1.3 Hz, 1H), 
7.57 (dd, J = 7.6, 1.0 Hz, 1H), 7.46 (d, J = 8.1 Hz, 2H), 7.40 (dt, J = 7.6, 
1.4 Hz, 1H), 7.35 (d, J = 8.1 Hz, 2H), 7.33 (dt, J = 7.5, 1.1 Hz, 1H), 7.16 (d, J = 7.8 Hz, 2H), 
7.10 (d, J = 7.8 Hz, 2H), 6.15 (d, J = 5.9 Hz, 1H), 2.77 (d, J = 5.9 Hz, 1H), 2.38 (s, 3H), 2.34 
(s, 3H); 13C NMR (150 MHz, CDCl3) δ 142.3, 138.8, 138.6, 132.4, 131.7, 131.5, 129.2, 129.0, 
128.7, 128.2, 126.8, 121.7, 119.7, 119.4, 95.3, 87.6, 86.7, 86.0, 63.9, 21.53, 21.46. The 
spectral data were in accordance with previously published results.66 
 
1-(2-([1,1'-Biphenyl]-4-yl-ethynyl)phenyl)-3-(p-tolyl)prop-2-yn-1-ol (8c). With 7c (540 
mg, 1.8 mmol) following the general procedure B. Column 
chromatography (5/1 hexanes/EtOAc) yielded 650 mg (90%) of the title 
compound as a light yellow oil: 1H NMR (600 MHz, CDCl3) δ 7.80 (ddd, 
J = 7.8, 0.9, 0.4 Hz, 1H), 7.60-7.66 (m, 7H), 7.47 (m, 2H), 7.42 (dt, J = 
7.6, 1.3 Hz, 1H), 7.34-7.40 (m, 4H), 7.10 (d, J = 7.9 Hz, 2H), 6.18 (d, J = 5.9 Hz, 1H), 2.78 
(d, J = 5.9 Hz, 1H), 2.34 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 142.4, 141.3, 140.2, 138.6, 
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132.5, 132.0, 131.7, 129.0, 128.9, 128.9, 128.3, 127.7, 127.1, 127.0, 126.8, 121.7, 121.5, 
119.4, 95.0, 87.6, 87.3, 86.7, 63.9, 21.5; IR (KBr) νmax 3548, 3342, 3060, 3028, 2947, 2920, 
2866, 2211, 1595, 1512, 1494, 1446, 1404, 1374, 1275, 1224, 1183, 1108, 1027, 1009, 967, 
842, 815, 764, 698 cm-1; HRMS (m/z) for C30H22ONa (M + Na) calcd: 421.15629 found: 
421.15630; Rf (2/1 hexanes/EtOAc) = 0.43 (silica gel plate). 
 
1-(2-(Phenylethynyl)phenyl)-3-(p-tolyl)prop-2-yn-1-ol (8d). With 7d (396 mg, 1.95 mmol) 
following the general procedure B. Column chromatography (5/1 
hexanes/EtOAc) yielded 590 mg (93%) of the title compound as pale yellow 
oil: 1H NMR (600 MHz, CDCl3) δ 7.80 (dd, J = 7.8, 1.3 Hz, 1H), 7.57-7.60 
(m, 3H), 7.42 (dt, J = 7.6, 1.4 Hz, 1H), 7.33-7.37 (m, 6H), 7.10 (d, J = 7.8 
Hz, 2H), 6.16 (d, J = 5.9 Hz, 1H), 2.76 (d, J = 5.9 Hz, 1H), 2.34 (s, 3H); 13C NMR (150 MHz, 
CDCl3) δ 142.4, 138.6, 132.5, 131.64, 131.58, 129.0, 128.9, 128.6, 128.4, 128.3, 126.8, 122.8, 
121.5, 119.4, 95.0, 87.5, 86.7, 86.6, 63.8, 21.5. The spectral data were in accordance with 
previously published results.66 
 
1-(2-((4-Chlorophenyl)ethynyl)phenyl)-3-(p-tolyl)prop-2-yn-1-ol (8e). With 7e (434 mg, 
1.8 mmol) following the general procedure B. Column chromatography 
(5/1 hexanes/EtOAc) yielded 570 mg (89%) of the title compound as 
colorless solid: mp (decomp) 126-131 °C; 1H NMR (600 MHz, CDCl3) δ 
7.78 (dd, J = 7.8, 1.3 Hz, 1H), 7.56 (dd, J = 7.6, 1.3 Hz, 1H), 7.48 (m, 2H), 
7.42 (dt, J = 7.7, 1.3 Hz, 1H), 7.32-7.36 (m, 5H), 7.10 (d, J = 7.8 Hz, 2H), 6.12 (s, 1H), 2.67 
(s, 1H), 2.34 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 142.4, 138.7, 134.6, 132.8, 132.5, 131.6, 
129.1, 129.0, 128.8, 128.3, 126.8, 121.3, 121.2, 119.3, 93.8, 87.6, 87.5, 86.8, 63.8, 21.5; IR 
(KBr) νmax 3276, 3189, 3066, 3034, 2989, 2914, 2864, 2851, 2217, 1568, 1512, 1488, 1470, 
1392, 1284, 1219, 1186, 1090, 1027, 1015, 970, 830, 818, 749 cm-1; HRMS (m/z) for 
C24H17OClNa (M + Na) calcd: 379.08601, found: 379.08618; Rf (2/1 hexanes/EtOAc) = 0.45 
(silica gel plate). 
 
3-(p-Tolyl)-1-(2-((4-(trifluoromethyl)phenyl)ethynyl)phenyl)prop-2-yn-1-ol (8f). With 7f 
(442 mg, 1.6 mmol) following the general procedure B. Column 
chromatography (5/1 hexanes/EtOAc) yielded 564 mg (90%) of the title 
compound as colorless solid: mp (decomp) 133-138 °C; 1H NMR (600 
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MHz, CDCl3) δ 7.81 (dd, J = 7.8, 1.1 Hz, 1H), 7.66 (d, J = 8.1 Hz, 2H), 7.60 (m, 3H), 7.45 
(dt, J = 7.6, 1.3 Hz, 1H), 7.36 (dt, J = 7.6, 1.2 Hz, 1H), 7.33 (d, J = 8.1 Hz, 2H), 7.10 (d, J = 
7.9 Hz, 2H), 6.13 (d, J = 5.9 Hz, 1H), 2.63 (d, J = 5.9 Hz, 1H), 2.34 (s, 3H); 13C NMR (150 
MHz, CDCl3) δ 142.6, 138.8, 132.7, 131.8, 131.6, 130.2 (q, 2JC-F = 32.7 Hz), 129.5, 129.0, 
128.4, 126.8, 126.7, 125.3 (q, 3JC-F = 3.8 Hz), 121.2-126.7 (q, 1JC-F = 272.3 Hz), 120.8, 119.3, 
93.4, 89.0, 87.5, 86.8, 63.7, 21.5; IR (KBr) νmax 3273, 3180, 3066, 3028, 2992, 2926, 2875, 
2223, 1610, 1509, 1476, 1404, 1332, 1165, 1108, 1066, 1030, 967, 842, 815, 749 cm-1; 
HRMS (m/z) for C25H18OF3 (M + H) calcd: 391.13043, found: 391.13058; Rf (2/1 
hexanes/EtOAc) = 0.47 (silica gel plate). 
 
4-((2-(1-Hydroxy-3-(p-tolyl)prop-2-yn-1-yl)phenyl)ethynyl)benzonitrile (8g). With 7g 
(392 mg, 1.7 mmol) following the general procedure B. Column 
chromatography (5/1 hexanes/EtOAc) yielded 556 mg (94%) of the title 
compound as light brown solid: mp (decomp) 151-156 °C; 1H NMR (600 
MHz, CDCl3) δ 7.81 (dd, J = 7.8, 0.6 Hz, 1H), 7.63 (s, 4H), 7.58 (dd, J = 
7.6, 0.9 Hz, 1H), 7.46 (dt, J = 7.6, 1.3 Hz, 1H), 7.37 (dt, J = 7.6, 1.2 Hz, 1H), 7.32 (m, 2H), 
7.10 (d, J = 7.9 Hz, 2H), 6.10 (d, J = 5.1 Hz, 1H), 2.62 (d, J = 5.1 Hz, 1H), 2.34 (s, 3H); 13C 
NMR (150 MHz, CDCl3) δ 142.7, 138.9, 132.7, 132.1, 132.0, 131.6, 129.8, 129.1, 128.4, 
127.8, 126.9, 120.5, 119.2, 118.4, 111.8, 93.1, 91.0, 87.4, 86.9, 63.6, 21.5; IR (KBr) νmax 
3279, 3324, 3192, 3060, 3028, 2992, 2914, 2881, 2857, 2226, 1598, 1504, 1473, 1455, 1407, 
1290, 1183, 1120, 1105, 1027, 973, 839, 818, 752 cm-1; HRMS (m/z) for C25H17NO (M+) 
calcd: 347.1310, found: 347.1311; Rf (2/1 hexanes/EtOAc) = 0.38 (silica gel plate). 
 
1-(2-Ethynylphenyl)-3-(p-tolyl)prop-2-yn-1-ol (12a). With 2-ethynylbenzaldehyde (650 mg, 
5.0 mmol) following the general procedure B. Column chromatography (5/1 
hexanes/EtOAc) yielded 1.19 g (96%) of the title compound as light brown 
oil: 1H NMR (400 MHz, CDCl3) δ 7.79 (dd, J = 7.8, 1.2 Hz, 1H), 7.54 (dd, J 
= 7.7, 1.2 Hz, 1H), 7.43 (dt, J = 7.6, 1.4 Hz, 1H), 7.36 (m, 2H), 7.31 (dt, J = 7.6, 1.3 Hz, 1H), 
7.11 (d, J = 7.9 Hz, 2H), 6.12 (d, J = 5.4 Hz, 1H), 3.41 (s, 1H), 2.74 (d, J = 5.4 Hz, 1H), 2.35 
(s, 3H); 13C NMR (100 MHz, CDCl3) δ 142.9, 138.7, 133.2, 131.6, 129.4, 129.0, 128.3, 126.9, 
120.4, 119.3, 87.3, 86.8, 82.7, 81.0, 63.5, 21.5; IR (KBr) νmax 3536, 3291, 3063, 3031, 2914, 
2863, 2226, 1509, 1476, 1443, 1383, 1266, 1207, 1180, 1096, 1021, 967, 821, 761 cm-1; 
HRMS (m/z) for C18H14ONa (M + Na) calcd: 269.09369, found: 269.09360; Rf (2/1 
hexanes/EtOAc) = 0.43 (silica gel plate). 
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Preparation of 1-(2-Ethynylphenyl)hex-2-yn-1-ol (12b). With 2-ethynylbenzaldehyde (1.3 
g, 10.0 mmol) and 1-pentyne (1.5 mL, 15 mmol) following the general 
procedure B. Column chromatography (5/1 hexanes/EtOAc) yielded 1.8 g 
(91%) of the title compound as light brown oil: 1H NMR (400 MHz, CDCl3) 
δ 7.72 (dd, J = 7.8, 1.0 Hz, 1H), 7.50 (dd, J = 7.6, 1.1 Hz, 1H), 7.40 (dt, J = 7.6, 1.3 Hz, 1H), 
7.29 (dt, J = 7.6, 1.3 Hz, 1H), 5.88 (s, 1H), 3.37 (s, 1H), 2.49 (d, J = 4.5 Hz, 1H), 2.25 (dt, J = 
7.1, 2.0 Hz, 2H), 1.56 (m, 2H), 0.99 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 143.5, 
133.1, 129.4, 128.1, 126.7, 120.3, 87.7, 82.5, 81.1, 79.2, 63.1, 22.0, 20.8, 13.5; IR (KBr) νmax 
3545, 3288, 3069, 3028, 2962, 2932, 2905, 2869, 2836, 2283, 2223, 1482, 1452, 1383, 1335, 
1275, 1201, 1132, 1036, 991, 758 cm-1; HRMS (m/z) for C14H14O (M+) calcd: 198.1045, 
found: 198.1044; Rf (5/1 hexanes/EtOAc) = 0.25 (silica gel plate).  
 
1-(2-((4-Bromophenyl)ethynyl)phenyl)-3-(p-tolyl)prop-2-yn-1-ol (8h). 12a (736 mg, 4.6 
mmol), 1-bromo-4-iodobenzene (1.1 g, 3.6 mmol), PdCl2(PPh3)2 (104 mg, 
0.15 mmol, 5 mol%) and CuI (57 mg, 0.3 mmol, 10 mol%) were dissolved 
in a flask in diisopropylamine (30 mL) and the reaction was stirred 16 h at 
50 °C. The reaction mixture was cooled down, filtered off with celite/silica 
and washed with diethyl ether. The organic fraction was concentrated on vacuum evaporator. 
Column chromatography of the residue on silica gel (2/1 hexanes/EtOAc) yielded 1.15 g 
(95%) of the title compound as brown solid: mp (decomp) 127-132 °C; 1H NMR (400 MHz, 
CDCl3) δ 7.79 (dd, J = 7.8, 1.3 Hz, 1H), 7.56 (dd, J = 7.5, 1.1 Hz, 1H), 7.47-7.50 (m, 2H), 
7.40-7.44 (m, 3H), 7.32-7.36 (m, 3H), 7.09 (d, J = 7.9 Hz, 2H), 6.12 (d, J = 4.9 Hz, 1H), 2.74 
(d, J = 4.9 Hz, 1H), 2.34 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 142.4, 138.7, 133.0, 132.5, 
131.7, 131.6, 129.1, 129.0, 128.3, 126.8, 122.9, 121.8, 121.1, 119.3, 93.9, 87.8, 87.5, 86.7, 
63.7, 21.5; IR (KBr) νmax 3548, 3342, 3060, 3022, 2914, 2863 2223, 1506, 1488, 1446, 1389, 
1314, 1269, 1189, 1099, 1069, 1024, 1012, 961, 821, 758, 525 cm-1; HRMS (m/z) for 
C24H17OBrNa (M + Na) calcd: 423.03550, found: 423.03553; Rf (2/1 hexanes/EtOAc) = 0.46 
(silica gel plate). 
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1-(2-(Naphthalen-2-ylethynyl)phenyl)hex-2-yn-1-ol (15a). With 12b and 2-
bromonaphthalene (397 mg, 2.0 mmol) following the general procedure 
A. Column chromatography (3/1 hexanes/EtOAc) yielded 434 mg (57%) 
of the title compound as a light brown oil: 1H NMR (400 MHz, CDCl3) δ 
8.08 (s, 1H), 7.82 (m, 3H), 7.75 (dd, J = 7.8, 0.9 Hz, 1H), 7.59 (m, 2H), 
7.50 (m, 2H), 7.41 (dt, J = 7.5, 1.4 Hz, 1H), 7.34 (dt, J = 7.6, 1.3 Hz, 1H), 6.02 (s, 1H), 2.64 
(s, 1H), 2.27 (dt, J = 7.1, 2.0 Hz, 2H), 1.56 (m, 2H), 0.99 (t, J = 7.4 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 142.9, 135.2 133.0, 132.4, 131.5, 128.9, 128.2, 128.12, 128.08, 127.80, 
127.78, 126.8, 126.7, 126.6, 121.4, 120.2, 95.20, 87.56, 87.01, 79.49, 63.5, 22.0, 20.9, 13.5; 
IR (KBr) νmax 3368, 3055, 2962, 2929, 2869, 2220, 1601, 1503, 1482, 1467, 1434, 1272, 
1183, 1135, 1096, 1030, 997, 955, 896, 857, 815, 749, cm-1; HRMS (m/z) for C24H20O (M+) 
calcd: 324.1514 found: 324.1515; Rf (2/1 hexanes/EtOAc) = 0.44 (silica gel plate). 
 
1-(2-(Phenanthren-9-ylethynyl)phenyl)hex-2-yn-1-ol (15b). With 12b and 2-bromo-
phenanthrene (40 mg, 0.2 mmol) following the general procedure A. 
Column chromatography (2/1 hexanes/EtOAc) yielded 53 mg (71%) of 
the title compound as a light brown oil: 1H NMR (400 MHz, CDCl3) δ 
8.72 (dd, J = 5.9, 3.6 Hz, 1H), 8.67 (d, J = 8.3 Hz, 1H), 8.60 (m, 1H), 8.12 
(s, 1H), 7.88 (d, J = 7.8 Hz, 1H), 7.81 (d, J = 7.7 Hz, 1H), 7.67-7.74 (m, 
4H), 7.62 (t, J = 7.5 Hz, 1H), 7.45 (t, J = 7.5 Hz, 1H), 7.38 (t, J = 7.5 Hz, 1H), 6.12 (s, 1H), 
2.64 (s, 1H), 2.28 (t, J = 7.1 Hz, 2H), 1.58 (m, 2H), 0.97 (t, J = 7.4 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 142.9, 132.7, 132.2, 131.2, 131.0, 130.4, 130.1, 129.0, 128.6, 128.2, 127.6, 
127.2, 127.1, 127.01, 126.97, 126.6, 122.8, 122.6, 121.5, 119.4, 93.2, 91.1, 87.7, 79.6, 63.5, 
22.0, 20.9, 13.5; IR (KBr) νmax 3545, 3354, 3058, 2962, 2932, 2902, 2869, 2833, 2280, 2214, 
1598, 1479, 1449, 1377, 1278, 1245, 1180, 1126, 1096, 1039, 1000, 955, 893, 755, 722 cm-1; 
HRMS (m/z) for C28H22ONa (M + Na) calcd: 397.15629 found: 397.15631; Rf (2/1 
hexanes/EtOAc) = 0.42 (silica gel plate). 
 
1-(2-(Anthracen-9-ylethynyl)phenyl)hex-2-yn-1-ol (15c). With 12b and 2-
bromonaphthalene (257 mg, 1.0 mmol) following the general procedure A. 
Column chromatography (5/1 hexanes/EtOAc) yielded 153 mg (41%) of 
the title compound as a light brown oil: 1H NMR (400 MHz, CDCl3) δ 8.70 
(dd, J = 8.7, 0.9 Hz, 2H), 8.45 (s, 1H), 8.01 (d, J = 8.5 Hz, 2H), 7.86 (dd, J 
= 7.7, 1.4 Hz, 1H), 7.81 (dd, J = 7.5, 1.3 Hz, 1H), 7.62 (m, 2H), 7.52 (m, 2H), 7.47 (dt, J = 
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7.5, 1.5 Hz, 1H), 7.43 (dt, J = 7.5, 1.6 Hz, 1H), 6.21 (s, 1H), 2.64 (s, 1H), 2.27 (dt, J = 7.1, 2.1 
Hz, 2H), 1.54 (m, 2H), 0.95 (t, J = 7.3 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 142.6, 132.8, 
132.7, 131.1, 129.0, 128.7, 128.2, 128.1, 126.8, 126.7, 126.5, 125.7, 121.8, 97.9, 91.7, 87.8, 
79.8, 63.5, 22.0, 20.9, 13.5; IR (KBr) νmax 3304, 3053, 2962, 2932, 2902, 2870, 2224, 2187, 
1621, 1597, 1483, 1436, 1412, 1362, 1259, 1183, 1096, 1034, 1013, 999, 888, 845, 756, 739, 
693 cm-1; HRMS (m/z) for C28H22ONa (M + Na) calcd: 397.25629 found: 397.25602; Rf (2/1 
hexanes/EtOAc) = 0.41 (silica gel plate). 
 
1-(2-(Pyren-2-ylethynyl)phenyl)hex-2-yn-1-ol (15d). With 12b and 2-bromopyrene (281 
mg, 1.0 mmol) following the general procedure A. Column 
chromatography (5/1 hexanes/EtOAc) yielded 246 mg (62%) of the title 
compound as a light brown oil: 1H NMR (400 MHz, CDCl3) δ 8.68 (d, 
J = 9.1 Hz, 1H), 8.16-8.22 (m, 4H), 8.00-8.12 (m, 4H), 7.83 (dd, J = 
7.7, 1.3 Hz, 1H), 7.74 (dd, J = 7.5, 1.3 Hz, 1H), 7.46 (dt, J = 7.5, 1.5 
Hz, 1H), 7.40 (dt, J = 7.5, 1.5 Hz, 1H), 6.19 (s, 1H), 2.73 (s, 1H), 2.30 (dt, J = 7.1, 2.1 Hz, 
2H), 1.57 (m, 2H), 0.99 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 142.8, 132.6, 
131.9, 131.4, 131.2, 131.0, 129.7, 128.9, 128.5, 128.2, 128.2, 127.2, 126.6, 126.2, 125.7, 
125.6, 125.4, 124.5, 124.4, 124.2, 121.7, 117.4, 94.1, 92.3, 87.7, 79.7, 63.6, 22.0, 20.9, 13.5; 
IR (KBr) νmax 3545, 3291, 3044, 2961, 2932, 2902, 2871, 2206, 1927, 1600, 1508, 1486, 
1448, 1435, 1379, 1275, 1242, 1184, 1133, 1033, 998, 848, 757, 717 cm-1; HRMS (m/z) for 
C30H22ONa (M + Na) calcd: 421.15629 found: 421.15618; Rf (2/1 hexanes/EtOAc) = 0.40 
(silica gel plate). 
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6.2.2. Cyclotrimerization reaction for 4, 9 and 16 
 
C1:  General procedure for cyclotrimerization with Wilkinson’s catalyst RhCl(PPh3)3 
under thermal conditions (Preparation of 4).68 A dry flask was charged with starting diynol 
(0.5 mmol), alkyne 3 (1.0 mmol) and dissolved under argon atmosphere in toluene (15 mL). 
After addition of Wilkinson’s catalyst (46 mg, 0.05 mmol, 10 mol%) the reaction mixture was 
heated up to 90 °C for 16h. The reaction mixture was cooled down to room temperature and 
the solvent was evaporated under reduced pressure. Column chromatography of the residue on 
silica gel yielded products. 
 
C:  General procedure for cyclotrimerization with Wilkinson’s catalyst RhCl(PPh3)3 
under MW irradiation (Preparation of 9 and 16). A dry microwave vial was charged with 
starting diynol (0.5 mmol), 3-hexyne 3b (115 µL, 1.0 mmol) and dissolved under argon 
atmosphere in THF (15 mL). After addition of Wilkinson’s catalyst (23 mg, 0.015 mmol, 3 
mol%) and the additive Ag2CO3 (14 mg, 0.05 mmol, 10 mol%) the reaction mixture was 
sealed and heated up to 180 °C for 1.5h in a microwave reactor. The reaction mixture was 
cooled down to room temperature and the solvent was evaporated under reduced pressure. 
Column chromatography of the residue on silica gel yielded products. 
 
2,3-Dimethyl-1,4-diphenyl-9H-fluoren-9-ol (4aa). With 2a (30.8 mg, 0.1 mmol) and 2-
butyne 3a (14.8 µL, 0.2 mmol) following the general procedure C1. Column 
chromatography (5/1 hexanes/EtOAc) yielded 9 mg (25%) of the title 
compound as a slightly yellow solid: mp (decomp) 132-137 °C; 1H NMR 
(600 MHz, CDCl3) δ 7.48-7.56 (m, 5H), 7.39-7.46 (m, 4H), 7.30-7.34 (m, 2H), 7.11 (dt, J = 
7.4, 1.1 Hz, 1H), 6.95 (dt, J = 7.4, 1.2 Hz, 1H), 6.10 (d, J = 7.8 Hz, 1H), 5.53 (d, J = 5.2 Hz, 
1H), 2.10 (s, 3H), 2.08 (s, 3H), 1.63 (d, J = 5.2 Hz, 1H); 13C NMR (150 MHz, CDCl3) δ 
145.3, 141.2, 140.6, 140.5, 139.6, 138.7, 136.5, 136.2, 135.4, 134.2, 130.0, 129.3, 129.2, 
129.02, 128.96, 128.5, 128.42, 128.41, 127.44, 127.37, 126.8, 124.7, 122.5, 73.9, 17.40, 
17.38; IR (KBr) νmax 3563, 3559, 3052, 3025, 2926, 2863, 1601, 1571, 1497, 1440, 1359, 
1296, 1180, 1099, 1060, 1027, 740, 701 cm-1; HRMS (m/z) for C27H22ONa (M + Na) calcd: 
385.15629, found: 385.15633; Rf (5/1 hexanes/EtOAc) = 0.46 (silica gel plate). 
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2,3-Diethyl-1,4-diphenyl-9H-fluoren-9-ol (4ab). With 2a (30.8 mg, 0.1 mmol) and 3-hexyne 
3b (22.7 µL, 0.2 mmol) following the general procedure C1. Column 
chromatography (5/1 hexanes/EtOAc) yielded 29 mg (76%) of the title 
compound as a slightly yellow solid: mp (decomp) 146-151 °C; 1H NMR 
(600 MHz, CDCl3) δ 7.49-7.55 (m, 5H), 7.44-7.48 (m, 2H), 7.35-7.45 (m, 4H), 7.09 (dt, J = 
7.4, 1.1 Hz, 1H), 6.93 (dt, J = 7.4, 1.2 Hz, 1H), 5.94 (d, J = 7.8 Hz, 1H), 5.44 (s, 1H), 2.64 
(dq, J = 15.0, 7.5 Hz, 1H), 2.59 (dq, J = 15.0, 7.5 Hz, 1H), 2.56 (dq, J = 15.0, 7.5 Hz, 1H), 
2.54 (dq, J = 15.0, 7.5 Hz, 1H), 1.62 (s, 1H), 1.03 (t, J = 7.5 Hz, 3H), 1.02 (t, J = 7.5 Hz, 3H); 
13C NMR (150 MHz, CDCl3) δ 145.2, 141.6, 141.4, 140.5, 140.3, 139.8, 139.4, 139.1, 136.8, 
135.8, 129.9, 129.5, 129.4, 129.0, 128.82, 128.80, 128.7, 128.4, 128.3, 127.44, 127.35, 126.7, 
124.6, 122.5, 73.9, 22.9, 22.8, 15.82, 15.78; IR (KBr) νmax 3566, 3058, 3022, 2965, 2935, 
2872, 1604, 1470, 1443, 1377, 1227, 1072, 1030, 761, 698 cm-1; HRMS (m/z) for C29H26ONa 
(M + Na) calcd: 413.18759, found: 413.18784; Rf (5/1 hexanes/EtOAc) = 0.48 (silica gel 
plate). 
 
1,4-Diphenyl-2,3-dipropyl-9H-fluoren-9-ol (4ac). With 4a (30.8 mg, 0.1 mmol) and 4-
octyne 3c (28.6 µL, 0.2 mmol) following the general procedure C1. Column 
chromatography (5/1 hexanes/EtOAc) yielded 11 mg (26%) of the title 
compound as a slightly yellow solid: mp (decomp) 153-158 °C; 1H NMR 
(600 MHz, CDCl3) δ 7.48-7.54 (m, 5H), 7.43-7.46 (m, 2H), 7.39-7.41 (m, 2H), 7.33-7.37 (m, 
2H), 7.09 (dt, J = 7.4, 1.1 Hz, 1H), 6.93 (dt, J = 7.4, 1.2 Hz, 1H), 5.95 (d, J = 7.9 Hz, 1H), 
5.45 (d, J = 4.6 Hz, 1H), 2.49-2.54 (m, 1H), 2.42-2.46 (m, 2H), 2.37-2.41 (m, 1H), 1.62 (d, J 
= 4.7 Hz, 1H), 1.40-1.47 (m, 4H), 0.774 (t, J = 7.2 Hz, 3H), 0.772 (t, J = 7.2 Hz, 3H); 13C 
NMR (150 MHz, CDCl3) δ 145.2, 141.4, 140.6, 140.5, 140.3, 139.4, 139.0, 138.7, 136.8, 
135.7, 129.8, 129.4, 129.0, 128.8, 128.74, 128.69, 128.4, 128.3, 127.4, 127.3, 126.7, 124.6, 
122.5, 73.9, 32.4, 32.3, 24.9, 24.8, 14.8, 14.7; IR (KBr) νmax 3569, 3554, 3446, 3055, 2956, 
2932, 2866, 1601, 1574, 1464, 1440, 1380, 1024, 749, 704 cm-1; HRMS (m/z) for C31H30ONa 
(M + Na) calcd: 441.21889, found: 441.21886; Rf (5/1 hexanes/EtOAc) = 0.50 (silica gel 
plate). 
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(9-Hydroxy-1,4-diphenyl-9H-fluorene-2,3-diyl)dimethanol (4ad). With 2a (30.8 mg, 0.1 
mmol) and 2-butyne-1,4-diol 3d (8.6 mg, 0.1 mmol) following the general 
procedure C1. Column chromatography (2/1 hexanes/EtOAc) yielded 34 mg 
(86%) of the title compound as a slightly yellow solid: mp (decomp) 139-
144 °C; 1H NMR (600 MHz, CDCl3) δ 7.44-7.53 (m, 8H), 7.41 (d, J = 7.3 Hz, 1H), 7.34 (m, 
2H),  7.16 (t, J = 7.5 Hz, 1H), 6.98 (t, J = 7.6 Hz, 1H), 6.11 (d, J = 7.9 Hz, 1H), 5.56 (s, 2H), 
4.57 (m, 4H), 3.14 (s, 2H, OH), 1.83 (s, 1H); 13C NMR (150 MHz, CDCl3) δ 145.5, 143.8, 
139.8, 139.7, 139.5, 138.6, 138.1, 137.9, 137.4, 137.3, 130.0, 129.3, 129.2, 129.07, 129.06, 
128.96, 128.63, 128.59, 128.4, 127.93, 127.90, 127.6, 124.8, 123.0, 73.8, 60.0, 59.9; IR (KBr) 
νmax 3569, 3327, 3055, 3022, 2926, 2887, 1503, 1473, 1443, 1347, 1296, 1111, 1009, 917, 
860, 752, 707 cm-1; HRMS (m/z) for C27H22O3Na (M + Na) calcd: 417.14612, found: 
417.14604; Rf (1/1 hexanes/EtOAc) = 0.49 (silica gel plate). 
 
(2,3-Dimethyl-1,4-diphenyl-9H-fluoren-9-yl)oxy-tert-butyl-dimethylsilane (4aa-TBS). 
With 2a-TBS (42.3 mg, 0.1 mmol) and 2-butyne 3a (14.8 µL, 0.2 mmol) 
following the general procedure C1. Column chromatography (30/1 
hexanes/EtOAc) yielded 9 mg (19%) of the title compound as a pale yellow 
oil: 1H NMR (600 MHz, CDCl3) δ 7.52-7.55 (m, 2H), 7.40-7.50 (m, 5H), 7.33-7.38 (m, 3H), 
7.28-7.30 (m, 1H), 7.05 (dt, J = 7.4, 1.1 Hz, 1H), 6.92 (dt, J = 7.4, 1.2 Hz, 1H), 6.05 (d, J = 
7.8 Hz, 1H), 5.80 (s, 1H), 2.09 (s, 3H), 2.07 (s, 3H), 0.63 (s, 9H), -0.32 (s, 3H), -0.66 (s, 3H); 
13C NMR (150 MHz, CDCl3) δ 145.7, 141.1, 141.0, 140.9, 140.0, 139.4, 136.19, 136.17, 
135.6, 134.4, 131.2, 129.4, 129.3, 129.1, 128.9, 128.8, 128.4, 128.3, 128.0, 127.3, 126.8, 
126.2, 125.8, 122.4, 74.9, 26.0, 18.1, 17.8, 17.6, -3.2, -3.8; IR (KBr) νmax 3058, 3028, 2956, 
2929, 2893, 2854, 1718, 1601, 1473, 1437, 1257, 1105, 1072, 833 cm-1; HRMS (m/z) for 
C33H36OSiNa (M + Na) calcd: 499.24276, found: 499.24283; Rf (20/1 hexanes/EtOAc) = 0.49 
(silica gel plate). 
 
(2,3-Diethyl-1,4-diphenyl-9H-fluoren-9-yl)oxy-tert-butyl-dimethylsilane (4ab-TBS). With 
2a-TBS (42.3 mg, 0.1 mmol) and 3-hexyne 3b (22.7 µL, 0.2 mmol) 
following the general procedure C1. Column chromatography (30/1 
hexanes/EtOAc) yielded 36 mg (71%) of the title compound as a pale 
yellow oil: 1H NMR (600 MHz, CDCl3) δ 7.50-7.56 (m, 4H), 7.44-7.47 (m, 2H), 7.36-7.40 
(m, 4H), 7.30-7.32 (m, 1H), 7.04 (dt, J = 7.4, 1.1 Hz, 1H), 6.91 (dt, J = 7.4, 1.2 Hz, 1H), 5.92 
(d, J = 7.8 Hz, 1H), 5.66 (s, 1H), 2.69 (dq, J = 15.0, 7.5 Hz, 1H), 2.61 (dq, J = 15.0, 7.5 Hz, 
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1H), 2.57 (dq, J = 15.0, 7.5 Hz, 1H), 2.50 (dq, J = 15.0, 7.5 Hz, 1H), 1.03 (t, J = 7.5 Hz, 3H), 
0.98 (t, J = 7.5 Hz, 3H), 0.69 (s, 9H), -0.29 (s, 3H), -0.66 (s, 3H); 13C NMR (150 MHz, 
CDCl3) δ 145.7, 141.6, 141.4, 141.0, 140.6, 140.2, 139.81, 139.75, 136.5, 135.9, 130.8, 129.7, 
129.4, 129.2, 128.9, 128.7, 128.3, 128.2, 127.8, 127.3, 126.8, 126.2, 125.8, 122.4, 74.9, 26.1, 
22.9, 22.8, 18.2, 15.9, 15.7, -3.2, -3.8; IR (KBr) νmax 3055, 3022, 2968, 2929, 2851, 1718, 
1601, 1559, 1473, 1440, 1257, 1105, 1078, 836 cm-1; HRMS (m/z) for C35H41OSi (M + H) 
calcd: 505.2927, found: 505.2923; Rf (20/1 hexanes/EtOAc) = 0.51 (silica gel plate). 
 
(1,4-Diphenyl-2,3-dipropyl-9H-fluoren-9-yl)oxy-tert-butyl-dimethylsilane (4ac-TBS). 
With 2a-TBS (42.3 mg, 0.1 mmol) and 4-octyne 3c (28.6 µL, 0.2 mmol) 
following the general procedure C1. Column chromatography (30/1 
hexanes/EtOAc) yielded 30 mg (56%) of the title compound as a colorless 
oil: 1H NMR (600 MHz, CDCl3) δ 7.47-7.54 (m, 4H), 7.42-7.45 (m, 2H), 7.33-7.39 (m, 4H), 
7.28 (m, 1H), 7.03 (dt, J = 7.4, 1.1 Hz, 1H), 6.90 (dt, J = 7.4, 1.2 Hz, 1H), 5.91 (d, J = 7.6 Hz, 
1H), 5.65 (s, 1H), 2.54-2.59 (m, 1H), 2.40-2.50 (m, 2H), 2.33-2.38 (m, 1H), 1.32-1.46 (m, 
4H), 0.77 (t, J = 7.3 Hz, 3H), 0.75 (t, J = 7.3 Hz, 3H), 0.67 (s, 9H), -0.31 (s, 3H), -0.68 (s, 
3H); 13C NMR (150 MHz, CDCl3) δ 145.7, 141.3, 141.1, 140.6, 140.5, 139.83, 139.81, 139.1, 
136.5, 135.8, 130.8, 129.7, 129.3, 129.2, 128.8, 128.6, 128.3, 128.1, 127.8, 127.2, 126.7, 
126.2, 125.8, 122.4, 74.9, 32.4, 32.2, 26.1, 24.9, 24.7, 18.2, 14.7, 14.6, -3.2, -3.8; IR (KBr) 
νmax 3058, 3022, 2953, 2932, 2854, 1598, 1500, 1476, 1440, 1317, 1257, 1108, 1063, 833 cm-
1; HRMS (m/z) for C37H44OSiNa (M + Na)calcd: 555.30536, found: 555.30535; Rf (20/1 
hexanes/EtOAc) = 0.53 (silica gel plate). 
 
[9-((tert-Butyldimethylsilyl)oxy]-1,4-diphenyl-9H-fluorene-2,3-diyl)dimethanol (4ad-
TBS). With 2a-TBS (84 mg, 0.2 mmol) and 2-butyne-1,4-diol 3d (26 mg, 
0.3 mmol) following the general procedure C1. Column chromatography 
(5/1 hexanes/EtOAc) yielded 83 mg (82%) of the title compound as a 
colorless oil: 1H NMR (600 MHz, CDCl3) δ 7.51-7.57 (m, 4H), 7.44-7.47 (m, 3H), 7.35-7.42 
(m, 4H), 7.12 (dt, J = 7.4, 0.9 Hz, 1H), 6.96 (dt, J = 7.4, 0.6 Hz, 1H), 6.07 (d, J = 7.8 Hz, 1H), 
5.84 (s, 1H), 4.67 (d, J = 12.0 Hz, 1H), 4.62 (d, J = 12.0 Hz, 1H), 4.59 (d, J = 12.0 Hz, 1H), 
4.49 (d, J = 12.0 Hz, 1H), 3.00 (bs, 2H), 0.63 (s, 9H), -0.32 (s, 3H), -0.65 (s, 3H); 13C NMR 
(150 MHz, CDCl3) δ 145.8, 143.8, 140.5, 140.1, 139.7, 138.9, 138.3, 138.2, 137.7, 137.1, 
131.0, 129.4, 129.3, 129.1, 129.0, 128.8, 128.5, 128.4, 128.2, 127.9, 127.4, 127.0, 125.9, 
123.0,74.8, 60.2, 60.1, 25.9, 18.1, -3.2, -3.8; IR (KBr) νmax 3318, 3052, 3022, 2950, 2932, 
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2893, 2854, 1601, 1476, 1446, 1317, 1254, 1213, 1135, 1111, 1072, 1009, 833, 776, 701 cm-
1; HRMS (m/z) for C33H36O3SiNa (M + Na) calcd: 531.23259, found: 531.23254; Rf (2/1 
hexanes/EtOAc) = 0.21 (silica gel plate). 
 
2,3-Diethyl-1,4-diphenyl-9H-fluoren-9-ol (4ab). With 2a (30.8 mg, 0.1 mmol) and 3-hexyne 
3b (22.7 µL, 0.2 mmol) following the general procedure C1. Column 
chromatography (5/1 hexanes/EtOAc) yielded 29 mg (76%) of the title 
compound as a slightly yellow solid: mp (decomp) 146-151 °C; 1H NMR (600 
MHz, CDCl3) δ 7.49-7.55 (m, 5H), 7.44-7.48 (m, 2H), 7.35-7.45 (m, 4H), 7.09 (dt, J = 7.4, 
1.1 Hz, 1H), 6.93 (dt, J = 7.4, 1.2 Hz, 1H), 5.94 (d, J = 7.8 Hz, 1H), 5.44 (s, 1H), 2.64 (dq, J = 
15.0, 7.5 Hz, 1H), 2.59 (dq, J = 15.0, 7.5 Hz, 1H), 2.56 (dq, J = 15.0, 7.5 Hz, 1H), 2.54 (dq, J 
= 15.0, 7.5 Hz, 1H), 1.62 (s, 1H), 1.03 (t, J = 7.5 Hz, 3H), 1.02 (t, J = 7.5 Hz, 3H); 13C NMR 
(150 MHz, CDCl3) δ 145.2, 141.6, 141.4, 140.5, 140.3, 139.8, 139.4, 139.1, 136.8, 135.8, 
129.9, 129.5, 129.4, 129.0, 128.82, 128.80, 128.7, 128.4, 128.3, 127.44, 127.35, 126.7, 124.6, 
122.5, 73.9, 22.9, 22.8, 15.82, 15.78; IR (KBr) νmax 3566, 3058, 3022, 2965, 2935, 2872, 
1604, 1470, 1443, 1377, 1227, 1072, 1030, 761, 698 cm-1; HRMS (m/z) for C29H26ONa (M + 
Na) calcd: 413.18759, found: 413.18784; Rf (5/1 hexanes/EtOAc) = 0.48 (silica gel plate). 
 
2,3-Diethyl-4-phenyl-1-propyl-9H-fluoren-9-ol (4bb). With 2b (100 mg, 0.4 mmol) and 3-
hexyne 3b (90 µL, 0.8 mmol) following the general procedure C1. Column 
chromatography (5/1 hexanes/EtOAc) yielded 65 mg (48%) of the title 
compound as a light brown solid: mp (decomp) 151-156 °C; 1H NMR (600 
MHz, CDCl3) δ 7.53 (d, J = 6.9 Hz, 1H), 7.45-7.51 (m, 3H), 7.31 (m, 1H), 7.28 (m, 1H), 7.12 
(dt, J = 7.4, 1.0 Hz, 1H), ), 6.92 (dt, J = 7.4, 0.8 Hz, 1H), 5.88 (d, J = 7.8 Hz, 1H), 5.64 (d, J = 
10.2 Hz, 1H), 3.10-3.15 (m, 1H), 2.81-2.84 (m, 1H), 2.78 (m, 2H), 2.51 (m, 2H), 1.71-1.78 
(m, 2H), 1.67 (d, J = 10.1 Hz, 1H), 1.26 (t, J = 7.5 Hz, 3H), 1.14 (t, J = 7.3 Hz, 3H), 0.99 (t, J 
= 7.5 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 146.0, 141.8, 141.0, 140.6, 140.5, 140.3, 138.9, 
135.9, 135.3, 129.6, 129.5, 128.7, 128.5, 127.2, 126.6, 124.5, 122.4, 74.6, 31.8, 25.0, 22.8, 
21.8, 16.0, 15.8, 15.1; IR (KBr) νmax  3536, 3392, 3055, 3019, 2962, 2932, 2869, 1601, 1494, 
1464, 1437, 1377, 1281, 1189, 1066, 1039, 758, 704 cm-1; HRMS (m/z) for C29H26ONa (M + 
Na) calcd: 379.20324, found: 379.20331; Rf (5/1 hexanes/EtOAc) = 0.56 (silica gel plate). 
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2,3-Diethyl-1-phenyl-4-propyl-9H-fluoren-9-ol (4cb). With 2c (137 mg, 0.5 mmol) and 3-
hexyne 3b (120 µL, 1.0 mmol) following the general procedure C1. Column 
chromatography (5/1 hexanes/EtOAc) yielded 108 mg (62%) of the title 
compound as a light brown solid: mp (decomp) 137-142 °C; 1H NMR (600 
MHz, CDCl3) δ 7.70 (d, J = 7.9 Hz, 1H), 7.47-7.52 (m, 3H), 7.43 (dt, J = 7.5, 1.4 Hz, 1H), 
7.39-7.42 (m, 1H), 7.34-7.39 (m, 2H), 7.25 (dt, J = 7.4, 0.9 Hz, 1H), 5.39 (d, J = 4.9 Hz, 1H), 
3.03 (m, 2H), 2.81 (q, J = 7.5 Hz, 2H), 2.54-2.60 (m, 1H), 2.42-2.48 (m, 1H), 1.73-1.80 (m, 
2H), 1.60 (d, J = 4.9 Hz, 1H), 1.27 (t, J = 7.6 Hz, 3H), 1.20 (t, J = 7.3 Hz, 3H), 1.00 (t, J = 7.5 
Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 145.5, 142.1, 141.4, 140.8, 139.9, 139.6, 137.5, 
136.3, 135.8, 130.0, 129.0, 128.9, 128.2, 127.3, 126.6, 125.0, 122.8, 73.8, 31.7, 23.3, 23.0, 
21.9, 16.0, 15.8, 14.7; IR (KBr) νmax 3566, 3391, 3055, 3022, 2962, 2926, 2869, 1607, 1464, 
1443, 1374, 1260, 1198, 1075, 1033, 761, 704 cm-1; HRMS (m/z) for C26H28ONa (M + Na) 
calcd: 379.20324, found: 379.20328; Rf (5/1 hexanes/EtOAc) = 0.51 (silica gel plate). 
 
2,3-Diethyl-1,4-dipropyl-9H-fluoren-9-ol (4db). With 2d (120 mg, 0.5 mmol) and 3-hexyne 
3b (120 µL, 1.0 mmol) following the general procedure C1. Column 
chromatography (5/1 hexanes/EtOAc) yielded 61 mg (38%) of the title 
compound as a slightly yellow solid: mp 122-127 °C (decomp); 1H NMR (600 
MHz, CDCl3) δ 7.65 (d, J = 7.9 Hz, 1H), 7.61 (m, 1H), 7.38 (dt, J = 7.8, 1.3 Hz, 1H), 7.28 (dt, 
J = 7.4, 1.0 Hz, 1H), 5.57 (d, J = 10.4 Hz, 1H), 3.04-3.09 (m, 1H), 2.95 (m, 2H), 2.71-2.78 
(m, 5H), 1.65-1.73 (m, 4H), 1.64 (d, J = 10.4 Hz, 1H), 1.23 (t, J = 7.5 Hz, 3H), 1.22 (t, J = 7.5 
Hz, 3H), 1.17 (t, J = 7.3 Hz, 3H), 1.11 (t, J = 7.3 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 
146.4, 141.8, 141.7, 140.9, 140.5, 137.2, 136.0, 134.6, 129.0, 126.5, 124.9, 122.7, 74.5, 31.8, 
31.6, 25.0, 23.3, 21.9, 21.8, 16.0, 15.9, 15.1, 14.6; IR (KBr) νmax 3518, 3392, 3069, 3043, 
2959, 2926,2896, 2869, 1607, 1464, 1431, 1377, 1302, 1245, 1192, 1069, 1003, 764, 737 cm-
1; HRMS (m/z) for C23H30ONa (M + Na) calcd: 345.21889, found: 345.21890; Rf (5/1 
hexanes/EtOAc) = 0.63 (silica gel plate). 
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2,3-Diethyl-4-(4-methoxyphenyl)-1-(p-tolyl)-9H-fluoren-9-ol (9a). With 8a (176 mg, 0.5 
mmol) following the general procedure C. Column chromatography (5/1 
hexanes/EtOAc) yielded 103 mg (47%) of the title compound as a brown oil: 
1H NMR (600 MHz, CDCl3) δ 7.40 (m, 1H), 7.25-7.36 (m, 6H), 7.10 (dt, J = 
7.4, 1.0 Hz, 1H), 7.06-7.08 (m, 2H), 6.97 (dt, J = 7.4, 0.7 Hz, 1H), 6.07 (d, J 
= 7.8 Hz, 1H), 5.45 (d, J = 4.7 Hz, 1H), 3.94 (s, 3H), 2.60-2.66 (m, 1H), 2.55 
(q, J = 7.5 Hz, 2H), 2.50-2.53 (m, 1H), 2.46 (s, 3H), 1.69 (d, J = 4.7 Hz, 1H), 1.03 (t, J = 7.5 
Hz, 3H), 1.02 (t, J = 7.5 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 158.8, 145.2, 142.0, 141.5, 
140.7, 139.9, 138.9, 137.0, 136.30, 136.27, 136.1, 132.5, 130.47, 130.45, 129.8, 129.6, 129.0, 
128.6, 128.4, 126.7, 124.6, 122.6, 114.2, 114.1, 73.9, 55.3, 22.83, 22.81, 21.3, 15.9, 15.8; IR 
(KBr) νmax 3566, 3452, 3069, 3040, 3022, 2968, 2929, 2869, 2839, 1607, 1571, 1515, 1467, 
1428, 1374, 1284, 1245, 1177, 1105, 1033, 854, 824, 764, 746 cm-1; HRMS (m/z) for 
C31H30O2Na (M + Na) calcd: 457.21380, found: 457.21381; Rf (5/1 hexanes/EtOAc) = 0.36 
(silica gel plate). 
 
2,3-Diethyl-1,4-di-p-tolyl-9H-fluoren-9-ol (9b). With 8b (168 mg, 0.5 mmol) following the 
general procedure C. Column chromatography (5/1 hexanes/EtOAc) yielded 
133 mg (64%) of the title compound as a light brown viscous oil. 1H NMR 
(600 MHz, CDCl3) δ 7.40 (d, J = 7.4, Hz, 1H), 7.30-7.36 (m, 6H), 7.23-7.27 
(m, 2H), 7.10 (dt, J = 7.4, 1.0 Hz, 1H), 6.95 (dt, J = 7.6, 0.7 Hz, 1H), 6.02 (d, 
J = 7.8 Hz, 1H), 5.44 (d, J = 4.7 Hz, 1H), 2.60-2.66 (m, 1H), 2.55 (q, J = 7.5 
Hz, 2H), 2.50-2.53 (m, 1H), 2.51 (s, 3H), 2.47 (s, 3H), 1.68 (d, J = 4.7 Hz, 1H), 1.03 (t, J = 
7.5 Hz, 6H); 13C NMR (150 MHz, CDCl3) δ 145.1, 141.7, 141.5, 140.7, 139.9, 138.9, 137.2, 
137.0, 136.8, 136.7, 136.3, 135.8, 129.8, 129.7, 129.5, 129.4, 129.3, 129.2, 129.0, 128.7, 
128.3, 126.6, 124.6, 122.6, 73.9, 22.84, 22.79, 21.4, 21.3, 15.9, 15.8; IR (KBr) νmax 3425, 
3058, 3019, 2968, 2926, 2890, 2869, 1598, 1556, 1470, 1437, 1374, 1290, 1195, 1177, 1072, 
1024, 734, 758, 701 cm-1; HRMS (m/z) for C31H30ONa (M + Na) calcd: 441.21889, found: 
441.21893; Rf (5/1 hexanes/EtOAc) = 0.46 (silica gel plate). 
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4-([1,1'-Biphenyl]-4-yl)-2,3-diethyl-1-(p-tolyl)-9H-fluoren-9-ol (9c). With 8c (199.1 mg, 
0.5 mmol) following the general procedure C. Column chromatography 
(5/1 hexanes/EtOAc) yielded 115 mg (48%) of the title compound as a 
viscous brown oil: 1H NMR (600 MHz, CDCl3) δ 7.78-7.82 (m, 4H), 7.52 
(m, 2H), 7.40-7.47 (m, 4H), 7.32-7.38 (m, 4H), 7.11 (dt, J = 7.4, 1.0 Hz, 
1H), 6.94 (dt, J = 7.4, 0.8 Hz, 1H), 6.11 (d, J = 7.9 Hz, 1H), 5.47 (d, J = 4.7 
Hz, 1H), 2.63-2.69 (m, 1H), 2.60 (q, J = 7.5 Hz, 2H), 2.51-2.57 (m, 1H), 2.48 (s, 3H), 1.71 (d, 
J = 4.7 Hz, 1H), 1.07 (t, J = 7.5 Hz, 3H), 1.05 (t, J = 7.5 Hz, 3H); 13C NMR (150 MHz, 
CDCl3) δ 145.2, 141.7, 141.6, 140.7, 140.5, 140.0, 139.9, 139.4, 139.1, 137.1, 136.24, 136.23, 
135.7, 129.93, 129.90, 129.8, 129.6, 129.1, 128.9, 128.6, 128.4, 127.4, 127.33, 127.27, 127.0, 
126.74, 124.67, 122.5, 73.9, 22.9, 22.8, 21.3, 15.9 (2xCH3); IR (KBr) νmax 3566, 3440, 3049, 
3028, 2968, 2926, 2866, 1598, 1515, 1488, 1473, 1449, 1431, 1371, 1311, 1290, 1251, 1180, 
1141, 1102, 1066, 1021, 1012, 857, 839, 824, 767, 746, 698 cm-1; HRMS (m/z) for 
C36H32ONa (M + Na) calcd: 503.23454, found: 503.23464; Rf (5/1 hexanes/EtOAc) = 0.42 
(silica gel plate). 
 
2,3-Diethyl-4-phenyl-1-(p-tolyl)-9H-fluoren-9-ol (9d). With 8d (161 mg, 0.5 mmol) 
following the general procedure C. Column chromatography (5/1 
hexanes/EtOAc) yielded 122 mg (61%) of the title compound as a light 
brown solid: mp (decomp) 70-75 °C; 1H NMR (600 MHz, CDCl3) δ 7.48-
7.57 (m, 3H), 7.30-7.41 (m, 7H), 7.09 (dt, J = 7.4, 1.0 Hz, 1H), 6.92 (dt, J = 
7.4, 0.7 Hz, 1H), 5.93 (d, J = 7.9 Hz, 1H), 5.44 (d, J = 4.7 Hz, 1H), 2.60-2.66 (m, 1H), 2.55 
(q, J = 7.5 Hz, 2H), 2.50-2.53 (m, 1H), 2.47 (s, 3H), 1.68 (d, J = 4.7 Hz, 1H), 1.03 (t, J = 7.5 
Hz, 3H), 1.02 (t, J = 7.5 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 145.2, 141.6, 141.5, 140.6, 
140.3, 140.0, 139.0, 137.1, 136.6, 136.2, 135.7, 129.8, 129.6, 129.5, 129.4, 129.1, 128.8, 
128.7, 128.6, 128.4, 127.3, 126.7, 124.6, 122.5, 73.9, 22.9, 22.8, 21.3, 15.9, 15.8; IR (KBr) 
νmax 3572, 3443, 3078, 3049, 3022, 2968, 2932, 2866, 1598, 1515, 1470, 1446, 1431, 1371, 
1308, 1242, 1180, 1141, 1099, 1069, 1036, 1021, 997, 830, 797, 743, 764, 707 cm-1; HRMS 
(m/z) for C30H28ONa (M + Na) calcd: 427.20324, found: 427.20329; Rf (5/1 hexanes/EtOAc) 
= 0.44 (silica gel plate). 
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4-(4-Chlorophenyl)-2,3-diethyl-1-(p-tolyl)-9H-fluoren-9-ol (9e). With 8e (178 mg, 0.5 
mmol) following the general procedure C. Column chromatography (5/1 
hexanes/EtOAc) yielded 97 mg (44%) of the title compound as a viscous 
brown oil: 1H NMR (600 MHz, CDCl3) δ 7.51-7.53 (m, 2H), 7.41 (m, 1H), 
7.28-7.35 (m, 6H), 7.12 (dt, J = 7.4, 1.0 Hz, 1H), 6.98 (dt, J = 7.4, 0.7 Hz, 
1H), 6.05 (d, J = 7.8 Hz, 1H), 5.44 (d, J = 4.6 Hz, 1H), 2.59-2.65 (m, 1H), 
2.53 (q, J = 7.5 Hz, 2H), 2.47-2.53 (m, 1H), 2.46 (s, 3H), 1.68 (d, J = 4.7 Hz, 1H), 1.02 (t, J = 
7.5 Hz, 3H), 1.01 (t, J = 7.5 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 145.2, 141.8, 141.5, 
140.3, 140.1, 139.4, 138.8, 137.2, 136.1, 135.6, 135.2, 133.3, 131.0, 130.9, 129.8, 129.6, 
129.10, 129.09, 129.0, 128.6, 128.5, 126.9, 124.8, 122.3, 73.8, 22.81, 22.77, 21.3, 15.9, 15.7; 
IR (KBr) νmax 3563, 3437, 3066, 3049, 3022, 2962, 2929, 2866, 1607, 1565, 1518, 1491, 
1470, 1461, 1425, 1392, 1371, 1248, 1204, 1183, 1141, 1087, 1069, 1018, 997, 857, 821, 803, 
761, 749, 516 cm-1; HRMS (m/z) for C30H27OClNa (M + Na) calcd: 461.16426, found: 
461.16433; Rf (5/1 hexanes/EtOAc) = 0.43 (silica gel plate). 
 
2,3-Diethyl-1-(p-tolyl)-4-(4-(trifluoromethyl)phenyl)-9H-fluoren-9-ol (9f). With 8f (195 
mg, 0.5 mmol) following the general procedure C. Column chromatography 
(5/1 hexanes/EtOAc) yielded 115 mg (49%) of the title compound as a 
viscous brown oil: 1H NMR (600 MHz, CDCl3) δ 7.82 (m, 2H), 7.50-7.54 
(m, 2H), 7.41 (m, 1H), 7.29-7.36 (m, 4H), 7.12 (dt, J = 7.4, 1.0 Hz, 1H), 6.95 
(dt, J = 7.6, 1.1 Hz, 1H), 5.89 (d, J = 7.8 Hz, 1H), 5.45 (d, J = 4.6 Hz, 1H), 
2.60-2.66 (m, 1H), 2.51 (q, J = 7.5 Hz, 2H), 2.47-2.54 (m, 1H), 2.47 (s, 3H), 1.70 (d, J = 4.6 
Hz, 1H), 1.03 (t, J = 7.4 Hz, 3H), 1.01 (t, J = 7.5 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 
145.2, 144.3, 141.9, 141.2, 140.2, 140.1, 139.6, 137.2, 136.0, 135.4, 135.0, 130.04, 130.01, 
129.9, 129.8 (q, 2JC-F = 32.4 Hz), 129.53, 129.1, 128.6, 128.5, 127.0, 125.8 (q, 3JC-F = 3.8 Hz), 
124.9, 121.6-127.0 (q, 1JC-F = 272.1 Hz), 122.1, 73.8, 22.8, 22.7, 21.3, 15.8, 15.7; IR (KBr) 
νmax 3566, 3428, 3075, 3046, 3016, 2968, 2932, 2872, 1616, 1565, 1509, 1464, 1404, 1374, 
1323, 1245, 1171, 1132, 1102, 1069, 1021, 866, 827, 767 cm-1; HRMS (m/z) for 
C31H27OF3Na (M + Na) calcd: 495.19062, found: 495.19065; Rf (5/1 hexanes/EtOAc) = 0.41 
(silica gel plate). 
 
 
 
p-Tol
Et
Et
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4-(2,3-Diethyl-9-hydroxy-1-(p-tolyl)-9H-fluoren-4-yl)benzonitrile (9g). With 8g (178 mg, 
0.5 mmol) following the general procedure C. Column chromatography 
(5/1 hexanes/EtOAc) yielded 65 mg (30%) of the title compound as a light 
brown solid: mp (decomp) 227-232 °C; 1H NMR (600 MHz, CDCl3) δ 7.85 
(m, 2H), 7.50-7.54 (m, 2H), 7.42 (m, 1H), 7.33-7.36 (m, 3H), 7.29 (m, 1H), 
7.13 (dt, J = 7.4, 1.0 Hz, 1H), 6.97 (dt, J = 7.5, 0.8 Hz, 1H), 5.88 (d, J = 7.8 
Hz, 1H), 5.44 (d, J = 4.6 Hz, 1H), 2.59-2.65 (m, 1H), 2.47-2.53 (m, 3H), 2.47 (s, 3H), 1.70 (d, 
J = 4.6 Hz, 1H), 1.02 (t, J = 7.5 Hz, 3H), 1.00 (t, J = 7.5 Hz, 3H); 13C NMR (150 MHz, 
CDCl3) δ 145.7, 145.2, 142.0, 140.8, 140.3, 139.9, 139.8, 137.3, 135.8, 135.2, 134.5, 132.7, 
132.6, 130.63, 130.59, 129.9, 129.5, 129.2, 128.53, 128.50, 127.1, 125.0, 121.9, 118.9, 111.5, 
73.7, 22.9, 22.7, 21.3, 15.8, 15.7; IR (KBr) νmax 3476, 3090, 3075, 3049, 3028, 2971, 2926, 
2866, 2235, 1607, 1515, 1473, 1428, 1395, 1371, 1308, 1263, 1192, 1144, 1099, 1069, 1033, , 
860, 818, 761, 740, 567 cm-1; HRMS (m/z) for C31H27NO (M+) calcd: 429.2093, found: 
429.2095; Rf (5/1 hexanes/EtOAc) = 0.31 (silica gel plate). 
 
4-(4-Bromophenyl)-2,3-diethyl-1-(p-tolyl)-9H-fluoren-9-ol (9h). With 8h (100 mg, 0.25 
mmol) following the general procedure C. Column chromatography (5/1 
hexanes/EtOAc) yielded 61 mg (51%) of the title compound as a brown 
solid: mp (decomp) 147-152 °C; 1H NMR (400 MHz, CDCl3) δ 7.67 (m, 
2H), 7.41 (m, 1H), 7.33 (m, 3H), 7.24-7.30 (m, 3H), 7.13 (dt, J = 7.4, 1.0 Hz, 
1H), 6.99 (dt, J = 7.5, 0.8 Hz, 1H), 6.05 (d, J = 7.8 Hz, 1H), 5.44 (bs, 1H), 
2.58-2.67 (m, 1H), 2.52 (q, J = 7.5 Hz, 2H), 2.48-2.53 (m, 1H), 2.47 (s, 3H), 1.69 (bs, 1H), 
1.02 (t, J = 7.5 Hz, 3H), 1.01 (t, J = 7.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 145.2, 141.8, 
141.4, 140.2, 140.1, 139.4, 139.3, 137.1, 136.1, 135.5, 135.2, 132.02, 131.96, 131.32, 131.29, 
129.8, 129.6, 129.1, 128.6, 128.5, 126.9, 124.8, 122.3, 121.5, 73.8, 22.81, 22.75, 21.3, 15.84, 
15.75; IR (KBr) νmax 3563, 3047, 3025, 2962, 2929, 2869, 1601, 1512, 1488, 1467, 1431, 
1392, 1371, 1263, 1183, 1099, 1069, 1012, 821, 764, 522 cm-1; HRMS (m/z) for 
C30H27OBrNa (M + Na) calcd: 505.11375, found: 505.11368; Rf (5/1 hexanes/EtOAc) = 0.42 
(silica gel plate). 
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2,3-Diethyl-4-(naphthalen-2-yl)-1-propyl-9H-fluoren-9-ol (16a). With 15a (162 mg, 0.5 
mmol) following the general procedure C. Column chromatography (5/1 
hexanes/EtOAc) yielded 91 mg (45%) of the title compound as a light brown 
solid: mp (decomp) 93-98 °C; 1H NMR (400 MHz, CDCl3) δ 7.99 (m, 2H), 
7.86 (m, 1H), 7.79 (d, J = 8.9 Hz, 1H), 7.53-7.60 (m, 3H), 7.45 (ddd, J = 13.1, 
8.3, 1.6 Hz, 1H), 7.09 (dt, J = 7.4, 0.9 Hz, 1H), 6.81 (dt, J = 7.7, 0.9 Hz, 1H), 
5.86 (d, J = 7.8 Hz, 1H), 5.67 (s, 1H), 3.15 (m, 1H), 2.86 (m, 1H), 2.82 (dq, J = 7.5, 2.2 Hz, 
2H), 2.46-2.63 (m, 2H), 1.77 (m, 2H), 1.73 (s, 1H), 1.29 (t, J = 7.5 Hz, 3H), 1.17 (t, J = 7.3 
Hz, 3H), 0.99 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 146.0, 142.1, 141.1, 140.6, 
140.5, 140.4, 139.1, 139.0, 138.0, 135.9, 135.0, 133.6, 132.5, 128.6, 128.3, 128.19, 128.16, 
128.15, 128.13, 128.08, 128.0, 127.9, 126.7, 126.1, 125.9, 124.48, 124.47, 122.5, 74.6, 31.9, 
31.8, 25.02, 24.96, 22.90, 22.88, 21.8, 16.0, 15.9, 15.1; IR (KBr) νmax 3386, 3052, 2965, 2932, 
2866, 1604, 1565, 1470, 1434, 1371, 1302, 1189, 1102, 1069, 1021, 964, 863, 806, 761, 752, 
cm-1; HRMS (m/z) for C30H30O (M+) calcd: 406.2297, found: 406.2295; Rf (5/1 
hexanes/EtOAc) = 0.45 (silica gel plate). 
 
2,3-Diethyl-4-(phenanthren-9-yl)-1-propyl-9H-fluoren-9-ol (16b). With 15b (94 mg, 0.25 
mmol) following the general procedure C. Column chromatography (5/1 
hexanes/EtOAc) yielded 67 mg (59%) of the title compound as a light brown 
solid: mp (decomp) 109-114 °C; 1H NMR (400 MHz, CDCl3) δ 8.83 (m, 2H), 
7.88 (m, 1H), 7.71-7.77 (m, 2H), 7.63-7.68 (m, 2H), 7.37-7.60 (m, 3H), 7.02 
(m, 1H), 6.65 (dt, J = 7.8, 0.9 Hz, 1H), 5.83 (dd, J = 7.8, 2.5 Hz, 1H), 5.70 (d, 
J = 9.8 Hz, 1H), 3.11-3-31 (m, 1H), 2.91 (m, 1H), 2.83 (m, 2H), 2.55 (m, 1H), 2.27 (m, 1H), 
1.79 (m, 2H), 1.73 (d, J = 9.9 Hz, 1H), 1.31 (dt, J = 7.3, 1.0 Hz, 3H), 1.19 (dt, J = 7.2, 2.2 Hz, 
3H), 0.93 (dt, J = 7.4, 1.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 146.0, 142.86, 142.83, 
141.4, 140.8, 140.24, 140.22, 139.29, 139.20, 136.54, 136.52, 136.51, 136.47, 132.58, 132.56, 
131.8, 131.74, 131.73, 130.5, 130.20, 130.18, 128.79, 128.77, 128.68, 128.65, 127.8, 127.7, 
126.9, 126.75, 126.73, 126.66, 126.63, 126.56, 126.53, 124.38, 124.35, 122.9, 122.7, 122.5, 
122.4, 74.65, 74.62, 32.11, 31.61, 25.21, 24.91, 23.3, 21.84, 21.81, 16.23, 16.20, 16.17, 16.12, 
15.13; IR (KBr) νmax 3321, 3072, 2959, 2932, 2866, 1607, 1494, 1464, 1452, 1374, 1251, 
1195, 1099, 1060, 1009, 908, 812, 770, 755, 725 cm-1; HRMS (m/z) for C34H32ONa (M + Na) 
calcd: 479.23454, found: 479.23450; Rf (5/1 hexanes/EtOAc) = 0.38 (silica gel plate). 
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4-(Anthracen-9-yl)-2,3-diethyl-1-propyl-9H-fluoren-9-ol (16c). With 15c (94 mg, 0.25 
mmol) following the general procedure C. Column chromatography (5/1 
hexanes/EtOAc) yielded 55 mg (48%) of the title compound as a light brown 
solid: mp (decomp) 104-109 °C; 1H NMR (400 MHz, CDCl3) δ 8.60 (s, 1H), 
8.08 (dd, J = 8.5, 3.9 Hz, 2H), 7.61 (dd, J = 8.8, 0.9 Hz, 1H), 7.41–7.50 (m, 
4H), 7.22-7.28 (m 2H), 6.93 (dt, J = 7.4, 1.0 Hz, 1H), 6.47 (dt, J = 7.6, 0.8 Hz, 1H), 5.73 (d, J 
= 8.4 Hz, 1H), 4.91 (d, J = 7.8 Hz, 1H), 3.24 (m, 1H), 2.96 (m, 1H), 2.85 (q, J = 7.6 Hz, 2H), 
2.24 (q, J = 7.5 Hz, 2H), 1.86 (m, 2H), 1.78 (d, J = 9.2 Hz, 1H), 1.33 (t, J = 7.4 Hz, 3H), 1.21 
(t, J = 7.3 Hz, 3H), 0.66 (t, J = 7.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 145.9, 143.3, 
141.7, 141.1, 140.1, 139.4, 137.1, 134.9, 131.6, 130.7, 130.5, 130.4, 128.6, 128.4, 126.64, 
126.59, 126.5, 126.4, 125.6, 125.4, 125.3, 124.3, 121.8, 74.7, 31.9, 25.1, 23.5, 21.8, 16.2, 
15.5, 15.1; IR (KBr) νmax 3549, 3261, 2961, 2930, 2870, 2205, 1947, 1818, 1605, 1519, 1465, 
1441, 1408, 1375, 1230, 1190, 1101, 1059, 1012, 973, 884, 845, 762, 738 cm-1; HRMS (m/z) 
for C34H32ONa (M + Na) calcd: 479.23454, found: 479.23448; Rf (5/1 hexanes/EtOAc) = 0.39 
(silica gel plate). 
 
2,3-Diethyl-1-propyl-4-(pyren-2-yl)-9H-fluoren-9-ol (16d). With 15d (100 mg, 0.25 mmol) 
following the general procedure C. Column chromatography (5/1 
hexanes/EtOAc) yielded 64 mg (54%) of the title compound as a light 
brown solid: mp (decomp) 98-103 °C; 1H NMR (400 MHz, CDCl3) δ 8.33 
(dd, J = 7.8, 4.7 Hz, 1H), 8.24 (m, 1H), 8.13-8.20 (m, 3H), 8.02 (dt, J = 
7.6, 2.6 Hz, 1H), 7.94-8.00 (dd, J = 17.0, 7.8 Hz, 1H), 7.90 (dd, J = 9.2, 
6.1 Hz, 1H), 7.64-7.78 (dd, J = 46.1, 9.2 Hz, 1H), 7.50 (d, J = 7.4 Hz, 1H), 6.98 (m, 1H), 6.53 
(dt, J = 7.6, 0.5 Hz, 1H), 5.75 (dd, J = 9.7, 4.5 Hz, 1H), 5.21 (d, J = 7.8 Hz, 1H), 3.17-3.32 
(m, 1H), 2.94 (m, 1H), 2.86 (m, 2H), 2.48 (m, 1H), 2.31 (m, 1H), 1.88 (m, 2H), 1.77 (d, J = 
10.4 Hz, 1H), 1.34 (dt, J = 7.3, 1.2 Hz, 3H), 1.26 (dt, J = 7.2, 1.6 Hz, 3H), 0.86 (t, J = 7.5 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 145.97, 145.94, 142.85, 142.82, 141.35, 140.77, 140.76, 
140.39, 139.33, 139.29, 136.67, 136.63, 135.63, 135.57, 133.18, 133.16, 131.38, 131.37, 
131.22, 131.21, 130.75, 130.74, 129.62, 129.55, 128.60, 128.58, 127.97, 127.80, 127.61, 
127.57, 127.46, 127.41, 126.55, 126.53, 126.02, 125.40, 125.28, 125.07, 125.05, 125.04, 
124.95, 124.92, 124.38, 124.37, 122.15, 122.11, 74.69, 74.66, 32.05, 31.80, 25.16, 25.00, 
23.2, 21.9, 16.19, 16.17, 15.77, 15.75, 15.16, 15.15; IR (KBr) νmax 3545, 3349, 3043, 2961, 
2930, 2869, 1697, 1602, 1464, 1374, 1306, 1191, 1178, 1099, 1057, 1022, 944, 847, 760, 743 
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cm-1; HRMS (m/z) for C36H32ONa (M + Na) calcd: 503.23454, found: 503.23448; Rf (5/1 
hexanes/EtOAc) = 0.34 (silica gel plate). 
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6.2.3.  Synthesis of 9,9’-spirobifluorenes 6, 11 and 18 
 
D:  General procedure for Oxidation reaction with PCC (preparation of 5, 10 and 
17). To a solution of pyridinium chlorochromate (PCC, 64 mg, 0.3 mmol) and celite (64 mg) 
in anhydrous CH2Cl2 (10 mL) the starting fluorenol (0.2 mmol) was added and the mixture 
was stirred for 3 h at rt. Afterwards, the residue was filtered through a celite/silica gel plug. 
Column chromatography of the residue on silica gel yielded products. 
 
2,3-Diethyl-1,4-diphenyl-9H-fluoren-9-one (5a). With 4ab (100 mg, 0.26 mmol) following 
the general procedure D. Column chromatography (10/1 hexanes/EtOAc) 
yielded 89 mg (89%) of the title compound as a bright yellow solid: mp 
(decomp) 75-80 °C; 1H NMR (600 MHz, CDCl3) δ 7.51-7.57 (m, 3H), 7.47-
7.50 (m, 2H), 7.43-7.46 (m, 1H), 7.38-7.41 (m, 3H), 7.28-7.30 (m, 2H), 7.05 (dt, J = 7.4, 1.1 
Hz, 1H), 7.01 (dt, J = 7.5, 1.4 Hz, 1H), 5.79 (d, J = 7.6 Hz, 1H), 2.52-2.57 (m, 4H), 1.04 (t, J 
= 7.4 Hz, 3H), 1.00 (t, J = 7.4 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 193.2, 147.8, 144.0, 
142.1, 140.9, 140.2, 139.2, 137.9, 137.3, 134.9, 133.8, 129.3, 129.03, 128.99, 128.7, 128.97, 
127.95, 127.8, 127.2, 123.4, 122.6, 23.4, 22.4, 15.5, 15.4; IR (KBr) νmax 3055, 3019, 2971, 
2932, 2869, 1712, 1598, 1580, 1559, 1467, 1446, 1308, 1192, 1066, 764, 704  cm-1; HRMS 
(m/z) for C29H24ONa (M + Na) calcd: 411.17194, found: 411.17219; Rf (5/1 hexanes/EtOAc) 
= 0.55 (silica gel plate). 
 
2,3-Diethyl-4-phenyl-1-propyl-9H-fluoren-9-one (5b). With 4bb (95 mg, 0.27 mmol) 
following the general procedure D. Column chromatography (10/1 
hexanes/EtOAc) yielded 89 mg (93%) of the title compound as a bright 
yellow solid: mp (decomp) 127-132 °C, 1H NMR (600 MHz, CDCl3) δ 7.47-
7.53 (m, 4H), 7.31 (m, 2H), 7.07 (dt, J = 7.4, 0.8 Hz, 1H), 6.99 (dt, J = 7.6, 1.2 Hz, 1H), 5.74 
(d, J = 7.6 Hz, 1H), 3.12 (m, 2H), 2.73 (q, J = 7.2 Hz, 2H), 2.48 (q, J = 7.5 Hz, 2H), 1.63 (m, 
2H), 1.23 (t, J = 7.5 Hz, 3H), 1.14 (t, J = 7.3 Hz, 3H), 0.99 (t, J = 7.5 Hz, 3H); 13C NMR (150 
MHz, CDCl3) δ 195.0, 147.6, 144.0, 142.8, 142.0, 140.7, 139.5, 135.9, 135.1, 133.7, 129.4, 
128.9, 128.8, 127.7, 127.6, 123.2, 122.5, 29.7, 24.6, 23.4, 21.4, 15.7, 15.3, 14.9; IR (KBr) νmax 
3060, 3016, 2965, 2929, 2869, 1703, 1604, 1559, 1464, 1452, 1320, 1186, 1060, 761, 710 cm-
1; HRMS (m/z) for C26H27O (M + H) calcd: 355.20564, found: 355.20576; Rf (5/1 
hexanes/EtOAc) = 0.64 (silica gel plate). 
 
Ph
Ph
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2,3-Diethyl-1-phenyl-4-propyl-9H-fluoren-9-one (5c). With 4cb (70 mg, 0.2 mmol) 
following the general procedure D. Column chromatography (10/1 
hexanes/EtOAc) yielded 66 mg (94%) of the title compound as a bright 
yellow solid: mp (decomp) 70-75 °C, 1H NMR (600 MHz, CDCl3) δ 7.57 (d, J 
= 7.7 Hz, 1H), 7.50 (m, 1H), 7.40-7.47 (m, 4H), 7.20-7.22 (m, 3H), 2.96 (m, 2H), 2.79 (q, J = 
7.6 Hz, 2H), 2.47 (q, J = 7.5 Hz, 2H), 1.75 (m, 2H), 1.27 (t, J = 7.6 Hz, 3H), 1.20 (t, J = 7.3 
Hz, 3H), 0.97 (t, J = 7.5 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 193.3, 147.9, 144.3, 142.2, 
140.3, 139.6, 138.3, 137.1, 135.2, 134.2, 129.7, 128.7, 127.90, 127.89, 127.0, 123.7, 122.9, 
31.5, 23.3, 22.5, 22.4, 15.6, 15.5, 14.6; IR (KBr) νmax 3055, 3019, 2959, 2929, 2872, 1709, 
1601, 1586, 1562, 1467, 1442, 1305, 1189, 1063, 764, 704 cm-1; HRMS (m/z) for C26H27O (M 
+ H) calcd: 355.20564, found: 355.20590; Rf (5/1 hexanes/EtOAc) = 0.57 (silica gel plate). 
 
2,3-Diethyl-1,4-dipropyl-9H-fluoren-9-one (5d). With 4db (61 mg, 0.20 mmol) following 
the general procedure D. Column chromatography (10/1 hexanes/EtOAc) 
yielded 55 mg (90%) of the title compound as a bright yellow yellow solid: 
mp (decomp) 76-81 °C, 1H NMR (600 MHz, CDCl3) δ 7.62 (d, J = 7.2 Hz, 
1H), 7.51 (d, J = 7.7 Hz, 1H), 7.44 (dt, J = 7.5, 1.2 Hz, 1H), 7.23 (dt, J = 7.4, 0.7 Hz, 1H), 
3.05 (m, 2H), 2.86 (m, 2H), 2.72 (q, J = 7.6 Hz, 2H), 2.67 (q, J = 7.5 Hz, 2H), 1.67 (m, 2H), 
1.56 (m, 2H), 1.22 (t, J = 7.5 Hz, 3H), 1.18 (t, J = 7.5 Hz, 3H), 1.15 (t, J = 7.3 Hz, 3H), 1.09 
(t, J = 7.3 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 195.1, 147.8, 144.3, 142.2, 141.3, 140.8, 
135.5, 135.4, 134.1, 129.4, 127.7, 123.5, 122.8, 31.4, 29.6, 24.5, 23.3, 22.4, 21.5, 15.6, 15.5, 
14.8, 14.6; IR (KBr) νmax 3066, 3049, 2962, 2926, 2869, 1700, 1610, 1589, 1568, 1461, 1425, 
1296, 1248, 1192, 1096, 1060, 994, 761, 716 cm-1; HRMS (m/z) for C23H29O (M + H) calcd: 
321.22129, found: 321.22131; Rf (5/1 hexanes/EtOAc) = 0.66 (silica gel plate). 
 
2,3-Diethyl-4-(4-methoxyphenyl)-1-(p-tolyl)-9H-fluoren-9-one (10a). With 9a (87 mg, 0.26 
mmol) following the general procedure D. Column chromatography (10/1 
hexanes/EtOAc) yielded 69 mg (80%) of the title compound as a bright 
yellow solid: mp (decomp) 231-236 °C; 1H NMR (600 MHz, CDCl3) δ 7.40 
(m, 1H), 7.28 (m, 4H), 7.16 (m, 2H), 7.08 (m, 2H), 7.05 (m, 2H), 5.92 (m, 
1H), 3.95 (s, 3H), 2.55 (q, J = 7.5 Hz, 2H), 2.53 (q, J = 7.5 Hz, 2H), 2.47 (s, 
3H), 1.03 (t, J = 7.5 Hz, 3H), 0.99 (t, J = 7.5 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 193.3, 
159.1, 148.4, 144.1, 142.3, 141.0, 140.6, 136.9, 136.6, 135.0, 134.9, 133.8, 131.4, 130.3, 
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129.1, 128.7, 128.5, 127.9, 123.4, 122.6, 114.3, 55.3, 23.4, 22.4, 21.4, 15.6, 15.4; IR (KBr) 
νmax 3022, 3001, 2962, 2932, 2893, 2869, 2836, 1712, 1613, 1586, 1562, 1512, 1461, 1422, 
1302, 1284, 1242, 1192, 1186, 1066, 1030, 842, 824, 779 cm-1; HRMS (m/z) for C31H28O2 
(M+) calcd: 432.2089, found: 432.2091; Rf (5/1 hexanes/EtOAc) = 0.39 (silica gel plate). 
 
2,3-Diethyl-1,4-di-p-tolyl-9H-fluoren-9-one (10b). With 9b (83 mg, 0.2 mmol) following 
the general procedure D. Column chromatography (10/1 hexanes/EtOAc) 
yielded 70 mg (84%) of the title compound as a bright yellow solid: mp 
(decomp) 76-81 °C; 1H NMR (600 MHz, CDCl3) δ 7.39 (m, 1H), 7.34 (d, J = 
7.6 Hz, 2H), 7.28 (d, J = 7.6 Hz, 2H), 7.25 (d, J = 7.9 Hz, 2H), 7.16 (d, J = 
7.6 Hz, 2H), 7.05 (dt, J = 7.4, 1.2 Hz, 1H), 7.02 (dt, J = 7.5, 1.5 Hz, 1H), 
5.87 (m, 1H), 2.55 (q, J = 7.5 Hz, 2H), 2.54 (q, J = 7.5 Hz, 2H), 2.51 (s, 3H), 2.47 (s, 3H), 
1.03 (t, J = 7.4 Hz, 3H), 0.99 (t, J = 7.4 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 193.3, 148.1, 
144.1, 142.3, 141.0, 140.3, 137.4, 137.3, 136.6, 136.2, 135.0, 134.9, 133.7, 129.7, 129.11, 
129.08, 128.7, 128.5, 127.9, 123.3, 122.6, 23.4, 22.4, 21.4 (2xCH3), 15.6, 15.4; IR (KBr) νmax 
3078, 3046, 3025, 2965, 2932, 2893, 2872, 1709, 1607, 1586, 1556, 1515, 1467, 1446, 1422, 
1374, 1299, 1195, 1063, 875, 818, 779, 764, 725 cm-1; HRMS (m/z) for C31H28O (M + Na) 
calcd: 416.2140, found: 416.2142; Rf (5/1 hexanes/EtOAc) = 0.49 (silica gel plate). 
 
4-([1,1'-Biphenyl]-4-yl)-2,3-diethyl-1-(p-tolyl)-9H-fluoren-9-one (10c). With 9c (96 mg, 
0.2 mmol) following the general procedure D. Column chromatography 
(10/1 hexanes/EtOAc) yielded 78 mg (82%) of the title compound as a bright 
yellow solid: mp (decomp) 194-199 °C; 1H NMR (600 MHz, CDCl3) δ 7.81 
(m, 2H), 7.78 (m, 2H), 7.53 (m, 2H), 7.46 (m, 2H), 7.42 (m, 2H), 7.29 (m, 
2H), 7.18 (m, 2H), 7.06 (dt, J = 7.4, 1.1 Hz, 1H), 7.02 (dt, J = 7.6, 1.4 Hz, 
1H), 5.96 (d, J = 7.6 Hz, 1H), 2.59 (q, J = 7.5 Hz, 2H), 2.56 (q, J = 7.5 Hz, 2H), 2.47 (s, 3H), 
1.04 (t, J = 7.5 Hz, 3H), 1.00 (t, J = 7.5 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 193.2, 147.9, 
144.0, 142.4, 141.2, 140.39, 140.37, 140.3, 138.3, 136.8, 136.7, 135.0, 134.9, 133.8, 129.8, 
129.2, 128.9, 128.7, 128.5, 128.0, 127.6, 127.5, 127.0, 123.4, 122.6, 23.4, 22.4, 21.4, 15.6, 
15.4; IR (KBr) νmax 3078, 3049, 3022, 2974, 2938, 2878, 1712, 1601, 1583, 1559, 1488, 1467, 
1446, 1302, 1230, 1186, 1117, 1063, 1006, 872, 776, 752, 695 cm-1; HRMS (m/z) for 
C36H30O (M+) calcd: 478.2297, found: 478.2296; Rf (5/1 hexanes/EtOAc) = 0.47 (silica gel 
plate). 
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2,3-Diethyl-4-phenyl-1-(p-tolyl)-9H-fluoren-9-one (10d). With 9d (81 mg, 0.2 mmol) 
following the general procedure D. Column chromatography (10/1 
hexanes/EtOAc) yielded 69 mg (86%) of the title compound as a bright 
yellow solid: mp (decomp) 71-76 °C; 1H NMR (600 MHz, CDCl3) δ 7.51-
7.57 (m, 3H), 7.38-7.42 (m, 3H), 7.29 (d, J = 7.6 Hz, 2H), 7.17 (m, 2H), 7.05 
(dt, J = 7.5, 1.0 Hz, 1H), 7.00 (dt, J = 7.6, 1.4 Hz, 1H), 5.79 (d, J = 7.6 Hz, 1H), 2.560 (q, J = 
7.5 Hz, 2H), 2.559 (q, J = 7.5 Hz, 2H), 2.47 (s, 3H), 1.04 (t, J = 7.5 Hz, 3H), 1.01 (t, J = 7.5 
Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 193.2, 147.7, 144.0, 142.3, 141.1, 140.2, 139.3, 
137.2, 136.6, 134.9, 134.9, 133.7, 129.3, 129.1, 129.0, 128.7, 128.5, 127.9, 127.8, 123.4, 
122.5, 23.4, 22.4, 21.4, 15.6, 15.3; IR (KBr) νmax 3049, 3022, 2971, 2929, 2869, 1715, 1601, 
1559, 1512, 1464, 1440, 1305, 1186, 1060, 1009, 952, 866, 764, 719, 707 cm-1; HRMS (m/z) 
for C30H26O (M+) calcd: 402.1984, found: 402.1988; Rf (5/1 hexanes/EtOAc) = 0.53 (silica gel 
plate). 
 
4-(4-Chlorophenyl)-2,3-diethyl-1-(p-tolyl)-9H-fluoren-9-one (10e). With 9e (87 mg, 0.2 
mmol) following the general procedure D. Column chromatography (10/1 
hexanes/EtOAc) yielded 75 mg (86%) of the title compound as a bright 
yellow solid: mp (decomp) 193-198 °C; 1H NMR (600 MHz, CDCl3) δ 7.54 
(m, 2H), 7.42 (m, 1H), 7.34 (m, 2H), 7.28 (m, 2H), 7.15 (m, 2H), 7.08 (m, 
2H), 5.91 (m, 1H), 2.53 (q, J = 7.5 Hz, 2H), 2.52 (q, J = 7.5 Hz, 2H), 2.47 
(s, 3H), 1.02 (t, J = 7.5 Hz, 3H), 0.99 (t, J = 7.5 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 
193.0, 147.6, 143.7, 142.5, 141.4, 140.2, 137.8, 136.7, 135.7, 134.9, 134.7, 133.9, 133.8, 
130.8, 129.3, 129.2, 128.7, 128.4, 128.1, 123.6, 122.4, 23.3, 22.4, 21.4, 15.6, 15.3; IR (KBr) 
νmax 3081, 3063, 3052, 3025, 2974, 2929, 2866, 1712, 1607, 1589, 1556, 1512, 1488, 1464, 
1425, 1302, 1198, 1087, 955, 872, 821, 773, 725 cm-1; HRMS (m/z) for C30H26OCl (M + H) 
calcd: 437.16667, found: 437.16665; Rf (5/1 hexanes/EtOAc) = 0.52 (silica gel plate). 
 
2,3-Diethyl-1-(p-tolyl)-4-(4-(trifluoromethyl)phenyl)-9H-fluoren-9-one (10f). With 9f (95 
mg, 0.2 mmol) following the general procedure D. Column chromatography 
(10/1 hexanes/EtOAc) yielded 57 mg (61%) of the title compound as a bright 
yellow solid: mp (decomp) 77-82 °C; 1H NMR (600 MHz, CDCl3) δ 7.83 (d, 
J = 7.9 Hz, 2H), 7.54 (d, J = 7.8 Hz, 2H), 7.42 (m, 1H), 7.29 (m, 2H), 7.16 
(m, 2H), 7.08 (dt, J = 7.5, 1.0 Hz, 1H), 7.04 (dt, J = 7.6, 1.4 Hz, 1H), 5.76 
(m, 1H), 2.54 (q, J = 7.5 Hz, 2H), 2.49 (q, J = 7.5 Hz, 2H), 2.47 (s, 3H), 1.02 (t, J = 7.5 Hz, 
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3H), 1.00 (t, J = 7.5 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 192.8, 147.2, 143.5, 143.3, 
142.7, 141.7, 139.9, 136.8, 135.5, 134.9, 134.6, 133.9, 130.2 (q, 2JC-F = 32.6 Hz), 129.9, 
129.3, 128.8, 128.4, 128.3, 126.0 (q, 3JC-F = 3.8 Hz), 121.5-126.9 (q, 1JC-F = 272.2 Hz), 123.7, 
122.2, 23.4, 22.3, 21.4, 15.5, 15.3; IR (KBr) νmax 3028, 2965, 2932, 2869, 1715, 1619, 1601, 
1559, 1464, 1401, 1374, 1332, 1323, 1192, 1162, 1132, 1123, 1102, 1069, 1021, 872, 857, 
824, 770, 719 cm-1; HRMS (m/z) for C31H26OF3 (M + H) calcd: 471.19303, found: 
471.19297; Rf (5/1 hexanes/EtOAc) = 0.54 (silica gel plate). 
 
4-(2,3-Diethyl-9-oxo-1-(p-tolyl)-9H-fluoren-4-yl)benzonitrile (10g). With 9g (65 mg, 0.15 
mmol) following the general procedure D. Column chromatography (10/1 
hexanes/EtOAc) yielded 47 mg (73%) of the title compound as a bright 
yellow solid: mp (decomp) 239-244 °C; 1H NMR (600 MHz, CDCl3) δ 7.87 
(m, 2H), 7.55 (m, 2H), 7.43 (m, 1H), 7.29 (d, J = 7.7 Hz, 2H), 7.14 (m, 2H), 
7.10 (dt, J = 7.5, 1.0 Hz, 1H), 7.05 (dt, J = 7.6, 1.4 Hz, 1H), 5.76 (d, J = 7.6 
Hz, 1H), 2.54 (q, J = 7.5 Hz, 2H), 2.48 (q, J = 7.5 Hz, 2H), 2.46 (s, 3H), 1.01 (t, J = 7.5 Hz, 
3H), 0.99 (t, J = 7.5 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 192.6, 146.8, 144.6, 143.2, 
142.8, 141.9, 139.7, 136.9, 135.0, 134.9, 134.4, 133.9, 132.8, 130.5, 129.3, 128.8, 128.41, 
128.35, 123.8, 122.0, 118.6, 112.1, 23.4, 22.3, 21.4, 15.5, 15.2; IR (KBr) νmax 3120, 3081, 
3066, 3046, 3022, 2977, 2926, 2893, 2872, 2229, 1718, 1604, 1559, 1512, 1467, 1422, 1371, 
1320, 1169, 1069, 1021, 949, 872, 833, 764, 716 cm-1; HRMS (m/z) for C31H26ON (M + H) 
calcd: 428.20089, found: 428.20087; Rf (5/1 hexanes/EtOAc) = 0.37 (silica gel plate). 
 
4-(4-Bromophenyl)-2,3-diethyl-1-(p-tolyl)-9H-fluoren-9-one (10h). With 9h (510 mg, 1.1 
mmol) following the general procedure D. Column chromatography (5/1 
hexanes/EtOAc) yielded 475 mg (93%) of the title compound as a bright 
yellow solid: mp (decomp) 78-83 °C; 1H NMR (600 MHz, CDCl3) δ 7.69 (m, 
2H), 7.42 (m, 1H), 7.27-7.30 (m, 4H), 7.15 (m, 2H), 7.08 (m, 2H), 5.92 (m, 
1H), 2.53 (q, J = 7.5 Hz, 2H), 2.51 (q, J = 7.5 Hz, 2H), 2.46 (s, 3H), 1.02 (t, J 
= 7.5 Hz, 3H), 0.99 (t, J = 7.5 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 193.0, 147.6, 143.7, 
142.5, 141.4, 140.1, 138.2, 136.8, 135.7, 134.9, 134.7, 133.9, 132.2, 131.1, 129.2, 128.7, 
128.4, 128.2, 123.6, 122.4, 122.0, 23.3, 22.3, 21.4, 15.6, 15.3; IR (KBr) νmax 3022, 2968, 
2932, 2866, 1709, 1604, 1556, 1515, 1485, 1464, 1422, 1371, 1302, 1192, 1120, 1072, 1012, 
949, 869, 824, 761, 719 cm-1; HRMS (m/z) for C30H26OBr (M + H) calcd: 481.11615, found: 
481.11621; Rf (5/1 hexanes/EtOAc) = 0.51 (silica gel plate). 
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2,3-Diethyl-4-(naphthalen-2-yl)-1-propyl-9H-fluoren-9-one (17a). With 16a (81 mg, 0.2 
mmol) following the general procedure D. Column chromatography (5/1 
hexanes/EtOAc) yielded 84 mg (91%) of the title compound as a bright 
yellow solid: mp (decomp) 69-74 °C; 1H NMR (600 MHz, CDCl3) δ 8.00 (m, 
2H), 7.87 (m, 1H), 7.81 (s, 1H), 7.56-7.61 (m, 2H), 7.53 (d, J = 7.2 Hz, 1H), 
7.44 (dd, J = 8.3, 1.6 Hz, 1H), 7.04 (t, J = 7.4 Hz, 1H), 6.86 (dt, J = 7.6, 1.1 
Hz, 1H), 5.71 (d, J = 7.6 Hz, 1H), 3.15 (m, 2H), 2.75 (q, J = 7.5 Hz, 2H), 2.45-2.53 (m, 2H), 
1.65 (m, 2H), 1.25 (t, J = 7.4 Hz, 3H), 1.16 (t, J = 7.2 Hz, 3H), 0.99 (t, J = 7.5 Hz, 3H); 13C 
NMR (150 MHz, CDCl3) δ 194.9, 147.9, 144.0, 142.9, 142.2, 140.7, 136.9, 135.7, 135.1, 
133.8, 133.5, 132.7, 128.8, 128.6, 128.14, 128.10, 127.9, 127.8, 127.7, 126.4, 126.2, 123.2, 
122.5, 29.7, 24.7, 23.5, 21.4, 15.7, 15.4, 14.9; IR (KBr) νmax 3052, 2962, 2929, 2866, 1700, 
1601, 1562, 1467, 1428, 1374, 1299, 1186, 1102, 1063, 1012, 961, 860, 806, 764, 746, 716 
cm-1; HRMS (m/z) for C30H28O (M+) calcd: 404.2140, found: 404.2141; Rf (5/1 
hexanes/EtOAc) = 0.56 (silica gel plate). 
 
2,3-Diethyl-4-(phenanthren-9-yl)-1-propyl-9H-fluoren-9-one (17b). With 16b (100 mg, 
0.22 mmol) following the general procedure D. Column chromatography (5/1 
hexanes/EtOAc) yielded 85 mg (86%) of the title compound as a bright 
yellow solid: mp (decomp) 81-86 °C; 1H NMR (400 MHz, CDCl3) δ 8.82 (d, 
J = 8.3 Hz, 2H), 7.90 (dd, J = 7.9, 1.3 Hz, 1H), 7.77 (dt, J = 7.1, 1.4 Hz, 1H), 
7.75 (s, 1H), 7.66-7.71 (m, 2H), 7.59 (dd, J = 8.2, 1.1 Hz, 1H), 7.45-7.50 (m, 
2H), 6.97 (dt, J = 7.5, 0.9 Hz, 1H), 6.72 (dt, J = 7.6, 1.3 Hz, 1H), 5.71 (d, J = 7.7 Hz, 1H), 
3.33 (m, 1H), 3.11 (m, 1H), 2.79 (m, 2H), 2.53 (m, 1H), 2.25 (m, 1H), 1.73 (m, 2H), 1.28 (t, J 
= 7.5 Hz, 3H), 1.19 (t, J = 7.2 Hz, 3H), 0.93 (t, J = 7.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) 
δ 195.0, 148.6, 143.6, 143.2, 142.6, 141.5, 135.4, 135.0, 133.9, 133.3, 131.6, 131.3, 130.6, 
130.3, 129.2, 128.8, 127.9, 127.7, 127.1, 126.99, 126.95, 126.9, 126.3, 123.2, 123.0, 122.7, 
122.5, 29.7, 24.7, 23.9, 21.5, 15.84, 15.82, 14; IR (KBr) νmax 3075, 2965, 2935, 2869, 1703, 
1604, 1562, 1491, 1470, 1449, 1377, 1257, 1192, 1060, 761, 746, 722 cm-1; HRMS (m/z) for 
C34H31O (M + H) calcd: 455.23694, found: 455.23707; Rf (5/1 hexanes/EtOAc) = 0.49 (silica 
gel plate). 
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4-(Anthracen-9-yl)-2,3-diethyl-1-propyl-9H-fluoren-9-one (17c). With 16c (100 mg, 0.23 
mmol) following the general procedure D. Column chromatography (5/1 
hexanes/EtOAc) yielded 84 mg (83%) of the title compound as a bright 
yellow solid: mp (decomp) 75-80 °C; 1H NMR (400 MHz, CDCl3) δ 8.63 (s, 
1H), 8.10 (d, J = 8.5 Hz, 2H), 7.66 (d, J = 8.8 Hz, 2H), 7.46–7.50 (m, 3H), 
7.32 (m 2H), 6.89 (dt, J = 7.6, 0.6 Hz, 1H), 6.55 (dt, J = 7.6, 1.1 Hz, 1H), 4.82 (d, J = 7.7 Hz, 
1H), 3.28 (m, 2H), 2.84 (q, J = 7.4 Hz, 2H), 2.25 (q, J = 7.5 Hz, 2H), 1.79 (m, 2H), 1.32 (t, J 
= 7.4 Hz, 3H), 1.24 (t, J = 7.3 Hz, 3H), 0.69 (t, J = 7.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) 
δ 195.0, 149.2, 143.34, 143.0, 142.2, 135.0, 133.8, 133.4, 131.6, 131.5, 130.3, 129.5, 128.5, 
127.6, 127.2, 126.1, 126.0, 125.5, 123.0, 121.8, 29.8, 24.8, 24.0, 21.5, 15.9, 15.2, 14.9; IR 
(KBr) νmax 3049, 2959, 2926, 2886, 1703, 1601, 1562, 1464, 1404, 1293, 1245, 1222, 1183, 
1096, 1054, 1012, 973, 890, 848, 785, 761, 737, 716 cm-1; HRMS (m/z) for C34H31O (M + H) 
calcd: 455.23694, found: 455.23681; Rf (5/1 hexanes/EtOAc) = 0.50 (silica gel plate). 
 
2,3-Diethyl-1-propyl-4-(pyren-2-yl)-9H-fluoren-9-one (17d). With 16d (96 mg, 0.2 mmol) 
following the general procedure D. Column chromatography (5/1 
hexanes/EtOAc) yielded 80 mg (84%) of the title compound as a bright 
yellow solid: mp (decomp) 87-93 °C; 1H NMR (400 MHz, CDCl3) δ 8.32 
(d, J = 7.8 Hz, 1H), 8.25 (dd, J = 7.6, 1.0 Hz, 1H), 8.16–8.22 (m, 3H), 8.04 
(t, J = 7.6 Hz, 1H), 7.98 (d, J = 3.4 Hz, 1H), 7.95 (d, J = 4.8 Hz, 1H), 7.75 
(d, J = 9.2 Hz, 1H), 7.50 (m 1H), 6.93 (dt, J = 7.5, 0.8 Hz, 1H), 6.58 (dt, J = 7.6, 1.2 Hz, 1H), 
5.06 (d, J = 7.7 Hz, 1H), 3.31 (m, 1H), 3.18 (m, 1H), 2.81 (m, 2H), 2.48 (m, 1H), 2.29 (m, 
1H), 1.73 (m, 2H), 1.31 (t, J = 7.4 Hz, 3H), 1.29 (t, J = 7.2 Hz, 3H), 0.85 (t, J = 7.5 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 195.0, 148.6, 143.8, 143.2, 142.6, 141.6, 135.1, 134.3, 133.9, 
133.8, 131.4, 131.2, 131.0, 129.5, 129.2, 128.0, 127.71, 127.68, 127.6, 127.5, 126.2, 125.33, 
125.29, 125.1, 125.0, 124.9, 124.8, 123.2, 122.2, 29.8, 24.8, 23.8, 21.5, 15.9, 15.4, 14.9; IR 
(KBr) νmax 3040, 2963, 2931, 2870, 1702, 1603, 1565, 1465, 1423, 1375, 1297, 1187, 1057, 
1011, 952, 872, 849, 838, 761, 721 cm-1; HRMS (m/z) for C36H31O (M + H) calcd: 479.23694, 
found: 479.23680; Rf (5/1 hexanes/EtOAc) = 0.46 (silica gel plate). 
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E:  General procedure for creation of 9,9’-spirobifluorene (preparation of 6, 11 and 
18).46 A solution of 2-bromobiphenyl (40 µL, 0.23 mmol) in anhydrous THF (3 mL) was 
cooled down to -78 °C and n-BuLi 1.6 M (140 µL, 0.23 mmol) was added dropwise. The 
resulted solution was stirred for 30 min, followed by the addition of fluorenone (0.15 mmol) 
in THF (3 mL) and stirred for 3 h first for 15 min at -78 °C, but during time it was allowed to 
reach ambient temperature. The reaction mixture was poured in a saturated solution of 
NaHCO3 solution and extracted with diethyl ether (3 x 15 mL). The combined organic 
fractions were dried over MgSO4 and concentrated under reduced pressure. The crude was 
purified by column chromatography on silica gel (10/1 hexanes/EtOAc) to yield desired 
alcohols. The alcohols were dissolved in acetic acid (10 mL) with a catalytic amount of HCl 
(12 mol/L) and the resulted solution stirred under reflux for 3 h. The reaction mixture was 
neutralized with H2O and K2CO3 and extracted with diethyl ether (3 x 15 mL). Column 
chromatography of the residue on silica gel provided products. 
 
2,3-Diethyl-1,4-diphenyl-9,9'-spirobifluorene (6a). With 5a (60 mg, 0.15 mmol) following 
the general procedure E. Column chromatography of the residue on silica gel 
(20/1 hexanes/EtOAc) provided 52 mg (66%) of the title compound as a 
colorless solid: mp (decomp) 115-120 °C; 1H NMR (600 MHz, CDCl3) δ 
7.52-7.62 (m, 4H), 7.40-7.46 (m, 1H), 7.40 (m, 1H), 7.28-7.35 (m, 2H), 7.18 
(dt, J = 7.3, 1.2 Hz, 2H), 7.05 (dt, J = 7.5, 1.2 Hz, 2H), 6.80-6.87 (m, 4H), 6.57-6.62 (m, 2H), 
6.39-6.42 (m, 1H), 6.06-6.12 (m, 3H), 2.58 (q, J = 7.5 Hz, 2H), 2.28 (q, J = 7.5 Hz, 2H), 1.06 
(t, J = 7.5 Hz, 3H), 0.86 (t, J = 7.5 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 149.7, 149.0, 
143.3, 142.0, 141.8, 140.8, 140.3, 140.0, 139.3, 137.9, 137.1, 136.3, 133.1, 131.3, 129.8, 
129.3, 128.8, 128.0, 127.6, 127.3, 127.0, 126.8, 126.7, 126.6, 126.2, 124.9, 123.8, 123.2, 
122.5, 119.6, 65.5, 23.0, 22.9, 15.8, 15.6; IR (KBr) νmax 3055, 3019, 2965, 2929, 2866, 1601, 
1470, 1446, 1368, 1278, 1224, 1117, 1069, 1030, 752, 737 cm-1; HRMS (m/z) for C41H32Na 
(M + Na) calcd: 547.23962, found: 547.23933; Rf (20/1 hexanes/EtOAc) = 0.45 (silica gel 
plate). 
 
2,3-Diethyl-4-phenyl-1-propyl-9,9'-spirobifluorene (6b). With 5b (87 mg, 0.25 mmol) 
following the general procedure E. Column chromatography of the residue on 
silica gel (20/1 hexanes/EtOAc) provided 88 mg (74%) of the title compound 
as a colorless solid: mp (decomp) 227-232 °C; 1H NMR (600 MHz, CDCl3) δ 
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7.87 (d, J = 7.6 Hz, 2H), 7.56 (m, 2H), 7.51 (m, 1H), 7.46 (m, 2H), 7.39 (dt, J = 7.5, 0.9 Hz, 
2H), 7.13 (dt, J = 7.5, 1.0 Hz, 2H), 6.84 (d, J = 7.5 Hz, 2H), 6.81 (m, 2H), 6.38 (m, 1H), 5.98 
(m, 1H), 2.60 (q, J = 7.4 Hz, 2H), 2.54 (q, J = 7.5 Hz, 2H), 1.47 (m, 2H), 1.11 (t, J = 7.4 Hz, 
3H), 1.02 (t, J = 7.4 Hz, 3H), 0.65 (m, 2H), 0.32 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, 
CDCl3) δ 149.8, 149.6, 143.1, 141.73, 141.70, 141.1, 140.52, 140.46, 138.4, 137.6, 135.1, 
129.9, 128.7, 127.7, 127.4, 127.2, 126.6, 126.4, 124.2, 122.8, 122.5, 119.9, 66.0, 31.1, 23.6, 
22.8, 21.7, 16.1, 15.8, 14.8; IR (KBr) νmax 3055, 3016, 2962, 2932, 2869, 1598, 1470, 1449, 
1374, 1278, 1260, 1150, 1105, 1063, 1027, 758, 740, 704 cm-1; HRMS (m/z) for C38H35 (M + 
H) calcd: 591.27333, found: 591.27349; Rf (20/1 hexanes/EtOAc) = 0.48 (silica gel plate).  
 
2,3-Diethyl-1-phenyl-4-propyl-9,9'-spirobifluorene (6c). With 5c (66 mg, 0.2 mmol) 
following the general procedure E. Column chromatography of the residue on 
silica gel (20/1 hexanes/EtOAc) provided 67 mg (68%) of the title compound 
as a colorless solid: mp (decomp) 106-111 °C; 1H NMR (600 MHz, CDCl3) δ 
7.90 (d, J = 8.0 Hz, 1H), 7.30-7.34 (m, 3H), 7.18 (t, J = 7.4 Hz, 2H), 7.04 (t, J 
= 7.4 Hz, 2H), 6.99 (t, J = 7.4 Hz, 1H), 6.82 (t, J = 7.4 Hz, 1H), 6.76 (d, J = 7.5 Hz, 2H), 6.57 
(t, J = 7.6 Hz, 2H), 6.49 (d, J = 7.6 Hz, 1H), 6.04 (d, J = 7.5 Hz, 2H), 3.22 (m, 2H), 2.86 (q, J 
= 7.5 Hz, 2H), 2.26 (q, J = 7.4 Hz, 2H), 1.95 (m, 2H), 1.32 (t, J = 7.7 Hz, 3H), 1.31 (t, J = 7.5 
Hz, 3H), 0.84 (t, J = 7.4 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 150.0, 149.2, 143.7, 142.1, 
141.9, 140.4, 139.9, 138.1, 137.8, 137.4, 135.7, 129.5, 127.2, 126.9, 126.7, 126.4, 126.0, 
124.7, 123.8, 123.6, 122.8, 119.6, 65.5, 32.0, 23.5, 23.2, 22.0, 16.0, 15.6, 14.8; IR (KBr) νmax 
3058, 3034, 2962, 2932, 2872, 1598, 1473, 1449, 1368, 1266, 1236, 1108, 1072, 1027, 758, 
731, 704 cm-1; HRMS (m/z) for C38H35 (M + H) calcd: 491.27333, found: 491.27334; Rf (20/1 
hexanes/EtOAc) = 0.52 (silica gel plate). 
 
2,3-Diethyl-1,4-dipropyl-9,9'-spirobifluorene (6d). With 5d (50 mg, 0.15 mmol) following 
the general procedure E. Column chromatography of the residue on silica gel 
(20/1 hexanes/EtOAc) provided 57 mg (83%) of the title compound as a 
colorless solid: mp (decomp) 101-106 °C, 1H NMR (600 MHz, CDCl3) δ 7.86 
(m, 2H), 7.82 (d, J = 8.0 Hz, 1H), 7.37 (dt, J = 7.4, 1.1 Hz, 2H), 7.28 (dt, J = 
7.4, 1.2 Hz, 1H), 7.11 (dt, J = 7.5, 1.1 Hz, 2H), 6.97 (dt, J = 7.5, 1.0 Hz, 1H), 6.78 (m, 2H), 
6.46 (m, 1H), 3.11 (m, 2H), 2.80 (q, J = 7.5 Hz, 2H), 2.57 (q, J = 7.4 Hz, 2H), 1.86 (m, 2H), 
1.70 (m, 2H), 1.28 (t, J = 7.7 Hz, 3H), 1.25 (t, J = 7.5 Hz, 3H), 1.09 (t, J = 7.5 Hz, 3H), 0.60 
(m, 2H), 0.29 (t, J = 7.4 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 149.69, 148.97, 143.25, 
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141.95, 141.78, 140.80, 140.27, 140.04, 139.31, 137.91, 137.11, 136.34, 133.09, 131.26, 
129.79, 129.36, 129.32, 128.78, 127.95, 127.58, 127.33, 126.97, 126.80, 126.74, 126.60, 
126.15, 124.89, 123.80, 123.22, 122.53, 119.63, 65.51, 22.99, 22.92, 15.77, 15.61; IR (KBr) 
νmax 3058, 3037, 3016, 2953, 2929, 2896, 2869, 1598, 1476, 1446, 1365, 1284, 1219, 1114, 
1069, 1030, 758, 740 cm-1; HRMS (m/z) for C35H37 (M + H) calcd: 457.2895, found: 
457.2895; Rf (20/1 hexanes/EtOAc) = 0.54 (silica gel plate). 
 
2,3-Diethyl-4-(4-methoxyphenyl)-1-(p-tolyl)-9,9'-spirobifluorene (11a). With 10a (65 mg, 
0.15 mmol) following the general procedure E. Column chromatography of 
the residue on silica gel (20/1 hexanes/EtOAc) provided 71 mg (83%) of the 
title compound as a colorless solid: mp (decomp) 260-265 °C; 1H NMR (600 
MHz, CDCl3) δ 7.43 (m, 2H), 7.30 (d, J = 7.6 Hz, 2H), 7.18 (dt, J = 7.4, 1.0 
Hz, 2H), 7.14 (m, 2H), 7.04 (dt, J = 7.4, 1.0 Hz, 2H), 6.90 (dt, J = 7.3, 1.1 
Hz, 1H), 6.84 (dt, J = 7.4, 1.1 Hz, 1H), 6.79 (d, J = 7.5 Hz, 2H), 6.40 (d, J = 7.4 Hz, 1H), 6.37 
(d, J = 7.7 Hz, 2H), 6.19 (d, J = 7.8 Hz, 1H), 5.95 (d, J = 7.9 Hz, 2H), 3.98 (s, 3H), 2.59 (q, J 
= 7.4 Hz, 2H), 2.31 (q, J = 7.4 Hz, 2H), 2.18 (s, 3H), 1.06 (t, J = 7.4 Hz, 3H), 0.87 (t, J = 7.4 
Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 158.8, 149.7, 149.1, 143.7, 142.01, 141.99, 140.5, 
140.3, 139.3, 138.3, 135.8, 134.2, 134.1, 133.1, 130.8, 129.1, 126.9, 126.8, 126.74, 126.70, 
126.5, 123.8, 123.2, 122.6, 119.4, 114.1, 65.5, 55.3, 23.1, 22.9, 21.1, 15.8, 15.7; IR (KBr) νmax 
3063, 3040, 3022, 2956, 2932, 2869, 2839, 1613, 1574, 1512, 1476, 1467, 1440, 1425, 1371, 
1290, 1245, 1177, 1111, 1063, 1033, 824, 815, 770, 737 cm-1; HRMS (m/z) for C43H37O (M + 
H) calcd: 569.28389, found: 569.28369; Rf (20/1 hexanes/EtOAc) = 0.36 (silica gel plate). 
 
2,3-Diethyl-1,4-di-p-tolyl-9,9'-spirobifluorene (11b). With 11b (62 mg, 0.15 mmol) 
following the general procedure E. Column chromatography of the residue 
on silica gel (20/1 hexanes/EtOAc) provided 61 mg (74%) of the title 
compound as a colorless solid: mp (decomp) 226-231 °C; 1H NMR (600 
MHz, CDCl3) δ 7.40 (s, 4H), 7.29 (d, J = 7.6 Hz, 2H), 7.18 (dt, J = 7.5, 1.0 
Hz, 2H), 7.04 (dt, J = 7.5, 1.0 Hz, 2H), 6.88 (dt, J = 7.6, 1.2 Hz, 1H), 6.83 
(dt, J = 7.4, 1.2 Hz, 1H), 6.79 (d, J = 7.5 Hz, 2H), 6.39 (d, J = 7.5 Hz, 1H), 6.37 (d, J = 7.7 
Hz, 2H), 6.14 (d, J = 7.8 Hz, 1H), 5.95 (d, J = 7.9 Hz, 2H), 2.57 (q, J = 7.4 Hz, 2H), 2.55 (s, 
3H), 2.30 (q, J = 7.4 Hz, 2H), 2.16 (s, 3H), 1.06 (t, J = 7.4 Hz, 3H), 0.86 (t, J = 7.4 Hz, 3H); 
13C NMR (150 MHz, CDCl3) δ 149.7, 149.1, 143.7, 142.0, 140.3, 140.2, 139.2, 138.0, 137.7, 
136.8, 136.2, 134.2, 134.0, 129.6, 129.4, 129.1, 126.9, 126.8, 126.7, 126.5, 123.8, 123.1, 
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122.6, 119.4, 65.5, 23.1, 22.9, 21.5, 21.1, 15.8, 15.7; IR (KBr) νmax 3060, 3043, 3016, 2977, 
2959, 2929, 2869, 1515, 1476, 1449, 1428, 1371, 1281, 1239, 1111, 1060, 1021, 863, 824, 
755, 749, 734 cm-1; HRMS (m/z) for C43H37 (M + H) calcd: 553.28898, found: 553.28902; Rf 
(20/1 hexanes/EtOAc) = 0.50 (silica gel plate). 
 
4-([1,1'-Biphenyl]-4-yl)-2,3-diethyl-1-(p-tolyl)-9,9'-spirobifluorene (11c). With 10c (72 
mg, 0.15 mmol) following the general procedure E. Column chromatography 
of the residue on silica gel (20/1 hexanes/EtOAc) provided 58 mg (63%) of 
the title compound as a colorless solid: mp (decomp) >270 °C; 1H NMR (600 
MHz, CDCl3) δ 7.86 (m, 2H), 7.83 (m, 2H), 7.60 (m, 2H), 7.54 (t, J = 7.5 Hz, 
2H), 7.42 (m, 2H), 7.30 (d, J = 7.6 Hz, 2H), 7.19 (dt, J = 7.4, 1.0 Hz, 2H), 
7.05 (dt, J = 7.4, 1.0 Hz, 2H), 6.87 (dt, J = 7., 1.4 Hz, 1H), 6.84 (dt, J = 7.4, 1.4 Hz, 1H), 6.81 
(d, J = 7.4 Hz, 2H), 6.40 (m, 1H), 6.38 (d, J = 7.6 Hz, 2H), 6.22 (m, 1H), 5.96 (d, J = 7.9 Hz, 
2H), 2.62 (q, J = 7.4 Hz, 2H), 2.32 (q, J = 7.4 Hz, 2H), 2.18 (s, 3H), 1.09 (t, J = 7.4 Hz, 3H), 
0.88 (t, J = 7.4 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 149.7, 149.1, 143.8, 142.0, 141.8, 
140.8, 140.5, 140.1, 139.9, 139.8, 139.5, 137.9, 135.8, 134.11, 134.10, 130.3, 129.1, 128.9, 
127.4, 127.3, 127.1, 126.9, 126.78, 126.77, 126.73, 126.6, 123.8, 123.2, 122.6, 119.4, 65.5, 
29.7, 23.1, 23.0, 21.1, 15.9, 15.7; IR (KBr) νmax 3078, 3058, 3043, 3016, 2968, 2929, 2869, 
1601, 1518, 1491, 1440, 1386, 1368, 1111, 1060, 1006, 848, 824, 755, 737 cm-1; HRMS (m/z) 
for C48H39 (M + H) calcd: 615.30463, found: 615.30474; Rf (20/1 hexanes/EtOAc) = 0.40 
(silica gel plate). 
 
2,3-Diethyl-4-phenyl-1-(p-tolyl)-9,9'-spirobifluorene (11d). With 10d (60 mg, 0.15 mmol) 
following the general procedure E. Column chromatography of the residue 
on silica gel (20/1 hexanes/EtOAc) provided 56 mg (73%) of the title 
compound as a colorless solid: mp (decomp) 238-243 °C; 1H NMR (600 
MHz, CDCl3) δ 7.60 (m, 2H), 7.54 (m, 3H), 7.30 (d, J = 7.6 Hz, 2H), 7.18 
(dt, J = 7.4, 1.0 Hz, 2H), 7.04 (dt, J = 7.4, 1.0 Hz, 2H), 6.86 (dt, J = 7.4, 1.3 
Hz, 1H), 6.83 (dt, J = 7.4, 1.4 Hz, 1H), 6.79 (d, J = 7.5 Hz, 2H), 6.39 (m, 1H), 6.37 (d, J = 7.6 
Hz, 2H), 6.07 (m, 1H), 5.96 (d, J = 7.9 Hz, 2H), 2.58 (q, J = 7.4 Hz, 2H), 2.31 (q, J = 7.4 Hz, 
2H), 2.18 (s, 3H), 1.06 (t, J = 7.4 Hz, 3H), 0.87 (t, J = 7.4 Hz, 3H); 13C NMR (150 MHz, 
CDCl3) δ 149.7, 149.1, 143.7, 142.0, 141.8, 140.9, 140.4, 139.9, 139.4, 137.8, 136.2, 134.13, 
134.08, 129.8, 129.1, 128.8, 127.3, 126.9, 126.8, 126.72, 126.70, 126.5, 123.8, 123.2, 122.5, 
119.4, 65.5, 23.0, 22.9, 21.1, 15.8, 15.7; IR (KBr) νmax 3052, 3013, 2968, 2926, 2869, 1601, 
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1488, 1446, 1428, 1350, 1251, 1198, 1183, 1126, 1018, 860, 815, 758, 749, 701 cm-1;HRMS 
(m/z) for C42H35 (M + H) calcd: 539.27333, found: 539.27337; Rf (20/1 hexanes/EtOAc) = 
0.44 (silica gel plate). 
 
4-(4-Chlorophenyl)-2,3-diethyl-1-(p-tolyl)-9,9'-spirobifluorene (11e). With 10e (65 mg, 
0.15 mmol) following the general procedure E. Column chromatography of 
the residue on silica gel (20/1 hexanes/EtOAc) provided 72 mg (82%) of the 
title compound as a colorless solid: mp (decomp) 247-252 °C; 1H NMR (600 
MHz, CDCl3) δ 7.58 (m, 2H), 7.48 (m, 2H), 7.29 (d, J = 7.6 Hz, 2H), 7.18 
(dt, J = 7.4, 1.0 Hz, 2H), 7.04 (dt, J = 7.4, 1.0 Hz, 2H), 6.92 (dt, J = 7.3, 1.1 
Hz, 1H), 6.86 (dt, J = 7.4, 1.1 Hz, 1H), 6.77 (d, J = 7.5 Hz, 2H), 6.41 (d, J = 7.4 Hz, 1H), 6.37 
(d, J = 7.7 Hz, 2H), 6.17 (d, J = 7.8 Hz, 1H), 5.94 (d, J = 7.9 Hz, 2H), 2.54 (q, J = 7.4 Hz, 
2H), 2.30 (q, J = 7.4 Hz, 2H), 2.18 (s, 3H), 1.04 (t, J = 7.4 Hz, 3H), 0.86 (t, J = 7.4 Hz, 3H); 
13C NMR (150 MHz, CDCl3) δ 149.8, 148.9, 143.9, 142.0, 141.5, 140.6, 140.0, 139.8, 139.3, 
137.7, 134.7, 134.2, 134.0, 133.3, 131.3, 129.1, 129.0, 126.9, 126.82, 126.80, 126.78, 126.75, 
123.8, 123.4, 122.3, 119.4, 65.5, 23.0, 22.9, 21.1, 15.7, 15.6; IR (KBr) νmax 3060, 3040, 3016, 
2971, 2965, 2929, 2866, 1598, 1512, 1494, 1476, 1443, 1368, 1281, 1223, 1090, 1060, 1015, 
842, 821, 758, 740 cm-1; HRMS (m/z) for C42H33Cl (M + H) calcd: 573.23436, found: 
573.23444; Rf (20/1 hexanes/EtOAc) = 0.57 (silica gel plate). 
 
2,3-Diethyl-1-(p-tolyl)-4-(4-(trifluoromethyl)phenyl)-9,9'-spirobifluorene (11f). With 10f 
(47 mg, 0.1 mmol) following the general procedure E. Column 
chromatography of the residue on silica gel (20/1 hexanes/EtOAc) provided 
55 mg (90%) of the title compound as a colorless solid: mp (decomp) 202-
207 °C; 1H NMR (600 MHz, CDCl3) δ 7.88 (d, J = 7.9 Hz, 2H), 7.68 (d, J = 
7.9 Hz, 2H), 7.30 (d, J = 7.6 Hz, 2H), 7.19 (dt, J = 7.5, 1.0 Hz, 2H), 7.05 (dt, 
J = 7.5, 1.0 Hz, 2H), 6.89 (dt, J = 7.4, 1.3 Hz, 1H), 6.85 (dt, J = 7.4, 1.5 Hz, 1H), 6.79 (d, J = 
7.5 Hz, 2H), 6.42 (m, 1H), 6.38 (d, J = 7.6 Hz, 2H), 6.03 (m, 1H), 5.95 (d, J = 7.9 Hz, 2H), 
2.53 (q, J = 7.4 Hz, 2H), 2.31 (q, J = 7.4 Hz, 2H), 2.18 (s, 3H), 1.04 (t, J = 7.4 Hz, 3H), 0.87 
(t, J = 7.4 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 149.8, 148.8, 144.9, 144.1, 142.0, 141.3, 
140.7, 140.0, 139.7, 137.4, 134.6, 134.2, 133.9, 126.9-133.1, (q, 1JC-F = 275.6 Hz), 130.36, 
129.6, (q, 2JC-F = 32.6 Hz), 129.4, 129.0, 128.7, 127.9, 127.6, 127.0, 126.8, 125.7 (q, 3JC-F = 
3.5 Hz), 123.8, 123.4, 122.1, 119.4, 65.5, 23.0, 22.9, 21.1, 15.71, 15.65; IR (KBr) νmax 3060, 
3037, 3013, 2968, 2932, 2869, 1613, 1512, 1473, 1452, 1374, 1320, 1165, 1129, 1108, 1069, 
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1021, 851, 758, 743, 728 cm-1; HRMS (m/z) for C43H34F3 (M + H) calcd: 607.26071, found: 
607.26063; Rf (20/1 hexanes/EtOAc) = 0.46 (silica gel plate).  
 
4-(4-Bromophenyl)-2,3-diethyl-1-(p-tolyl)-9,9'-spirobifluorene (11h). With 10h (495 mg, 
1.03 mmol) following the general procedure E. Column chromatography of 
the residue on silica gel (20/1 hexanes/EtOAc) provided 466 mg (74%) of the 
title compound as a slight yellow solid: mp (decomp) 111-116 °C; 1H NMR 
(600 MHz, CDCl3) δ 7.74 (m, 2H), 7.42 (m, 2H), 7.30 (d, J = 7.5 Hz, 2H), 
7.19 (dt, J = 7.4, 1.1 Hz, 2H), 7.05 (dt, J = 7.5, 1.1 Hz, 2H), 6.93 (dt, J = 7.4, 
1.3 Hz, 1H), 6.86 (dt, J = 7.4, 1.2 Hz, 1H), 6.78 (d, J = 7.5 Hz, 2H), 6.41 (d, J = 7.4 Hz, 1H), 
6.38 (d, J = 7.7 Hz, 2H), 6.19 (d, J = 7.8 Hz, 1H), 5.94 (d, J = 7.9 Hz, 2H), 2.55 (q, J = 7.4 
Hz, 2H), 2.30 (q, J = 7.4 Hz, 2H), 2.18 (s, 3H), 1.05 (t, J = 7.4 Hz, 3H), 0.86 (t, J = 7.4 Hz, 
3H); 13C NMR (150 MHz, CDCl3) δ 149.7, 148.9, 144.0, 142.0, 141.5, 140.6, 139.9, 139.81, 
139.79, 137.6, 134.7, 134.2, 133.9, 132.0, 131.7, 129.0, 126.9, 126.84, 126.80, 126.78, 
126.76, 123.8, 123.4, 122.3, 121.4, 119.40, 65.47, 23.0, 22.9, 21.1, 15.74, 15.65; IR (KBr) 
νmax 3066, 3013, 2959, 2926, 2866, 1512, 1491, 1449, 1425, 1371, 1156, 1111, 1069, 1003, 
839, 824, 758, 752, 737, 522 cm-1; HRMS (m/z) for C42H34Br (M + H) calcd: 617.18384, 
found: 617.18402; Rf (20/1 hexanes/EtOAc) = 0.53 (silica gel plate). 
 
2,3-Diethyl-4-(naphthalen-2-yl)-1-propyl-9,9'-spirobifluorene (18a). With 17a (84 mg, 
0.21 mmol) following the general procedure E. Column chromatography of 
the residue on silica gel (20/1 hexanes/EtOAc) provided 64 mg (57%) of the 
title compound as a colorless solid: mp (decomp) 154-159 °C; 1H NMR (400 
MHz, CDCl3) δ 8.06 (d, J = 8.4 Hz, 1H), 8.02 (m, 1H), 7.98 (s, 1H), 7.93 (m, 
1H), 7.88 (d, J = 7.6 Hz, 2H), 7.58-7.63 (m, 3H), 7.39 (dt, J = 7.5, 0.8 Hz, 
2H), 7.16 (m, 2H), 6.90 (t, J = 7.6 Hz, 2H), 6.79 (dt, J = 7.4, 1.1 Hz, 1H), 6.70 (dt, J = 7.8, 1.2 
Hz, 1H), 6.39 (d, J = 7.5 Hz, 1H), 5.98 (d, J = 7.7 Hz, 1H), 2.64 (q, J = 7.4 Hz, 2H), 2.60 (m, 
1H), 2.52 (m, 1H), 1.81 (m, 2H), 1.15 (t, J = 7.4 Hz, 3H), 1.02 (t, J = 7.4 Hz, 3H), 0.69 (m, 
2H), 0.35 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 149.8, 149.6, 143.2, 141.72, 
141.69, 141.65, 140.8, 140.6, 138.5, 138.4, 137.8, 134.8, 133.7, 132.6, 128.6, 128.4, 128.3, 
128.2, 127.9, 127.7, 127.4, 126.7, 126.4, 126.1, 125.9, 124.3, 124.2, 122.8, 122.5, 120.0, 66.0, 
31.1, 23.7, 22.9, 21.7, 16.1, 15.9, 14.8; IR (KBr) νmax 3055, 3019, 2974, 2959, 2950, 2929, 
2869, 1604, 1506, 1470, 1446, 1392, 1374, 1281, 905, 860, 833, 806, 755, 746 cm-1; HRMS 
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(m/z) for C42H37 (M + H) calcd: 541.28898, found: 541.28907; Rf (20/1 hexanes/EtOAc) = 
0.46 (silica gel plate). 
 
2,3-Diethyl-4-(phenanthren-9-yl)-1-propyl-9,9'-spirobifluorene (18b). With 17b (65 mg, 
0.15 mmol) following the general procedure E. Column chromatography of 
the residue on silica gel (20/1 hexanes/EtOAc) provided 81 mg (91%) of the 
title compound as a colorless solid: mp (decomp) >270°C °C; 1H NMR (400 
MHz, CDCl3) δ 8.86 (dd, J = 8.3, 2.6 Hz, 2H), 7.96 (dd, J = 7.8, 1.2 Hz, 1H), 
7.91 (s, 1H), 7.88 (dd, J = 7.6, 0.7 Hz, 2H), 7.78 (dt, J = 7.0, 1.4 Hz, 1H), 
7.65-7.72 (m, 3H), 7.51 (m, 1H), 7.39 (ddt, J = 7.5, 2.8, 1.1 Hz, 2H), 7.18 (m, 2H), 6.95 (d, J 
= 7.5 Hz, 1H), 6.83 (d, J = 7.5 Hz, 1H), 6.70 (dt, J = 7.4, 1.1 Hz, 1H), 6.53 (dt, J = 7.9, 1.2 
Hz, 1H), 6.35 (d, J = 7.5 Hz, 1H), 5.97 (d, J = 7.8 Hz, 1H), 2.66 (q, J = 7.4 Hz, 2H), 2.60 (m, 
1H), 2.32 (m, 1H), 1.85 (m, 2H), 1.16 (t, J = 7.4 Hz, 3H), 0.93 (t, J = 7.4 Hz, 3H), 0.73 (m, 
2H), 0.36 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 149.8, 149.7, 149.5, 143.4, 
141.7, 141.6, 141.3, 141.1, 139.1, 138.0, 137.0, 132.4, 132.1, 131.9, 130.6, 130.3, 128.9, 
127.9, 127.8, 127.7, 127.5, 127.4, 127.0, 126.78, 126.76, 126.7, 126.6, 126.4, 124.4, 124.0, 
122.9, 122.8, 122.7, 122.5, 120.0, 66.1, 31.2, 23.7, 23.2, 21.7, 16.23, 16.18, 14.8; IR (KBr) 
νmax 3071, 3015, 2965, 2931, 2869, 1599, 1472, 1447, 1426, 1373, 1281, 1154, 1059, 891, 
866, 757, 745, 725 cm-1; HRMS (m/z) for C46H38 (M + H) calcd: 591.30463, found: 
591.30468; Rf (20/1 hexanes/EtOAc) = 0.38 (silica gel plate). 
 
4-(Anthracen-9-yl)-2,3-diethyl-1-propyl-9,9'-spirobifluorene (18c). With 17c (68 mg, 0.15 
mmol) following the general procedure E. Column chromatography of the 
residue on silica gel (20/1 hexanes/EtOAc) provided 45 mg (51%) of the title 
compound as a light brown solid: mp (decomp) 251-256 °C; 1H NMR (400 
MHz, CDCl3) δ 8.66 (d, J = 8.8 Hz, 2H), 7.88 (d, J = 7.6 Hz, 2H), 7.74 (d, J = 
8.7 Hz, 2H), 7.64 (m, 2H), 7.39-7.44 (m, 4H), 7.28 (m, 1H), 7.19 (dt, J = 7.7, 
1.2 Hz, 2H), 6.87 (d, J = 7.5 Hz, 2H), 6.64 (dt, J = 7.4, 1.1 Hz, 1H), 6.40 (dt, J = 7.6, 1.2 Hz, 
1H), 6.31 (d, J = 7.5 Hz, 1H), 5.10 (d, J = 7.9 Hz, 1H), 2.66 (q, J = 7.4 Hz, 2H), 2.22 (q, J = 
7.5 Hz, 2H), 1.88 (m, 2H), 1.16 (t, J = 7.4 Hz, 3H), 0.78 (m, 2H), 0.64 (t, J = 7.5 Hz, 3H), 
0.38 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 149.8, 149.7, 149.5, 143.4, 141.8, 
141.6, 141.3, 141.1, 139.2, 138.1, 137.0, 132.4, 132.1, 132.0, 130.6, 130.3, 128.9, 127.9, 
127.82, 127.76, 127.51, 127.46, 127.0, 126.81, 126.78, 126.7, 126.6, 126.4, 124.4, 124.0, 
122.9, 122.8, 122.7, 122.5, 120.0, 68.1, 31.2, 23.8, 23.2, 21.7, 16.3, 16.2, 14.8; IR (KBr) νmax 
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3064, 2963, 2871, 1525, 1468, 1446, 1372, 1345, 1262, 1241, 1155, 1055, 1027, 938, 755, 
737 cm-1; HRMS (m/z) for C46H39 (M + H) calcd: 591.30463, found: 591.30469; Rf (20/1 
hexanes/EtOAc) = 0.43 (silica gel plate). 
 
2,3-Diethyl-1-propyl-4-(pyren-2-yl)-9,9'-spirobifluorene (18d). With 17d (72 mg, 0.15 
mmol) following the general procedure E. Column chromatography of the 
residue on silica gel (20/1 hexanes/EtOAc) provided 54 mg (59%) of the 
title compound as a colorless solid: mp (decomp) 159-164 °C; 1H NMR 
(400 MHz, CDCl3) δ 8.39 (d, J = 7.8 Hz, 1H), 8.21-8.27 (m, 3H), 8.17 (d, 
J = 6.9 Hz, 1H), 8.13 (d, J = 7.8 Hz, 1H), 8.04 (t, J = 7.7 Hz, 1H), 7.99 (d, 
J = 9.2 Hz, 1H), 7.89 (d, J = 7.5 Hz, 2H), 7.83 (d, J = 9.2 Hz, 1H), 7.43 (t, 
J = 7.4 Hz, 1H), 7.21 (t, J = 7.5 Hz, 1H), 7.18 (t, J = 7.4 Hz, 1H), 6.96 (d, J = 7.5 Hz, 1H), 
6.90 (d, J = 7.4 Hz, 1H), 6.66 (t, J = 7.4 Hz, 1H), 6.39 (t, J = 7.8 Hz, 1H), 6.34 (d, J = 7.5 Hz, 
1H), 5.32 (d, J = 7.7 Hz, 1H), 2.68 (q, J = 7.4 Hz, 2H), 2.51 (m, 1H), 2.36 (m, 1H), 1.87 (m, 
2H), 1.19 (t, J = 7.4 Hz, 3H), 0.85 (t, J = 7.4 Hz, 3H), 0.78 (m, 2H), 0.38 (t, J = 7.1 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 149.7, 149.6, 149.5, 143.4, 141.8, 141.7, 141.6, 141.4, 141.1, 
139.3, 138.1, 136.2, 133.0, 131.4, 131.3, 130.8, 129.9, 128.2, 127.83, 127.82, 127.76, 127.71, 
127.65, 127.50, 127.46, 127.37, 126.7, 126.4, 126.0, 125.4, 125.2, 125.11, 125.07, 125.0, 
124.4, 124.1, 122.7, 122.2, 120.03, 120.00, 66.1, 31.2, 23.7, 23.2, 21.8, 16.3, 15.7, 14.8; IR 
(KBr) νmax 3039, 2963, 2929, 2870, 1601, 1584, 1470, 1446, 1424, 1374, 1282, 1242, 1177, 
1154, 1056, 848, 820, 756, 740, 726 cm-1; HRMS (m/z) for C48H39 (M + H) calcd: 615.30463, 
found: 615.30465; Rf (20/1 hexanes/EtOAc) = 0.37 (silica gel plate). 
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6.2.4.  Synthesis of 9,9’-spirobifluorenes 13, 14, and carborane-14a 
 
F:  General procedure for Suzuki reaction (preparation of 13). Starting compound 
11h (0.1 mmol), boronic acid compound (0.12 mmol), Pd(OAc)2 (1.3 mg, 5 mol%) and 
K2CO3 (17 mg, 0.12 mmol) were dissolved in a microwave vial ethanol (5 mL) and the 
reaction was stirred 3 h at 80 °C. The reaction mixture was cooled down, quenched with water 
and extracted with diethyl ether. The organic fraction was dried over Mg2SO4, filtered off and 
concentrated on vacuum evaporator. Column chromatography of the residue on silica gel 
(hexanes/EtOAc) provided products. 
 
2,3-Diethyl-4-(4'-methoxy-[1,1'-biphenyl]-4-yl)-1-(p-tolyl)-9,9'-spirobifluorene (13a). 
With 11h (61 mg, 0.1 mmol) and 4-methoxyphenylboronic acid following the 
general procedure F. Column chromatography of the residue on silica gel 
(20/1 hexanes/EtOAc) provided 40 mg (62%) of the title compound as a 
colorless solid: mp (decomp) 138-143 °C; 1H NMR (400 MHz, CDCl3) δ 7.82 
(d, J = 8.1 Hz, 2H), 7.76 (d, J = 8.7 Hz, 2H), 7.58 (d, J = 8.1 Hz, 2H), 7.31 (d, 
J = 7.6 Hz, 2H), 7.20 (dt, J = 7.3, 0.7 Hz, 2H), 7.08 (d, J = 8.8 Hz, 2H), 7.06 
(dt, J = 7.4, 0.8 Hz, 2H), 6.88 (dt, J = 7.3, 1.3 Hz, 1H), 6.82-6.85 (m, 3H), 6.39-6-43 (m, 3H), 
6.25 (dd, J = 6.9, 1.1 Hz, 1H), 5.97 (d, J = 7.9 Hz, 2H), 3.92 (s, 3H), 2.63 (q, J = 7.4 Hz, 2H), 
2.33 (q, J = 7.4 Hz, 2H), 2.19 (s, 3H), 1.10 (t, J = 7.4 Hz, 3H), 0.89 (t, J = 7.4 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 159.3, 149.7, 149.1, 143.8, 142.0, 141.9, 140.5, 140.2, 139.5, 
139.4, 139.3, 137.9, 135.9, 134.2, 134.1, 133.4, 130.2, 129.1, 128.1, 127.0, 126.9, 126.81, 
126.76, 126.6, 123.9, 123.3, 122.6, 119.4, 114.4, 65.6, 55.5, 23.1, 23.0, 21.1, 15.9, 15.7; IR 
(KBr) νmax 3069, 3037, 3013, 2953, 2836, 1604, 1500, 1470, 1437, 1278, 1251, 1086, 1039, 
1009, 827, 809, 743 cm-1; HRMS (m/z) for C49H41O (M + H) calcd: 645.31519, found: 
645.31521; Rf (20/1 hexanes/EtOAc) = 0.30 (silica gel plate). 
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2,3-Diethyl-1-(p-tolyl)-4-(4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)-9,9'-spirobifluorene 
(13b). With 11h (61 mg, 0.1 mmol) following the general procedure F. 
Column chromatography of the residue on silica gel (20/1 hexanes/ CH2Cl2) 
provided 39 mg (58%) of the title compound as a colorless solid: mp 
(decomp) 157-162 °C; 1H NMR (400 MHz, CDCl3) δ 7.92 (d, J = 8.1 Hz, 
2H), 7.87 (d, J = 8.2 Hz, 2H), 7.79 (d, J = 8.3 Hz, 2H), 7.65 (d, J = 8.2 Hz, 
2H), 7.30 (d, J = 7.6 Hz, 2H), 7.19 (dt, J = 7.4, 0.9 Hz, 2H), 7.06 (dt, J = 7.5, 
1.0 Hz, 2H), 6.87 (dt, J = 7.3, 1.6 Hz, 1H), 6.84 (dt, J = 7.4, 1.4 Hz, 1H), 6.80 
(d, J = 7.6 Hz, 2H), 6.43 (m, 1H), 6.38 (d, J = 7.8 Hz, 2H), 6.22 (m, 1H), 5.96 (d, J = 7.9 Hz, 
2H), 2.61 (q, J = 7.4 Hz, 2H), 2.33 (q, J = 7.4 Hz, 2H), 2.18 (s, 3H), 1.09 (t, J = 7.4 Hz, 3H), 
0.88 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 149.8, 149.0, 144.3, 143.9, 142.0, 
141.7, 141.0, 140.6, 140.0, 139.7, 138.4, 137.7, 135.4, 134.2, 134.0, 130.6, 129.8, 129.1, 
127.5, 127.4, 126.8 (q, 2JC-F = 16.8 Hz), 125.8, (q, 3JC-F = 3.6 Hz), 123.2-126.5 , (q, 1JC-F = 
160.1 Hz) 123.8, 123.3, 122.4, 119.4, 65.5, 23.1, 23.0, 21.1, 15.9, 15.7; IR (KBr) νmax 3063, 
3037, 3019, 2965, 2929, 2872, 1622, 1515, 1470, 1446, 1371, 1326, 1165, 1129, 1069, 1006, 
836, 824, 758, 746, 737 cm-1; HRMS (m/z) for C49H38F3 (M + H) calcd: 683.29201, found: 
683.29207; Rf (20/1 hexanes/EtOAc) = 0.52 (silica gel plate). 
 
2,3-Diethyl-4-(4-((4-methoxyphenyl)ethynyl)phenyl)-1-(p-tolyl)-9,9'-spirobifluorene 
(14a). Starting compound 11h (61 mg, 0.1 mmol), PdCl2(PPh3)2 catalyst 
(8.5 mg, 5 mol%) and CuI (0.01 mmol, 10 mol%) were dissolved in a 
microwave vial in diisopropylamine (5 mL), afterwards 4-ethynylanisole 
(29 µL, 0.2 mmol) was added and the reaction was stirred at 180 °C in the 
microwave reactor for 1 h. The reaction mixture was cooled down, filtered 
off with celite/silica and washed with diethyl ether. The organic fraction was 
concentrated on vacuum evaporator. Column chromatography of the residue 
on silica gel (20/1 hexanes/EtOAc) provided 36 mg (54%) of the title compound as a colorless 
solid: mp (decomp) 131-136 °C; 1H NMR (400 MHz, CDCl3) δ 7.76 (d, J = 8.1 Hz, 2H), 7.56 
(d, J = 8.7 Hz, 2H), 7.52 (d, J = 8.1 Hz, 2H), 7.30 (d, J = 7.5 Hz, 2H), 7.19 (dt, J = 7.4, 0.6 
Hz, 2H), 7.05 (dt, J = 7.5, 0.6 Hz, 2H), 6.93 (d, J = 8.7 Hz, 2H), 6.91 (dt, J = 7.5, 0.9 Hz, 1H), 
6.85 (dt, J = 7.4, 0.9 Hz, 1H), 6.79 (d, J = 7.5 Hz, 2H), 6.41 (d, J = 7.6 Hz, 1H), 6.37 (d, J = 
7.8 Hz, 2H), 6.24 (d, J = 7.7 Hz, 1H), 5.95 (d, J = 7.9 Hz, 2H), 3.87 (s, 3H), 2.58 (q, J = 7.4 
Hz, 2H), 2.31 (q, J = 7.4 Hz, 2H), 2.18 (s, 3H), 1.05 (t, J = 7.4 Hz, 3H), 0.87 (t, J = 7.4 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 159.7, 149.7, 149.0, 143.9, 142.0, 141.6, 140.8, 140.5, 
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139.9, 139.7, 137.6, 135.5, 134.2, 134.1, 133.1, 131.9, 130.0, 129.1, 127.0, 126.9, 126.81, 
126.78, 126.7, 123.8, 123.3, 122.6, 122.5, 119.4, 115.4, 114.1, 89.8, 88.2, 65.5, 55.4, 23.1, 
22.9, 21.1, 15.8, 15.7; IR (KBr) νmax 3040, 2971, 2872, 2836, 2211, 1604, 1565, 1518, 1446, 
1371, 1287, 1251, 1171, 1105, 1030, 839, 755, 743 cm-1; HRMS (m/z) for C51H41O (M + H) 
calcd: 669.31519, found: 669.31522; Rf (20/1 hexanes/EtOAc) = 0.25 (silica gel plate). 
 
2,3-Diethyl-4-(4-(phenylethynyl)phenyl)-1-(p-tolyl)-9,9'-spirobifluorene (14b). Starting 
compound 11h (122 mg, 0.25 mmol), PEPPSI-IPr catalyst (8.5 mg, 5 mol%) 
and CuI (0.01 mmol, 10 mol%) were dissolved in a microwave vial in 
triethylamine (2 mL) and THF (3 mL), afterwards phenylacetylene (55 µL, 
0.5 mmol) was added and the reaction was stirred 3 h at 80 °C. The reaction 
mixture was cooled down, filtered off with celite/silica and washed with 
diethyl ether. The organic fraction was concentrated on vacuum evaporator. 
Column chromatography of the residue on silica gel (20/1 hexanes/EtOAc) 
provided 116 mg (72%) of the title compound as a colorless solid: mp (decomp) 167-172 °C; 
1H NMR (400 MHz, CDCl3) δ 7.78 (m, 2H), 7.62 (m, 2H), 7.53 (m, 2H), 7.35-7.43 (m, 3H), 
7.29 (d, J = 7.6 Hz, 2H), 7.18 (dt, J = 7.4, 1.0 Hz, 2H), 7.04 (dt, J = 7.4, 1.0 Hz, 2H), 6.91 (dt, 
J = 7.3, 1.1 Hz, 1H), 6.86 (dt, J = 7.4, 1.1 Hz, 1H), 6.79 (d, J = 7.5 Hz, 2H), 6.40 (d, J = 7.5 
Hz, 1H), 6.37 (d, J = 7.6 Hz, 2H), 6.22 (d, J = 7.9 Hz, 1H), 5.94 (d, J = 7.9 Hz, 2H), 2.56 (q, J 
= 7.4 Hz, 2H), 2.30 (q, J = 7.4 Hz, 2H), 2.17 (s, 3H), 1.05 (t, J = 7.4 Hz, 3H), 0.86 (t, J = 7.4 
Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 149.7, 149.0, 143.9, 142.0, 141.6, 141.2, 140.5, 
139.9, 139.7, 137.6, 135.4, 134.2, 134.0, 132.5, 132.1, 131.7, 130.0, 129.2, 129.0, 128.43, 
128.36, 126.94, 126.86, 126.80, 126.77, 126.7, 123.8, 123.31, 123.27, 122.5, 122.2, 119.4, 
89.8, 89.5, 29.7, 23.0, 22.9, 21.1, 15.8, 15.7; IR (KBr) νmax 3060, 2969, 2931, 2870, 2251, 
2230, 1596, 1515, 1487, 1446, 1373, 1281, 1238, 1179, 1158, 1068, 1019, 913, 848, 823, 755, 
742, 689 cm-1; HRMS (m/z) for C50H38Na (M + Na) calcd: 661.28657, found: 661.28601; Rf 
(20/1 hexanes/EtOAc) = 0.46 (silica gel plate). 
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2,3-Diethyl-1-(p-tolyl)-4-(4-((4-(trifluoromethyl)phenyl)ethynyl)phenyl)-9,9'-
spirobifluorene (14c). Starting compound 11h (61 mg, 0.1 mmol), 
PdCl2(PPh3)2 (3.5 mg, 5 mol%) and CuI (0.01 mmol, 10 mol%) were 
dissolved in a microwave vial in DMF (3 mL) and NEt3 (2 mL), afterwards 
1-ethynyl-trifluortoluene (65 µL, 0.15 mmol) was added and the reaction 
was stirred over night at 80 °C. The reaction mixture was cooled down, 
filtered off with celite/silica and washed with diethyl ether. The organic 
fraction was concentrated on vacuum evaporator. Column chromatography 
of the residue on silica gel (10/1 hexanes/ CH2Cl2) provided 40 mg (57%) of the title 
compound as a light brown solid: mp (decomp) 151-156 °C; 1H NMR (400 MHz, CDCl3) δ 
7.80 (d, J = 8.3 Hz, 2H), 7.72 (d, J = 8.1 Hz, 2H), 7.66 (d, J = 8.2 Hz, 2H), 7.56 (d, J = 8.3 
Hz, 2H), 7.30 (d, J = 7.4 Hz, 2H), 7.19 (dt, J = 7.4, 1.1 Hz, 2H), 7.05 (dt, J = 7.5, 1.1 Hz, 2H), 
6.91 (dt, J = 7.4, 1.3 Hz, 1H), 6.86 (dt, J = 7.4, 1.3 Hz, 1H), 6.79 (d, J = 7.4 Hz, 2H), 6.41 (m, 
1H), 6.38 (d, J = 7.7 Hz, 2H), 6.21 (m, 1H), 5.95 (d, J = 7.9 Hz, 2H), 2.56 (q, J = 7.4 Hz, 2H), 
2.31 (q, J = 7.4 Hz, 2H), 2.18 (s, 3H), 1.06 (t, J = 7.4 Hz, 3H), 0.87 (t, J = 7.4 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 149.8, 148.9, 144.0, 142.0, 141.8, 141.5, 140.6, 139.81, 139.78, 
137.5, 135.3, 134.2, 134.0, 132.2, 131.9, 130.1, 129.0, 127.0 (q, 2JC-F = 32.6 Hz), 126.8, 125.3 
(q, 3JC-F = 3.6 Hz), 123.8, 123.4, 122.4, 121.5, 121.3-126.8, (q, 1JC-F = 272.1 Hz), 119.4, 91.9, 
88.4, 65.5, 23.0, 22.9, 21.1, 15.74, 15.66; IR (KBr) νmax 3069, 3037, 2968, 2932, 2875, 2220, 
1610, 1518, 1476, 1449, 1374, 1323, 1171, 1132, 1108, 1069, 1015, 845, 824, 758, 743 cm-1; 
HRMS (m/z) for C51H38F3 (M + H) calcd: 707.29201, found: 707.29211; Rf (20/1 
hexanes/EtOAc) = 0.51 (silica gel plate). 
 
1-[2,3-Diethyl-4-phenyl)-1-(p-tolyl)-9,9'-spirobifluorenyl]-2-(4-methoxyphenyl)-1,2-
dicarba-closo-dicarborane (carborane-14a). Starting compound 
14a (67 mg, 0.1 mmol and 6,9-(Me2S)2B10H12 (70 mg, 0.15 mmol) 
were dissolved in a microwave vial under argon atmosphere in 
toluene (5 mL) and the reaction was stirred at 120 °C for 16 h. The 
reaction mixture was cooled down, quenched with MeOH and 
concentrated on vacuum evaporator. Column chromatography of the 
residue on silica gel (2/1 hexanes/EtOAc) provided 47 mg (60%) of the title compound as a 
colorless solid: mp (decomp) 149-154 °C; 1H NMR (400 MHz, CDCl3) δ 7.70 (d, J = 8.5 Hz, 
2H), 7.53 (m, 2H), 7.35 (d, J = 8.4 Hz, 2H), 7.29 (d, J = 7.4 Hz, 2H), 7.18 (dt, J = 7.4, 1.0 Hz, 
2H), 7.02 (dt, J = 7.5, 1.1 Hz, 2H), 6.82 (dt, J = 7.5, 1.0 Hz, 1H), 6.76 (d, J = 9.0 Hz, 2H), 
C C
Et
Et
p-Tol
MeO
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6.72 (d, J = 7.5 Hz, 2H), 6.66 (dt, J = 7.9, 1.2 Hz, 1H), 6.36-6-39 (m, 3H), 5.91 (d, J = 8.0 Hz, 
2H), 5.69 (d, J = 7.8 Hz, 1H), 3.74 (s, 3H), 2.35 (q, J = 7.4 Hz, 2H), 2.26 (q, J = 7.4 Hz, 2H), 
2.17 (s, 3H), 0.90 (t, J = 7.4 Hz, 3H), 0.83 (t, J = 7.4 Hz, 3H); additional: 1H-11B NMR (400 
MHz, CDCl3) δ 3.41 (bs, 2H), 2.70 (bs, 2H), 2.61 (bs, 4H), 2.41 (bs, 2H); 13C NMR (100 
MHz, CDCl3) δ 160.9, 149.8, 148.8, 143.9, 143.1, 142.0, 141.2, 140.6, 139.9, 139.7, 137.1, 
134.3, 134.2, 133.8, 132.3, 131.2, 130.0, 129.9, 128.9, 126.9, 126.8, 126.7, 126.6, 123.7, 
123.4, 123.2, 122.0, 119.4, 113.6, 86.1, 85.6, 65.4, 55.2, 23.0, 22.7, 21.1, 15.60. 15.58; IR 
(KBr) ν
 max 3219, 3063, 2966, 2932, 2870, 2592, 1607, 1514, 1462, 1447, 1374, 1301, 1260, 
1184, 1075, 1032, 836, 824, 756, 744, 730 cm-1; HRMS (m/z) for C51H50OB10Na (M + Na) 
calcd: 811.46844, found: 811.46871, for C51H50O10BB9Na (M + Na) calcd: 810.47207, found: 
810.47278, for C51H50O10B2B8Na (M + Na) calcd: 809.47571, found: 809.47651, for 
C51H50O10B3B7Na (M + Na) calcd: 808.47934, found: 808.48029; Rf (20/1 hexanes/EtOAc) = 
0.27 (silica gel plate). 
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6.2.5.  X-ray data of 9,9’-spirobifluorenes 
 
 Crystallographic data for 6a, 6c, 11a, 11c, 11e, 13a, 14b, carborane-14a and 18b 
were collected on Nonius KappaCCD diffractometer equipped with Bruker APEX-II CCD 
detector by monochromatized MoKα radiation (λ = 0.71073 Å) at a temperature either 120 K 
or 150(2) K. The structures were solved by direct methods (SHELXS)69 and refined by full 
matrix least squares based on F2 (SHELXL97). The absorption corrections were carried on 
using multi-scan method. The hydrogen atoms were found on difference Fourier map and 
were recalculated into idealized positions. All hydrogen atoms were refined as fixed (riding 
model) with assigned temperature factors Hiso(H) = 1.2 Ueq(pivot atom) or 1.5 Ueq for methyl 
moiety. The crystallographic data are summarized in Table Exp1-4.  
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Table Exp1. X-ray crystallographic data 9,9’-spirobifluorenes 6a and 6c 
 6a  6c  
Formula C41H32 C38H34 
M.w. 524.67 490.65 
Crystal system orthorhombic triclinic 
Space group [No.] Pca21 (No 29) P-1 (No 2) 
a [Å] 29.4235 (18) 11.0066 (2) 
b [Å] 11.4496 (7)  11.0845 (2) 
c [Å] 17.2284 (14)  11.5394 (2)   
α [°]  81.815 (1) 
β [°]  87.544 (1) 
γ [°]  80.909 
Z 8 2 
V [Å3] 5804.0 (7) 1375.69 (4) 
Dx [g cm-3] 1.201 1.184 
Crystal size [mm] 0.74×0.38×0.29 0.56×0.54×0.34 
Crystal color, shape a colorless prism a colorless prism 
µ [mm-1] 0.07 0.07 
Tmin,Tmax 0.952, 0.980 0.964, 0.978 
Measured reflections 37907 20792 
Independent diffractions (Rint a) 9397 (0.049) 6299 (0.018) 
Observed diffract. [I>2σ(I)] 8103 5492 
No. of parameters 743 346 
Rb 0.072 0.041 
wR(F2) 
 
 for all data 0.184 0.110 
GOFc 1.06 1.05 
Residual electron density [e/Å3] 0.62, -0.290 0.26, -0.24 
CCDC no. 1403002 1403003 
a Rint = Σ│Fo2 - Fo,mean2│/ ΣFo2    
b
 R(F) = Σ ││Fo│ - │Fc││/Σ│Fo│, wR(F2) = [Σ (w(Fo2 - Fc2)2)/( Σw(Fo2)2)]½.   c GOF = 
[Σ(w(Fo2 - Fc2)2)/(Ndiffrs - Nparams)]½ 
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Figure Exp1. Platon plot of 6a showing displacement ellipsoids at a 30% probability level 
 
Figure Exp2. Platon plot of 6c showing displacement ellipsoids at a 30% probability level 
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Table Exp2. X-ray crystallographic data for 9,9’-spirobifluorenes 11a, 11c and 11e 
 11a  11c  11e 
Formula C43H36O C48H38 C42H33Cl 
M.w. 568.72 614.78 573.13 
Crystal system monoclinic triclinic monoclinic 
Space group [No.] P21/n (No14) P1 (No. 2) P21/n (No 14) 
a [Å] 9.4308 (2) 8.3330 (2) 35.6573 (8) 
b [Å] 17.6455 (3) 11.6908 (3) 9.6469 (2) 
c [Å] 18.5101 (3) 18.3693 (4) 22.6588 (4) 
a [°]  88.570 (1)  
β [°] 92.764 (1) 86.248 (1) 128.8580 (5) 
γ [°]  72.826 (1)  
Z 4 2 8 
V [Å3] 3076.70 (10) 1706.04 (7) 6069.4 (2) 
Dx [g cm-3] 1.228 1.197 1.254 
Crystal size [mm] 0.22×0.58×0.60 0.14×0.39×0.65 0.57×0.56×0.41 
Crystal color, shape a colorless prism a colorless prism a colorless prism 
µ [mm-1] 0.071 0.067 0.156 
Tmin, Tmax 0.89, 0.98 0.93, 0.99 0.83, 0.94 
Measured reflections 21163 18051 16117 
Independent diffractions (Rint a) 7059 (0.019) 7428 (0.024) 6626 (0.018) 
Observed diffract. [I>2σ(I)] 5820 5525 5486 
No. of parameters 401 436 391 
Rb 0.041 0.0471 0.042 
wR(F2) 
 
 for all data 0.118 0.1366 0.111 
GOFc 1.00 1.06 0.97 
Residual electron density [e/Å3] 0.28, -0.25 0.25, -0.22 0.61, -0.30 
CCDC no. 1542107 1542108 1542109 
a Rint = Σ│Fo2 - Fo,mean2│/ ΣFo2   
b
 R(F) = Σ ││Fo│ - │Fc││/Σ│Fo│, wR(F2) = [Σ (w(Fo2 - Fc2)2)/( Σw(Fo2)2)]½.   c GOF = 
[Σ(w(Fo2 - Fc2)2)/(Ndiffrs - Nparams)]½ 
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Figure Exp3. Platon plot of 11a showing displacement ellipsoids at a 50% probability level 
 
 
Figure Exp4. Platon plot of 11c showing displacement ellipsoids at a 50% probability level 
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Figure Exp5. Platon plot of 11e showing displacement ellipsoids at a 50% probability level 
 
  
150 
 
Table Exp3. X-ray crystallographic data for 9,9’-spirobifluorenes 13a and 14b 
 13a  14b  
Formula C49H40O C50H38, CHCl3 
M.w. 644.81 758.17 
Crystal system triclinic triclinic 
Space group [No.] P1 (No 2) P1 (No 2) 
a [Å] 8.8276 (3) 9.9228(4) 
b [Å] 11.6527 (3) 12.9083(6) 
c [Å] 18.1740 (5) 16.2089(7) 
a [°] 91.5340(10) 75.028(2) 
β [°] 90.2770(10) 85.120(2) 
γ[°] 107.9720(10) 71.846(2) 
Z 2 2 
V [Å3] 1777.45(9) 1905.80(15) 
Dx [g cm-3] 1.205 1.321 
Crystal size [mm] 0.24×0.16×0.15 0.15×0.17×0.27 
Crystal color, shape a colorless prism a colorless prism 
µ [mm-1] 0.533 0.278 
Tmin, Tmax 0.86, 0.96 0.93, 0.96 
Measured reflections 34479 42155 
Independent diffractions (Rint a) 6986 (0.029) 8754 (0.067) 
Observed diffract. [I>2σ(I)] 5694 7212 
No. of parameters 455 490 
Rb 0.043 0.042 
wR(F2) for all data 0.110 0.124 
GOFc 1.04 1.05 
Residual electron density [e/Å3] 0.19, -0.21 0.43, -0.68 
CCDC no. 1542110 1542111 
a Rint = Σ│Fo2 - Fo,mean2│/ ΣFo2    
b
 R(F) = Σ ││Fo│ - │Fc││/Σ│Fo│, wR(F2) = [Σ (w(Fo2 - Fc2)2)/( Σw(Fo2)2)]½.   c GOF = 
[Σ(w(Fo2 - Fc2)2)/(Ndiffrs - Nparams)]½ 
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Figure Exp6. Platon plot of 13a show displacement ellipsoids at a 50% probability level 
 
 
Figure Exp7. Platon plot of 14b show displacement ellipsoids at a 50% probability level 
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Table Exp4. X-ray crystallographic data for 9,9’-spirobifluorenes 18b and carborane-14a 
 18b carborane-14a 
Formula C46H38 C51H50B10O 
M.w. 590.76 787.01 
Crystal system monoclinic monoclinic 
Space group [No.] P1 (21/c1) P21/c 
a [Å] 16.8419(5) 16.9235(4) 
b [Å] 8.6097(2) 9.1410(2) 
c [Å] 23.3066(6) 28.7305(7) 
a [°]   
β [°] 98.9400(10) 100.7280(10) 
γ [°]   
Z 4 4 
V [Å3] 3338.49(15) 4366.86(18) 
Dx [g cm-3] 1.175 1.197 
Crystal size [mm] 0.22×0.13×0.04 0.35×0.20×0.12 
Crystal color, shape a colorless bar a colorless plate 
µ [mm-1] 0.498 0.489 
Tmin, Tmax 0.82, 0.98 0.85, 0.94 
Measured reflections 25788 48496 
Independent diffractions (Rint a) 6307 (0.051) 8591 (0.034) 
Observed diffract. [I>2σ(I)] 5047 7272 
No. of parameters 418 603 
Rb 0.057 0.045 
wR(F2) for all data 0.137 0.121 
GOFc 1.057 1.03 
Residual electron density [e/Å3] 0.43, -0.27 0.22, -0.24 
CCDC no. 1542112 1542113 
a Rint = Σ│Fo2 - Fo,mean2│/ ΣFo2    
b
 R(F) = Σ ││Fo│ - │Fc││/Σ│Fo│, wR(F2) = [Σ (w(Fo2 - Fc2)2)/( Σw(Fo2)2)]½.   c GOF = 
[Σ(w(Fo2 - Fc2)2)/(Ndiffrs - Nparams)]½ 
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Figure Exp8. Platon plot of 18b showing displacement ellipsoids at a 50% probability level 
 
 
Figure Exp9. Platon plot of carborane-14a show displacement ellipsoids at a 50% probability 
level 
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6.2.6.  Photophysical analysis of 9,9’-spirobifluorenes 
 
Chemicals. 
9,10-Diphenylanthracene (DPA) was purchased from Sigma-Aldrich. 
 
 The UV/Vis absorption spectra were recorded using Unicam 340 spectrometer. 
Corrected steady-state emission spectra were recorded on an Aminco Bowman (AB2) 
spectrometer.  
 Quantum yields of fluorescence of a sample (Φs) were calculated relative to 
diphenyleneanthracene DPA (Φref = 0.97 in cyclohexane) as a reference. Φs was determined 
according to the following equation.70 
Φs = Φref × As / Aref          (1) 
where As and Aref represent integrated areas of the emission (in arbitrary units) of a sample 
and the reference, respectively.  
 Micromolar solutions of the reference (DPA) and the samples were prepared in 
cyclohexane. The absorption of the reference and the samples were the same at the selected 
excitation wavelength (A ≤ 0.1). Quantum yields were calculated from 5 independent 
measuring. The average value is reported. 
 The emission quantum yields (Φs) of the derivatives were determined in cyclohexane 
by standard procedures with DPA as reference (Figures Exp10-13 and tables Exp5-8).  
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UV/Vis absorption and emission spectra of 6a-d.  
 
 
Figure Exp10. Absorption spectra of 6a-d in cyclohexane (left). Normalized and corrected 
emission spectra of 10-6 M samples in cyclohexane. Emission after excitation at λ =240-243 
nm (right).  
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Table Exp5. Photophysical properties of 6a-d derivatives in cyclodexane 
Sample λabs /nm  (ε /104 mol-1 dm3 cm-1) λexc /nm  λem /nm Φsa 
6a 217 (4.8) 
283 (1.6) 
300 (0.9) 
312 (1.2) 
241 333 0.62 
6b 218 (5.0) 
233 (5.1) 
271 (2.3) 
282 (2.0) 
312 (1.5) 
241 315, 328 0.72 
6c 219 (4.4) 
260 (1.9) 
282 (1.7) 
312 (1.3) 
242 315, 328 0.87 
6d 218 (5.1) 
232 (5.3) 
270 (2.2) 
282 (1.9) 
312 (1.4) 
243 330 0.48 
a
 Quantum yields were calculated relative to DPA (Φr = 0.97). 
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UV/Vis absorption and emission spectra of 11a-g.  
 
 
Figure Exp11. Absorption spectra of 11a-g in cyclohexane (left). Normalized and corrected 
emission spectra of 10-6 M samples in cyclohexane. Emission after excitation at λ =240-243 
nm (right).  
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Table Exp6. Photophysical properties of 11a-g derivatives in cyclohexane 
Sample λabs /nm  (ε /104 mol-1 dm3 cm-1) λexc /nm  λem /nm Φsa 
11a 262 (sh) 
269 (sh)  
300 (sh) 
313 (1.6) 
241 330 0.50 
11b 262 (sh)  
284 (sh) 
300 (sh) 
313 (1.6) 
241 331 0.61 
11c 250 (6.0) 
255 (sh)  
300 (sh) 
313 (1.7) 
243 367 0.87 
11d 261 (sh)  
284 (sh) 
300 (sh) 
313 (1.9) 
242 333 0.66 
11e 262 (sh)  
284 (sh) 
300 (sh) 
313 (1.5) 
241 344 0.61 
11f 263 (sh)  
274 (sh) 
300 (sh) 
313 (1.6) 
240 361 0.64 
a
 Quantum yields were calculated relative to DPA (Φr = 0.97). 
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UV/Vis absorption and emission spectra of 13 and 14.  
 
 
Figure Exp12. Absorption spectra of 13 and 14 in cyclohexane (left). Normalized and 
corrected emission spectra of 10-6 M samples in cyclohexane. Emission after excitation at λ = 
248-255 nm (right). 
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Table Exp7. Photophysical properties of 13 and 14 derivatives in cyclohexane 
Sample λabs /nm (ε /105 mol-1 dm3 cm-1) λexc /nm  λem /nm Φsa 
13a 216 (1.1)  
264 (0.9) 
284 (sh) 
313 (sh) 
254 366 0.65 
13b 218 (1.1) 
250 (sh) 
261 (sh) 
300 (sh) 
251 369 0.99 
14a 220 (1.4)  
285 (sh) 
296 (sh) 
313 (sh) 
253 367 0.82 
14b 220 (1.6)  
305 (sh) 
312 (sh) 
328 (sh) 
254 369 0.79 
14c 220 (1.0)  
266 (sh) 
291 (sh) 
300 (sh) 
312 (sh) 
248 370 1.00 
a
 Quantum yields were calculated relative to DPA (Φr = 0.97). 
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UV/Vis absorption and emission spectra of 18a-d.  
 
 
Figure Exp13. Absorption spectra of 18a-d in cyclohexane (left). Normalized and corrected 
emission spectra of 10-6 M samples in cyclohexane. Emission after excitation at λ =269 nm 
(right).  
 
 
 
 
 
 
 
 
 
 
 
162 
 
Table Exp8. Photophysical properties of 18a-d derivatives in cyclohexane 
Sample λabs /nm (ε /105 mol-1 dm3 cm-1) λexc /nm  λem /nm Φsa 
18a 229 (1.2)  
270 (sh) 
282 (sh) 
299 (sh) 
312 (0.2) 
- - 0.00 
18b 215 (sh)  
228 (sh) 
231 (sh) 
300 (sh) 
312 (0.1) 
267 353 
370 
391 
413 
0.12 
18c 219 (sh)  
260 (1.1) 
312 (0.1) 
380 (0.1) 
401 (0.1) 
270 392 
405 
429 
454 
485 
0.80 
18d 237 (sh) 
246 (1.0) 
278 (0.7) 
328 (0.3) 
345 (0.5) 
267 378 
389 
398 
0.11 
a
 Quantum yields were calculated relative to DPA (Φr = 0.97). 
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6.3.  Synthesis of dispiroindeno[2,1-c]fluorenes 
6.3.1.  Synthesis of starting material 
 
A:  General procedure for Sonogashira reaction60 (preparation of 19, 30 and 37). 
Starting halo-arylaldehyde (2.0 mmol), PdCl2(PPh3)2 (69 mg, 0.1 mmol, 5 mol%) and CuI (38 
mg, 0.2 mmol, 10 mol%) were dissolved in a Schlenk flask with reflux condensor in 
triethylamine (7 mL) and THF (7 mL), afterwards ethynyl-arylaldehyde (2.4 mmol) was 
added and the reaction was stirred 3 h under reflux. The reaction mixture was cooled down, 
filtered off with celite/silica and washed with diethyl ether. The organic fraction was 
concentrated on vacuum evaporator. Column chromatography of the residue on silica gel 
(hexanes/EtOAc) provided products. 
 
2,2'-(Ethyne-1,2-diyl)dibenzaldehyde (19). With 2-ethynylbenzaldehyde (650 mg, 5.0 
mmol) and 2-bromobenzaldehyde (580 µL, 5.0 mmol) following the 
general procedure A. Column chromatography (5/1 hexanes/EtOAc) 
yielded 1.24 g (96%) of the title compound as a light brown solid: mp 
(decomp) 113-118 °C; 1H NMR (400 MHz, CDCl3) δ 10.59 (d, J = 0.7 Hz, 2H), 7.94 (ddd, J 
= 7.8, 1.3, 0.5 Hz, 2H), 7.67 (ddd, J = 7.7, 1.3, 0.5 Hz, 2H), 7.61 (dt, J = 7.4, 1.4 Hz, 2H), 
7.50 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 190.9, 136.0, 133.8, 133.5, 129.3, 128.0, 125.3, 
91.6; IR (KBr) νmax 3366, 3135, 3083, 3067, 3025, 2998, 2833, 2747, 1988, 1951, 1869, 1697, 
1636, 1593, 1567, 1484, 1454, 1390, 1291, 1263, 1194, 1159, 1094, 954, 865, 814, 762, 642, 
525, 434 cm-1; HRMS (m/z) for C16H10O2 (M+) calcd: 234.0681, found: 234.0679; Rf (2/1 
hexanes/EtOAc) = 0.38 (silica gel plate). The spectral data were in accordance with 
previously published results.71 
 
2-((2-Formyl-4-(trifluoromethyl)phenyl)ethynyl)-5-methoxybenzaldehyde (30). With 2-
ethynyl-5-methoxybenzaldehyde57 (235 mg, 1.4 mmol) and 2-
bromo-5-(trifluoromethyl)benzaldehyde58 (225 mg, 0.9 mmol) 
following the general procedure A. Column chromatography (5/1 
hexanes/EtOAc) yielded 305 mg as a mixture of the title compound with inseparable side 
product in the ratio of 1:0.4 (217 mg, 73%) as a light brown oil: 1H NMR (400 MHz, CDCl3) 
δ 10.62 (s, 1H), 10.56 (s, 1H), 8.22 (s, 1H), 7.84 (dd, J = 8.2, 1.5 Hz, 1H), 7.81 (s, 1H), 7.64 
(d, J = 8.6 Hz, 1H), 7.47 (d, J = 2.7 Hz, 1H), 7.18 (dd, J = 8.6, 2.7 Hz, 1H), 3.92 (s, 3H); 13C 
O
O
MeO CF3
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NMR (100 MHz, CDCl3) δ 190.5, 189.7, 160.9, 137.8, 135.8, 135.2, 134.7, 133.9, 125.1 (q, 
2JC-F = 3.7 Hz), 121.7, 120.6-126.4 (q, 1JC-F = 382.4 Hz), 121.5, 111.4, 110.5, 105.0, 94.5, 
90.4, 89.0, 78.9, 55.8; IR (KBr) νmax 3363, 3083, 3064, 2953, 2865, 2761, 2206, 1697, 1600, 
1557, 1505, 1489, 1433, 1392, 1330, 1286, 1252, 1228, 1190, 1122, 1094, 1068, 1026, 936, 
879, 834, 730, 633 cm-1; HRMS (m/z) for C18H11O3F3 (M+) calcd: 332.0660, found: 332.0662; 
Rf (2/1 hexanes/EtOAc) = 0.44 (silica gel plate). 
 
1,1'-(Ethyne-1,2-diyl)bis(2-naphthaldehyde) (37). With 1-ethynyl-2-naphthaldehyde71 (350 
mg, 1.5 mmol) and 1-bromo-2-naphthaldehyde (260 mg, 1.4 mmol) 
following the general procedure A. Filtration of the crude mixture with 5/1 
hexanes/EtOAc yielded 490 mg (96%) of the title compound as a light 
yellow solid: mp (decomp) 126-131 °C; 1H NMR (400 MHz, CDCl3) δ 
10.98 (s, 1H), 10.97 (s, 1H), 8.66 (m, 2H), 8.06 (d, J = 8.6 Hz, 2H), 8.00 (d, J = 9.0 Hz, 2H), 
7.96 (m, 2H), 7.72-7.75 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 191.2, 135.8, 134.9, 133.3, 
130.0, 129.6, 128.8, 128.3, 127.0, 125.8, 122.5, 95.4; IR (KBr) νmax 3342, 3074, 2838, 2238, 
1693, 1617, 1589, 1461, 1434, 1397, 1371, 1336, 1248, 1231, 867, 822, 780, 745 cm-1; 
HRMS (m/z) for C24H14O2 (M+) calcd: 334.0994, found: 334.0995; Rf (2/1 hexanes/EtOAc) = 
0.46 (silica gel plate). The spectral data were in accordance with previously published 
results.73 
 
B:  General procedure for alkynylation reaction60 (preparation of 20, 24, 25 and 38). 
n-BuLi 1.6M (5.3 mmol, 3 eq) was added dropwise to a solution of alkyne compound (5.3 
mmol, 3 eq) in anhydrous THF (15 mL), at -78 °C. After 30 min of stirring, dialdehyde 
compound (1.78 mmol) in THF (5 mL) was added and the reaction mixture was stirred for 5 
min at -78 °C, afterwards it was allowed to warm up to ambient temperature and the reaction 
was stirred 3 h. Then NH4Cl aq was used to quench the reaction mixture, it was extracted with 
diethyl ether (3 x 15 mL), the combined organic fractions were washed with a saturated 
solution of NaHCO3 and brine, the organic layer was dried over anhydrous MgSO4, filtered, 
and concentrated under reduced pressure. Column chromatography of the residue on silica gel 
(hexanes/EtOAc) provided products. 
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1,1'-(Ethyne-1,2-diylbis(2,1-phenylene))bis(3-(4-methoxyphenyl)prop-2-yn-1-ol) (20a). 
With 19 (234 mg, 1.0 mmol) and 4-ethynylanisole (390 µL, 3.0 
mmol) following the general procedure B. Column 
chromatography (2/1 hexanes/EtOAc) yielded 470 mg (94%) of 
the title compound as a light brown solid: mp (decomp) 57-62 
°C; 1H NMR (400 MHz, CDCl3) δ 7.83 (dd, J = 7.7, 1.3 Hz, 1H), 7.76 (dd, J = 7.6, 1.5 Hz, 
1H), 7.60 (dd, J = 7.3, 1.6 Hz, 2H), 7.35-7-41 (m, 6H), 7.32 (dt, J = 7.5, 1.6 Hz, 2H), 6.77 (m, 
4H), 6.21 (s, 2H), 3.98 (s, 1H), 3.75 (s, 3H), 3.74 (s, 3H) 3.70 (s, 1H); 13C NMR (100 MHz, 
CDCl3) δ 159.58, 159.56, 142.3, 142.2, 133.2, 132.7, 132.6, 128.9, 128.8, 128.19, 128.17, 
127.2, 126.9, 121.7, 121.6, 114.5, 114.4, 113.8, 92.2, 86.9, 86.81, 86.80, 86.79, 63.7, 63.6, 
55.1; IR (KBr) νmax 3372, 3065, 2958, 2836, 2226, 1605, 1569, 1509, 1490, 1443, 1291, 1249, 
1173, 1106, 1032, 963, 832, 761, 536 cm-1; HRMS (m/z) for C34H26O4Na (M + Na) calcd: 
521.17233 found: 521.17222; Rf (1/1 hexanes/EtOAc) = 0.38 (silica gel plate). 
 
1,1'-(Ethyne-1,2-diylbis(2,1-phenylene))bis(3-(p-tolyl)prop-2-yn-1-ol) (20b). With 19 (106 
mg, 0.45 mmol) and 1-ethynyl-4-p-toluene (170 µL, 1.35 mmol) 
following the general procedure B. Column chromatography (2/1 
hexanes/EtOAc) yielded 187 mg (89%) of the title compound as a red 
solid: mp (decomp) 152-157 °C; 1H NMR (400 MHz, CDCl3) δ 7.85 
(dd, J = 7.7, 1.2 Hz, 1H), 7.78 (dd, J = 7.6, 1.4 Hz, 1H), 7.62 (m, 2H), 7.34-7-44 (m, 8H), 
7.10 (m, 4H), 6.20 (s, 1H), 6.19 (s, 1H), 3.51 (s, 1H), 3.26 (s, 1H), 2.33 (s, 3H), 2.32 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 142.2, 142.1, 138.71, 138.66, 132.8, 132.7, 131.7, 129.02, 
129.00, 128.97, 128.39, 128.37, 127.3, 127.1, 121.83, 121.80, 119.3, 92.31, 92.26, 87.37, 
87.31, 87.30, 87.2, 63.95, 63.88, 21.47, 21.46; IR (KBr) νmax 3324, 3061, 3028, 2920, 2860, 
2232, 2193, 1635, 1601, 1509, 1489, 1448, 1377, 1307, 1270, 1181, 1024, 964, 816, 760, 526 
cm-1; HRMS (m/z) for C34H26O2Na (M + Na) calcd: 489.18250 found: 489.18242; Rf (2/1 
hexanes/EtOAc) = 0.31 (silica gel plate). 
 
1,1'-(Ethyne-1,2-diylbis(2,1-phenylene))bis(3-phenylprop-2-yn-1-ol) (20c). With 19 (468 
mg, 2.0 mmol) and phenylacetylene (660 µL, 6.0 mmol) following the 
general procedure B. Column chromatography (2/1 hexanes/EtOAc) 
yielded 730 mg (84%) of the title compound as a light brown solid: mp 
(decomp) 177-182 °C; 1H NMR (400 MHz, CDCl3) δ 7.83 (d, J = 7.5 Hz, 
1H), 7.76 (d, J = 7.4 Hz, 1H), 7.60 (d, J = 7.3 Hz, 2H), 7.31-7-46 (m, 10H), 7.25 (m, 4H), 
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6.20 (s, 2H), 3.79 (s, 1H), 3.50 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 142.1, 132.8, 131.8, 
129.0, 128.5, 128.4, 128.2, 127.3, 127.0, 122.4, 121.8, 92.3, 88.1, 87.04, 86.97, 63.82, 63.75; 
IR (KBr) νmax 3276, 3055, 2921, 2869, 2231, 1598, 1489, 1451, 1282, 1182, 1105, 1037, 970, 
913, 752, 690, 525 cm-1; HRMS (m/z) for C32H22O2Na (M + Na) calcd: 461.15120, found: 
461.15127; Rf (2/1 hexanes/EtOAc) = 0.24 (silica gel plate). 
 
1,1'-(Ethyne-1,2-diylbis(2,1-phenylene))bis(3-(4-bromophenyl)prop-2-yn-1-ol) (20d). 
With 19 (234 mg, 1.0 mmol) and 1-bromo-4-ethynylbenzene (543 
mg, 3.0 mmol) following the general procedure B. Column 
chromatography (2/1 hexanes/EtOAc) yielded 455 mg (77%) of the 
title compound as a light brown solid: mp (decomp) 181-186 °C; 1H 
NMR (400 MHz, CDCl3) δ 7.73-7.87 (m, 2H), 7.62 (m, 2H), 7.35-7.48 (m, 10H), 7.28-7-33 
(m, 4H), 6.21 (m, 1H), 6.18 (m, 1H), 3.44 (bs, 1H), 3.19 (bs, 1H); 13C NMR (100 MHz, 
CDCl3) δ 142.0, 132.9, 132.8, 131.8, 129.1, 129.0, 128.6, 128.5, 128.47, 128.4, 128.3, 127.3, 
127.1, 122.4, 121.8, 92.3, 88.0, 87.2, 63.94, 63.88; IR (KBr) νmax 3286, 3064, 2883, 2229, 
1587, 1570, 1487, 1451, 1394, 1283, 1181, 1071, 1027, 1013, 968, 822, 754, 690, 524 cm-1; 
HRMS (m/z) for C32H20O2Br2Na (M + Na) calcd: 616.97223 found: 616.97233; Rf (2/1 
hexanes/EtOAc) = 0.29 (silica gel plate). 
 
1,1'-(Ethyne-1,2-diylbis(2,1-phenylene))bis(3-(4-(trifluoromethyl)phenyl)prop-2-yn-1-ol) 
(20e). With 19 (234 mg, 1.0 mmol) and 1-ethynyl-4-
(trifluoromethyl)benzene (490 µL, 3.0 mmol) following the 
general procedure B. Column chromatography (2/1 
hexanes/EtOAc) yielded 483 mg (86%) of the title compound as a 
light brown solid: mp (decomp) 149-154 °C; 1H NMR (400 MHz, CDCl3) δ 7.74 (dd, J = 7.8, 
1.4 Hz, 2H), 7.63 (dd, J = 7.3, 1.4 Hz, 2H), 7.52-7.57 (m, 8H), 7.42 (dt, J = 7.5, 1.6 Hz, 2H), 
7.38 (dd, J = 7.5, 1.4 Hz, 2H), 6.21 (s, 2H), 3.65 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 
141.6, 133.0, 132.0, 129.2, 128.7, 127.3, 125.2 (q, 2JC-F = 3.8 Hz), 121.8, 120.6-126.4 (q, 1JC-F 
= 188.4 Hz), 92.3, 90.4, 85.6, 63.9; IR (KBr) νmax 3281, 3089, 2945, 2927, 2861, 2230, 1615, 
1489, 1453, 1405, 1328, 1161, 1118, 1070, 1027, 1018, 969, 843, 756 cm-1; HRMS (m/z) for 
C34H20O2F6Na (M + Na) calcd: 597.12597 found: 597.12606; Rf (2/1 hexanes/EtOAc) = 0.38 
(silica gel plate). 
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1,1'-(Ethyne-1,2-diylbis(2,1-phenylene))bis(3-(thiophen-3-yl)prop-2-yn-1-ol) (20f). With 
19 (234 mg, 1.0 mmol) and 3-ethynyl-thiophene (300 µL, 3.0 mmol) 
following the general procedure B. Column chromatography (2/1 
hexanes/EtOAc) yielded 398 mg (88%) of the title compound as a light 
brown solid: mp (decomp) 57-62 °C; 1H NMR (400 MHz, CDCl3) δ 7.81 
(dd, J = 7.7, 1.2 Hz, 1H), 7.75 (dd, J = 7.6, 1.4 Hz, 1H), 7.61 (dd, J = 7.5, 1.4 Hz, 2H), 7.47 
(m, 2H), 7.38-7.43 (m, 2H), 7.35 (dt, J = 7.5, 1.5 Hz, 2H), 7.24 (t, J = 3.1 Hz, 1H), 7.22 (t, J = 
3.1 Hz, 1H), 7.13 (ddd, J = 5.0, 2.2, 1.2 Hz, 2H), 6.19 (s, 1H), 6.18 (s, 1H), 3.62 (s, 1H), 3.36 
(s, 1H); 13C NMR (100 MHz, CDCl3) δ 162.4, 142.0, 141.9, 132.9, 132.7, 129.9, 129.40, 
129.38, 129.04, 129.00, 128.42, 128.40, 127.2, 127.0, 125.29, 125.26, 121.73, 121.68, 121.4, 
92.28, 92.27, 87.70, 87.67, 82.3, 82.2, 63.9, 63.8; IR (KBr) νmax 3527, 3334, 3106, 3061, 
3022, 2869, 2231, 1599, 1520, 1489, 1449, 1358, 1270, 1177, 1027, 986, 864, 783, 760, 626 
cm-1; HRMS (m/z) for C28H18O2S2Na (M + Na) calcd: 473.06404 found: 473.06415; Rf (2/1 
hexanes/EtOAc) = 0.24 (silica gel plate). 
 
1,1'-(Ethyne-1,2-diylbis(2,1-phenylene))bis(hex-2-yn-1-ol) (20g). With 19 (234 mg, 1.0 
mmol) and 1-pentyne (300 µL, 3.0 mmol) following the general procedure 
B. Column chromatography (2/1 hexanes/EtOAc) yielded 351 mg (95%) of 
the title compound as a light brown oil: 1H NMR (400 MHz, CDCl3) δ 7.77 
(dd, J = 7.7, 0.9 Hz, 1H), 7.72 (dd, J = 7.7, 1.0 Hz, 1H), 7.57 (m, 2H), 7.39 
(dt, J = 7.5, 1.4 Hz, 1H), 7.37 (dt, J = 7.5, 1.5 Hz, 1H), 7.32 (m, 2H), 5.94 (m, 2H), 3.42 (s, 
1H), 3.21 (s, 1H), 2.27 (m, 4H), 1.57 (m, 4H), 0.99 (t, J = 7.3 Hz, 3H), 0.98 (t, J = 7.4 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 142.7, 142.5, 132.6, 132.5, 128.8, 128.13, 128.10, 127.0, 
126.8, 121.70, 121.68, 92.1, 92.0, 88.0, 87.9, 79.3, 79.2, 63.5, 63.4, 22.0, 20.84, 20.82, 13.53, 
13.51; IR (KBr) νmax 3558, 3063, 3022, 2962, 2933, 2899, 2871, 2833, 2277, 2226, 1598, 
1565, 1489, 1449, 1379, 1328, 1276, 1189, 1133, 1033, 992, 807, 758, 630 cm-1; HRMS (m/z) 
for C26H26O2Na (M + Na) calcd: 393.18250 found: 393.18269; Rf (2/1 hexanes/EtOAc) = 0.29 
(silica gel plate). 
 
 
 
 
 
168 
 
1,1'-(Ethyne-1,2-diylbis(2,1-phenylene))bis(3-(trimethylsilyl)prop-2-yn-1-ol) (20h). With 
19 (234 mg, 1.0 mmol) and ethynyltrimethylsilane (430 µL, 3.0 mmol) 
following the general procedure B. Column chromatography (2/1 
hexanes/EtOAc) yielded 361 mg (84%) of the title compound as a light 
brown oil: 1H NMR (400 MHz, CDCl3) δ 7.77 (dd, J = 7.7, 1.2 Hz, 1H), 
7.70 (dd, J = 7.6, 1.4 Hz, 1H), 7.58 (m, 2H), 7.39 (m, 2H), 7.34 (m, 2H), 3.55 (s, 1H), 3.25 (s, 
1H), 0.21 (s, 9H), 0.19 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 141.7, 141.6, 132.8, 132.6, 
128.92, 128.87, 128.4, 128.3, 127.3, 127.0, 121.9, 121.8, 104.2, 104.1, 92.2, 92.1, 63.8, 63.6, 
-0.20, -0.21; IR (KBr) νmax 3346, 3058, 3025, 2959, 2898, 2173, 1598, 1490, 1449, 1408, 
1374, 1250, 1188, 1038, 983, 844, 759 cm-1; HRMS (m/z) for C26H30O2NaSi2 (M + Na) calcd: 
453.16765 found: 453.16768; Rf (2/1 hexanes/EtOAc) = 0.30 (silica gel plate). 
 
1,1'-(Ethyne-1,2-diylbis(2,1-phenylene))bis(3-(naphthalen-1-yl)prop-2-yn-1-ol) (20i). 
With 19 (234 mg, 1.0 mmol) and 1-ethynylnaphthalene (430 µL, 3.0 
mmol) following the general procedure B. Column chromatography (2/1 
hexanes/EtOAc) yielded 458 mg (85%) of the title compound as a light 
brown solid: mp (decomp) 86-91 °C; 1H NMR (400 MHz, CDCl3) δ 8.30 
(m, 1H), 8.25 (m, 1H), 7.91 (dd, J = 7.7, 1.3 Hz, 1H), 7.85 (dd, J = 7.6, 1.4 
Hz, 1H), 7.76-7.81 (m, 4H), 7.68 (m, 2H), 7.66 (dt, J = 8.5, 1.2 Hz, 2H), 
7.32-7-48 (m, 10H), 6.39 (s, 1H), 6.37 (s, 1H), 3.65 (s, 1H), 3.42 (s, 1H); 13C NMR (100 
MHz, CDCl3) δ 142.2, 142.1, 133.2, 133.03, 132.96, 132.9, 130.8, 129.13, 129.12, 129.0, 
128.49, 128.46, 128.17, 128.15, 127.3, 127.1, 126.8, 126.4, 126.3, 126.12, 126.08, 125.1, 
121.8, 121.7, 120.98, 119.95, 92.9, 92.5, 92.4, 85.2, 85.1, 64.2; IR (KBr) νmax 3371, 3058, 
2954, 2869, 2219, 1586, 1489, 1450, 1396, 1284, 1187, 1098, 1054, 1016, 950, 800, 773, 760 
cm-1; HRMS (m/z) for C40H26O2Na (M + Na) calcd: 561.18250, found: 561.18256; Rf (2/1 
hexanes/EtOAc) = 0.28 (silica gel plate). 
 
1-(2-Iodophenyl)-3-(4-(trifluoromethyl)phenyl)prop-2-yn-1-ol (24). With 2-iodo 
benzaldehyde (116 mg, 0.5 mmol) and 1-ethynyl-4-(trifluoromethyl)-
benzene (82 µL, 0.5 mmol) following the general procedure B. 
Column chromatography (2/1 hexanes/EtOAc) yielded 195 mg (96%) 
of the title compound as a colorless liquid: 1H NMR (400 MHz, CDCl3) δ 7.87 (dd, J = 7.9, 
1.2 Hz, 1H), 7.80 (dd, J = 7.8, 1.7 Hz, 1H), 7.58 (s, 4H), 7.43 (dt, J = 7.7, 1.2 Hz, 1H), 7.06 
(dt, J = 7.6, 1.7 Hz, 1H), 5.90 (d, J = 5.0 Hz, 1H), 2.59 (d, J = 5.0 Hz, 1H); 13C NMR (100 
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MHz, CDCl3) δ 142.1, 139.8, 132.0, 130.3, 128.8, 128.1, 122.6-130.6 (q, 1JC-F = 365.7 Hz), 
125.2 (q, 2JC-F = 3.8 Hz), 97.9, 90.2, 85.5, 69.0; IR (KBr) νmax 3285, 3180, 3061, 2887, 2229, 
1614, 1497, 1464, 1436, 1405, 1326, 1279, 1170, 1137, 1114, 1070, 1053, 1012, 970, 840, 
752, 731 cm-1; HRMS (m/z) for C16H10OF3INa (M + Na) calcd: 424.96206, found: 424.96208; 
Rf (2/1 hexanes/EtOAc) = 0.52 (silica gel plate). 
 
1-(2-Ethynylphenyl)-3-(4-methoxyphenyl)prop-2-yn-1-ol (25). With 2-ethynyl 
benzaldehyde (260 mg, 2.0 mmol) and 4-ethynylanisole (260 µL, 2.0 
mmol) following the general procedure B. Column chromatography 
(2/1 hexanes/EtOAc) yielded 436 mg (83%) of the title compound as 
a light brown liquid: 1H NMR (400 MHz, CDCl3) δ 7.78 (dd, J = 7.8, 0.7 Hz, 1H), 7.53 (dd, J 
= 7.6, 1.1 Hz, 1H), 7.39-7.44 (m, 3H), 7.31 (dt, J = 7.6, 1.3 Hz, 1H), 6.82 (m, 2H), 6.09 (s, 
1H), 3.80 (s, 3H), 3.41 (s, 1H), 2.77 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 159.8, 143.1, 
133.3, 133.2, 132.8, 129.4, 129.2, 128.2, 127.4, 127.3, 126.9, 120.4, 114.5, 113.9, 86.7, 82.7, 
81.9, 81.1, 63.8, 55.2; IR (KBr) νmax 3427, 3288, 3066, 2935, 2837, 2227, 1606, 1509, 1479, 
1446, 1291, 1248, 1174, 1107, 1029, 964, 832, 761, 663, 536 cm-1; HRMS (m/z) for C18H14O2 
(M+) calcd: 262.0994, found: 262.0999; Rf (2/1 hexanes/EtOAc) = 0.35 (silica gel plate). 
 
1-(2-((2-(1-Hydroxy-3-(4-(trifluoromethyl)phenyl)prop-2-yn-1-yl)phenyl)ethynyl)-
phenyl)-3-(4-methoxyphenyl)prop-2-yn-1-ol (26). With 24 
(200 mg, 0.5 mmol) and 25 (131 mg, 0.5 mmol) following the 
general procedure A. Column chromatography (2/1 
hexanes/EtOAc) yielded 244 mg (91%) of the title compound as 
mixture as a light brown oil: 1H NMR (400 MHz, CDCl3) (major) δ 7.80 (dd, J = 7.7, 1.1 Hz, 
1H), 7.73 (dd, J = 7.8, 1.6 Hz, 1H), 7.62 (dt, J = 6.9, 1.3 Hz, 2H), 7.52 (m, 4H), 7.34-7.44 (m, 
6H), 6.77 (m, 2H), 6.22 (s, 1H), 6.18 (s, 1H), 3.95 (s, 1H), 3.76 (s, 3H), 3.54 (s, 1H), (minor) 
δ 7.83 (dd, J = 7.7, 1.0 Hz, 1H), 7.76 (dd, J = 7.7, 1.3 Hz, 1H), 7.62 (dt, J = 6.9, 1.3 Hz, 2H), 
7.52 (m, 4H), 7.34-7.44 (m, 6H), 6.79 (m, 2H), 6.22 (s, 1H), 6.18 (s, 1H), 3.77 (s, 3H), 3.63 
(s, 1H), 3.29 (s, 1H); 13C NMR (100 MHz, CDCl3) (major) δ 159.8, 142.1, 141.8, 133.3, 
132.92, 132.86, 132.0, 129.1, 128.6, 128.4, 127.3, 127.0, 119.8-126.2 (q, 1JC-F = 272.4 Hz), 
125.2 (q, 2JC-F = 3.8 Hz), 121.7, 113.9, 92.4, 92.1, 90.7, 87.2, 86.6, 85.4, 64.0, 63.8, 55.2, 
(minor) δ 159.8, 142.1, 141.7, 133.3, 132.8, 132.7, 132.0, 129.1, 128.5, 128.4, 127.3, 127.0, 
119.8-126.2 (q, 1JC-F = 272.4 Hz), 125.2 (q, 2JC-F = 3.8 Hz), 121.8, 114.3, 92.5, 92.1, 90.7, 
87.2, 86.6, 85.5, 63.9, 63.7, 55.2; IR (KBr) νmax 3348, 3064, 2928, 2871, 2234, 1606, 1509, 
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1490, 1443, 1323, 1291, 1249, 1171, 1125, 1068, 1032, 1018, 965, 833, 760 cm-1; HRMS 
(m/z) for C34H23O3F3Na (M + Na) calcd: 559.14915, found: 559.14928; Rf (2/1 
hexanes/EtOAc) = 0.28 (silica gel plate). 
 
1-(2-((2-(1-Hydroxy-3-(p-tolyl)prop-2-yn-1-yl)-4-(trifluoromethyl)phenyl)ethynyl)-5-
methoxyphenyl)-3-(p-tolyl)prop-2-yn-1-ol (31). With 30 (270 
mg, 0.8 mmol) and 1-ethynyl-4-p-toluene (310 µL, 2.4 mmol) 
following the general procedure B. Column chromatography (2/1 
hexanes/EtOAc) yielded 345 mg (75%) of the title compound as 
mixture as a light brown solid: mp (decomp) 72-77 °C; 1H NMR (400 MHz, CDCl3) δ 7.51 (s, 
1H), 7.49 (s, 1H), 7.31-7.39 (m, 6H), 7.07-7.12 (m, 4H), 6.85 (dt, J = 8.5, 2.7 Hz, 2H), 6.15 
(d, J = 5.7 Hz, 1H), 6.04 (d, J = 5.2 Hz, 1H), 3.86 (s, 3H), 3.76 (s, 1H), 2.69 (s, 1H) 2.33 (s, 
6H); 13C NMR (100 MHz, CDCl3) δ 160.6, 159.8, 145.7, 143.6, 138.7, 135.1, 134.0, 133.9, 
131.7, 131.7, 129.0, 127.9-143.5 (q, 1JC-F = 254.8 Hz), 119.3, 114.3, 114.1, 114.0 (q, 2JC-F = 
4.7 Hz), 113.9, 112.9, 112.6, 112.5, 112.1, 90.9, 87.3, 87.2, 86.9, 79.9, 77.9, 63.9, 63.4, 55.5, 
21.5; IR (KBr) νmax 3372, 3031, 3004, 2923, 2836, 2210, 1605, 1509, 1487, 1429, 1329, 1293, 
1272, 1168, 1126, 1095, 1028, 973, 816, 527 cm-1; HRMS (m/z) for C36H28O3F3 (M + H) 
calcd: 565.19851, found: 565.19818; Rf (2/1 hexanes/EtOAc) = 0.34 (silica gel plate). 
 
1,1'-(Ethyne-1,2-diylbis(naphthalene-1,2-diyl))bis(3-(4-methoxyphenyl)prop-2-yn-1-ol) 
(38a). With 37 (250 mg, 0.75 mmol) and 4-ethynylanisole (290 µL, 
2.25 mmol) following the general procedure B. Column 
chromatography (2/1 hexanes/EtOAc) yielded 423 mg (94%) of the 
title compound as a light brown solid: mp (decomp) 97-102 °C; 1H 
NMR (400 MHz, CDCl3) δ 8.66 (m, 2H), 8.00 (dd, J = 8.6, 4.7 Hz, 
2H), 7.92 (d, J = 8.6 Hz, 2H), 7.88 (d, J = 7.9 Hz, 2H), 7.56-7.63 
(m, 4H), 7.40 (m, 4H), 6.78 (m, 4H), 6.62 (s, 2H), 3.76 (s, 6H), 3.47 (s, 1H), 3.28 (s, 1H); 13C 
NMR (100 MHz, CDCl3) δ 159.7, 141.4, 141.3, 133.4, 133.3, 133.0, 129.5, 128.3, 127.4, 
126.8, 126.6, 124.3, 124.2, 118.9, 118.8, 114.4, 114.4, 113.88, 113.82, 95.6, 95.5, 87.3, 87.2, 
87.1, 87.0, 64.14, 64.10, 55.2; IR (KBr) νmax 3418, 3055, 3004, 2956, 2929, 2836, 2223, 1605, 
1569, 1509, 1463, 1440, 1291, 1249, 1173, 1107, 1033, 979, 829, 802, 762 cm-1; HRMS (m/z) 
for C42H30O4Na (M + Na) calcd: 621.20363, found: 621.20367; Rf (2/1 hexanes/EtOAc) = 
0.16 (silica gel plate). 
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1,1'-(Ethyne-1,2-diylbis(naphthalene-1,2-diyl))bis(3-phenylprop-2-yn-1-ol) (38b). With 
37 (84 mg, 0.25 mmol) and phenylacetylene (83 µL, 0.75 mmol) 
following the general procedure B. Column chromatography (2/1 
hexanes/EtOAc) yielded 119 mg (88%) of the title compound as a light 
brown solid: mp (decomp) 93-98 °C; 1H NMR (400 MHz, CDCl3) δ 
8.68 (m, 2H), 8.03 (dd, J = 8.6, 3.4 Hz, 2H), 7.95 (d, J = 8.6 Hz, 2H), 
7.89 (m, 2H), 7.54-7.61 (m, 4H), 7.45 (m, 4H), 7.22-7.32 (m, 6H), 6.63 (s, 1H), 6.62 (s, 1H), 
3.47 (s, 1H), 3.28 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 141.2, 141.1, 133.4, 133.3, 133.03, 
133.02, 131.8, 129.6, 128.5, 128.32, 128.26, 128.22, 128.19, 127.5, 126.8, 126.6, 124.3, 
124.2, 122.4, 122.3, 119.0, 118.9, 95.6, 95.5, 88.6, 88.5, 87.26, 87.1, 64.10, 64.08.; IR (KBr) 
νmax 3371, 3053, 2926, 2856, 2224, 1591, 1571, 1484, 1443, 1401, 1260, 1218, 1173, 1032, 
980, 918, 824, 755, 693 cm-1; HRMS (m/z) for C40H26O2Na (M + Na) calcd: 561.18250, 
found: 561.18256; Rf (2/1 hexanes/EtOAc) = 0.24 (silica gel plate).  
 
1,1'-(Ethyne-1,2-diylbis(naphthalene-1,2-diyl))bis(3-(4-(trifluoromethyl)phenyl)prop-2-
yn-1-ol) (38c). With 37 (84 mg, 0.25 mmol) and 1-ethynyl-4-
(trifluoromethyl)-benzene (122 µL, 0.75 mmol) following the 
general procedure B. Column chromatography (2/1 hexanes/EtOAc) 
yielded 128 mg (76%) of the title compound as a light brown solid: 
mp (decomp) 98-103 °C; 1H NMR (400 MHz, CDCl3) δ 8.63 (m, 
2H), 7.86-7.94 (m, 6H), 7.54-7.62 (m, 4H), 7.39-7.42 (m, 4H), 7.44-
7.49 (m, 4H), 6.63 (s, 1H), 6.61 (s, 1H), 3.83 (s, 1H), 3.73 (s, 1H); 13C NMR (100 MHz, 
CDCl3) δ 140.7, 140.6, 133.4, 133.3, 133.1, 133.0, 132.0, 131.9, 129.8, 129.7, 128.4, 127.62, 
127.60, 127.04, 127.00, 126.5, 126.4, 126.0 (q, 3JC-F = 1.4 Hz), 125.0 (q, 2JC-F = 3.8 Hz), 
122.9-129.8 (q, 1JC-F = 261.6 Hz), 124.2, 124.1, 119.0, 118.9, 95.6, 95.5, 90.9, 90.8, 85.8, 
85.7, 64.1, 64.0; IR (KBr) νmax 3381, 3053, 2935, 2856, 2099, 1612, 1408, 1318, 1249, 1218, 
1166, 1125, 1073, 1021, 983, 835, 762 cm-1; HRMS (m/z) for C42H24O2F6Na (M + Na) calcd: 
697.15727, found: 697.15738; Rf (2/1 hexanes/EtOAc) = 0.25 (silica gel plate). 
  
172 
 
6.3.2. Cyclotrimerization reaction for 21, 27, 32 and 39 
 
C:  General procedure for cyclotrimerization with Wilkinson’s catalyst RhCl(PPh3)3 
(Preparation of 21, 27, 32 and 39). A dry microwave vial was charged with starting triyndiol 
(0.25 mmol), and dissolved under argon atmosphere in THF (5 mL). After addition of 
Wilkinson’s catalyst (9 mg, 0.0075 mmol, 3 mol%) and the additive Ag2CO3 (4 mg, 0.015 
mmol, 6 mol%) the reaction mixture was sealed and heated up to 180°C for 1.5 h in a 
microwave reactor. The reaction mixture was cooled down to room temperature and the 
solvent was evaporated under reduced pressure. Column chromatography of the residue on 
silica gel yielded products. 
 
6,7-Bis(4-methoxyphenyl)-5,8-dihydroindeno[2,1-c]fluorene-5,8-diol (21a). With 20a (125 
mg, 0.25 mmol) following the general procedure C. Column 
chromatography (1/1 hexanes/EtOAc) yielded 114 mg (92%) of the title 
compound as a light brown solid: mp (decomp) >260 °C; 1H NMR (400 
MHz, CDCl3) δ 8.37 (dd, J = 7.7, 3.7 Hz, 2H), 7.60 (m, 2H), 7.49 (t, J = 
7.6 Hz, 3H), 7.37 (m, 3H), 7.14 (m, 2H), 6.80 (m, 4H), 5.88 (s, 1H), 5.59 
(s, 1H) 3.80 (s, 3H), 3.79 (s, 3H), 1.90 (s, 1H), 1.78 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 
158.6, 147.1, 145.8, 139.9, 137.3, 129.93, 129.89, 128.9, 128.8, 127.9, 125.5, 125.4, 123.51, 
123.47, 114.1, 74.3, 74.1, 55.2, 55.1; IR (KBr) νmax 3554, 3008, 2933, 2837, 1608, 1517, 
1462, 1432, 1289, 1247, 1180, 1107, 1031, 837, 763, 736 cm-1; HRMS (m/z) for C34H26O4Na 
(M + Na) calcd: 521.17233, found: 521.17249; Rf (1/1 hexanes/EtOAc) = 0.43 (silica gel 
plate). 
 
6,7-Di-p-tolyl-5,8-dihydroindeno[2,1-c]fluorene-5,8-diol (21b). With 20b (45 mg, 0.1 
mmol) following the general procedure C. Column chromatography (2/1/1 
hexanes/EtOAc/CH2Cl2) yielded 45 mg (96%) of the title compound as a 
light brown solid: mp (decomp) 254-259 °C; 1H NMR (400 MHz, CDCl3) δ 
8.37 (d, J = 7.8 Hz, 2H), 8.23-8.32 (m, 2H), 7.59 (m, 3H), 7.49 (m, 3H), 
7.34-7.43 (m, 4H), 7.02 (d, J = 7.8 Hz, 1H), 6.88 (d, J = 8.1 Hz, 1H), 5.85 
(d, J = 2.9 Hz, 2H), 2.33 (s, 6H), 1.74 (d, J = 3.9 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 
146.9, 145.8, 139.9, 137.4, 136.9, 135.0, 134.7, 129.4, 129.3, 128.8, 128.2, 127.8, 125.4, 
123.5, 74.3, 21.3; IR (KBr) νmax 3575, 3550, 3518, 3460, 3046, 3023, 2947, 2921, 2868, 1605, 
1515, 1464, 1431, 1328, 1247, 1184, 1105, 1071, 1022, 933, 830, 763, 735 cm-1; HRMS (m/z) 
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for C34H26O2Na (M + Na) calcd: 489.18250, found: 489.18242; Rf (2/1 hexanes/EtOAc) = 
0.40 (silica gel plate). 
 
6,7-Diphenyl-5,8-dihydroindeno[2,1-c]fluorene-5,8-diol (21c). With 20c (109 mg, 0.25 
mmol) following the general procedure C. Column chromatography (2/1/1 
hexanes/EtOAc/CH2Cl2) yielded 102 mg (93%) of the title compound as a 
light brown solid: mp (decomp) >260 °C; 1H NMR (400 MHz, CDCl3) δ 
8.42 (dd, J = 7.8, 3.7 Hz, 2H), 7.64 (m, 2H), 7.53 (t, J = 7.6 Hz, 3H), 7.40 
(ddt, J = 7.4, 2.0. 0.9 Hz, 3H), 7.29-7.31 (m, 2H), 7.17-7.25 (m, 6H), 5.90 (s, 1H), 5.62 (s, 
1H), 1.72-1.87 (bs, 2H); 13C NMR (100 MHz, CDCl3) δ 146.8, 146.1, 145.81, 145.77, 139.8, 
139.7, 138.6, 137.8, 137.7, 137.4, 135.1, 134.9, 128.9, 128.9, 128.0, 127.3, 127.2, 125.5, 
125.4, 123.54, 123.49, 74.3, 74.1; IR (KBr) νmax 3579, 3554, 3423, 3050, 3021, 2945, 2865, 
1604, 1464, 1441, 1422, 1330, 1179, 1101, 1067, 1029, 848, 766, 742, 714, 704 cm-1; HRMS 
(m/z) for C34H26O2Na (M + Na) calcd: 461.15120, found: 461.15131; Rf (2/1 hexanes/EtOAc) 
= 0.26 (silica gel plate). 
 
6,7-Bis(4-bromophenyl)-5,8-dihydroindeno[2,1-c]fluorene-5,8-diol (21d). With 20d (148 
mg, 0.25 mmol) following the general procedure C. Column 
chromatography (2/1/1 hexanes/EtOAc/CH2Cl2) yielded 124 mg (84%) of 
the title compound as a light brown solid: mp (decomp) 222-227 °C; 1H 
NMR (400 MHz, CDCl3) δ 8.37 (dd, J = 7.7, 2.4 Hz, 2H), 7.59 (d, J = 7.3 
Hz, 2H), 7.50 (t, J = 7.5 Hz, 4H), 7.39 (m, 4H), 7.28-7-33 (m, 2H), 6.78 (m, 
2H), 5.84 (m, 1H), 5.78 (s, 1H), 1.62 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 146.7, 145.9, 
145.8, 139.6, 139.5, 137.5, 137.4, 136.9, 136.6, 136.4, 135.5, 135.4, 135.2, 132.1, 131.7, 
130.4, 129.1, 129.0, 128.9, 128.2, 128.1, 127.5, 125.4, 123.6, 121.6, 74.2, 74.1; IR (KBr) νmax 
3566, 3444, 3050, 2868, 1605, 1489, 1465, 1427, 1392, 1330, 1247, 1179, 1103, 1073, 1026, 
1012, 833, 761, 736, 729 cm-1; HRMS (m/z) for C32H22O2Br2Na (M + Na) calcd: 616.97223, 
found: 616.97181; Rf (2/1 hexanes/EtOAc) = 0.38 (silica gel plate). 
 
 
 
 
 
174 
 
6,7-Bis(4-(trifluoromethyl)phenyl)-5,8-dihydroindeno[2,1-c]fluorene-5,8-diol (21e). With 
20e (143 mg, 0.25 mmol) following the general procedure C. Column 
chromatography (2/1/1 hexanes/EtOAc/CH2Cl2) yielded 138 mg (96%) of 
the title compound as a light brown solid: mp (decomp) >260 °C; 1H 
NMR (400 MHz, CDCl3) δ 8.39 (d, J = 7.8 Hz, 2H), 7.64-7.72 (m, 2H), 
7.61 (d, J = 7.1 Hz, 4H), 7.53 (m, 4H), 7.41 (t, J = 7.3 Hz, 4H), 7.02 (bs, 
2H), 5.79 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 146.7, 146.5, 145.9, 145.8, 139.7, 139.5, 
137.5, 136.7, 136.4, 135.5, 129.1, 122.6-129.6 (q, 1JC-F = 272.1 Hz), 128.3, 128.1, 127.4, 
125.5 (q, 2JC-F = 2.9 Hz), 123.5, 121.5, 74.2; IR (KBr) νmax 3303, 3040, 2945, 2923, 1617, 
1467, 1406, 1328, 1164, 1120, 1069, 1021, 849, 762, 741 cm-1; HRMS (m/z) for 
C34H20O2F6Na (M + Na) calcd: 597.12597 found: 597.12610; Rf (2/1 hexanes/EtOAc) = 0.44 
(silica gel plate). 
 
6,7-Di(thiophen-3-yl)-5,8-dihydroindeno[2,1-c]fluorene-5,8-diol (21f). With 20f (113 mg, 
0.25 mmol) following the general procedure C. Column chromatography 
(2/1/1 hexanes/EtOAc/CH2Cl2) yielded 108 mg (95%) of the title 
compound as a light brown solid: mp (decomp) 231-236 °C; 1H NMR (400 
MHz, CDCl3) δ 8.33 (d, J = 7.8 Hz, 2H), 7.62 (d, J = 7.4 Hz, 2H), 7.50 (t, J 
= 7.4 Hz, 2H), 7.39 (ddt, J = 7.4, 2.8, 0.7 Hz, 2H), 7.31 (dd, J = 7.9, 3.0 Hz, 
1H), 7.27 (m, 1H), 7.23 (dd, J = 2.9, 1.3 Hz, 1H), 7.16 (dd, J = 2.9, 1.2 Hz, 1H), 6.92 (dd, J = 
4.9, 1.2 Hz, 2H), 5.88 (s, 1H), 5.64 (s, 1H), 1.91 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 
147.2, 146.7, 145.8, 145.7, 139.7, 139.6, 137.9, 137.8, 135.3, 135.1, 133.9, 132.8, 129.2, 
129.0, 128.9, 128.6, 128.1, 126.1, 125.5, 125.41, 125.37, 124.2, 123.6, 123.54, 123.49, 74.3, 
74.1; IR (KBr) νmax 3546, 3393, 3103, 3029, 2869, 1605, 1466, 1440, 1353, 1264, 1192, 1070, 
1024, 966, 856, 838, 802, 761, 732, 624 cm-1; HRMS (m/z) for C28H18O2S2Na (M + Na) 
calcd: 473.06404 found: 473.06409; Rf (2/1 hexanes/EtOAc) = 0.30 (silica gel plate). 
 
6,7-Dipropyl-5,8-dihydroindeno[2,1-c]fluorene-5,8-diol (21g). With 20g (92 mg, 0.25 
mmol) following the general procedure C. Column chromatography (2/1 
hexanes/EtOAc) yielded 68 mg (73%) of the title compound as a light 
brown solid: mp (decomp) 204-209 °C; 1H NMR (400 MHz, CDCl3) δ 8.25 
(d, J = 7.7 Hz, 2H), 7.67 (d, J = 7.2 Hz, 2H), 7.45 (t, J = 7.1 Hz, 2H), 7.35 
(t, J = 7.4 Hz, 2H), 5.69 (s, 1H), 5.67 (s, 1H), 3.11 (m, 2H), 2.80 (m, 2H), 1.69 (m, 4H), 1.57 
(s, 2H), 1.11 (t, J = 7.2 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 146.3, 145.9, 140.1, 139.7, 
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128.9, 128.1, 127.5, 125.2, 123.1, 74.7, 31.1, 24.9, 15.0; IR (KBr) νmax 3530, 3366, 3050, 
2957, 2927, 2870, 1607, 1586, 1465, 1431, 1374, 1294, 1258, 1201, 1086, 1020, 933, 842, 
763, 731, 724 cm-1; HRMS (m/z) for C26H26O2Na (M + Na) calcd: 393.18250, found: 
393.18264; Rf (2/1 hexanes/EtOAc) = 0.39 (silica gel plate).  
 
6,7-Bis(trimethylsilyl)-5,8-dihydroindeno[2,1-c]fluorene-5,8-diol (major) (21h-TMS), 6-
(Trimethylsilyl)-5,8-dihydroindeno[2,1-c]fluorene-5,8-diol (minor) 
(21h). With 20h (108 mg, 0.25 mmol) following the general procedure C. 
Column chromatography (2/1 hexanes/EtOAc) yielded 85 mg (80%) of the 
title compound as mixture as a light brown oil: 1H NMR (400 MHz, 
CDCl3) δ 8.31 (dd, J = 7.9, 2.1 Hz, 2H), 7.70 (m, 2H), 7.46 (m, 2H), 7.38 
(dt, J = 7.4, 0.9 Hz, 2H), 5.72 (d, J = 8.0 Hz, 1H), 5.64 (m, 1H), 1.70 (s, 
1H), 1.57 (s, 1H), 0.47 (s, 9H), 0.24 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 
(major) 152.9, 147.4, 147.0, 146.3, 139.9, 139.8, 136.4, 130.1, 128.9, 128.5, 127.8, 127.7, 
125.3, 125.18, 123.55, 123.4, 75.4, 75.1, 1.0, 0.1; δ (minor) 153.7, 147.9, 147.2, 146.6, 140.0, 
139.9, 135.8, 134.7, 129.8, 128.8, 128.5, 127.7, 125.2, 125.0, 123.6, 75.6, 75.3, 1.0, 0.1; IR 
(KBr) νmax 3540, 3393, 3067, 3046, 2954, 2896, 1606, 1465, 1407, 1380, 1248, 1198, 1117, 
1039, 933, 843, 760, 736 cm-1; HRMS (m/z) for C26H30O2NaSi2 (M + Na) (major) calcd: 
453.16765, found: 453.16774, HRMS (m/z) for C23H22O2NaSi (M + Na) (minor) calcd: 
381.12813, found: 381.12830; Rf (2/1 hexanes/EtOAc) (major) = 0.44 (silica gel plate), Rf (2/1 
hexanes/EtOAc) (minor) = 0.26 (silica gel plate). 
 
6,7-Di(naphthalen-1-yl)-5,8-dihydroindeno[2,1-c]fluorene-5,8-diol (21i). With 20i (135 
mg, 0.25 mmol) following the general procedure C. Column 
chromatography (2/1/1 hexanes/EtOAc/CH2Cl2) yielded 112 mg (83%) 
of the title compound as a light brown solid: mp (decomp) 217-222 °C; 
1H NMR (400 MHz, CDCl3) δ 8.49 (d, J = 7.8 Hz, 2H), 7.63 (d, J = 8.1 
Hz, 4H), 7.58 (t, J = 8.5 Hz, 2H), 7.50-7.54 (m, 6H), 7.34-7.39 (m, 4H), 7.25 (t, J = 7.2 Hz, 
2H), 7.14 (t, J = 7.2 Hz, 2H), 5.32 (s, 2H), 1.65 (bs, 2H); 13C NMR (100 MHz, CDCl3) δ 
147.0, 145.8, 139.8, 137.0, 134.1, 133.6, 130.9, 129.3, 128.9, 128.2, 128.1, 128.0, 125.9, 
125.7, 125.6, 124.4, 123.6, 74.29; IR (KBr) νmax 3553, 3422, 3053, 2953, 2869, 1593, 1507, 
1465, 1390, 1330, 1189, 1040, 1019, 801, 780, 767, 733 cm-1; HRMS (m/z) for C40H26O2Na 
(M + Na) calcd: 561.18250, found: 561.18255; Rf (2/1 hexanes/EtOAc) = 0.36 (silica gel 
plate). 
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6-(4-Methoxyphenyl)-7-(4-(trifluoromethyl)phenyl)-5,8-dihydroindeno[2,1-c]fluorene-
5,8-diol (27). With 26 (134 mg, 0.25 mmol) following the general 
procedure C. Column chromatography (2/1/1 hexanes/EtOAc/CH2Cl2) 
yielded 113 mg (84%) of the title compound as a light brown solid: mp 
(decomp) >260 °C; 1H NMR (400 MHz, CDCl3) δ 8.37 (d, J = 7.8 Hz, 
2H), 7.61 (t, J = 7.9 Hz, 4H), 7.51 (dt, J = 7.4, 1.0 Hz, 4H), 7.37-7.41 (m, 
6H), 5.86 (s, 1H), 5.81 (s, 1H), 3.79 (s, 3H), 1.78 (s, 1H), 1.69 (s, 1H); 13C NMR (100 MHz, 
CDCl3) δ 158.8, 146.5, 145.9, 145.8, 139.6, 136.6, 135.1, 122.9-129.2 (q, 1JC-F = 272.1 Hz), 
129.1, 128.9, 128.2, 125.5, 125.4, 123.6 (q, 2JC-F = 3.9 Hz), 74.3, 74.2, 55.2; IR (KBr) νmax 
3566, 3221, 3040, 2952, 2921, 2861, 1609, 1513, 1463, 1434, 1405, 1323, 1249, 1163, 1125, 
1107, 1065, 1032, 840, 764, 736 cm-1; HRMS (m/z) for C34H23O3F3Na (M + Na) calcd: 
559.14915, found: 559.14932; Rf (2/1 hexanes/EtOAc) = 0.34 (silica gel plate). 
 
3-Methoxy-6,7-di-p-tolyl-10-(trifluoromethyl)-5,8-dihydroindeno[2,1-c]fluorene-5,8-diol 
(32). With 31 (134 mg, 0.25 mmol) following the general procedure 
C. Column chromatography (2/1/1 hexanes/EtOAc/CH2Cl2) yielded 
84 mg (60%) of the title compound as a light brown solid: mp 
(decomp) 141-146 °C; 1H NMR (400 MHz, CDCl3) δ 8.40 (d, J = 8.2 
Hz, 1H), 8.20 (d, J = 8.6 Hz, 1H), 7.82 (s, 1H), 7.72 (d, J = 8.2 Hz, 
1H), 7.34-7.41 (m, 3H), 7.16 (d, J = 2.1 Hz, 1H), 7.02 (dd, J = 8.6, 2.6 Hz, 2H), 7.00 (m, 2H), 
6.76 (m, 2H), 5.89 (s, 1H), 5.81 (s, 1H), 3.88 (s, 3H), 2.33 (s, 6H), 1.80 (s, 1H), 1.76 (s, 1H); 
13C NMR (100 MHz, CDCl3) δ 160.0, 148.1, 147.4, 146.8, 146.1, 143.5, 138.4, 137.0, 136.5, 
135.7, 134.5, 134.4, 132.4, 132.1, 130.2, 129.5, 129.1, 128.4, 126.1, 126.0, 125.6-133.6 (q, 
1JC-F = 194.6 Hz), 124.3, 123.1, 122.3 (q, 2JC-F = 3.8 Hz), 114.6, 110.9, 74.2, 74.0, 55.5, 21.2; 
IR (KBr) νmax 3567, 3458, 3019, 2923, 2871, 1611, 1512, 1484, 1434, 1327, 1300, 1252, 
1166, 1144, 1123, 1177, 1034, 833, 818, 527 cm-1; HRMS (m/z) for C36H28O3F3 (M + H) 
calcd: 565.19851, found: 565.19819; Rf (2/1 hexanes/EtOAc) = 0.46 (silica gel plate). 
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8,9-Bis(4-methoxyphenyl)-7,10-dihydrobenzo[c]benzo[6,7]indeno[1,2-g]fluorene-7,10-
diol (39a). With 38a (150 mg, 0.25 mmol) following the general 
procedure C. Column chromatography (2/1/1 hexanes/EtOAc/CH2Cl2) 
yielded 145 mg (96%) of the title compound as diastereoisomers as a light 
brown solid: mp (decomp) 178-183 °C; 1H NMR (400 MHz, CDCl3) δ 
7.89 (d, J = 8.0 Hz, 2H), 7.82 (d, J = 8.2 Hz, 2H), 7.79 (d, J = 8.1 Hz, 2H), 
7.39 (dd, J = 8.4, 0.8 Hz, 2H), 7.18 (m, 4H), 6.87 (m, 4H), 6.53 (ddd, J = 8.3, 6.8, 1.3 Hz, 
2H), 5.84 (s, 2H), 3.81 (s, 6H), 2.05 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 158.5, 145.3, 
143.6, 138.0, 137.4, 134.6, 134.3, 129.6, 129.2, 129.1, 127.9, 127.7, 125.6, 124.5, 124.2, 
122.2, 113.9, 74.4, 55.2; IR (KBr) νmax 3548, 3053, 3001, 2954, 2835, 1608, 1511, 1462, 
1362, 1287, 1247, 1176, 1033, 832, 800, 744 cm-1; HRMS (m/z) for C42H30O4Na (M + Na) 
calcd: 621.20363, found: 621.20369; Rf (2/1 hexanes/EtOAc) = 0.22 (silica gel plate). 
 
8,9-Diphenyl-7,10-dihydrobenzo[c]benzo[6,7]indeno[1,2-g]fluorene-7,10-diol (39b). With 
38b (107 mg, 0.2 mmol) following the general procedure C. Column 
chromatography (2/1/1 hexanes/EtOAc/CH2Cl2) yielded 103 mg (96%) of 
the title compound as diastereoisomers as a light brown solid: mp (decomp) 
171-176 °C; 1H NMR (400 MHz, CDCl3) δ 9.58 (s, 1H), 9.02 (d, J = 8.3 
Hz, 1H), 8.95 (d, J = 8.3 Hz, 1H), 8.00 (d, J = 8.2 Hz, 1H), 7.93 (m, 2H), 
7.87 (d, J = 8.2 Hz, 2H), 7.68-7.85 (m, 5H), 7.66 (s, 1H), 7.60-7.64 (m, 4H), 7.53-7.58 (m, 
4H), 6.26 (d, J = 4.5 Hz, 1H), 5.84 (s, 1H), 1.88 (bs, 1H), 1.77 (d, J = 4.6 Hz, 1H); 13C NMR 
(100 MHz, CDCl3) δ 130.8, 129.6, 129.4, 129.3, 129.2, 128.7, 128.6, 128.1, 128.0, 127.3, 
126.9, 126.8, 126.7, 126.0, 125.5, 124.5, 124.3, 124.1, 123.0, 122.7, 121.9, 116.2, 75.5, 74.1; 
IR (KBr) νmax 3580, 3426, 3055, 2951, 1608, 1498, 1464, 1441, 1423, 1331, 1176, 1067, 
1029, 766, 742, 714 cm-1; HRMS (m/z) for C40H26O2Na (M + Na) calcd: 561.18250, found: 
561.18267; Rf (2/1 hexanes/EtOAc) = 0.30 (silica gel plate). 
 
8,9-Bis(4-(trifluoromethyl)phenyl)-7,10-dihydrobenzo[c]benzo[6,7]indeno[1,2-g] 
fluorene-7,10-diol (39c). With 38c (100 mg, 0.15 mmol) following the 
general procedure C. Column chromatography (2/1/1 
hexanes/EtOAc/CH2Cl2) yielded 93 mg (94%) of the title compound as 
diastereoisomers as a light brown solid: mp (decomp) 189-194 °C; 1H 
NMR (400 MHz, CDCl3) δ 7.92 (m, 2H), 7.84 (d, J = 8.2 Hz, 2H), 7.67-
7.79 (m, 4H), 7.57 (m, 4H), 7.48 (m, 2H), 7.40 (m, 2H), 7.21 (m, 2H), 6.65 (m, 1H), 6.56 (m, 
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1H), 5.73 (s, 2H), 1.96 (s, 1H), 1.59 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 149.0, 145.1, 
144.2, 143.9, 142.0, 141.0, 137.4, 136.1, 135.4, 134.4, 134.1, 131.6, 130.1, 130.0, 129.7, 
129.4, 129.2, 128.2, 128.1, 127.5, 127.2, 126.9, 125.9, 125.3 (q, 2JC-F = 4.7 Hz), 124.7, 124.6, 
124.0, 122.6, 122.1, 121.8, 119.6-126.5 (q, 1JC-F = 305.7 Hz), 116.6, 75.5, 74.2; IR (KBr) νmax 
3478, 3053, 3018, 2929, 2846, 1626, 1598, 1446, 1301, 1270, 1232, 1177, 1049, 1028, 990, 
824, 769, 696 cm-1; HRMS (m/z) for C42H24O2F6Na (M + Na) calcd: 697.15727, found: 
697.15750; Rf (2/1 hexanes/EtOAc) = 0.38 (silica gel plate).  
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6.3.3.  Synthesis of Dispiroindeno[2,1-c]fluorenes 23, 29, 34 and 41 
 
D:  General procedure for Oxidation reaction with PCC (preparation of 22, 28, 33 
and 40). To a solution of pyridinium chlorochromate (PCC, 64 mg, 0.3 mmol) and celite (64 
mg) in anhydrous CH2Cl2 (10 mL) the starting indeno[2,1-c]fluorene-5,8-diol (0.2 mmol) was 
added and the mixture was stirred for 3h at rt. Afterwards the residue was filtered through a 
celite/silica gel plug. Column chromatography of the residue on silica gel yielded products. 
 
6,7-Bis(4-methoxyphenyl)indeno[2,1-c]fluorene-5,8-dione (22a). With 21a (230 mg, 0.46 
mmol) following the general procedure D. Column chromatography (2/1/1 
hexanes/EtOAc/CH2Cl2) yielded 210 mg (94%) of the title compound as a 
bright yellow solid: mp (decomp) 245-250 °C; 1H NMR (400 MHz, 
CDCl3) δ 8.21 (d, J = 7.7 Hz, 2H), 7.69 (dd, J = 7.3, 0.6 Hz, 2H), 7.66 (dt, 
J = 7.6, 1.3 Hz, 2H), 7.41 (dt, J = 7.5, 0.6 Hz, 2H), 6.90 (m, 4H), 6.77 (m, 
4H), 3.79 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 191.8, 158.8, 143.3, 142.7, 138.0, 136.2, 
135.5, 134.8, 130.9, 129.6, 127.2, 124.8, 123.7, 113.0, 55.1; IR (KBr) νmax 3073, 3046, 3007, 
2959, 2837, 1714, 1609, 1517, 1466, 1426, 1302, 1288, 1246, 1200, 1179, 1030, 941, 835, 
754, 721, cm-1; HRMS (m/z) for C34H23O4 (M + H) calcd: 495.15909, found: 495.15921; Rf 
(2/1 hexanes/EtOAc) = 0.47 (silica gel plate). 
 
6,7-Di-p-tolylindeno[2,1-c]fluorene-5,8-dione (22b). With 21b (140 mg, 0.3 mmol) 
following the general procedure D. Column chromatography (2/1/1 
hexanes/EtOAc/ CH2Cl2) yielded 125 mg (90%) of the title compound as a 
bright yellow solid: mp (decomp) 167-172 °C; 1H NMR (400 MHz, CDCl3) δ 
8.21 (d, J = 7.7 Hz, 2H), 7.68 (dd, J = 7.3, 0.5 Hz, 2H), 7.65 (dt, J = 7.6, 1.3 
Hz, 2H), 7.41 (dt, J = 7.5, 0.6 Hz, 2H), 7.02 (d, J = 7.8 Hz, 4H), 6.88 (m, 4H), 
2.31 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 191.7, 143.4, 142.7, 138.0, 136.9, 136.2, 135.4, 
134.8, 132.0, 129.6, 129.3, 128.2, 124.8, 123.7, 21.4; IR (KBr) νmax 3069, 3043, 3010, 2919, 
2863, 1734, 1711, 1605, 1578, 1517, 1465, 1423, 1377, 1304, 1237, 1193, 1096, 1069, 1022, 
931, 851, 826, 765, 753, 722, 665 cm-1; HRMS (m/z) for C34H23O2 (M + H) calcd: 463.16926, 
found: 463.16927; Rf (2/1 hexanes/EtOAc) = 0.41 (silica gel plate). 
 
 
180 
 
6,7-Diphenylindeno[2,1-c]fluorene-5,8-dione (22c). With 21c (285 mg, 0.65 mmol) 
following the general procedure D. Column chromatography (2/1/1 
hexanes/EtOAc/CH2Cl2) yielded 257 mg (92%) of the title compound as a 
bright yellow solid: mp (decomp) >260 °C; 1H NMR (400 MHz, CDCl3) δ 
8.20 (d, J = 7.7 Hz, 2H), 7.69 (d, J = 7.3 Hz, 2H), 7.65 (dt, J = 7.6, 1.2 Hz, 
2H), 7.41 (dt, J = 7.5, 0.6 Hz, 2H), 7.20-7.22 (m, 6H), 6.99-7.02 (m, 4H); 13C NMR (100 
MHz, CDCl3) δ 191.6, 143.0, 142.7, 138.1, 136.1, 135.3, 135.0, 134.8, 129.7, 129.4, 127.4, 
127.3, 124.8, 123.8; IR (KBr) νmax 3055, 2921, 1711, 1607, 1571, 1466, 1417, 1379, 1302, 
1198, 1076, 1027, 936, 830, 765, 752, 716, 702 cm-1; HRMS (m/z) for C32H19O2 (M + H) 
calcd: 435.13796, found: 435.13789; Rf (2/1 hexanes/EtOAc) = 0.36 (silica gel plate). 
 
6,7-Bis(4-bromophenyl)indeno[2,1-c]fluorene-5,8-dione (22d). With 21d (297 mg, 0.5 
mmol) following the general procedure D. Column chromatography (2/1/1 
hexanes/EtOAc/ CH2Cl2) yielded 285 mg (96%) of the title compound as a 
bright yellow solid: mp (decomp) >260 °C; 1H NMR (400 MHz, CDCl3) δ 
8.22 (m, 2H), 7.70 (d, J = 7.5 Hz, 2H), 7.68 (dt, J = 7.6, 1.2 Hz, 2H), 7.32-
7.37 (m, 4H), 7.25 (m, 2H), 6.98 (m, 2H), 6.84 (m, 2H); 13C NMR (100 MHz, 
CDCl3) δ 191.4, 142.5, 141.3, 138.6, 136.3, 135.2, 135.1, 133.6, 131.1, 130.9, 130.0, 127.6, 
125.0, 123.9, 122.0; IR (KBr) νmax 3055, 3041, 3010, 1712, 1606, 1580, 1492, 1466, 1423, 
1393, 1298, 1238, 1196, 1099, 1074, 1012, 933, 835, 756, 719 cm-1; HRMS (m/z) for 
C32H17O2Br2 (M + H) calcd: 590.95898, found: 590.95892; Rf (2/1 hexanes/EtOAc) = 0.40 
(silica gel plate). 
 
6,7-Bis(4-(trifluoromethyl)phenyl)indeno[2,1-c]fluorene-5,8-dione (22e). With 21e (400 
mg, 0.7 mmol) following the general procedure D. Column chromatography 
(2/1/1 hexanes/EtOAc/CH2Cl2) yielded 363 mg (91%) of the title 
compound as a bright yellow solid: mp (decomp) >260 °C; 1H NMR (400 
MHz, CDCl3) δ 8.23 (d, J = 7.7 Hz, 2H), 7.72 (d, J = 7.3 Hz, 2H), 7.70 (dt, 
J = 7.6, 1.3 Hz, 2H), 7.48 (d, J = 8.0 Hz, 4H), 7.46 (dt, J = 7.3, 0.5 Hz, 2H), 
7.11 (d, J = 8.0 Hz, 4H); 13C NMR (100 MHz, CDCl3) δ 191.3, 142.5, 140.8, 138.8, 138.5, 
136.3, 135.2, 135.1, 130.1, 129.9, 122.6-129.6 (q, 1JC-F = 272.1 Hz) 125.33, 125.05, 124.6 (q, 
2JC-F = 3.8 Hz), 124.0; IR (KBr) νmax 3067, 3040, 2922, 1712, 1606, 1467, 1409, 1328, 1171, 
1127, 1111, 1067, 1020, 935, 850, 758, 721 cm-1; HRMS (m/z) for C34H17O2F6 (M + H) calcd: 
571.11273 found: 571.11255; Rf (2/1 hexanes/EtOAc) = 0.34 (silica gel plate). 
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6,7-Di(thiophen-3-yl)indeno[2,1-c]fluorene-5,8-dione (22f). With 21f (315 mg, 0.7 mmol) 
following the general procedure D. Column chromatography (2/1/1 
hexanes/EtOAc/CH2Cl2) yielded 284 mg (91%) of the title compound as a 
light orange solid: mp (decomp) >260 °C; 1H NMR (400 MHz, CDCl3) δ 8.18 
(d, J = 7.7 Hz, 2H), 7.71 (dd, J = 7.3, 0.5 Hz, 2H), 7.65 (dt, J = 7.6, 1.2 Hz, 
2H), 7.42 (d, J = 7.4 Hz, 2H), 7.22 (dd, J = 4.9, 2.9 Hz, 2H), 6.90 (dd, J = 2.9, 1.2 Hz, 2H) 
6.78 (dd, J = 4.9, 1.2 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 191.4, 142.6, 138.5, 138.2, 
136.5, 135.3, 134.9, 134.5, 129.7, 129.0, 124.8, 124.7, 124.1, 123.8; IR (KBr) νmax 3114, 
3085, 3049, 3013, 1709, 1607, 1583, 1465, 1437, 1349, 1314, 1275, 1204, 1189, 1071, 953, 
832, 808, 763, 745, 718, 663 cm-1; HRMS (m/z) for C28H15O2S2 (M + H) calcd: 447.05080 
found: 447.05076; Rf (2/1 hexanes/EtOAc) = 0.34 (silica gel plate). 
 
6,7-Dipropylindeno[2,1-c]fluorene-5,8-dione (22g). With 21g (130 mg, 0.35 mmol) 
following the general procedure D. Column chromatography (2/1/1 
hexanes/EtOAc/CH2Cl2) yielded 124 mg (96%) of the title compound as a 
bright yellow solid: mp (decomp) 181-186 °C; 1H NMR (400 MHz, CDCl3) δ 
8.07 (d, J = 7.7 Hz, 2H), 7.74 (d, J = 7.4 Hz, 2H), 7.59 (dt, J = 7.6, 1.1 Hz, 
2H), 7.38 (t, J = 7.4 Hz, 2H), 3.12 (m, 4H), 1.54 (m, 4H), 0.99 (t, J = 7.3 Hz, 
6H); 13C NMR (100 MHz, CDCl3) δ 194.6, 146.0, 143.0, 140.1, 135.9, 135.4, 134.7, 129.1, 
124.5, 123.5, 28.4, 24.4, 14.6; IR (KBr) νmax 3082, 3052, 2970, 2926, 2868, 1701, 1608, 1588, 
1466, 1419, 1313, 1293, 1253, 1209, 1157, 1113, 1086, 1016, 960, 923, 837, 756, 719 cm-1; 
HRMS (m/z) for C26H22O2 (M+) calcd: 366.1620, found: 366.1625; Rf (2/1 hexanes/EtOAc) = 
0.51 (silica gel plate).  
 
6-(Trimethylsilyl)indeno[2,1-c]fluorene-5,8-dione (22h). With 21h (59 mg, 0.16 mmol) 
following the general procedure D. Column chromatography (2/1/1 
hexanes/EtOAc/CH2Cl2) yielded 47 mg (83%) of the title compound as a 
bright yellow solid: mp (decomp) 260 °C; 1H NMR (400 MHz, CDCl3) δ 8.08 
(m, 2H), 7.82 (s, 1H), 7.78 (ddd, J = 7.4, 1.2, 0.6 Hz, 2H), 7.63 (m, 2H), 7.41 
(ddt, J = 7.5, 2.0, 0.8 Hz, 2H), 0.41 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 193.9, 192.9, 
145.6, 143.7, 143.6, 142.6, 139.1, 139.0, 138.3, 135.1, 135.0, 134.9, 134.7, 130.8, 129.7, 
129.5, 125.0, 124.7, 124.2, 123.9, -1.30; IR (KBr) ν
 max 3082, 3005, 2953, 2896, 1714, 1611, 
1580, 1471, 1413, 1323, 1246, 1207, 1096, 1084, 975, 929, 867, 843, 824, 758, 716 cm-1; 
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HRMS (m/z) for C23H19O2Si (M + H) calcd: 355.11488, found: 355.11493; Rf (2/1 
hexanes/EtOAc) = 0.48 (silica gel plate). 
 
6,7-Di(naphthalen-1-yl)indeno[2,1-c]fluorene-5,8-dione (22i). With 21i (271 mg, 0.50 
mmol) following the general procedure D. Column chromatography 
(2/1/1 hexanes/EtOAc/CH2Cl2) yielded 258 mg (96%) of the title 
compound as a bright yellow solid: mp (decomp) >260 °C; 1H NMR (400 
MHz, CDCl3) δ 8.32 (d, J = 7.7 Hz, 2H), 7.76 (dd, J = 7.7, 1.6 Hz, 2H), 
7.76 (dt, J = 7.6, 1.2 Hz, 2H), 7.55-7-67 (m, 6H), 7.37-7.45 (m, 4H), 7.29 
(t, J = 7.1 Hz, 1H), 7.23 (dd, J = 7.1, 1.2 Hz, 1H), 7.16 (dt, J = 8.1, 1.1 Hz, 1H), 7.04 (m, 1H), 
6.97 (dd, J = 8.2, 7.1 Hz, 1H), 6.84 (dd, J = 7.1, 1.1 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 
191.0, 142.90, 142.85, 141.9, 141.8, 138.5, 137.73, 137.71, 135.30, 135.25, 134.9, 133.4, 
132.9, 132.8, 132.7, 132.5, 131.6, 129.8, 128.4, 128.0, 127.9, 127.8, 127.5, 125.9, 125.4, 
125.3, 125.24, 125.21, 125.0, 124.7, 124.2, 123.98, 123.95; IR (KBr) νmax 3052, 2919, 1712, 
1608, 1507, 1467, 1375, 1317, 1296, 1202, 1003, 935, 799, 778, 759, 718 cm-1; HRMS (m/z) 
for C40H23O2 (M + H) calcd: 535.16926, found: 535.16938; Rf (2/1 hexanes/EtOAc) = 0.39 
(silica gel plate). 
 
6-(4-Methoxyphenyl)-7-(4-(trifluoromethyl)phenyl)indeno[2,1-c]fluorene-5,8-dione (28). 
With 27 (188 mg, 0.35 mmol) following the general procedure D. Column 
chromatography (2/1/1 hexanes/EtOAc/CH2Cl2) yielded 149 mg (80%) of 
the title compound as a bright yellow solid: mp (decomp) >260 °C; 1H 
NMR (400 MHz, CDCl3) δ 8.19 (d, J = 7.7 Hz, 2H), 7.63-7.72 (m, 4H), 
7.47 (d, J = 8.0 Hz, 2H), 7.43 (dt, J = 7.5, 0.7 Hz, 1H), 7.41 (dt, J = 7.5, 0.7 
Hz, 1H), 7.13 (d, J = 7.9 Hz, 2H), 6.87 (m, 2H), 6.73 (m, 2H), 3.78 (s, 3H); 13C NMR (100 
MHz, CDCl3) δ 191.6, 191.5, 159.0, 142.7, 142.6, 142.4, 141.5, 139.1, 138.8, 137.9, 136.4, 
136.1, 135.3, 135.1, 135.0, 125.6-136.2 (q, 1JC-F = 366.4 Hz), 134.9, 130.8, 130.0, 129.9, 
129.8, 129.1, 126.4, 124.9, 124.4 (q, 2JC-F = 3.8 Hz), 123.9, 123.8, 113.1, 55.1; IR (KBr) νmax 
3073, 3004, 2952, 2952, 2905, 2836, 1712, 1608, 1514, 1467, 1425, 1325, 1302, 1247, 1166, 
1121, 1074, 1035, 1020, 932, 837, 757, 719 cm-1; HRMS (m/z) for C34H20O3F3 (M + H) calcd: 
533.13591, found: 533.13596; Rf (2/1 hexanes/EtOAc) = 0.38 (silica gel plate). 
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3-Methoxy-6,7-di-p-tolyl-10-(trifluoromethyl)indeno[2,1-c]fluorene-5,8-dione (33). With 
32 (188 mg, 0.35 mmol) following the general procedure D. Column 
chromatography (2/1/1 hexanes/EtOAc/CH2Cl2) yielded 68 mg (87%) 
of the title compound as a bright yellow solid: mp (decomp) 109-114 
°C; 1H NMR (400 MHz, CDCl3) δ 8.26 (d, J = 8.5 Hz, 1H), 8.03 (d, J 
= 8.4 Hz, 1H), 7.91 (m, 2H), 7.21 (d, J = 2.6 Hz, 1H), 7.14 (dd, J = 
8.4, 2.6 Hz, 1H), 7.04 (dd, J = 7.8, 1.8 Hz, 4H), 6.90 (dd, J = 8.1, 1.8 Hz, 4H), 3.88 (s, 3H), 
2.34 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 191.2, 190.2, 161.2, 145.8, 144.3, 143.0, 139.2, 
137.5, 137.1, 137.0, 136.7, 136.1, 135.6, 135.2, 134.6, 131.7, 131.6, 131.5, 131.4, 129.3, 
129.2, 128.3, 128.2, 124.8, 123.5, 121.4 (q, 2JC-F = 3.8 Hz), 120.6, 119.4-127.5 (q, 1JC-F = 
272.5 Hz), 109.5, 55.7, 21.4; IR (KBr) νmax 3022, 3001, 2924, 2869, 1713, 1622, 1608, 1487, 
1434, 1329, 1302, 1246, 1169, 1130, 1071, 1021, 914, 835, 791, 754 cm-1; HRMS (m/z) for 
C36H24O3F3 (M + H) calcd: 561.16721, found: 561.16724; Rf (2/1 hexanes/EtOAc) = 0.54 
(silica gel plate). 
 
8,9-Bis(4-methoxyphenyl)benzo[c]benzo[6,7]indeno[1,2-g]fluorene-7,10-dione (40a). 
With 39a (272 mg, 0.45 mmol) following the general procedure D. 
Column chromatography (2/1/1 hexanes/EtOAc/CH2Cl2) yielded 229 mg 
(86%) of the title compound as a red solid: mp (decomp) >260 °C; 1H 
NMR (400 MHz, CDCl3) δ 7.91 (d, J = 8.2 Hz, 2H), 7.84 (d, J = 8.3 Hz, 
2H), 7.81 (d, J = 8.2 Hz, 2H), 7.32 (m, 2H), 7.28 (d, J = 9.4 Hz, 2H), 7.14 
(d, J = 8.5 Hz, 2H), 6.87 (d, J = 7.9 Hz, 2H), 6.84 (d, J = 7.7 Hz, 2H), 
6.67 (ddd, J = 8.2, 6.9, 1.0 Hz, 2H), 3.81 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 191.4, 
158.9, 145.2, 142.3, 138.5, 137.8, 137.2, 134.2, 131.7, 130.8, 128.7, 128.6, 128.4, 127.0, 
126.7, 125.7, 119.7, 113,1, 55.1; IR (KBr) νmax 3052, 2930, 2833, 1704, 1609, 1516, 1441, 
1291, 1249, 1178, 1109, 1035, 901, 835, 800, 777 cm-1; HRMS (m/z) for C42H27O4 (M + H) 
calcd: 595.19039, found: 595.19049; Rf (2/1 hexanes/EtOAc) = 0.32 (silica gel plate). 
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8,9-Diphenylbenzo[c]benzo[6,7]indeno[1,2-g]fluorene-7,10-dione (40b). With 39b (103 
mg, 0.19 mmol) following the general procedure D. Column 
chromatography (2/1/1 hexanes/EtOAc/CH2Cl2) yielded 96 mg (95%) of the 
title compound as a red solid: mp (decomp) >260 °C; 1H NMR (400 MHz, 
CDCl3) δ 7.92 (d, J = 8.1 Hz, 2H), 7.85 (d, J = 8.3 Hz, 2H), 7.81 (d, J = 8.2 
Hz, 2H), 7.68 (m, 1H), 7.57 (m, 1H), 7.33 (ddd, J = 8.1, 6.8, 1.1 Hz, 2H), 
7.30 (m, 2H), 7.21-7.28 (m, 6H), 7.00 (d, J = 6.9 Hz, 2H), 6.69 (ddd, J = 8.3, 7.8, 1.2 Hz, 
2H); 13C NMR (100 MHz, CDCl3) δ 191.2, 145.1, 142.1, 138.7, 137.7, 137.2, 134.8, 134.1, 
130.9, 130.2, 130.1, 129.9, 129.6, 129.2, 128.9, 128.7, 128.6, 128.4, 128.3, 128.1, 128.0, 
127.9, 127.8, 127.7, 127.5, 127.4, 127.3, 127.1, 126.6, 125.7, 125.5, 125.0, 123.4, 119.9, 
119.7, 117.0; IR (KBr) νmax 3054, 2919, 1710, 1617, 1570, 1464, 1419, 1375, 1304, 1197, 
1074, 1025, 936, 830, 766, 752, 716, 701  cm-1; HRMS (m/z) for C40H23O2 (M + H) calcd: 
535.16926, found: 535.16935; Rf (2/1 hexanes/EtOAc) = 0.40(silica gel plate). 
 
8,9-Bis(4-(trifluoromethyl)phenyl)benzo[c]benzo[6,7]indeno[1,2-g]fluorene-7,10-dione 
(40c). With 39c (93 mg, 0.14 mmol) following the general procedure D. 
Column chromatography (2/1/1 hexanes/EtOAc/CH2Cl2) yielded 85 mg 
(92%) of the title compound as a red solid: mp (decomp) >260 °C; 1H NMR 
(400 MHz, CDCl3) δ 7.95 (d, J = 8.1 Hz, 2H), 7.87 (d, J = 8.3 Hz, 2H), 7.81 
(d, J = 8.2 Hz, 2H), 7.53 (d, J = 6.9 Hz, 2H), 7.49 (d, J = 8.2 Hz, 2H), 7.37 
(ddd, J = 8.1, 6.9, 1.1 Hz, 2H), 7.30 (m, 4H), 7.12 (d, J = 8.0 Hz, 2H), 6.67 
(ddd, J = 8.3, 6.9, 1.2 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 190.8, 145.0, 139.7, 139.2, 
138.2, 138.0, 137.4, 133.9, 131.4, 130.6, 130.2, 130.01, 129.96, 129.7, 129.6, 129.0, 128.9, 
128.5, 128.4, 126.6, 126.0, 117.5-125.5 (q, 1JC-F = 236.3 Hz), 125.4, 124.7 (q, 2JC-F = 3.5 Hz), 
119.7; IR (KBr) νmax 3072, 3041, 2920, 1711, 1605, 1469, 1404, 1329, 1170, 1127, 1067, 
1019, 934, 855, 757, 721 cm-1 HRMS (m/z) for C42H21O2F6 (M + H) calcd: 671.14403, found: 
671.14394; Rf (2/1 hexanes/EtOAc) = 0.42 (silica gel plate). 
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E:  General procedure for creation of dispiroindeno[2,1-c]fluorenes (preparation of 
23, 29, 34 and 41).46 A solution of 2-bromobiphenyl (40 µL, 0.23 mmol) in anhydrous THF 
(3 mL) was cooled down to -78 °C and n-BuLi 1.6 M (140 µL, 0.23 mmol) was added 
dropwise. The resulted solution was stirred for 30 min, followed by the addition of fluorenone 
(0.07 mmol) in THF (3 mL) and stirred for 3h first for 15 min at -78 °C, but during time it 
was allowed to reach ambient temperature. The reaction mixture was poured in a saturated 
solution of NaHCO3 solution and extracted with diethyl ether (3 x 15 mL). The combined 
organic fractions were dried over MgSO4 and concentrated under reduced pressure. The crude 
was purified by column chromatography on silica gel (10/1 hexanes/EtOAc) to yield desired 
alcohols. The alcohols were dissolved in acetic acid (10 mL) with a catalytic amount of HCl 
(12 mol/L) and the resulted solution stirred under reflux for 3 h. The reaction mixture was 
neutralized with H2O and K2CO3 and extracted with diethyl ether (3 x 15 mL). Column 
chromatography of the residue on silica gel provided products. 
 
6',7'-bis(4-methoxyphenyl)dispirofluorene-9,5'-indeno[2,1-c]fluorene-8',9''-fluorene 
(23a). With 22a (98 mg, 0.20 mmol) following the general procedure E. 
Column chromatography of the residue on silica gel (5/1/1 
hexanes/EtOAc/CH2Cl2) provided 87 mg (57%) of the title compound as 
a colorless solid: mp (decomp) >260 °C; 1H NMR (400 MHz, CDCl3) δ 
8.76 (d, J = 7.9 Hz, 2H), 7.48 (dt, J = 7.9, 1.2 Hz, 2H), 7.31 (d, J = 7.4 
Hz, 4H), 7.15 (dt, J = 7.4, 1.1 Hz, 4H), 7.13 (dt, J = 7.5, 0.9 Hz, 2H), 7.06 (dt, J = 7.5, 1.2 Hz, 
4H), 6.91 (d, J = 7.4 Hz, 4H), 6.59 (dd, J = 7.6, 0.6 Hz, 2H), 5.73 (m, 4H), 5.57 (m, 4H), 3.48 
(s, 6H); 13C NMR (100 MHz, CDCl3) δ 156.2, 150.5, 148.9, 147.1, 142.0, 141.4, 139.6, 136.4, 
130.5, 128.8, 127.5, 127.1, 127.0, 126.9, 124.0, 123.7, 123.4, 119.7, 111.1, 66.2, 54.9; IR 
(KBr) νmax 3040, 2953, 2931, 2827, 1612, 1516, 1465, 1447, 1418, 1283, 1243, 1174, 1106, 
1036, 833, 765, 754, 740, 732 cm-1; HRMS (m/z) for C58H38O2 (M + H) calcd: 767.29446, 
found: 767.29447; Rf (1/1 hexanes/EtOAc) = 0.66 (silica gel plate). 
 
6',7'-Di-p-tolyldispirofluorene-9,5'-indeno[2,1-c]fluorene-8',9''-fluorene (23b). With 22b 
(116 mg, 0.25 mmol) following the general procedure E. Column 
chromatography of the residue on silica gel (5/1/1 
hexanes/EtOAc/CH2Cl2) provided 99 mg (56%) of the title compound as 
a colorless solid: mp (decomp) >260 °C; 1H NMR (400 MHz, CDCl3) δ 
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8.76 (d, J = 7.9 Hz, 2H), 7.47 (dt, J = 7.8, 1.2 Hz, 2H), 7.25-7.27 (m, 4H), 7.15 (dt, J = 7.4, 
1.1 Hz, 4H), 7.12 (dt, J = 7.3, 0.9 Hz, 2H), 7.05 (dt, J = 7.5, 1.2 Hz, 4H), 6.90 (d, J = 7.5 Hz, 
4H), 6.58 (dd, J = 7.6, 0.6 Hz, 2H), 5.96 (d, J = 7.8 Hz, 4H), 5.55 (m, 4H), 1.88 (s, 6H); 13C 
NMR (100 MHz, CDCl3) δ 150.6, 148.9, 146.9, 142.0, 141.4, 139.7, 136.4, 133.3, 133.1, 
129.3, 127.5, 127.1, 127.0, 126.8, 126.0, 124.0, 123.8, 123.4, 119.5, 66.2, 20.9; IR (KBr) νmax 
3042, 2917, 2866, 1600, 1510, 1446, 1415, 1367, 1282, 1244, 1155, 1109, 1020, 826, 810, 
754, 741, 730 cm-1; HRMS (m/z) for C58H39 (M + H) calcd: 735.30463, found: 735.30470; Rf 
(2/1 hexanes/EtOAc) = 0.56 (silica gel plate).  
 
6',7'-Diphenyldispirofluorene-9,5'-indeno[2,1-c]fluorene-8',9''-fluorene (23c). With 22c 
(109 mg, 0.25 mmol) following the general procedure E. Column 
chromatography of the residue on silica gel (5/1/1 
hexanes/EtOAc/CH2Cl2) provided 108 mg (61%) of the title compound 
as a colorless solid: mp (decomp) >260 °C; 1H NMR (400 MHz, CDCl3) 
δ 8.78 (d, J = 7.9 Hz, 2H), 7.49 (dt, J = 7.8, 1.2 Hz, 2H), 7.24-7.27 (m, 4H), 7.14 (m, 6H), 
7.06 (dt, J = 7.5, 1.2 Hz, 4H), 6.93 (d, J = 7.2 Hz, 4H), 6.60 (dd, J = 7.6, 0.6 Hz, 2H), 6.42 
(m, 2H), 6.18 (m, 4H), 5.67 (dd, J = 8.2, 1.2 Hz, 4H); 13C NMR (100 MHz, CDCl3) δ 150.5, 
148.7, 146.4, 142.0, 141.3, 139.5, 136.6, 135.9, 129.6, 127.6, 127.2, 127.1, 126.9, 125.3, 
124.3, 124.1, 123.8, 123.4, 119.7, 66.2; IR (KBr) νmax 3058, 2953, 2927, 2866, 1601, 1463, 
1445, 1412, 1367, 1155, 1071, 1029, 823, 753, 741, 702 cm-1; HRMS (m/z) for C56H35 (M + 
H) calcd: 707.27333, found: 707.27344; Rf (2/1 hexanes/EtOAc) = 0.58 (silica gel plate). 
 
6',7'-Bis(4-bromophenyl)dispirofluorene-9,5'-indeno[2,1-c]fluorene-8',9''-fluorene (23d). 
With 22d (59 mg, 0.1 mmol) following the general procedure E. 
Column chromatography of the residue on silica gel (5/1/1 
hexanes/EtOAc/CH2Cl2) provided 58 mg (67%) of the title compound as 
a colorless solid: mp (decomp) >260 °C; 1H NMR (400 MHz, CDCl3) δ 
8.77 (d, J = 8.0 Hz, 2H), 7.50 (m, 2H), 7.34 (dd, J = 7.5, 0.7 Hz, 2H), 
7.25 (m, 2H), 7.21 (dt, J = 7.5, 1.0 Hz, 2H), 7.20 (dt, J = 7.4, 1.0 Hz, 2H), 7.13-7.18 (m, 2H), 
7.07 (t, J = 7.5 Hz, 4H), 6.91 (m, 4H), 6.62 (t, J = 7.6 Hz, 2H), 6.32 (m, 2H), 6.28 (m, 1H), 
6.21 (m, 1H), 5.66 (m, 2H), 5.53 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 150.5, 150.2, 148.6, 
148.5, 142.0, 141.9, 141.1, 131.1, 131.0, 129.6, 129.4, 128.6, 128.3, 127.8, 127.2, 127.0, 
125.5, 125.3, 124.5, 124.0, 123.7, 123.5, 119.8; IR (KBr) νmax 3041, 2932, 2839, 1601, 1485, 
1446, 1414, 1386, 1282, 1155, 1072, 1011, 833, 756, 747, 738 cm-1; HRMS (m/z) for 
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C56H32Br2 (M + H) calcd: 863.09435, found: 863.09459; Rf (2/1 hexanes/EtOAc) = 0.62 
(silica gel plate). 
 
6',7'-Bis(4-(trifluoromethyl)phenyl)dispirofluorene-9,5'-indeno[2,1-c]fluorene-8',9''-
fluorene (23e). With 22e (57 mg, 0.10 mmol) following the general 
procedure E. Column chromatography of the residue on silica gel (5/1/1 
hexanes/EtOAc/CH2Cl2) provided 69 mg (82%) of the title compound as 
a colorless solid: mp (decomp) >260 °C; 1H NMR (400 MHz, CDCl3) δ 
8.80 (d, J = 7.8 Hz, 2H), 7.53 (dt, J = 7.7, 1.1 Hz, 2H), 7.25 (d, J = 7.3 
Hz, 4H), 7.17-7.19 (m, 6H), 7.09 (dt, J = 7.5, 1.2 Hz, 4H), 6.94 (d, J = 7.5 Hz, 4H), 6.64 (dd, 
J = 7.6, 0.5 Hz, 2H), 6.46 (d, J = 8.0 Hz, 4H), 5.80 (d, J = 7.9 Hz, 4H); 13C NMR (100 MHz, 
CDCl3) δ 150.1, 148.1, 146.8, 141.9, 140.9, 139.3, 137.3, 137.2, 129.7, 122.0-129.1 (q, 1JC-F = 
271.9 Hz), 128.1, 127.4, 127.3, 124.2, 123.8, 123.6, 122.4 (q, 2JC-F = 3.8 Hz), 119.9, 66.0; IR 
(KBr) νmax 3064, 3023, 2932, 2839, 1617, 1448, 1404, 1328, 1168, 1121, 1109, 1065, 1020, 
850, 841, 756, 745, 736 cm-1; HRMS (m/z) for C58H33F6 (M + H) calcd: 843.24810, found: 
843.24886; Rf (2/1 hexanes/EtOAc) = 0.60 (silica gel plate). 
 
6',7'-Di(thiophen-3-yl)dispirofluorene-9,5'-indeno[2,1-c]fluorene-8',9''-fluorene (23f). 
With 22f (45 mg, 0.1 mmol) following the general procedure E. Column 
chromatography of the residue on silica gel (5/1/1 
hexanes/EtOAc/CH2Cl2) provided 38 mg (53%) of the title compound as 
a colorless solid: mp (decomp) >260 °C; 1H NMR (400 MHz, CDCl3) δ 
8.77 (d, J = 7.9 Hz, 2H), 7.50 (dt, J = 7.6, 1.0 Hz, 4H), 7.40 (m, 2H), 7.24 (m, 2H), 7.15 (t, J 
= 7.4 Hz, 4H), 6.85-7.03 (m, 8H), 6.63 (d, J = 7.3 Hz, 2H), 6.19 (s, 2H), 5.39 (m, 4H); 13C 
NMR (100 MHz, CDCl3) δ 150.4, 148.2, 147.3, 142.0, 141.2, 136.9, 136.1, 135.1, 128.7, 
127.8, 127.2, 127.1, 124.1, 123.5, 123.0, 122.5, 121.2, 119.8, 66.2; IR (KBr) νmax 3062, 2949, 
2871, 1598, 1464, 1447, 1349, 1281, 1225, 1154, 1069, 1005, 857, 803, 750, 739, 724, 390, 
368 cm-1; HRMS (m/z) for C52H31S2 (M + H) calcd: 719.18617, found: 719.18622; Rf (2/1 
hexanes/EtOAc) = 0.56 (silica gel plate). 
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6',7'-Dipropyldispirofluorene-9,5'-indeno[2,1-c]fluorene-8',9''-fluorene (23g). With 22g 
(37 mg, 0.1 mmol) following the general procedure E. Column 
chromatography of the residue on silica gel (5/1/1 
hexanes/EtOAc/CH2Cl2) provided 38 mg (59%) of the title compound as 
a colorless solid: mp (decomp) 218-223 °C; 1H NMR (400 MHz, 
CDCl3) δ 8.67 (d, J = 7.9 Hz, 2H), 7.87 (d, J = 7.6 Hz, 4H), 7.42 (dt, J = 7.9, 1.2 Hz, 2H), 
7.39 (dt, J = 7.5, 1.1 Hz, 4H), 7.15 (dt, J = 7.5, 1.1 Hz, 4H), 7.09 (dt, J = 7.6,0.8 Hz, 2H), 6.92 
(d, J = 7.6 Hz, 4H), 6.58 (dd, J = 7.6, 0.7 Hz, 2H), 1.65 (m, 4H), 0.45 (m, 4H), 0.21 (t, J = 7.1 
Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 150.3, 149.4, 146.7, 141.6, 141.4, 138.8, 135.7, 
127.8, 127.5, 127.1, 126.9, 124.2, 123.6, 123.0, 120.0, 66.6, 30.3, 23.8, 14.5; IR (KBr) νmax 
3063, 3034, 3016, 2958, 2926, 2868, 1595, 1577, 1466, 1447, 1413, 1373, 1281, 1153, 1084, 
1027, 752, 739 cm-1; HRMS (m/z) for C50H39 (M + H) calcd: 639.30463, found: 639.30476; Rf 
(2/1 hexanes/EtOAc) = 0.59 (silica gel plate). 
 
Dispirofluorene-9,5'-indeno[2,1-c]fluorene-8',9''-fluoren-6'-yltrimethylsilane (23h). With 
22h (42 mg, 0.12 mmol) following the general procedure E. Column 
chromatography of the residue on silica gel (5/1/1 
hexanes/EtOAc/CH2Cl2) provided 39 mg (52%) of the title compound as 
a colorless solid: mp (decomp) 254-259 °C; 1H NMR (400 MHz, 
CDCl3) δ 8.43 (d, J = 7.9 Hz, 1H), 8.32 (d, J = 7.6 Hz, 1H), 7.86 (d, J = 7.6 Hz, 2H), 7.74 (dd, 
J = 7.3, 0.5 Hz, 2H), 7.65 (dt, J = 7.6, 1.2 Hz, 2H), 7.44-7.52 (m, 4H), 7.37-7.42 (m, 4H), 
7.20 (dt, J = 7.5, 1.0 Hz, 2H), 7.14 (dt, J = 7.5, 1.0 Hz, 2H), 7.00 (m, 1H), 6.78 (m, 3H), 6.71 
(s, 1H), 0.18 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 155.6, 149.9, 148.4, 144.9, 141.7, 140.4, 
140.2, 138.4, 134.7, 134.5, 130.1, 128.81, 128.75, 128.0, 127.9, 127.8, 124.5, 124.3, 124.1, 
123.9, 123.6, 120.2, -1.1; IR (KBr) νmax 3065, 2956, 2930, 2861, 1604, 1549, 1465, 1449, 
1413, 1347, 1285, 1245, 1151, 1081, 982, 932, 868, 842, 755, 734, 705 cm-1; HRMS (m/z) for 
C473H35Si (M + H) calcd: 626.24235, found: 626.24239; Rf (2/1 hexanes/EtOAc) = 0.64 (silica 
gel plate). 
 
 
 
 
 
TMS
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6',7'-Di(naphthalen-1-yl)dispiro[fluorene-9,5'-indeno[2,1-c]fluorene-8',9''-fluorene] 
(23i). With 22i (134 mg, 0.25 mmol) following the general procedure E. 
Column chromatography of the residue on silica gel (10/1/1 
hexanes/EtOAc/CH2Cl2) provided 109 mg (54%) of the title compound 
as a colorless solid: mp (decomp) >260 °C; Due to lack of solubility in 
commom deuterated solvents only weak signals for 1H and 13C NMR 
were detectable: 1H NMR (400 MHz, CDCl3) δ 8.85 (d, J = 7.9 Hz, 2H), 7.52 (dt, J = 7.9, 0.6 
Hz, 2H), 7.06-7.23 (m, 12H), 6.85-6.93 (m, 6H), 6.80 (d, J = 7.7 Hz, 4H), 6.67 (d, J = 7.6 Hz, 
2H), 6.58 (d, J = 7.5 Hz, 2H), 6.52 (dt, J = 7.5, 0.7 Hz, 2H), 6.38 (dt, J = 7.5, 1.0 Hz, 2H), 
6.02 (t, J = 7.4 Hz, 2H), 5.59 (d, J = 6.8 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 150.7, 
149.8, 147.6, 145.6, 142.3, 141.3, 140.7, 137.4, 137.4, 132.9, 131.6, 131.4, 127.8, 127.3, 
127.2, 127.1, 127.0, 126.7, 126.5, 126.2, 125.9, 124.1, 123.8, 123.7, 123.5, 123.0, 119.9, 
118.4, 76.79, 66.3, 60.3; IR (KBr) νmax 3059, 3038, 3010, 2959, 1601, 1508, 1447, 1379, 
1364, 1282, 1158, 1030, 1005, 943, 800, 778, 752, 739, 727 cm-1; HRMS (m/z) for C64H39 (M 
+ H) calcd: 807.30463, found: 807.30505; Rf (2/1 hexanes/EtOAc) = 0.65 (silica gel plate). 
 
6'-(4-Methoxyphenyl)-7'-(4-(trifluoromethyl)phenyl)dispirofluorene-9,5'-indeno[2,1-c]-
fluorene-8',9''-fluorene (29). With 28 (53 mg, 0.10 mmol) following 
the general procedure E. Column chromatography of the residue on 
silica gel (5/1/1 hexanes/EtOAc/CH2Cl2) provided 69 mg (82%) of the 
title compound as a colorless solid: mp (decomp) >260 °C; 1H NMR 
(400 MHz, CDCl3) δ 8.78 (d, J = 7.9 Hz, 2H), 7.51 (t, J = 7.7 Hz, 2H), 
7.32 (d, J = 7.6 Hz, 2H), 7.25 (d, J = 6.4 Hz, 2H), 7.14-7.20 (m, 6H), 7.08 (t, J = 7.5 Hz, 4H), 
6.92 (d, J = 7.6 Hz, 4H), 6.62 (d, J = 7.6 Hz, 2H), 6.44 (d, J = 7.9 Hz, 2H), 5.81 (d, J = 7.9 
Hz, 2H), 5.75 (d, J = 8.3 Hz, 2H) 5.58 (d, J = 8.3 Hz, 2H) 3.48 (s, 3H); 13C NMR (100 MHz, 
CDCl3) δ 156.5, 150.5, 150.1, 148.6, 148.4, 147.4, 146.5, 142.0, 141.9, 141.2, 140.0, 138.6, 
138.3, 137.0, 136.7, 130.4, 129.8, 128.0, 127.82, 127.80, 127.31, 127.28, 127.2, 127.12, 
127.07, 124.1, 123.8, 123.5-131.7 (q, 1JC-F = 271.9 Hz), 123.7, 123.53, 123.49, 122.2 (q, 2JC-F 
= 3.8 Hz), 119.8, 119.7, 111.3, 66.2, 66.0, 54.9; IR (KBr) νmax 3062, 3037, 2951, 2831, 1614, 
1510, 1465, 1448, 1418, 1323, 1244, 1165, 1119, 1107, 1070, 1019, 846, 829, 756, 738 cm-1; 
HRMS (m/z) for C58H36OF3 (M + H) calcd: 805.27128, found: 805.27179; Rf (2/1 
hexanes/EtOAc) = 0.64 (silica gel plate). 
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3'-Methoxy-6',7'-di-p-tolyl-10'-(trifluoromethyl)dispirofluorene-9,5'-indeno[2,1-c] 
fluorene-8',9''-fluorene (34). With 33 (30 mg, 0.05 mmol) following 
the general procedure E. Column chromatography of the residue on 
silica gel (5/1/1 hexanes/EtOAc/CH2Cl2) provided 35 mg (84%) of the 
title compound as a colorless solid: mp (decomp) >260 °C; 1H NMR 
(400 MHz, CDCl3) δ 8.79 (d, J = 8.3 Hz, 1H), 8.58 (d, J = 8.7 Hz, 
1H), 7.71 (dd, J = 8.2, 0.9 Hz, 1H), 7.25 (m, 5H), 7.13-7.19 (m, 4H), 7.06 (m, 4H), 6.90 (d, J 
= 7.7 Hz, 2H), 6.88 (d, J = 7.7 Hz, 2H), 6.79 (s, 1H), 6.10 (d, J = 2.5 Hz, 1H), 5.96 (d, J = 7.9 
Hz, 4H), 5.52 (dd, J = 8.0, 2.5 Hz, 4H), 3.64 (s, 3H), 1.88 (s, 6H); 13C NMR (100 MHz, 
CDCl3) δ 159.5, 152.9, 151.0, 148.7, 147.8, 147.5, 147.0, 145.1, 142.1, 142.0, 137.0-141.7 (q, 
1JC-F = 267.7 Hz), 133.8, 133.7, 133.4, 132.8, 132.7, 129.2, 129.1, 127.1, 127.0, 126.9, 126.0, 
125.9, 124.5, 124.1, 123.8, 123.7, 123.6, 123.0, 120.8 (q, 2JC-F = 3.2 Hz), 119.7, 119.5, 113.2, 
109.3, 66.2, 66.1, 55.4, 29.7, 20.9; IR (KBr) νmax 3067, 3039, 3018, 2920, 2834, 1605, 1518, 
1481, 1447, 1369, 1329, 1266, 1242, 1166, 1126, 1078, 1033, 814, 740, 729 cm-1; HRMS 
(m/z) for C60H39OF3 (M + Na) calcd: 855.28452, found: 855.28494; Rf (2/1 hexanes/EtOAc) = 
0.68 (silica gel plate). 
 
8',9'-Bis(4-methoxyphenyl)dispiro[fluorene-9,7'-benzo[c]benzo[6,7]indeno[1,2-g]-
fluorene-10',9''-fluorene] (41a). With 40a (59 mg, 0.1 mmol) 
following the general procedure E. Column chromatography of the 
residue on silica gel (5/1/1 hexanes/EtOAc/CH2Cl2) provided 67 mg 
(78%) of the title compound as a slight orange solid: mp (decomp) >260 
°C; 1H NMR (400 MHz, CDCl3) δ 7.87 (d, J = 8.5 Hz, 2H), 7.80 (d, J = 
8.1 Hz, 2H), 7.63 (d, J = 8.3 Hz, 2H), 7.52 (d, J = 7.4 Hz, 2H), 7.33 (d, J 
= 7.4 Hz, 2H), 7.30 (d, J = 7.3 Hz, 4H), 7.22 (m, 4H), 7.06 (t, J = 7.5 Hz, 2H), 6.92 (t, J = 7.5 
Hz, 2H), 6.75 (m, 4H), 6.71 (d, J = 7.6 Hz, 2H), 5.89 (dd, J = 8.4, 2.7 Hz, 2H), 5.75 (dd, J = 
8.3, 2.4 Hz, 2H), 5.68 (m, 4H), 3.51 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 156.4, 148.4, 
148.1, 147.6, 147.3, 142.7, 142.0, 138.9, 137.8, 136.2, 133.3, 131.4, 129.8, 129.6, 128.9, 
128.8, 128.1, 127.34, 127.30, 127.2, 127.0, 126.9, 125.0, 124.4, 124.0, 123.8, 121.3, 120.2, 
119.5, 111.5, 111.1, 66.9, 54.9; IR (KBr) νmax 3052, 3052, 2832, 1611, 1516, 1448, 1364, 
1285, 1244, 1175, 1107, 1035, 815, 739 cm-1; HRMS (m/z) for C66H43O2 (M + H) calcd: 
867.32576, found: 867.32593; Rf (2/1 hexanes/EtOAc) = 0.52 (silica gel plate). 
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8',9'-Diphenyldispiro[fluorene-9,7'-benzo[c]benzo[6,7]indeno[1,2-g]fluorene-10',9''-
fluorene] (41b). With 40b (53 mg, 0.1 mmol) following the general 
procedure E. Column chromatography of the residue on silica gel (5/1/1 
hexanes/EtOAc/CH2Cl2) provided 61 mg (76%) of the title compound as 
a slight orange solid: mp (decomp) >260 °C; 1H NMR (400 MHz, 
CDCl3) δ 7.87 (dd, J = 8.5, 0.5 Hz, 2H), 7.80 (d, J = 8.0 Hz, 2H), 7.63 
(d, J = 8.3 Hz, 2H), 7.44 (m, 2H), 7.30-7.34 (m, 4H), 7.20-7.24 (m, 6H), 7.04 (dt, J = 7.5, 1.0 
Hz, 2H), 6.91 (dt, J = 7.6, 1.1 Hz, 2H), 6.67-6.77 (m, 6H), 6.48 (m, 2H), 6.33 (m, 2H), 6.17 
(m, 2H), 5.76 (dt, J = 6.9, 1.2 Hz, 4H); 13C NMR (100 MHz, CDCl3) δ 148.5, 148.0, 147.5, 
146.7, 146.6, 142.7, 141.9, 138.8, 137.7, 136.4, 135.9, 133.4, 130.3, 129.64, 129.61, 129.0, 
128.9, 128.1, 127.4, 127.3, 127.0, 126.9, 125.6, 125.3, 125.1, 124.5, 124.4, 124.0, 123.8, 
121.3, 120.2, 119.9, 119.6, 67.8.; IR (KBr) νmax 3049, 3018, 2956, 2922, 2853, 1602, 1515, 
1446, 1280, 1239, 1215, 1177, 1149, 1032, 810, 741, 696 cm-1; HRMS (m/z) for C64H39 (M + 
H) calcd: 807.30463, found: 807.30471; Rf (2/1 hexanes/EtOAc) = 0.56 (silica gel plate). 
 
8',9'-Bis(4-(trifluoromethyl)phenyl)dispiro[fluorene-9,7'-benzo[c]benzo[6,7]indeno[1,2-
g]-fluorene-10',9''-fluorene] (41c). With 40c (67 mg, 0.1 mmol) 
following the general procedure E. Column chromatography of the 
residue on silica gel (5/1/1 hexanes/EtOAc/CH2Cl2) provided 74 mg 
(79%) of the title compound as a slight orange solid: mp (decomp) >260 
°C; 1H NMR (400 MHz, CDCl3) δ 7.84 (dd, J = 8.4, 4.6 Hz, 4H), 7.68 
(d, J = 8.3 Hz, 2H), 7.45 (d, J = 7.6 Hz, 2H), 7.36 (dt, J = 7.5, 1.0 Hz, 
2H), 7.30 (d, J = 7.3 Hz, 2H), 7.21-7.28 (m, 6H), 7.09 (dt, J = 7.5, 0.7 Hz, 2H), 6.93 (dt, J = 
7.5, 0.7 Hz, 2H), 6.76 (m, 4H), 6.70 (d, J = 7.6 Hz, 2H), 6.61 (d, J = 7.7 Hz, 2H), 6.45 (d, J = 
7.9 Hz, 2H), 5.90 (t, J = 7.2 Hz, 4H); 13C NMR (100 MHz, CDCl3) δ 148.2, 147.3, 146.9, 
146.8, 142.6, 141.8, 139.3, 138.4, 137.0, 135.4, 133.4, 130.4, 129.7, 129.5, 129.1, 128.9, 
128.2, 128.1, 127.8, 127.5, 127.4, 127.2, 127.1, 127.0, 126.8, 125.3, 125.2, 124.6, 124.0, 
123.9, 122.6 (q, 2JC-F = 3.4 Hz), 121.2, 120.4, 119.8, 66.6; IR (KBr) νmax 3056, 2922, 2866, 
1619, 1446, 1405, 1325, 1246, 1166, 1125, 1079, 1018, 810, 738 cm-1; HRMS (m/z) for 
C66H37F6 (M + H) calcd: 943.27940, found: 943.27954; Rf (2/1 hexanes/EtOAc) = 0.58 (silica 
gel plate).  
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6.3.4.  X-ray analysis of dispiroindeno[2,1-c]fluorenes 
 
 Crystallographic data was collected on Bruker D8 VENTURE Kappa Duo 
PHOTON100 by IµS  micro-focus sealed tube at a temperature 150 K. The structures were 
solved by direct methods (XP) and refined by full matrix least squares based on F2 
(SHELXL2014).69 The hydrogen atoms on carbons were fixed into idealised positions (riding 
model) and assigned temperature factors either Hiso(H) = 1.2 Ueq(pivot atom) or 1.5 for methyl 
moiety. PLATON/ SQUEEZE (Spek, A. L., Acta Crystallographica Section D-Biological 
Crystallography 2009, 65, 148) procedure was used to correct the diffraction data of 41 for 
the presence of the disordered solvents. 
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Table Exp9. X-ray crystallographic data for indenofluorenes 23b, 40a, and 41a 
 23b  40a 41a 
Formula C58H38 C42H26O2 C66H42O2 
M.w. 734.88 594.63 866.99 
λ [Å] 0.71073 0.71073 1.54178 
Crystal system monoclinic triclinic orthorhombic 
Space group [No.] P21/n (No. 14) P -1 (No. 2) Pna21 (No 33) 
a [Å] 13.4315(4) 9.7309(3) 16.3016(5) 
b [Å] 13.7634(3) 12.1645(4) 13.3191(4) 
c [Å] 20.9116(5) 14.1640(5) 21.3258 (6) 
a [°]  65.993(1)  
β [°] 98.4780(10) 86.855(1)  
γ [°]  86.512(1)  
Z 4 2 4 
V [Å3] 3823.54(17) 1527.91(9) 4630.3(2) 
Dx [g cm-3] 1.277 1.293 1.244 
Crystal size [mm] 0.09×0.20×0.19 0.09×0.27×0.28 0.03×0.17×0.52 
Crystal color, shape a colorless prism a red plate a colorless bar 
µ [mm-1] 0.072 0.082 0.567 
Tmin, Tmax 0.89, 0.99 0.96, 0.98 0.88, 0.98 
Measured reflections 41342 33305 41883 
Independent diffract. (Rint a) 7545 (0.034) 7039 (0.024) 8955 (0.029) 
Observed diffract. [I>2σ(I)] 6313 6085 8711 
No. of parameters 525 417 615 
Rb 0.044 0.041 0.029 
wR(F2) 
 
 for all data 0.120 0.111 0.071 
GOFc 1.04 1.03 1.05 
Residual electron density 
[e/Å3] 
0.41, -0.24 0.27, -0.31 0.25, -0.18 
CCDC no. 1548067 1548069 1548068 
a Rint = Σ│Fo2 - Fo,mean2│/ ΣFo2    
b
 R(F) = Σ ││Fo│ - │Fc││/Σ│Fo│, wR(F2) = [Σ (w(Fo2 - Fc2)2)/( Σw(Fo2)2)]½.   c GOF = 
[Σ(w(Fo2 - Fc2)2)/(Ndiffrs - Nparams)]½ 
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Figure Exp14. Platon plot of 23b showing displacement ellipsoids at a 50% probability level 
 
Figure Exp15. PLATON drawing of 40a showing displacement ellipsoids on the 50% 
probability level 
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Figure Exp16. PLATON drawing of 41a showing displacement ellipsoids on the 50% 
probability level 
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6.3.5.  Photophysical analysis of dispiroindeno[2,1-c]fluorenes 
 
Chemicals. 
9,10-Diphenylanthracene (DPA) was purchased from Sigma-Aldrich. 
 
 The UV/Vis absorption spectra were recorded using Unicam 340 spectrometer. 
Corrected steady-state emission spectra were recorded on an Aminco Bowman (AB2) 
spectrometer.  
 Quantum yields of fluorescence of a sample (Φs) were calculated relative to DPA (Φref 
= 0.97 in cyclohexane) as a reference. Φs was determined according to the following 
equation:70 
Φs = Φref × As / Aref          (1) 
where As and Aref represent integrated areas of the emission (in arbitrary units) of a sample 
and the reference, respectively.  
 Micromolar solutions of the reference (DPA) and the samples were prepared in 
cyclohexane. The absorption of the reference and the samples were the same at the selected 
excitation wavelength (A ≤ 0.1). Quantum yields were calculated from 5 independent 
measurments. The average value is reported. 
The emission quantum yields (Φs) of the derivatives were determined in cyclohexane 
by standard procedures with DPA as reference (see Figures Exp17-19 and Tables Exp10-12).  
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UV/Vis absorption and emission spectra of 23a-i.  
 
 
Figure Exp17. Absorption spectra of 10-6 M DPA and 23a-i in cyclohexane (left). 
Normalized and corrected emission spectra of 10-6 M samples in cyclohexane. Excitation λ = 
264-271 nm (right).  
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Table Exp10. Photophysical properties of 23a-i derivatives in cyclohexane 
Sample λabs/nm (ε /105 mol-1 dm3 cm-1) λexc /nm  λem /nm Φsa 
23a 213 (0.2), 240 (sh), 265 (0.1), 612 (0.08) 264 370, 380 0.31 
23b 207 (0.1), 240 (sh), 267 (0.07), 312 (0.05) 266 366 0.09 
23c 225 (0.1), 239 (sh), 266 (0.07), 311 (0.05) 266 366 0.67 
23d 217 (0.1), 223 (sh), 266 (0.05), 312 (0.04) 269 365 0.33 
23e 226 (0.07), 239 (sh), 268 (0.04), 311 (0.03) 269 364 0.70 
23f 226 (0.07), 238 (sh), 268 (0.03), 312 (0.02) 271 366, 380 0.20 
23g 237 (0.09), 258 (sh), 277 (sh), 311 (0.05) 269 351, 359 0.63 
23h 214 (0.2), 231 (sh), 282 (sh), 296 (0.1) 266 - 0.00 
23i 217 (0.4), 242 (sh), 268 (0.1), 312 (0.09) 264 369 0.28 
a
 Quantum yields were calculated relative to DPA (Φr = 0.97). 
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UV/Vis absorption and emission spectra of 29 and 34.  
 
 
Figure Exp18. Absorption spectra of 10-6 M DPA, 29 and 34 in cyclohexane (left). 
Normalized and corrected emission spectra of 10-6 M samples in cyclohexane. Excitation λ = 
268-272 nm (right). 
 
Table Exp11. Photophysical properties of 29 and 34 in cyclohexane 
Sample λabs/nm (ε /105 mol-1 dm3 cm-1) λexc /nm  λem /nm Φsa 
29 227 (0.05), 238 (sh), 266 (sh), 312 (0.03) 272 370 0.54 
34 225 (0.09), 236 (sh), 274 (0.06), 311 (0.04) 268 389 0.60 
a
 Quantum yields were calculated relative to DPA (Φr = 0.97). 
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UV/Vis absorption and emission spectra of 41a-c.  
 
Figure Exp19. Absorption spectra of 10-6 M DPA and samples 41a-c in cyclohexane (left). 
Normalized and corrected emission spectra of 10-6 M samples in cyclohexane. Excitation λ = 
266-269 nm (right).  
 
Table Exp12. Photophysical properties of 41a-c derivatives in cyclohexane 
Sample λabs/nm (ε /105 mol-1 dm3 cm-1) λexc /nm  λem /nm Φsa 
41a 217 (0.1), 240 (sh), 315 (0.02) 269 418, 428 0.75 
41b 217 (0.09), 225 (sh), 245 (0.09), 314 (0.02) 269 398, 419 0.87 
41c 229 (sh), 242 (0.1), 314 (0.03) 269 408,423 0.88 
a
 Quantum yields were calculated relative to DPA (Φr = 0.97). 
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8. Abstrakt 
 Disertační práce je rozdělena do dvou částí zabývajících se syntézou a analýzou 
strukturně příbuzných (i) 9,9´-spirobifluorenů (SBFs) a (ii) dispiroindeno[2,1-c]fluorenů (DS-
IFs). 
 Disertační práce je rozdělena do dvou částí zaměřených na syntézu a fotofyzikální 
analýzu dvou skupin strukturně příbuzných látek: (i) 9,9´-spirobifluorenů (SBFs) a (ii) 
dispiroindeno[2,1-c]fluorenů (DS-IFs). 
 (i) V první části byla vyvinuta nová pětikroková syntéza SBFs, kde klíčovým krokem 
byla Rh-komplexy katalyzovaná [2+2+2] cyklotrimerizace symetricky či nesymetricky 
substituovaných diyn alkoholů s alkyny. Optimalizací této reakce (katalyzátor, teplota, čas, 
rozpouštědlo atd.) byly nalezeny ideální podmínky pro přípravu 1,2,3,4-substituovaných 
fluorenolů (klíčové intermediáty) a jako nejefektivnější se ukázal být Wilkinsonův katalyzátor 
(RhCl(PPh3)3). Tyto různě substituované fluorenoly byly následně ve dvou krocích převedeny 
na 19 nových SBFs, u kterých byl zkoumán vliv substituentu (elektronakceptorní, 
elektrondonorní) v poloze 4 na jejich spektroskopické vlastnosti. Získaná data ukazují emisní 
maxima λem v rozsahu 315 až 389 nm s excelentními kvantovými výtěžky Φs (až 1). 
(ii) V druhé části byla tato nová metoda pro přípravu SBFs aplikována na přípravu 
DS-IFs. Rh-katalyzovaná [2+2+2] cyklotrimerizace triyndiolů poskytla indeno[2,1-
c]fluorendioly ve vysokých výtěžcích. Tyto byly opět ve dvou krocích převedeny na 
odpovídající DS-IFs. Celkem bylo připraveno 9 symetricky substituovaných DS-IFs (pozice 6 
a 7) a 2 nesymetricky substituované DS-IFs (pozice 3 a 10). Pro potvrzení syntetického 
potenciálu této reakční sekvence byly připraveny také 3 [7]helikální DS-IFs. Spektroskopická 
analýza všech produktů poskytla emisní maxima v rozsahu 351 až 428 nm s excelentními 
kvantovými výtěžky Φs (až 0.8). [7]helikální DS-IFs mají navíc nejvyšší dosud naměřené 
hodnoty kvantových výtěžků Φs pro tento tip látek. 
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9. Abstract 
 
This work is divided into two parts that are focused on the synthesis and assessment of 
photophysical properties of two structurally related compounds: (i) 9,9´-spirobifluorenes 
(SBFs) and (ii) dispiroindeno[2,1-c]fluorenes (DS-IFs).  
(i) In the first part, a five-step synthetic approach to SBFs was developed and as the 
crucial step was used an intermolecular [2+2+2] cyclotrimerization of symmetrically or 
unsymmetrically substituted diynols with alkynes catalyzed by Rh-complexes. Catalyst 
screening showed that Wilkinson’s catalyst (RhCl(PPh3)3) had the highest efficiency in 
yielding 1,2,3,4-substituted fluorenols – the key intermediates. The fluorenols were then 
converted into SBFs bearing various electron-donating and -withdrawing groups, aromatic 
substituents, and π-extended aromatic hydrocarbon moieties (PAHs). Altogether 19 different 
SBFs were prepared and their photophysical properties screened. The fluorescent emission 
maxima λem were in the range of 315-389 nm with excellent quantum yields Φs (up to 1.00). 
As far as the substituent effect is concerned the presence of electron-withdrawing substituents 
on the SBF scaffold results in the red-shift of the emission maxima.  
(ii) In the second part, a similar synthetic strategy was applied for synthesis DS-IFs. In 
this instance was utilized again the Rh-complex catalyzed intramolecular [2+2+2] 
cyclotrimerization of triyndiols, which provided indeno[2,1-c]fluorenr-5,8-diols in high 
yields. These were then converted into the corresponding DS-IFs. In total, 9 symmetrically 
substituted DS-IFs at positions 6 and 7 and 2 unsymmetrically substituted DS-IFs at positions 
3 and 10 were synthesized. Furthermore, to demonstrate the potential of this synthetic 
approach, three [7]-helical DS-IFs were prepared. Photophysical properties of all compounds 
were evaluated as well. Their fluorescent emission maxima λem were in the range of 351-428 
nm with excellent quantum yields Φs (up to 0.80). [7]-helical DS-IFs have the highest 
measured quantum yields among the class of helicene like compounds recorded thus far.  
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10. List of Abbreviations 
 
DMAP  N,N'-Dimethylamino pyridine 
DMA   N,N'-Dimethylacetamide 
DMF   N,N'-Dimethylformamide 
DPA    9,10-Diphenylanthracene 
Et   Ethyl 
eq   Equivalent 
Fc   Ferrocenyl 
h   Hour 
HRMS   High Resolution Mass Spectroscopy 
Hz   Hertz 
IR   Infrared Spectroscopy 
J   Coupling constant 
LDA   Lithium diisopropylamide 
Me   Methyl 
mp   Melting Point 
MS   Molecular sieve 
NMR   Nuclear Magnetic Resonance 
p-Tol   para-Tolyl 
PCC   Pyridinium chlorochromate 
PEPPSITM   Pyridine–enhanced precatalyst preparation stabilization and initiation 
([1,3-Bis(2,6-Diisopropylphenyl)imidazol-2-ylidene](3-chloropyridyl) 
palladium(II) dichloride) 
Ph   Phenyl 
ppm   Parts per million 
n-Pr   n-Propyl 
THF   Tetrahydrofuran 
TLC   Thin layer chromatography 
UV   Ultraviolet  
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